{"PMC7087308": [["IntroductionThe etiology of SARS (severe acute respiratory syndrome) is associated with a newly discovered coronavirus, SARS-associated coronavirus (SARS-CoV) [24, 28, 30].", [["SARS", "DISEASE", 28, 32], ["acute respiratory syndrome", "DISEASE", 41, 67], ["coronavirus", "DISEASE", 107, 118], ["SARS-associated coronavirus", "DISEASE", 120, 147], ["SARS", "DISEASE", 149, 153], ["coronavirus", "ORGANISM", 107, 118], ["SARS-associated coronavirus", "ORGANISM", 120, 147], ["SARS-CoV", "ORGANISM", 149, 157], ["SARS-CoV", "SPECIES", 149, 157], ["SARS (severe acute respiratory syndrome", "PROBLEM", 28, 67], ["a newly discovered coronavirus", "PROBLEM", 88, 118], ["SARS", "PROBLEM", 120, 124], ["coronavirus", "PROBLEM", 136, 147], ["SARS", "OBSERVATION", 28, 32], ["severe", "OBSERVATION_MODIFIER", 34, 40], ["acute", "OBSERVATION_MODIFIER", 41, 46], ["respiratory syndrome", "OBSERVATION", 47, 67], ["coronavirus", "OBSERVATION", 107, 118]]], ["SARS-CoV is of animal origin, and its precursor is still present in animal populations [8].", [["SARS", "DISEASE", 0, 4], ["SARS-CoV", "ORGANISM", 0, 8], ["SARS-CoV", "SPECIES", 0, 8], ["SARS", "PROBLEM", 0, 4], ["CoV", "OBSERVATION_MODIFIER", 5, 8], ["animal origin", "OBSERVATION_MODIFIER", 15, 28]]], ["To date, no specific treatment exists to treat infection with this virus [48].", [["infection", "DISEASE", 47, 56], ["specific treatment", "TREATMENT", 12, 30], ["infection", "PROBLEM", 47, 56], ["this virus", "PROBLEM", 62, 72]]], ["SARS-CoV is only distantly related to members of the other coronavirus clades [18, 24].", [["SARS", "DISEASE", 0, 4], ["SARS-CoV", "ORGANISM", 0, 8], ["coronavirus", "ORGANISM", 59, 70], ["SARS-CoV", "SPECIES", 0, 8]]], ["Coronaviruses are exceptionally large RNA viruses that employ complex regulatory mechanisms to express their genomes [18, 31].", [["Coronaviruses", "GENE_OR_GENE_PRODUCT", 0, 13], ["Coronaviruses", "PROBLEM", 0, 13], ["exceptionally large RNA viruses", "PROBLEM", 18, 49], ["large", "OBSERVATION_MODIFIER", 32, 37], ["RNA viruses", "OBSERVATION", 38, 49]]], ["The genomic structure, gene expression pattern and protein profiles of SARS-CoV are similar to those of other coronaviruses.", [["SARS", "DISEASE", 71, 75], ["SARS-CoV", "ORGANISM", 71, 79], ["coronaviruses", "ORGANISM", 110, 123], ["SARS-CoV", "SPECIES", 71, 79], ["gene expression pattern", "TEST", 23, 46], ["protein profiles", "TEST", 51, 67], ["SARS-CoV", "PROBLEM", 71, 79], ["other coronaviruses", "PROBLEM", 104, 123], ["genomic structure", "OBSERVATION", 4, 21], ["expression", "OBSERVATION_MODIFIER", 28, 38], ["pattern", "OBSERVATION_MODIFIER", 39, 46], ["coronaviruses", "OBSERVATION", 110, 123]]], ["There are fourteen potential open reading frames (ORF) in the genome of SARS-CoV.", [["SARS", "DISEASE", 72, 76], ["SARS-CoV", "ORGANISM", 72, 80], ["open reading frames", "DNA", 29, 48], ["ORF", "DNA", 50, 53], ["SARS-CoV", "SPECIES", 72, 80]]], ["Nine SARS-CoV-specific mRNAs have been shown to be synthesized in virus-infected cells.", [["cells", "ANATOMY", 81, 86], ["CoV", "ORGANISM", 10, 13], ["cells", "CELL", 81, 86], ["SARS-CoV-specific mRNAs", "RNA", 5, 28], ["virus-infected cells", "CELL_TYPE", 66, 86], ["SARS-CoV", "SPECIES", 5, 13], ["Nine SARS", "TEST", 0, 9], ["specific mRNAs", "PROBLEM", 14, 28], ["infected cells", "PROBLEM", 72, 86], ["infected cells", "OBSERVATION", 72, 86]]], ["These RNAs are predicted to encode four structural proteins (spike, membrane, envelope, and nucleocapsid [N] proteins), sixteen non-structural proteins and eight accessory proteins [31, 36].", [["membrane", "ANATOMY", 68, 76], ["membrane", "CELLULAR_COMPONENT", 68, 76], ["nucleocapsid [N] proteins", "GENE_OR_GENE_PRODUCT", 92, 117], ["structural proteins", "PROTEIN", 40, 59], ["spike, membrane, envelope, and nucleocapsid [N] proteins", "PROTEIN", 61, 117], ["non-structural proteins", "PROTEIN", 128, 151], ["accessory proteins", "PROTEIN", 162, 180], ["nucleocapsid [N] proteins", "TEST", 92, 117], ["sixteen non-structural proteins", "TEST", 120, 151], ["eight accessory proteins", "TEST", 156, 180]]], ["As a structural protein, SARS-CoV N protein has been demonstrated to interact with itself and other structural proteins [16, 21, 34, 50].", [["SARS-CoV N", "GENE_OR_GENE_PRODUCT", 25, 35], ["structural protein", "PROTEIN", 5, 23], ["SARS-CoV N protein", "PROTEIN", 25, 43], ["structural proteins", "PROTEIN", 100, 119], ["SARS-CoV", "SPECIES", 25, 33], ["a structural protein", "TEST", 3, 23], ["SARS", "PROBLEM", 25, 29], ["CoV N protein", "TREATMENT", 30, 43], ["other structural proteins", "TEST", 94, 119]]], ["SARS-CoV M and E proteins are also able to interact with each other and other structural proteins [1, 5, 16].IntroductionThe pathogenesis of SARS-CoV remains largely unknown [40].", [["SARS", "DISEASE", 0, 4], ["SARS-CoV", "DISEASE", 141, 149], ["SARS-CoV M", "GENE_OR_GENE_PRODUCT", 0, 10], ["E proteins", "GENE_OR_GENE_PRODUCT", 15, 25], ["SARS-CoV", "GENE_OR_GENE_PRODUCT", 141, 149], ["SARS-CoV M and E proteins", "PROTEIN", 0, 25], ["structural proteins", "PROTEIN", 78, 97], ["SARS-CoV", "SPECIES", 0, 8], ["SARS-CoV", "SPECIES", 141, 149], ["SARS", "PROBLEM", 141, 145]]], ["SARS-CoV E protein is thought to interact with PALS1 and alter tight junction formation and epithelial morphogenesis [37].", [["tight junction", "ANATOMY", 63, 77], ["epithelial", "ANATOMY", 92, 102], ["SARS-CoV E", "GENE_OR_GENE_PRODUCT", 0, 10], ["PALS1", "GENE_OR_GENE_PRODUCT", 47, 52], ["tight junction", "CELLULAR_COMPONENT", 63, 77], ["epithelial", "TISSUE", 92, 102], ["SARS-CoV E protein", "PROTEIN", 0, 18], ["PALS1", "PROTEIN", 47, 52], ["SARS-CoV", "SPECIES", 0, 8], ["CoV E protein", "TEST", 5, 18], ["PALS1", "TREATMENT", 47, 52], ["epithelial morphogenesis", "PROBLEM", 92, 116], ["tight junction", "ANATOMY", 63, 77], ["epithelial", "ANATOMY_MODIFIER", 92, 102]]], ["The N protein of murine hepatitis virus type 3, another member of the family Coronaviridae, is known to cause fulminant hepatitis [26].", [["hepatitis virus", "DISEASE", 24, 39], ["fulminant hepatitis", "DISEASE", 110, 129], ["murine hepatitis virus type 3", "ORGANISM", 17, 46], ["Coronaviridae", "GENE_OR_GENE_PRODUCT", 77, 90], ["N protein", "PROTEIN", 4, 13], ["murine hepatitis virus", "SPECIES", 17, 39], ["murine hepatitis virus type 3", "SPECIES", 17, 46], ["The N protein", "TEST", 0, 13], ["murine hepatitis virus type", "PROBLEM", 17, 44], ["fulminant hepatitis", "PROBLEM", 110, 129], ["fulminant", "OBSERVATION_MODIFIER", 110, 119], ["hepatitis", "OBSERVATION", 120, 129]]], ["SARS-CoV N protein has multiple activities [35].", [["SARS", "DISEASE", 0, 4], ["SARS-CoV", "GENE_OR_GENE_PRODUCT", 0, 8], ["SARS-CoV N protein", "PROTEIN", 0, 18], ["SARS-CoV", "SPECIES", 0, 8]]], ["In addition to its role as a structural protein that packages the viral genome, the SARS-CoV N protein has also been demonstrated to interact with cellular proteins, and it also performs regulatory functions [14, 33, 41, 42, 51\u201354].", [["cellular", "ANATOMY", 147, 155], ["SARS-CoV N", "GENE_OR_GENE_PRODUCT", 84, 94], ["cellular", "CELL", 147, 155], ["structural protein", "PROTEIN", 29, 47], ["viral genome", "DNA", 66, 78], ["SARS-CoV N protein", "PROTEIN", 84, 102], ["cellular proteins", "PROTEIN", 147, 164], ["SARS-CoV", "SPECIES", 84, 92], ["the viral genome", "PROBLEM", 62, 78], ["the SARS", "TEST", 80, 88], ["CoV N protein", "TREATMENT", 89, 102], ["cellular proteins", "TEST", 147, 164], ["viral genome", "OBSERVATION", 66, 78]]], ["To study the function of the SARS-CoV N protein, a yeast two-hybrid screening experiment was conducted to identify cellular proteins that may interact with the SARS-CoV N protein.", [["cellular", "ANATOMY", 115, 123], ["SARS-CoV", "GENE_OR_GENE_PRODUCT", 29, 37], ["cellular", "CELL", 115, 123], ["SARS-CoV N", "GENE_OR_GENE_PRODUCT", 160, 170], ["SARS-CoV N protein", "PROTEIN", 29, 47], ["cellular proteins", "PROTEIN", 115, 132], ["SARS-CoV N protein", "PROTEIN", 160, 178], ["yeast", "SPECIES", 51, 56], ["SARS-CoV", "SPECIES", 29, 37], ["yeast", "SPECIES", 51, 56], ["SARS-CoV", "SPECIES", 160, 168], ["the SARS", "TEST", 25, 33], ["CoV N protein", "TEST", 34, 47], ["a yeast two-hybrid screening experiment", "PROBLEM", 49, 88], ["cellular proteins", "PROBLEM", 115, 132]]], ["Although the lungs and immune system are the organs that sustain the most severe damage during SARS-CoV infection, the tissue tropism of this virus includes not only the lung but also the gastrointestinal tract, kidney and liver [9, 12, 13, 40].", [["lungs", "ANATOMY", 13, 18], ["immune system", "ANATOMY", 23, 36], ["organs", "ANATOMY", 45, 51], ["tissue", "ANATOMY", 119, 125], ["lung", "ANATOMY", 170, 174], ["gastrointestinal tract", "ANATOMY", 188, 210], ["kidney", "ANATOMY", 212, 218], ["liver", "ANATOMY", 223, 228], ["SARS-CoV infection", "DISEASE", 95, 113], ["lungs", "ORGAN", 13, 18], ["immune system", "ANATOMICAL_SYSTEM", 23, 36], ["organs", "ORGAN", 45, 51], ["SARS-CoV", "ORGANISM", 95, 103], ["tissue", "TISSUE", 119, 125], ["lung", "ORGAN", 170, 174], ["gastrointestinal tract", "ORGAN", 188, 210], ["kidney", "ORGAN", 212, 218], ["liver", "ORGAN", 223, 228], ["SARS-CoV", "SPECIES", 95, 103], ["the most severe damage", "PROBLEM", 65, 87], ["SARS", "PROBLEM", 95, 99], ["CoV infection", "PROBLEM", 100, 113], ["this virus", "PROBLEM", 137, 147], ["lungs", "ANATOMY", 13, 18], ["immune system", "OBSERVATION", 23, 36], ["organs", "ANATOMY", 45, 51], ["most", "OBSERVATION_MODIFIER", 69, 73], ["severe", "OBSERVATION_MODIFIER", 74, 80], ["damage", "OBSERVATION", 81, 87], ["CoV", "OBSERVATION_MODIFIER", 100, 103], ["infection", "OBSERVATION", 104, 113], ["tissue tropism", "OBSERVATION", 119, 133], ["virus", "OBSERVATION", 142, 147], ["lung", "ANATOMY", 170, 174], ["gastrointestinal tract", "ANATOMY", 188, 210], ["kidney", "ANATOMY", 212, 218], ["liver", "ANATOMY", 223, 228]]], ["Liver tissues of SARS autopsies have shown hepatocyte mitoses, balloon degeneration of hepatocytes, lymphocytic infiltrates, fatty degeneration, or central lobular necrosis [4, 7, 12, 19, 32].", [["Liver tissues", "ANATOMY", 0, 13], ["hepatocyte", "ANATOMY", 43, 53], ["balloon", "ANATOMY", 63, 70], ["hepatocytes", "ANATOMY", 87, 98], ["lymphocytic infiltrates", "ANATOMY", 100, 123], ["lobular", "ANATOMY", 156, 163], ["SARS", "DISEASE", 17, 21], ["fatty degeneration", "DISEASE", 125, 143], ["necrosis", "DISEASE", 164, 172], ["Liver tissues", "TISSUE", 0, 13], ["hepatocyte", "CELL", 43, 53], ["hepatocytes", "CELL", 87, 98], ["lymphocytic infiltrates", "PATHOLOGICAL_FORMATION", 100, 123], ["fatty", "TISSUE", 125, 130], ["hepatocytes", "CELL_TYPE", 87, 98], ["SARS autopsies", "TEST", 17, 31], ["hepatocyte mitoses", "PROBLEM", 43, 61], ["balloon degeneration of hepatocytes", "PROBLEM", 63, 98], ["lymphocytic infiltrates", "PROBLEM", 100, 123], ["fatty degeneration", "PROBLEM", 125, 143], ["central lobular necrosis", "PROBLEM", 148, 172], ["hepatocyte mitoses", "OBSERVATION", 43, 61], ["balloon degeneration", "OBSERVATION", 63, 83], ["hepatocytes", "ANATOMY", 87, 98], ["lymphocytic infiltrates", "OBSERVATION", 100, 123], ["fatty degeneration", "OBSERVATION", 125, 143], ["central", "OBSERVATION_MODIFIER", 148, 155], ["lobular", "OBSERVATION_MODIFIER", 156, 163], ["necrosis", "OBSERVATION", 164, 172]]], ["Abnormal liver function (e.g., elevated serum aminotransferase levels) is often found in SARS patients [6, 43, 47].", [["liver", "ANATOMY", 9, 14], ["serum", "ANATOMY", 40, 45], ["SARS", "DISEASE", 89, 93], ["liver", "ORGAN", 9, 14], ["serum", "ORGANISM_SUBSTANCE", 40, 45], ["aminotransferase", "SIMPLE_CHEMICAL", 46, 62], ["patients", "ORGANISM", 94, 102], ["patients", "SPECIES", 94, 102], ["Abnormal liver function", "PROBLEM", 0, 23], ["elevated serum aminotransferase levels", "PROBLEM", 31, 69], ["liver", "ANATOMY", 9, 14]]], ["Infection of SARS-CoV in liver has also been demonstrated in animals experimentally infected by this virus [11, 45].", [["liver", "ANATOMY", 25, 30], ["SARS", "DISEASE", 13, 17], ["SARS-CoV", "ORGANISM", 13, 21], ["liver", "ORGAN", 25, 30], ["SARS-CoV", "SPECIES", 13, 21], ["Infection of SARS", "PROBLEM", 0, 17], ["CoV in liver", "PROBLEM", 18, 30], ["SARS", "OBSERVATION", 13, 17], ["CoV", "OBSERVATION", 18, 21], ["liver", "ANATOMY", 25, 30], ["infected", "OBSERVATION_MODIFIER", 84, 92]]], ["Hepatoma cell lines could also be infected by pseudotype viruses with SARS-CoV S proteins [15].", [["Hepatoma cell lines", "ANATOMY", 0, 19], ["Hepatoma cell lines", "CELL", 0, 19], ["SARS-CoV S proteins", "GENE_OR_GENE_PRODUCT", 70, 89], ["Hepatoma cell lines", "CELL_LINE", 0, 19], ["SARS-CoV S proteins", "PROTEIN", 70, 89], ["SARS-CoV", "SPECIES", 70, 78], ["Hepatoma cell lines", "PROBLEM", 0, 19], ["pseudotype viruses", "PROBLEM", 46, 64], ["SARS", "PROBLEM", 70, 74], ["CoV S proteins", "TEST", 75, 89], ["cell lines", "OBSERVATION", 9, 19], ["could also be", "UNCERTAINTY", 20, 33], ["infected", "OBSERVATION_MODIFIER", 34, 42], ["pseudotype viruses", "OBSERVATION", 46, 64]]], ["Therefore, the cDNA library used for the yeast two-hybrid screening in this study was derived from liver, a target organ of SARS-CoV [2, 12, 27].Plasmid construction ::: Materials and methodsTo isolate the DNA fragment that contains the SARS-CoV N protein coding sequence, PCR reactions were performed using SARS-CoV cDNA [16, 20] as template and the oligomers 5\u2032 CGCGGATCCATGTCTGATAATGGACC 3\u2032 and 5\u2032 TGCTCTAGATTATGCCTGAGTTGAATC 3\u2032 as primers.", [["liver", "ANATOMY", 99, 104], ["organ", "ANATOMY", 115, 120], ["liver", "ORGAN", 99, 104], ["organ", "ORGAN", 115, 120], ["SARS-CoV", "GENE_OR_GENE_PRODUCT", 124, 132], ["DNA", "CELLULAR_COMPONENT", 206, 209], ["cDNA library", "DNA", 15, 27], ["DNA fragment", "DNA", 206, 218], ["SARS-CoV N protein coding sequence", "DNA", 237, 271], ["SARS-CoV cDNA", "DNA", 308, 321], ["yeast", "SPECIES", 41, 46], ["yeast", "SPECIES", 41, 46], ["SARS-CoV", "SPECIES", 124, 132], ["SARS-CoV", "SPECIES", 237, 245], ["SARS-CoV", "SPECIES", 308, 316], ["the cDNA library", "TEST", 11, 27], ["the yeast", "PROBLEM", 37, 46], ["hybrid screening", "TEST", 51, 67], ["this study", "TEST", 71, 81], ["the DNA fragment", "PROBLEM", 202, 218], ["the SARS", "PROBLEM", 233, 241], ["CoV N protein coding sequence", "TEST", 242, 271], ["PCR reactions", "TEST", 273, 286], ["SARS", "TEST", 308, 312], ["CoV cDNA", "TEST", 313, 321], ["TGCTCTAGATTATGCCTGAGTTGAATC", "TREATMENT", 401, 428], ["liver", "ANATOMY", 99, 104], ["DNA fragment", "OBSERVATION", 206, 218]]], ["After PCR, the DNA fragment was digested by the restriction enzymes BamHI and XbaI and inserted into the vectors pcDNA3 (Invitrogene, USA) and pcDNA3-myc [23], which had been linearized with BamHI and XbaI, for transient expression.", [["DNA", "CELLULAR_COMPONENT", 15, 18], ["BamHI", "GENE_OR_GENE_PRODUCT", 68, 73], ["XbaI", "GENE_OR_GENE_PRODUCT", 78, 82], ["pcDNA3", "GENE_OR_GENE_PRODUCT", 113, 119], ["Invitrogene", "GENE_OR_GENE_PRODUCT", 121, 132], ["USA", "GENE_OR_GENE_PRODUCT", 134, 137], ["pcDNA3-myc [23]", "GENE_OR_GENE_PRODUCT", 143, 158], ["BamHI", "GENE_OR_GENE_PRODUCT", 191, 196], ["XbaI", "GENE_OR_GENE_PRODUCT", 201, 205], ["DNA fragment", "DNA", 15, 27], ["restriction enzymes", "PROTEIN", 48, 67], ["BamHI", "PROTEIN", 68, 73], ["XbaI", "DNA", 78, 82], ["pcDNA3", "DNA", 113, 119], ["Invitrogene", "DNA", 121, 132], ["USA", "DNA", 134, 137], ["pcDNA3", "DNA", 143, 149], ["myc [23]", "DNA", 150, 158], ["BamHI", "DNA", 191, 196], ["XbaI", "DNA", 201, 205], ["PCR", "TEST", 6, 9], ["the DNA fragment", "PROBLEM", 11, 27], ["BamHI and XbaI", "TREATMENT", 68, 82], ["the vectors pcDNA3", "TREATMENT", 101, 119], ["BamHI and XbaI", "TREATMENT", 191, 205], ["fragment", "OBSERVATION_MODIFIER", 19, 27]]], ["This SARS-CoV N DNA fragment was also amplified using the primers 5\u2032 CGGAATTCATGTCTGATAATGGACCC 3\u2032 and 5\u2032 TGCTCTAGATGCCTGAGTTGAATC 3\u2032, digested by treatment with the restriction enzymes EcoRI and XbaI, and inserted into the vector pcDNA3.1-V5-HisA (Invitrogen, USA), which had been linearized with EcoRI and XbaI, for stable expression.Plasmid construction ::: Materials and methodsTo clone the DNA fragment encoding the SARS-CoV N protein for yeast two-hybrid screening, the oligonucleotide primers 5\u2032 CGGAATTCATGTCTGATAATGGACCC 3\u2032 and 5\u2032 TTATTATGCCTGAGTTGAATC 3\u2032 were used to perform PCR.", [["DNA", "CELLULAR_COMPONENT", 16, 19], ["EcoRI", "GENE_OR_GENE_PRODUCT", 186, 191], ["XbaI", "GENE_OR_GENE_PRODUCT", 196, 200], ["pcDNA3.1", "GENE_OR_GENE_PRODUCT", 231, 239], ["Invitrogen, USA", "GENE_OR_GENE_PRODUCT", 249, 264], ["EcoRI", "GENE_OR_GENE_PRODUCT", 298, 303], ["XbaI", "GENE_OR_GENE_PRODUCT", 308, 312], ["clone", "CELL", 385, 390], ["DNA", "CELLULAR_COMPONENT", 395, 398], ["SARS-CoV N", "GENE_OR_GENE_PRODUCT", 421, 431], ["SARS-CoV N DNA fragment", "DNA", 5, 28], ["restriction enzymes", "PROTEIN", 166, 185], ["EcoRI", "PROTEIN", 186, 191], ["XbaI", "PROTEIN", 196, 200], ["pcDNA3.1", "DNA", 231, 239], ["V5", "DNA", 240, 242], ["HisA", "DNA", 243, 247], ["Invitrogen, USA", "DNA", 249, 264], ["EcoRI", "DNA", 298, 303], ["XbaI", "DNA", 308, 312], ["DNA fragment", "DNA", 395, 407], ["SARS-CoV N protein", "PROTEIN", 421, 439], ["yeast", "SPECIES", 444, 449], ["SARS-CoV", "SPECIES", 5, 13], ["SARS-CoV", "SPECIES", 421, 429], ["yeast", "SPECIES", 444, 449], ["This SARS", "PROBLEM", 0, 9], ["CoV N DNA fragment", "PROBLEM", 10, 28], ["the primers", "TREATMENT", 54, 65], ["the restriction enzymes EcoRI", "TREATMENT", 162, 191], ["XbaI", "TEST", 196, 200], ["EcoRI and XbaI", "TREATMENT", 298, 312], ["the DNA fragment", "PROBLEM", 391, 407], ["the SARS", "TEST", 417, 425], ["CoV N protein", "TEST", 426, 439], ["yeast", "TEST", 444, 449], ["hybrid screening", "TEST", 454, 470], ["the oligonucleotide primers", "TREATMENT", 472, 499], ["TTATTATGCCTGAGTTGAATC", "TREATMENT", 540, 561], ["PCR", "TEST", 586, 589], ["DNA fragment", "OBSERVATION", 16, 28]]], ["After PCR, the DNA fragment was treated with T4 polynucleotide kinase, digested by treatment with the restriction enzyme EcoRI, and cloned into the pBDGal4 Cam (Stratagene, USA) expression vector, which had been linearized with EcoRI and SmaI.", [["polynucleotide", "CHEMICAL", 48, 62], ["DNA", "CELLULAR_COMPONENT", 15, 18], ["T4 polynucleotide kinase", "GENE_OR_GENE_PRODUCT", 45, 69], ["EcoRI", "GENE_OR_GENE_PRODUCT", 121, 126], ["Cam", "GENE_OR_GENE_PRODUCT", 156, 159], ["Stratagene, USA", "GENE_OR_GENE_PRODUCT", 161, 176], ["EcoRI", "GENE_OR_GENE_PRODUCT", 228, 233], ["SmaI", "GENE_OR_GENE_PRODUCT", 238, 242], ["DNA fragment", "DNA", 15, 27], ["T4 polynucleotide kinase", "PROTEIN", 45, 69], ["restriction enzyme EcoRI", "DNA", 102, 126], ["pBDGal4 Cam (Stratagene, USA) expression vector", "DNA", 148, 195], ["EcoRI", "DNA", 228, 233], ["SmaI", "DNA", 238, 242], ["PCR", "TEST", 6, 9], ["the DNA fragment", "PROBLEM", 11, 27], ["T4 polynucleotide kinase", "TREATMENT", 45, 69], ["the restriction enzyme EcoRI", "TREATMENT", 98, 126], ["EcoRI and SmaI", "TREATMENT", 228, 242], ["fragment", "OBSERVATION_MODIFIER", 19, 27]]], ["The first 220 codons of this DNA fragment were cloned using the same forward primer and a different reverse primer (5\u2032 CTATTAGAGGGCAGTTTCACCACC 3\u2032).", [["DNA", "CELLULAR_COMPONENT", 29, 32], ["DNA fragment", "DNA", 29, 41], ["forward primer", "DNA", 69, 83], ["reverse primer", "DNA", 100, 114], ["this DNA fragment", "PROBLEM", 24, 41], ["a different reverse primer", "TREATMENT", 88, 114]]], ["The same reverse primer and another forward primer (5\u2032 CGGAATTCGCGCTATTGCTGCTAGA 3\u2032) were used to clone the DNA fragment without the first 220 codons.Plasmid construction ::: Materials and methodsTo clone the full-length pyruvate kinase (liver) DNA fragment (Gene ID: 5313; gi: 19343992) for yeast two-hybrid screening, PCR was performed using the oligomers 5\u2032 CCGAATTCGCATGTCGATCCAGGAGAA 3\u2032 and 5\u2032 CCGCTCGAGTCAGGATATGCTTAGCAC 3\u2032 as primers and the cDNA library from HuH7 cells as template.", [["liver", "ANATOMY", 238, 243], ["HuH7 cells", "ANATOMY", 467, 477], ["pyruvate", "CHEMICAL", 221, 229], ["pyruvate", "CHEMICAL", 221, 229], ["DNA", "CELLULAR_COMPONENT", 108, 111], ["clone", "CELL", 199, 204], ["pyruvate kinase", "GENE_OR_GENE_PRODUCT", 221, 236], ["liver", "ORGAN", 238, 243], ["DNA", "CELLULAR_COMPONENT", 245, 248], ["HuH7 cells", "CELL", 467, 477], ["reverse primer", "DNA", 9, 23], ["forward primer", "DNA", 36, 50], ["DNA fragment", "DNA", 108, 120], ["full-length pyruvate kinase (liver) DNA fragment", "DNA", 209, 257], ["CCGCTCGAGTCAGGATATGCTTAGCAC 3\u2032", "DNA", 399, 429], ["cDNA library", "DNA", 449, 461], ["HuH7 cells", "CELL_LINE", 467, 477], ["yeast", "SPECIES", 292, 297], ["yeast", "SPECIES", 292, 297], ["another forward primer", "TEST", 28, 50], ["5\u2032 CGGAATTCGCGCTATTGCTGCTAGA 3\u2032)", "TREATMENT", 52, 84], ["yeast", "PROBLEM", 292, 297], ["hybrid screening", "TEST", 302, 318], ["PCR", "TEST", 320, 323], ["CCGAATTCGCATGTCGATCCAGGAGAA", "TEST", 361, 388], ["CCGCTCGAGTCAGGATATGCTTAGCAC", "TREATMENT", 399, 426], ["the cDNA library", "TREATMENT", 445, 461], ["HuH7 cells", "TREATMENT", 467, 477], ["reverse primer", "OBSERVATION", 9, 23], ["DNA fragment", "OBSERVATION", 108, 120], ["liver", "ANATOMY", 238, 243], ["HuH7 cells", "OBSERVATION", 467, 477]]], ["After PCR, the DNA fragment was digested using the restriction enzymes EcoRI and XhoI and cloned into the pACT2 (Clontech, USA) expression vector (linearized by EcoRI/XhoI).", [["DNA", "CELLULAR_COMPONENT", 15, 18], ["EcoRI", "GENE_OR_GENE_PRODUCT", 71, 76], ["XhoI", "GENE_OR_GENE_PRODUCT", 81, 85], ["Clontech", "GENE_OR_GENE_PRODUCT", 113, 121], ["USA", "GENE_OR_GENE_PRODUCT", 123, 126], ["EcoRI", "GENE_OR_GENE_PRODUCT", 161, 166], ["XhoI", "GENE_OR_GENE_PRODUCT", 167, 171], ["DNA fragment", "DNA", 15, 27], ["restriction enzymes EcoRI", "DNA", 51, 76], ["XhoI", "DNA", 81, 85], ["pACT2 (Clontech, USA) expression vector", "DNA", 106, 145], ["EcoRI", "DNA", 161, 166], ["XhoI", "DNA", 167, 171], ["PCR", "TEST", 6, 9], ["the DNA fragment", "PROBLEM", 11, 27], ["the restriction enzymes EcoRI and XhoI", "TREATMENT", 47, 85], ["EcoRI/XhoI)", "TREATMENT", 161, 172], ["fragment", "OBSERVATION_MODIFIER", 19, 27]]], ["The same forward primer and a different reverse primer (5\u2032 CCGCTCGAGTTATGACAGCATGATGCAGTC 3\u2032) were used to clone the DNA fragment that contained the first 405 codons of the PKL sequence for yeast two-hybrid screening.", [["DNA", "CELLULAR_COMPONENT", 117, 120], ["PKL", "GENE_OR_GENE_PRODUCT", 173, 176], ["forward primer", "DNA", 9, 23], ["reverse primer", "DNA", 40, 54], ["DNA fragment", "DNA", 117, 129], ["PKL sequence", "DNA", 173, 185], ["yeast", "SPECIES", 190, 195], ["yeast", "SPECIES", 190, 195], ["a different reverse primer", "TREATMENT", 28, 54], ["5\u2032 CCGCTCGAGTTATGACAGCATGATGCAGTC 3\u2032)", "TREATMENT", 56, 93], ["the DNA fragment", "PROBLEM", 113, 129], ["the PKL sequence", "TEST", 169, 185], ["yeast", "TEST", 190, 195], ["hybrid screening", "TEST", 200, 216], ["DNA fragment", "OBSERVATION", 117, 129]]], ["The same forward primer and a different reverse primer (5\u2032 CCGCTCGAGTTACTGCTCGGACAGCCC 3\u2032) were used to clone the DNA fragment that contained the first 267 codons of the PKL sequence for yeast two-hybrid screening.", [["DNA", "CELLULAR_COMPONENT", 114, 117], ["PKL", "GENE_OR_GENE_PRODUCT", 170, 173], ["forward primer", "DNA", 9, 23], ["reverse primer", "DNA", 40, 54], ["DNA fragment", "DNA", 114, 126], ["PKL sequence", "DNA", 170, 182], ["yeast", "SPECIES", 187, 192], ["yeast", "SPECIES", 187, 192], ["a different reverse primer (5\u2032 CCGCTCGAGTTACTGCTCGGACAGCCC 3\u2032)", "TREATMENT", 28, 90], ["the DNA fragment", "PROBLEM", 110, 126], ["the PKL sequence", "TEST", 166, 182], ["yeast", "TEST", 187, 192], ["hybrid screening", "TEST", 197, 213], ["DNA fragment", "OBSERVATION", 114, 126]]], ["To clone the C-terminal domain (aa 352-530) of the M2PK gene (Gene ID: 5315; NM_002654.3) into the pACT2 expression vector (linearized by EcoRI/XhoI), the primers 5\u2032 CCGAATTCGCGTCCTGGATGGAGCCGACT 3\u2032 and 5\u2032 CCGCTCGAGTCACGGCACAGGAACAAC 3\u2032 and the cDNA library from NIH3T3 cells were used.", [["NIH3T3 cells", "ANATOMY", 263, 275], ["C", "CHEMICAL", 13, 14], ["clone", "CELL", 3, 8], ["M2PK", "GENE_OR_GENE_PRODUCT", 51, 55], ["pACT2", "GENE_OR_GENE_PRODUCT", 99, 104], ["EcoRI", "GENE_OR_GENE_PRODUCT", 138, 143], ["XhoI", "GENE_OR_GENE_PRODUCT", 144, 148], ["NIH3T3 cells", "CELL", 263, 275], ["C-terminal domain", "DNA", 13, 30], ["aa 352-530", "PROTEIN", 32, 42], ["M2PK gene", "DNA", 51, 60], ["Gene ID: 5315", "DNA", 62, 75], ["pACT2 expression vector", "DNA", 99, 122], ["EcoRI", "DNA", 138, 143], ["XhoI", "DNA", 144, 148], ["CCGCTCGAGTCACGGCACAGGAACAAC 3\u2032", "DNA", 206, 236], ["cDNA library", "DNA", 245, 257], ["NIH3T3 cells", "CELL_LINE", 263, 275], ["EcoRI/XhoI)", "TREATMENT", 138, 149], ["CCGAATTCGCGTCCTGGATGGAGCCGACT", "TEST", 166, 195], ["the cDNA library from NIH3T3 cells", "TREATMENT", 241, 275]]], ["To clone the full-length PKL for transient expression in mammalian cells, the primers 5\u2032 CCGAATTCGCATGTCGATCCAGGAGAA 3\u2032 and 5\u2032 TGCTCTAGAGGATATGCTTAGCAC 3\u2032 were used to perform PCR.", [["cells", "ANATOMY", 67, 72], ["clone", "CELL", 3, 8], ["PKL", "GENE_OR_GENE_PRODUCT", 25, 28], ["mammalian cells", "CELL", 57, 72], ["full-length PKL", "DNA", 13, 28], ["mammalian cells", "CELL_TYPE", 57, 72], ["transient expression in mammalian cells", "PROBLEM", 33, 72], ["CCGAATTCGCATGTCGATCCAGGAGAA", "TEST", 89, 116], ["TGCTCTAGAGGATATGCTTAGCAC", "TEST", 127, 151], ["PCR", "TEST", 176, 179], ["mammalian cells", "OBSERVATION", 57, 72]]], ["After PCR, the DNA fragment was digested using the restriction enzymes EcoRI and XbaI and inserted into the vector pcDNA3.1-V5-HisA, which had been linearized with EcoRI and XbaI.Plasmid construction ::: Materials and methodsTo clone the DNA fragment encoding the full-length SARS-CoV N protein for the expression of a GST-N fusion form of the protein, the primers 5\u2032 CGCGGATCCATGTCTGATAATGGACC 3\u2032 and 5\u2032 CGGAATTCTTATGCCTGAGTTGAATC 3\u2032 were used to perform the PCR.", [["DNA", "CELLULAR_COMPONENT", 15, 18], ["EcoRI", "GENE_OR_GENE_PRODUCT", 71, 76], ["XbaI", "GENE_OR_GENE_PRODUCT", 81, 85], ["pcDNA3.1", "GENE_OR_GENE_PRODUCT", 115, 123], ["V5", "GENE_OR_GENE_PRODUCT", 124, 126], ["HisA", "GENE_OR_GENE_PRODUCT", 127, 131], ["EcoRI", "GENE_OR_GENE_PRODUCT", 164, 169], ["XbaI", "GENE_OR_GENE_PRODUCT", 174, 178], ["clone", "CELL", 228, 233], ["DNA", "CELLULAR_COMPONENT", 238, 241], ["GST", "GENE_OR_GENE_PRODUCT", 319, 322], ["DNA fragment", "DNA", 15, 27], ["restriction enzymes EcoRI", "DNA", 51, 76], ["XbaI", "DNA", 81, 85], ["pcDNA3.1", "DNA", 115, 123], ["V5", "DNA", 124, 126], ["HisA", "DNA", 127, 131], ["EcoRI", "DNA", 164, 169], ["XbaI", "DNA", 174, 178], ["DNA fragment", "DNA", 238, 250], ["full-length SARS-CoV N protein", "PROTEIN", 264, 294], ["GST-N fusion form", "PROTEIN", 319, 336], ["PCR", "TEST", 6, 9], ["the DNA fragment", "PROBLEM", 11, 27], ["the restriction enzymes EcoRI", "TREATMENT", 47, 76], ["XbaI", "TREATMENT", 81, 85], ["EcoRI and XbaI", "TREATMENT", 164, 178], ["the DNA fragment", "PROBLEM", 234, 250], ["CoV N protein", "TREATMENT", 281, 294], ["a GST", "TEST", 317, 322], ["CGGAATTCTTATGCCTGAGTTGAATC", "TREATMENT", 405, 431], ["the PCR", "TEST", 456, 463], ["fragment", "OBSERVATION_MODIFIER", 19, 27]]], ["After PCR, the DNA fragment was digested using restriction enzymes BamHI and EcoRI and cloned into the pGEX2T (Amersham Biosciences, USA) expression vector, which had been linearized by BamHI and EcoRI.", [["DNA", "CELLULAR_COMPONENT", 15, 18], ["BamHI", "GENE_OR_GENE_PRODUCT", 67, 72], ["EcoRI", "GENE_OR_GENE_PRODUCT", 77, 82], ["BamHI", "GENE_OR_GENE_PRODUCT", 186, 191], ["EcoRI", "GENE_OR_GENE_PRODUCT", 196, 201], ["DNA fragment", "DNA", 15, 27], ["restriction enzymes", "PROTEIN", 47, 66], ["EcoRI", "DNA", 77, 82], ["pGEX2T (Amersham Biosciences, USA) expression vector", "DNA", 103, 155], ["EcoRI", "DNA", 196, 201], ["PCR", "TEST", 6, 9], ["the DNA fragment", "PROBLEM", 11, 27], ["restriction enzymes BamHI", "TREATMENT", 47, 72], ["EcoRI", "TREATMENT", 77, 82], ["fragment", "OBSERVATION_MODIFIER", 19, 27]]], ["All of the expression plasmids were verified by sequencing.Yeast two-hybrid screening ::: Materials and methodsThe yeast two-hybrid system used for screening was purchased from Clontech Laboratories (USA).", [["plasmids", "ANATOMY", 22, 30], ["expression plasmids", "DNA", 11, 30], ["Yeast", "SPECIES", 59, 64], ["yeast", "SPECIES", 115, 120], ["yeast", "SPECIES", 115, 120], ["the expression plasmids", "TREATMENT", 7, 30], ["Yeast", "TEST", 59, 64], ["The yeast two-hybrid system", "PROBLEM", 111, 138], ["screening", "TEST", 148, 157]]], ["The screening procedures were conducted following the manufacturer\u2019s instructions [23].", [["The screening procedures", "TEST", 0, 24]]], ["The cDNA library used for this screening was a human fetal liver library, HL4029AH (Clontech, USA).The GST pull-down assay ::: Materials and methodsGlutathione-S-transferase (GST) and GST-fusion proteins were purified following the manufacturer\u2019s instructions (Pharmacia, USA).", [["fetal liver", "ANATOMY", 53, 64], ["Glutathione", "CHEMICAL", 148, 159], ["Glutathione", "CHEMICAL", 148, 159], ["S", "CHEMICAL", 160, 161], ["human", "ORGANISM", 47, 52], ["fetal", "MULTI-TISSUE_STRUCTURE", 53, 58], ["liver", "ORGAN", 59, 64], ["GST", "GENE_OR_GENE_PRODUCT", 103, 106], ["Glutathione-S-transferase", "GENE_OR_GENE_PRODUCT", 148, 173], ["GST", "GENE_OR_GENE_PRODUCT", 175, 178], ["GST", "GENE_OR_GENE_PRODUCT", 184, 187], ["cDNA library", "DNA", 4, 16], ["human fetal liver library", "DNA", 47, 72], ["GST", "PROTEIN", 103, 106], ["Glutathione-S-transferase", "PROTEIN", 148, 173], ["GST", "PROTEIN", 175, 178], ["GST", "PROTEIN", 184, 187], ["fusion proteins", "PROTEIN", 188, 203], ["human", "SPECIES", 47, 52], ["human", "SPECIES", 47, 52], ["this screening", "TEST", 26, 40], ["The GST pull", "TEST", 99, 111], ["Materials", "TEST", 127, 136], ["methodsGlutathione", "TEST", 141, 159], ["transferase (GST)", "TREATMENT", 162, 179], ["GST-fusion proteins", "TREATMENT", 184, 203], ["liver", "ANATOMY", 59, 64]]], ["Vero E6 cells were maintained in RPMI 1640 medium containing 10% fetal calf serum, 1% glutamine (200 mM, Biological Industries, USA), and 100 \u03bcg/ml penicillin/streptomycin (Gibco BRL, USA).", [["Vero E6 cells", "ANATOMY", 0, 13], ["fetal calf serum", "ANATOMY", 65, 81], ["glutamine", "CHEMICAL", 86, 95], ["penicillin", "CHEMICAL", 148, 158], ["streptomycin", "CHEMICAL", 159, 171], ["glutamine", "CHEMICAL", 86, 95], ["penicillin", "CHEMICAL", 148, 158], ["streptomycin", "CHEMICAL", 159, 171], ["Vero E6 cells", "CELL", 0, 13], ["calf", "ORGANISM", 71, 75], ["serum", "ORGANISM_SUBSTANCE", 76, 81], ["glutamine", "SIMPLE_CHEMICAL", 86, 95], ["penicillin", "SIMPLE_CHEMICAL", 148, 158], ["streptomycin", "SIMPLE_CHEMICAL", 159, 171], ["Vero E6 cells", "CELL_LINE", 0, 13], ["calf", "SPECIES", 71, 75], ["Vero E6", "SPECIES", 0, 7], ["Vero E6 cells", "PROBLEM", 0, 13], ["fetal calf serum", "TEST", 65, 81], ["glutamine", "TEST", 86, 95], ["penicillin", "TREATMENT", 148, 158], ["streptomycin", "TREATMENT", 159, 171], ["E6 cells", "OBSERVATION", 5, 13]]], ["A total of 2.5 \u00d7 106 cells were plated in a 100-mm dish.", [["cells", "ANATOMY", 21, 26], ["cells", "CELL", 21, 26], ["A total of 2.5 \u00d7 106 cells", "TREATMENT", 0, 26], ["total", "OBSERVATION_MODIFIER", 2, 7]]], ["After overnight incubation, cells were transfected with 4 \u03bcg plasmid DNA (vector pcDNA3.1-V5-His A or pcDNA3.1-PKL expression plasmid) using Effectene transfection reagent (QIAGEN, Germany).", [["cells", "ANATOMY", 28, 33], ["cells", "CELL", 28, 33], ["DNA", "CELLULAR_COMPONENT", 69, 72], ["pcDNA3", "GENE_OR_GENE_PRODUCT", 81, 87], ["V5-His A", "GENE_OR_GENE_PRODUCT", 90, 98], ["pcDNA3.1-PKL", "GENE_OR_GENE_PRODUCT", 102, 114], ["4 \u03bcg plasmid DNA", "DNA", 56, 72], ["vector pcDNA3", "DNA", 74, 87], ["1-V5-His A or pcDNA3.1-PKL expression plasmid", "DNA", 88, 133], ["4 \u03bcg plasmid DNA", "TREATMENT", 56, 72], ["vector pcDNA3", "TREATMENT", 74, 87], ["His A", "TREATMENT", 93, 98], ["pcDNA3.1-PKL expression plasmid", "TREATMENT", 102, 133], ["Effectene transfection reagent", "TREATMENT", 141, 171]]], ["At 48 hours after transfection, recombinant proteins in the cells were released by lysis in buffer containing 50 mM Tris-HCl (pH 7.4), 300 mM NaCl, 10 mM NaN3, 0.2 mM DTT, 1% NP-40 and 1x protease inhibitor cocktail (Sigma, USA) and then analyzed by GST pull-down assay.", [["cells", "ANATOMY", 60, 65], ["Tris-HCl", "CHEMICAL", 116, 124], ["NaCl", "CHEMICAL", 142, 146], ["NaN3", "CHEMICAL", 154, 158], ["Tris-HCl", "CHEMICAL", 116, 124], ["NaCl", "CHEMICAL", 142, 146], ["NaN3", "CHEMICAL", 154, 158], ["DTT", "CHEMICAL", 167, 170], ["cells", "CELL", 60, 65], ["Tris-HCl", "SIMPLE_CHEMICAL", 116, 124], ["NaN3", "SIMPLE_CHEMICAL", 154, 158], ["DTT", "SIMPLE_CHEMICAL", 167, 170], ["NP-40", "SIMPLE_CHEMICAL", 175, 180], ["GST", "GENE_OR_GENE_PRODUCT", 250, 253], ["recombinant proteins", "PROTEIN", 32, 52], ["GST", "PROTEIN", 250, 253], ["transfection", "TREATMENT", 18, 30], ["recombinant proteins in the cells", "PROBLEM", 32, 65], ["pH", "TEST", 126, 128], ["NaCl", "TEST", 142, 146], ["NaN3", "TEST", 154, 158], ["DTT", "TEST", 167, 170], ["NP", "TEST", 175, 177], ["1x protease inhibitor cocktail", "TREATMENT", 185, 215], ["GST pull", "TEST", 250, 258]]], ["In total, 10% of the cell lysate was loaded directly onto the SDS-PAGE gel to serve as a control and 90% of the cell lysate was incubated at 4\u00b0C with about 2 \u03bcg purified GST or GST-fusion protein.", [["cell lysate", "ANATOMY", 21, 32], ["cell lysate", "ANATOMY", 112, 123], ["cell lysate", "CELL", 21, 32], ["cell lysate", "CELL", 112, 123], ["GST", "GENE_OR_GENE_PRODUCT", 170, 173], ["GST", "GENE_OR_GENE_PRODUCT", 177, 180], ["GST", "PROTEIN", 170, 173], ["GST", "PROTEIN", 177, 180], ["fusion protein", "PROTEIN", 181, 195], ["the cell lysate", "TREATMENT", 17, 32], ["the SDS-PAGE gel", "TREATMENT", 58, 74], ["the cell lysate", "TEST", 108, 123], ["GST-fusion protein", "TREATMENT", 177, 195]]], ["After overnight incubation, glutathione beads (Pharmacia, USA) were added to the reaction mixture.", [["glutathione", "CHEMICAL", 28, 39], ["glutathione", "CHEMICAL", 28, 39], ["glutathione", "SIMPLE_CHEMICAL", 28, 39], ["overnight incubation", "TREATMENT", 6, 26], ["glutathione beads (Pharmacia, USA)", "TREATMENT", 28, 62], ["the reaction mixture", "TREATMENT", 77, 97]]], ["Two hours later, the samples were centrifuged.", [["samples", "ANATOMY", 21, 28], ["the samples", "TEST", 17, 28]]], ["After washing, the pellet was resuspended in the protein sample buffer and analyzed by SDS-PAGE and western blotting.", [["washing", "TREATMENT", 6, 13], ["the pellet", "TREATMENT", 15, 25], ["the protein sample buffer", "TREATMENT", 45, 70]]], ["In order to detect the PKL protein using western blotting analysis, mouse anti-V5 monoclonal antibody (Invitrogen, USA) was used as the primary antibody.Co-immunoprecipitation assay ::: Materials and methodsHuH 7 or Vero E6 cells (2 \u00d7 106) were harvested 48 hours after transfection with the expression plasmids pcDNA3-myc-N and/or pcDNA3.1-PKL (or using the N-terminus of PKL or the C-terminus of PKL instead of full-length PKL), washed three times in PBS, and lysed in RIPA buffer (150 mM NaCl, 1% NP40, 0.5% deoxychloic acid, 0.1% SDS and 50 mM Tris, pH 7.5).", [["Vero E6 cells", "ANATOMY", 216, 229], ["plasmids", "ANATOMY", 303, 311], ["NaCl", "CHEMICAL", 491, 495], ["deoxychloic acid", "CHEMICAL", 511, 527], ["NaCl", "CHEMICAL", 491, 495], ["NP40", "CHEMICAL", 500, 504], ["deoxychloic acid", "CHEMICAL", 511, 527], ["Tris", "CHEMICAL", 548, 552], ["PKL", "GENE_OR_GENE_PRODUCT", 23, 26], ["mouse", "ORGANISM", 68, 73], ["anti-V5", "GENE_OR_GENE_PRODUCT", 74, 81], ["Invitrogen, USA", "ORGANISM", 103, 118], ["HuH 7", "CELL", 207, 212], ["Vero E6 cells", "CELL", 216, 229], ["pcDNA3-myc-N", "GENE_OR_GENE_PRODUCT", 312, 324], ["pcDNA3.1-PKL", "GENE_OR_GENE_PRODUCT", 332, 344], ["PKL", "GENE_OR_GENE_PRODUCT", 373, 376], ["PKL", "GENE_OR_GENE_PRODUCT", 398, 401], ["PKL", "GENE_OR_GENE_PRODUCT", 425, 428], ["deoxychloic acid", "SIMPLE_CHEMICAL", 511, 527], ["PKL protein", "PROTEIN", 23, 34], ["mouse anti-V5 monoclonal antibody", "PROTEIN", 68, 101], ["primary antibody", "PROTEIN", 136, 152], ["HuH 7", "CELL_LINE", 207, 212], ["Vero E6 cells", "CELL_LINE", 216, 229], ["expression plasmids", "DNA", 292, 311], ["pcDNA3", "DNA", 312, 318], ["myc", "PROTEIN", 319, 322], ["N", "DNA", 323, 324], ["pcDNA3.1", "DNA", 332, 340], ["PKL", "PROTEIN", 341, 344], ["N-terminus", "PROTEIN", 359, 369], ["PKL", "PROTEIN", 373, 376], ["C-terminus", "PROTEIN", 384, 394], ["PKL", "PROTEIN", 398, 401], ["PKL", "PROTEIN", 425, 428], ["mouse", "SPECIES", 68, 73], ["mouse", "SPECIES", 68, 73], ["Vero E6", "SPECIES", 216, 223], ["the PKL protein", "TEST", 19, 34], ["blotting analysis", "TEST", 49, 66], ["mouse anti-V5 monoclonal antibody", "TEST", 68, 101], ["methodsHuH", "TEST", 200, 210], ["Vero E6 cells", "TEST", 216, 229], ["transfection", "TREATMENT", 270, 282], ["the expression plasmids", "TREATMENT", 288, 311], ["myc", "TEST", 319, 322], ["the N-terminus of PKL", "TREATMENT", 355, 376], ["the C-terminus of PKL", "TREATMENT", 380, 401], ["NaCl", "TEST", 491, 495], ["deoxychloic acid", "TREATMENT", 511, 527], ["pH", "TEST", 554, 556]]], ["After centrifugation for 5 minutes at full speed in a microcentrifuge, the supernatant was used for further analysis.", [["supernatant", "ANATOMY", 75, 86], ["centrifugation", "TREATMENT", 6, 20], ["further analysis", "TEST", 100, 116]]], ["In each experiment, 10% of the supernatant was used directly for expression analysis by western blotting assay, while 90% of the supernatant was used for the co-immunoprecipitation assay.", [["supernatant", "ANATOMY", 31, 42], ["supernatant", "ANATOMY", 129, 140], ["the supernatant", "TREATMENT", 27, 42], ["expression analysis", "TEST", 65, 84], ["blotting assay", "TEST", 96, 110], ["the co-immunoprecipitation assay", "TEST", 154, 186]]], ["The supernatant was incubated with homemade rabbit anti-nucleocapsid polyclonal antibody (or anti-myc) at 4\u00b0C overnight with shaking.", [["supernatant", "ANATOMY", 4, 15], ["rabbit", "ORGANISM", 44, 50], ["anti-myc", "GENE_OR_GENE_PRODUCT", 93, 101], ["homemade rabbit anti-nucleocapsid polyclonal antibody", "PROTEIN", 35, 88], ["anti-myc", "PROTEIN", 93, 101], ["rabbit", "SPECIES", 44, 50], ["rabbit", "SPECIES", 44, 50], ["homemade rabbit anti-nucleocapsid polyclonal antibody", "TREATMENT", 35, 88], ["shaking", "PROBLEM", 125, 132]]], ["The antigen-antibody complexes were then pulled down using PANSORBIN cells (Merck, USA).", [["PANSORBIN cells", "ANATOMY", 59, 74], ["PANSORBIN cells", "CELL", 59, 74], ["antigen-antibody complexes", "PROTEIN", 4, 30], ["PANSORBIN cells", "CELL_LINE", 59, 74], ["The antigen-antibody complexes", "TEST", 0, 30]]], ["The immunoprecipitated pellets were treated at 100\u00b0C in the sample buffer (67.5 mM Tris-HCl (pH 6.8), 5% 2-mercaptoethanol, 3% SDS, 0.1% bromophenol blue and 10% glycerol) for 10 minutes, and this was followed by SDS-PAGE and western blotting analysis.", [["Tris-HCl", "CHEMICAL", 83, 91], ["2-mercaptoethanol", "CHEMICAL", 105, 122], ["bromophenol blue", "CHEMICAL", 137, 153], ["glycerol", "CHEMICAL", 162, 170], ["Tris-HCl", "CHEMICAL", 83, 91], ["2-mercaptoethanol", "CHEMICAL", 105, 122], ["bromophenol blue", "CHEMICAL", 137, 153], ["glycerol", "CHEMICAL", 162, 170], ["Tris-HCl", "SIMPLE_CHEMICAL", 83, 91], ["2-mercaptoethanol", "SIMPLE_CHEMICAL", 105, 122], ["bromophenol blue", "SIMPLE_CHEMICAL", 137, 153], ["glycerol", "SIMPLE_CHEMICAL", 162, 170], ["The immunoprecipitated pellets", "TREATMENT", 0, 30], ["pH", "TEST", 93, 95], ["mercaptoethanol", "TREATMENT", 107, 122], ["3% SDS", "TREATMENT", 124, 130], ["0.1% bromophenol blue", "TREATMENT", 132, 153], ["10% glycerol", "TREATMENT", 158, 170], ["blotting analysis", "TEST", 234, 251]]], ["In order to detect PKL protein, alkaline-phosphatase-conjugated anti-V5 antibody (Invitrogen, USA) was used, while mouse anti-myc monoclonal antibody (Oncogene, USA) (or homemade rabbit anti-nucleocapsid polyclonal antibody) was used as the primary antibody to detect SARS-CoV N protein.Western blotting analysis ::: Materials and methodsAfter electrophoresis, the SDS-PAGE gel was transferred to PVDF paper (Pall Corporation, USA).", [["PVDF", "CHEMICAL", 397, 401], ["PKL", "GENE_OR_GENE_PRODUCT", 19, 22], ["alkaline-phosphatase", "GENE_OR_GENE_PRODUCT", 32, 52], ["mouse", "ORGANISM", 115, 120], ["Oncogene", "GENE_OR_GENE_PRODUCT", 151, 159], ["rabbit", "ORGANISM", 179, 185], ["SARS-CoV N", "GENE_OR_GENE_PRODUCT", 268, 278], ["PKL protein", "PROTEIN", 19, 30], ["alkaline-phosphatase", "PROTEIN", 32, 52], ["anti-V5 antibody", "PROTEIN", 64, 80], ["mouse anti-myc monoclonal antibody", "PROTEIN", 115, 149], ["Oncogene", "PROTEIN", 151, 159], ["USA", "PROTEIN", 161, 164], ["homemade rabbit anti-nucleocapsid polyclonal antibody", "PROTEIN", 170, 223], ["primary antibody", "PROTEIN", 241, 257], ["SARS-CoV N protein", "PROTEIN", 268, 286], ["mouse", "SPECIES", 115, 120], ["rabbit", "SPECIES", 179, 185], ["mouse", "SPECIES", 115, 120], ["rabbit", "SPECIES", 179, 185], ["SARS-CoV", "SPECIES", 268, 276], ["PKL", "TEST", 19, 22], ["protein", "TEST", 23, 30], ["alkaline", "TEST", 32, 40], ["phosphatase", "TEST", 41, 52], ["conjugated anti-V5 antibody", "TEST", 53, 80], ["homemade rabbit anti-nucleocapsid polyclonal antibody", "TREATMENT", 170, 223], ["the primary antibody", "TEST", 237, 257], ["SARS", "PROBLEM", 268, 272], ["electrophoresis", "TEST", 344, 359], ["the SDS", "TEST", 361, 368]]], ["All procedures were then carried out at room temperature following our previous procedures [20, 22] except that the primary antibodies used in this study were different, namely anti-PK rabbit monoclonal antibody (Abcam, USA), anti-ERK-2 rabbit polyclonal antibody (Santa Cruz, USA), etc., as appropriate.Confocal analysis ::: Materials and methodsAbout 2.5 \u00d7 105 Huh7 or Vero E6 cells were seeded in 35-mm culture dishes.", [["Huh7", "ANATOMY", 363, 367], ["Vero E6 cells", "ANATOMY", 371, 384], ["rabbit", "ORGANISM", 185, 191], ["Abcam", "GENE_OR_GENE_PRODUCT", 213, 218], ["anti-ERK-2", "GENE_OR_GENE_PRODUCT", 226, 236], ["rabbit", "ORGANISM", 237, 243], ["Huh7", "CELL", 363, 367], ["Vero E6 cells", "CELL", 371, 384], ["primary antibodies", "PROTEIN", 116, 134], ["anti-PK rabbit monoclonal antibody", "PROTEIN", 177, 211], ["Abcam, USA), anti-ERK-2 rabbit polyclonal antibody", "PROTEIN", 213, 263], ["Santa Cruz", "PROTEIN", 265, 275], ["Vero E6 cells", "CELL_LINE", 371, 384], ["rabbit", "SPECIES", 185, 191], ["rabbit", "SPECIES", 237, 243], ["rabbit", "SPECIES", 185, 191], ["rabbit", "SPECIES", 237, 243], ["Vero E6", "SPECIES", 371, 378], ["All procedures", "TREATMENT", 0, 14], ["the primary antibodies", "TEST", 112, 134], ["this study", "TEST", 143, 153], ["anti-PK rabbit monoclonal antibody", "TEST", 177, 211], ["Abcam", "TEST", 213, 218], ["USA", "TEST", 220, 223], ["anti-ERK", "TEST", 226, 234], ["polyclonal antibody", "TEST", 244, 263], ["Confocal analysis", "TEST", 304, 321], ["methods", "TEST", 340, 347], ["Vero E6 cells", "TREATMENT", 371, 384]]], ["After overnight incubation, the cells were transfected with various different plasmids (pcDNA3-myc-N and/or pcDNA3.1-PKL) using an Effectene transfection kit (QIAGEN, Germany).", [["cells", "ANATOMY", 32, 37], ["plasmids", "ANATOMY", 78, 86], ["cells", "CELL", 32, 37], ["pcDNA3-myc-N", "GENE_OR_GENE_PRODUCT", 88, 100], ["pcDNA3.1-PKL", "GENE_OR_GENE_PRODUCT", 108, 120], ["plasmids", "DNA", 78, 86], ["pcDNA3", "DNA", 88, 94], ["myc", "DNA", 95, 98], ["N", "DNA", 99, 100], ["pcDNA3.1", "DNA", 108, 116], ["PKL", "DNA", 117, 120], ["the cells", "TREATMENT", 28, 37], ["various different plasmids", "TREATMENT", 60, 86], ["pcDNA3", "TEST", 88, 94], ["myc", "TEST", 95, 98], ["pcDNA3", "TREATMENT", 108, 114], ["an Effectene transfection kit", "TREATMENT", 128, 157]]], ["At 48 hours after transfection, the recombinant proteins in the cells were analyzed.", [["cells", "ANATOMY", 64, 69], ["cells", "CELL", 64, 69], ["recombinant proteins", "PROTEIN", 36, 56], ["transfection", "TREATMENT", 18, 30], ["the recombinant proteins in the cells", "PROBLEM", 32, 69]]], ["All procedures were then carried out following our previous procedures [5, 16, 46] except that the antibodies used in this study were different.", [["antibodies", "PROTEIN", 99, 109], ["All procedures", "TREATMENT", 0, 14], ["the antibodies", "TEST", 95, 109], ["this study", "TEST", 118, 128]]], ["Specifically, anti-myc mouse monoclonal antibody (Upstate, USA) followed by RITC-conjugated anti-mouse IgG antibody was used to detect SARS-CoV N protein, and FITC-conjugated anti-V5 monoclonal antibody (Invitrogen, USA) was used to detect PKL protein.", [["RITC", "CHEMICAL", 76, 80], ["FITC", "CHEMICAL", 159, 163], ["mouse", "ORGANISM", 23, 28], ["Upstate", "GENE_OR_GENE_PRODUCT", 50, 57], ["RITC", "SIMPLE_CHEMICAL", 76, 80], ["SARS-CoV", "GENE_OR_GENE_PRODUCT", 135, 143], ["FITC", "SIMPLE_CHEMICAL", 159, 163], ["PKL", "GENE_OR_GENE_PRODUCT", 240, 243], ["anti-myc mouse monoclonal antibody", "PROTEIN", 14, 48], ["Upstate", "PROTEIN", 50, 57], ["USA", "PROTEIN", 59, 62], ["RITC", "PROTEIN", 76, 80], ["conjugated anti-mouse IgG antibody", "PROTEIN", 81, 115], ["SARS-CoV N protein", "PROTEIN", 135, 153], ["FITC-conjugated anti-V5 monoclonal antibody", "PROTEIN", 159, 202], ["PKL protein", "PROTEIN", 240, 251], ["mouse", "SPECIES", 23, 28], ["anti-mouse", "SPECIES", 92, 102], ["mouse", "SPECIES", 23, 28], ["SARS-CoV", "SPECIES", 135, 143], ["anti-myc mouse monoclonal antibody", "TEST", 14, 48], ["RITC", "TEST", 76, 80], ["conjugated anti-mouse IgG antibody", "TEST", 81, 115], ["SARS", "TEST", 135, 139], ["CoV N protein", "TEST", 140, 153], ["FITC", "TEST", 159, 163], ["PKL protein", "PROBLEM", 240, 251]]], ["DAPI (Merck, Germany) was used to stain DNA for localization in the nucleus.", [["nucleus", "ANATOMY", 68, 75], ["DAPI", "CHEMICAL", 0, 4], ["DAPI", "SIMPLE_CHEMICAL", 0, 4], ["DNA", "CELLULAR_COMPONENT", 40, 43], ["nucleus", "CELLULAR_COMPONENT", 68, 75], ["stain DNA", "TEST", 34, 43], ["nucleus", "ANATOMY", 68, 75]]], ["Finally, the samples were observed under a confocal microscope (Leica TCS SP2).Pyruvate kinase activity assay ::: Materials and methodsHuH7 or Vero E6 cells (2 \u00d7 106) in 100-mm dishes were harvested 48 hours after transfection with the expression plasmids pcDNA3-myc vector, pcDNA3-myc-N or pcDNA3.1-PKL for transient expression, washed three times in PBS, and then lysed in RIPA buffer.", [["samples", "ANATOMY", 13, 20], ["HuH7", "ANATOMY", 135, 139], ["Vero E6 cells", "ANATOMY", 143, 156], ["Pyruvate", "CHEMICAL", 79, 87], ["Pyruvate", "CHEMICAL", 79, 87], ["Pyruvate kinase", "GENE_OR_GENE_PRODUCT", 79, 94], ["HuH7", "CELL", 135, 139], ["Vero E6 cells", "CELL", 143, 156], ["pcDNA3-myc", "GENE_OR_GENE_PRODUCT", 256, 266], ["pcDNA3-myc-N", "GENE_OR_GENE_PRODUCT", 275, 287], ["pcDNA3.1-PKL", "GENE_OR_GENE_PRODUCT", 291, 303], ["Leica TCS SP2", "DNA", 64, 77], ["Pyruvate kinase", "PROTEIN", 79, 94], ["HuH7", "CELL_LINE", 135, 139], ["Vero E6 cells", "CELL_LINE", 143, 156], ["expression plasmids pcDNA3-myc vector", "DNA", 236, 273], ["pcDNA3", "DNA", 275, 281], ["myc", "DNA", 282, 285], ["N", "DNA", 286, 287], ["pcDNA3", "DNA", 291, 297], ["PKL", "DNA", 300, 303], ["Vero E6", "SPECIES", 143, 150], ["the samples", "TEST", 9, 20], ["a confocal microscope", "TEST", 41, 62], ["Pyruvate kinase activity", "TEST", 79, 103], ["methodsHuH7", "TREATMENT", 128, 139], ["Vero E6 cells", "TEST", 143, 156], ["transfection", "TREATMENT", 214, 226], ["the expression plasmids pcDNA3", "TREATMENT", 232, 262], ["myc vector", "TREATMENT", 263, 273], ["myc", "TEST", 282, 285], ["pcDNA3", "TREATMENT", 291, 297], ["transient expression", "PROBLEM", 308, 328]]], ["The cellular pyruvate kinase activity was determined following published procedures [10, 39].", [["cellular", "ANATOMY", 4, 12], ["pyruvate", "CHEMICAL", 13, 21], ["pyruvate", "CHEMICAL", 13, 21], ["cellular", "CELL", 4, 12], ["cellular pyruvate kinase", "PROTEIN", 4, 28], ["The cellular pyruvate kinase activity", "TEST", 0, 37], ["pyruvate kinase activity", "OBSERVATION", 13, 37]]], ["For the activity assay in the stable clones, 48 hours after transfection with the pcDNA3.1-N plasmid, the HuH7 cells were treated with 800 \u03bcg/ml G418 for selection.", [["clones", "ANATOMY", 37, 43], ["HuH7 cells", "ANATOMY", 106, 116], ["G418", "CHEMICAL", 145, 149], ["G418", "CHEMICAL", 145, 149], ["clones", "CELL", 37, 43], ["pcDNA3", "GENE_OR_GENE_PRODUCT", 82, 88], ["HuH7 cells", "CELL", 106, 116], ["pcDNA3", "DNA", 82, 88], ["1-N plasmid", "DNA", 89, 100], ["HuH7 cells", "CELL_LINE", 106, 116], ["the activity assay", "TEST", 4, 22], ["the pcDNA3", "TREATMENT", 78, 88], ["N plasmid", "TREATMENT", 91, 100], ["the HuH7 cells", "TREATMENT", 102, 116], ["stable", "OBSERVATION_MODIFIER", 30, 36], ["HuH7", "ANATOMY", 106, 110]]], ["After seven days, the transfected cells were harvested and the pyruvate kinase activity assay carried out.RNAi experiments ::: Materials and methodsRNAi experiments were performed using a lentiviral expression system (http://rnai.genmed.sinica.edu.tw), following the manufacturer\u2019s instructions.", [["cells", "ANATOMY", 34, 39], ["pyruvate", "CHEMICAL", 63, 71], ["pyruvate", "CHEMICAL", 63, 71], ["cells", "CELL", 34, 39], ["pyruvate", "SIMPLE_CHEMICAL", 63, 71], ["transfected cells", "CELL_LINE", 22, 39], ["pyruvate kinase", "PROTEIN", 63, 78], ["the transfected cells", "TREATMENT", 18, 39], ["the pyruvate kinase activity assay", "TEST", 59, 93], ["methodsRNAi experiments", "TEST", 141, 164], ["a lentiviral expression system", "TREATMENT", 186, 216], ["transfected cells", "OBSERVATION", 22, 39]]], ["RNAi reagents were obtained from the National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica.Identification of pyruvate kinase (liver) as an interactive protein of SARS-CoV nucleocapsid protein by yeast two-hybrid screening ::: Results and discussionThe SARS-CoV N protein was used as the bait for yeast two-hybrid screening in order to identify cellular proteins that interact with it.", [["liver", "ANATOMY", 187, 192], ["cellular", "ANATOMY", 405, 413], ["pyruvate", "CHEMICAL", 170, 178], ["pyruvate", "CHEMICAL", 170, 178], ["pyruvate kinase", "GENE_OR_GENE_PRODUCT", 170, 185], ["liver", "ORGAN", 187, 192], ["SARS-CoV nucleocapsid", "ORGANISM", 223, 244], ["cellular", "CELL", 405, 413], ["pyruvate kinase", "PROTEIN", 170, 185], ["SARS-CoV nucleocapsid protein", "PROTEIN", 223, 252], ["SARS-CoV N protein", "PROTEIN", 313, 331], ["cellular proteins", "PROTEIN", 405, 422], ["yeast", "SPECIES", 256, 261], ["yeast", "SPECIES", 357, 362], ["SARS-CoV", "SPECIES", 223, 231], ["yeast", "SPECIES", 256, 261], ["yeast", "SPECIES", 357, 362], ["pyruvate kinase (liver)", "PROBLEM", 170, 193], ["an interactive protein of SARS", "PROBLEM", 197, 227], ["CoV nucleocapsid protein", "TEST", 228, 252], ["yeast", "TEST", 256, 261], ["The SARS-CoV N protein", "TREATMENT", 309, 331], ["hybrid screening", "TEST", 367, 383], ["cellular proteins", "PROBLEM", 405, 422], ["Academia Sinica", "OBSERVATION", 136, 151], ["pyruvate kinase", "OBSERVATION", 170, 185], ["liver", "ANATOMY", 187, 192]]], ["Only one cDNA clone, which encoded the C-terminal domain of the pyruvate kinase (liver) (PKL) protein (aa 406-581), was found to interact with the N protein, out of a total of 1 \u00d7 106 transformants (Fig. 1).", [["transformants", "ANATOMY", 184, 197], ["pyruvate", "CHEMICAL", 64, 72], ["aa 406-581", "CHEMICAL", 103, 113], ["C", "CHEMICAL", 39, 40], ["pyruvate", "CHEMICAL", 64, 72], ["pyruvate kinase", "GENE_OR_GENE_PRODUCT", 64, 79], ["liver", "ORGAN", 81, 86], ["PKL", "GENE_OR_GENE_PRODUCT", 89, 92], ["transformants", "CELL", 184, 197], ["cDNA clone", "DNA", 9, 19], ["C-terminal domain", "PROTEIN", 39, 56], ["pyruvate kinase (liver) (PKL) protein", "PROTEIN", 64, 101], ["aa 406-581", "PROTEIN", 103, 113], ["N protein", "PROTEIN", 147, 156], ["one cDNA clone", "PROBLEM", 5, 19], ["the pyruvate kinase", "TEST", 60, 79], ["PKL) protein", "TEST", 89, 101], ["aa", "TEST", 103, 105], ["the N protein", "TEST", 143, 156], ["cDNA clone", "OBSERVATION", 9, 19], ["terminal", "ANATOMY_MODIFIER", 41, 49], ["pyruvate kinase", "ANATOMY", 64, 79], ["liver", "ANATOMY", 81, 86]]], ["This yeast two-hybrid system was further used to identify the interactive domains of these two proteins.", [["yeast", "SPECIES", 5, 10], ["yeast", "SPECIES", 5, 10]]], ["As shown in Fig. 1, the deletion of the C-terminal sequence of PKL downstream of amino acid 406 abolished the interaction between these two proteins in the YTH assay.", [["amino acid 406", "CHEMICAL", 81, 95], ["amino acid 406", "CHEMICAL", 81, 95], ["PKL", "GENE_OR_GENE_PRODUCT", 63, 66], ["amino acid 406", "AMINO_ACID", 81, 95], ["C-terminal sequence", "DNA", 40, 59], ["PKL", "PROTEIN", 63, 66], ["YTH", "PROTEIN", 156, 159], ["the C-terminal sequence", "TEST", 36, 59], ["amino acid", "TEST", 81, 91]]], ["Similar deletion-mapping experiments were conducted on the SARS-CoV N protein.", [["SARS-CoV N", "GENE_OR_GENE_PRODUCT", 59, 69], ["SARS-CoV N protein", "PROTEIN", 59, 77], ["SARS-CoV", "SPECIES", 59, 67], ["Similar deletion-mapping experiments", "PROBLEM", 0, 36], ["the SARS", "TEST", 55, 63], ["deletion", "OBSERVATION", 8, 16]]], ["As shown in Fig. 1, deletion of the C-terminal sequence of the N protein downstream of amino acid 220 had no significant effect on the binding of these two proteins.", [["amino acid 220", "CHEMICAL", 87, 101], ["C", "CHEMICAL", 36, 37], ["amino acid 220", "CHEMICAL", 87, 101], ["amino acid 220", "AMINO_ACID", 87, 101], ["C-terminal sequence", "DNA", 36, 55], ["N protein", "PROTEIN", 63, 72], ["the C-terminal sequence", "TEST", 32, 55], ["amino acid", "TEST", 87, 97], ["no", "UNCERTAINTY", 106, 108], ["significant", "OBSERVATION_MODIFIER", 109, 120], ["effect", "OBSERVATION", 121, 127]]], ["However, deletion of the N-terminal sequence upstream of amino acid 221 abolished the interaction of these two proteins in the YTH assay.", [["amino acid 221", "CHEMICAL", 57, 71], ["N", "CHEMICAL", 25, 26], ["amino acid 221", "CHEMICAL", 57, 71], ["amino acid 221", "AMINO_ACID", 57, 71], ["YTH", "GENE_OR_GENE_PRODUCT", 127, 130], ["N-terminal sequence", "DNA", 25, 44], ["YTH", "PROTEIN", 127, 130], ["amino acid", "TEST", 57, 67]]], ["These results indicate that the N-terminal domain of the N protein interacts with the C-terminal domain of the PKL protein.", [["N", "CHEMICAL", 32, 33], ["C", "CHEMICAL", 86, 87], ["PKL", "GENE_OR_GENE_PRODUCT", 111, 114], ["N-terminal domain", "PROTEIN", 32, 49], ["N protein", "PROTEIN", 57, 66], ["C-terminal domain", "PROTEIN", 86, 103], ["PKL protein", "PROTEIN", 111, 122], ["the N-terminal domain", "PROBLEM", 28, 49]]]], "b52f3b7a525263af4c27e61d2cf4e2d4d8e5ba6f": [["IntroductionThe phenomenon of synonymous codon usage bias exists in a wide range of paradigms from prokaryote to eukaryote.", [["synonymous codon usage", "TREATMENT", 30, 52], ["synonymous codon", "OBSERVATION", 30, 46], ["wide", "OBSERVATION_MODIFIER", 70, 74]]], ["Due to different genomes having their own characteristic patterns of synonymous codon usage [1] , it has not been easy to provide a satisfactory explanation for the particular pattern found in a given genome.", [["synonymous codon", "OBSERVATION", 69, 85]]], ["Compositional constraints and translational selection are thought to be the main factors accounting for codon usage variation among genes in different organisms such as Escherichia coli, Bacillus subtilis, Saccharomyces cerevisiae, Dictyostelium discoideum [2] , Drosophila melanogaster [3] and Caenorhabditis elegans [4] .", [["Escherichia coli", "ORGANISM", 169, 185], ["Bacillus subtilis", "ORGANISM", 187, 204], ["Saccharomyces cerevisiae", "ORGANISM", 206, 230], ["Dictyostelium discoideum [2]", "ORGANISM", 232, 260], ["Drosophila melanogaster", "ORGANISM", 263, 286], ["Caenorhabditis elegans", "ORGANISM", 295, 317], ["Escherichia coli", "SPECIES", 169, 185], ["Bacillus subtilis", "SPECIES", 187, 204], ["Saccharomyces cerevisiae", "SPECIES", 206, 230], ["Dictyostelium discoideum", "SPECIES", 232, 256], ["Drosophila melanogaster", "SPECIES", 263, 286], ["Caenorhabditis elegans", "SPECIES", 295, 317], ["Escherichia coli", "SPECIES", 169, 185], ["Bacillus subtilis", "SPECIES", 187, 204], ["Saccharomyces cerevisiae", "SPECIES", 206, 230], ["Dictyostelium discoideum", "SPECIES", 232, 256], ["Drosophila melanogaster", "SPECIES", 263, 286], ["Caenorhabditis elegans", "SPECIES", 295, 317], ["Compositional constraints", "PROBLEM", 0, 25], ["translational selection", "TREATMENT", 30, 53], ["codon usage variation", "PROBLEM", 104, 125], ["different organisms", "PROBLEM", 141, 160], ["Escherichia coli", "PROBLEM", 169, 185], ["Bacillus subtilis", "PROBLEM", 187, 204], ["Saccharomyces cerevisiae", "PROBLEM", 206, 230], ["Dictyostelium discoideum", "PROBLEM", 232, 256], ["Drosophila melanogaster", "PROBLEM", 263, 286], ["Caenorhabditis elegans", "PROBLEM", 295, 317], ["Escherichia coli", "OBSERVATION", 169, 185]]], ["However, in some prokaryotes with extremely high A + T or G + C contents [2] and human [5] , mutation bias is the major factor accounting for the variation in codon usage.", [["A + T", "GENE_OR_GENE_PRODUCT", 49, 54], ["G + C", "GENE_OR_GENE_PRODUCT", 58, 63], ["human", "ORGANISM", 81, 86], ["human", "SPECIES", 81, 86], ["human", "SPECIES", 81, 86], ["G + C contents", "PROBLEM", 58, 72], ["mutation bias", "PROBLEM", 93, 106]]], ["In contrast, it was reported that translational selection at silent sites played the most important role in shaping codon usage in Zea mays [6] and Arabidopsis thaliana [7] .", [["Zea mays", "ORGANISM", 131, 139], ["Arabidopsis thaliana", "ORGANISM", 148, 168], ["silent sites", "DNA", 61, 73], ["Zea mays", "SPECIES", 131, 139], ["Arabidopsis thaliana", "SPECIES", 148, 168], ["Zea mays", "SPECIES", 131, 139], ["Arabidopsis thaliana", "SPECIES", 148, 168], ["translational selection at silent sites", "PROBLEM", 34, 73], ["Arabidopsis thaliana", "PROBLEM", 148, 168]]], ["Recently, codon usage was suggested to be related to gene function [8] and protein secondary structure [9] .IntroductionCodon usage information has also been analyzed for viruses, such as human immunodeficiency virus (HIV) [10] , nucleopolyhedroviruses [11] , cauliflower mosaic virus (CMV) [12] , human RNA viruses [13] , H5N1 virus [14] , and hepatitis A virus [15] .", [["human immunodeficiency virus (HIV)", "DISEASE", 188, 222], ["hepatitis A", "DISEASE", 345, 356], ["human immunodeficiency virus", "ORGANISM", 188, 216], ["HIV) [10", "ORGANISM", 218, 226], ["nucleopolyhedroviruses [11", "ORGANISM", 230, 256], ["cauliflower mosaic virus", "ORGANISM", 260, 284], ["CMV", "ORGANISM", 286, 289], ["human", "ORGANISM", 298, 303], ["RNA viruses [13", "ORGANISM", 304, 319], ["H5N1 virus", "ORGANISM", 323, 333], ["hepatitis A virus", "ORGANISM", 345, 362], ["human immunodeficiency virus (HIV", "SPECIES", 188, 221], ["cauliflower mosaic virus", "SPECIES", 260, 284], ["human", "SPECIES", 298, 303], ["H5N1 virus", "SPECIES", 323, 333], ["hepatitis A virus", "SPECIES", 345, 362], ["human immunodeficiency virus", "SPECIES", 188, 216], ["HIV", "SPECIES", 218, 221], ["cauliflower mosaic virus", "SPECIES", 260, 284], ["CMV", "SPECIES", 286, 289], ["human", "SPECIES", 298, 303], ["H5N1 virus", "SPECIES", 323, 333], ["hepatitis A virus", "SPECIES", 345, 362], ["codon usage", "TREATMENT", 10, 21], ["gene function", "TEST", 53, 66], ["IntroductionCodon usage", "TREATMENT", 108, 131], ["viruses", "PROBLEM", 171, 178], ["human immunodeficiency virus", "PROBLEM", 188, 216], ["nucleopolyhedroviruses", "TEST", 230, 252], ["cauliflower mosaic virus", "PROBLEM", 260, 284], ["human RNA viruses", "TEST", 298, 315], ["H5N1 virus", "PROBLEM", 323, 333], ["hepatitis A virus", "PROBLEM", 345, 362]]], ["For example, HIV has a marked codon usage bias, due to its strong preference for the A nucleotide [10] .", [["nucleotide", "CHEMICAL", 87, 97], ["nucleotide", "CHEMICAL", 87, 97], ["HIV", "ORGANISM", 13, 16], ["HIV", "SPECIES", 13, 16], ["HIV", "SPECIES", 13, 16], ["HIV", "PROBLEM", 13, 16], ["a marked codon usage bias", "PROBLEM", 21, 46], ["the A nucleotide", "TREATMENT", 81, 97]]], ["Rubella virus has a genomic G + C content of 0.70 [16] .", [["Rubella virus", "ORGANISM", 0, 13], ["G + C", "GENE_OR_GENE_PRODUCT", 28, 33], ["Rubella virus", "SPECIES", 0, 13], ["Rubella virus", "SPECIES", 0, 13], ["Rubella virus", "PROBLEM", 0, 13], ["a genomic G", "TEST", 18, 29], ["genomic G + C content", "OBSERVATION_MODIFIER", 20, 41]]], ["Codon usage in Epstein-Barr virus (a DNA virus) may have an influence on regulation of latent versus productive infection [17] .", [["infection", "DISEASE", 112, 121], ["Epstein-Barr virus", "ORGANISM", 15, 33], ["DNA", "CELLULAR_COMPONENT", 37, 40], ["Epstein-Barr virus", "SPECIES", 15, 33], ["Codon usage", "TREATMENT", 0, 11], ["Barr virus", "PROBLEM", 23, 33], ["a DNA virus", "PROBLEM", 35, 46], ["productive infection", "PROBLEM", 101, 121], ["latent", "OBSERVATION_MODIFIER", 87, 93], ["productive", "OBSERVATION_MODIFIER", 101, 111], ["infection", "OBSERVATION", 112, 121]]], ["These published studies are mostly restricted to particular groups of viruses and have usually addressed phylogenetic questions [11, [18] [19] [20] .", [["These published studies", "TEST", 0, 23], ["viruses", "OBSERVATION", 70, 77]]], ["Moreover, mutational pressure rather than translational selection is the most important determinant of the codon bias in some RNA viruses [11, 13, 14, 21, 22] .", [["mutational pressure", "TEST", 10, 29], ["translational selection", "TREATMENT", 42, 65], ["the codon bias", "PROBLEM", 103, 117], ["some RNA viruses", "PROBLEM", 121, 137], ["pressure", "OBSERVATION_MODIFIER", 21, 29], ["RNA viruses", "OBSERVATION", 126, 137]]], ["However, a recent study showed that the G + C compositional constraint is the main factor that determines the codon usage bias in iridovirus genomes [23] .", [["G + C", "GENE_OR_GENE_PRODUCT", 40, 45], ["iridovirus genomes", "DNA", 130, 148], ["a recent study", "TEST", 9, 23], ["the G + C compositional constraint", "TREATMENT", 36, 70], ["iridovirus genomes", "PROBLEM", 130, 148], ["iridovirus genomes", "OBSERVATION", 130, 148]]], ["Clearly, studies of the synonymous codon usage in viruses can reveal information about the molecular evolution of individual genes and such information would be relevant in understanding the regulation of viral gene expression and also to vaccine design where the efficient expression of viral proteins may be required to generate immunity [24] .IntroductionFoot-and-mouth disease (FMD) is a highly contagious disease of cattle and other cloven-hoofed animals.", [["IntroductionFoot-and-mouth disease", "DISEASE", 346, 380], ["FMD", "DISEASE", 382, 385], ["mouth", "ORGAN", 367, 372], ["cattle", "ORGANISM", 421, 427], ["viral proteins", "PROTEIN", 288, 302], ["IntroductionFoot-and-mouth", "SPECIES", 346, 372], ["cattle", "SPECIES", 421, 427], ["FMD", "SPECIES", 382, 385], ["cattle", "SPECIES", 421, 427], ["the synonymous codon usage in viruses", "PROBLEM", 20, 57], ["viral proteins", "PROBLEM", 288, 302], ["IntroductionFoot", "TEST", 346, 362], ["mouth disease", "PROBLEM", 367, 380], ["a highly contagious disease of cattle", "PROBLEM", 390, 427], ["synonymous codon", "OBSERVATION", 24, 40], ["mouth", "ANATOMY", 367, 372], ["disease", "OBSERVATION", 373, 380], ["highly", "OBSERVATION_MODIFIER", 392, 398], ["contagious", "OBSERVATION_MODIFIER", 399, 409]]], ["Apart from the influence on animal health and welfare, the economic impact of an outbreak of FMD can be of great importance for a country's export trade.", [["FMD", "DISEASE", 93, 96], ["FMD", "SPECIES", 93, 96]]], ["The 2001 European outbreak of FMD which mainly affected the UK is estimated to have cost of 6000 million Euros [25] .", [["FMD", "DISEASE", 30, 33], ["FMD", "SPECIES", 30, 33]]], ["Effective vaccines and stringent control measures have enabled FMD eradication in most developed countries, which maintain unvaccinated, seronegative herds in compliance with strict international trade policies.", [["FMD", "SPECIES", 63, 66], ["Effective vaccines", "TREATMENT", 0, 18], ["stringent control measures", "TREATMENT", 23, 49], ["FMD eradication", "TREATMENT", 63, 78], ["strict international trade policies", "TREATMENT", 175, 210]]], ["However, Outbreaks with devastating economic consequences still occur in many developing regions of Asia, Africa and South America, posing a serious problem for commercial trade with FMD-free countries.", [["devastating economic consequences", "PROBLEM", 24, 57], ["a serious problem", "PROBLEM", 139, 156]]], ["FMD is caused by FMD virus (FMDV), a small, non-enveloped virus that contains a single stranded positive-sense RNA genome of about 8500 nucleotides from the Aphthovirus genus of the Picornaviridae family.", [["FMD", "DISEASE", 0, 3], ["nucleotides", "CHEMICAL", 136, 147], ["FMD virus", "ORGANISM", 17, 26], ["FMDV", "ORGANISM", 28, 32], ["Aphthovirus genus", "ORGANISM", 157, 174], ["Picornaviridae", "GENE_OR_GENE_PRODUCT", 182, 196], ["FMDV", "SPECIES", 28, 32], ["FMD virus", "SPECIES", 17, 26], ["FMDV", "SPECIES", 28, 32], ["FMD virus (FMDV", "PROBLEM", 17, 32], ["a small, non-enveloped virus", "PROBLEM", 35, 63], ["a single stranded positive-sense RNA genome", "PROBLEM", 78, 121], ["virus", "OBSERVATION", 21, 26], ["small", "OBSERVATION_MODIFIER", 37, 42], ["non-enveloped virus", "OBSERVATION", 44, 63], ["sense RNA genome", "OBSERVATION_MODIFIER", 105, 121]]], ["The capsid is made of four proteins (VP1, VP2, VP3 and VP4) and there are seven serotypes (A, O, C, Asia I, SAT 1, SAT 2, and SAT 3) that can be further divided into many genotypes according to nucleotide difference in the capsid proteins [26] .", [["nucleotide", "CHEMICAL", 194, 204], ["nucleotide", "CHEMICAL", 194, 204], ["VP1", "GENE_OR_GENE_PRODUCT", 37, 40], ["VP2", "GENE_OR_GENE_PRODUCT", 42, 45], ["VP3", "GENE_OR_GENE_PRODUCT", 47, 50], ["VP4", "GENE_OR_GENE_PRODUCT", 55, 58], ["SAT 1", "GENE_OR_GENE_PRODUCT", 108, 113], ["SAT 2", "GENE_OR_GENE_PRODUCT", 115, 120], ["SAT 3", "GENE_OR_GENE_PRODUCT", 126, 131], ["VP1", "PROTEIN", 37, 40], ["VP2", "PROTEIN", 42, 45], ["VP3", "PROTEIN", 47, 50], ["VP4", "PROTEIN", 55, 58], ["SAT 1", "PROTEIN", 108, 113], ["SAT 2", "PROTEIN", 115, 120], ["SAT 3", "PROTEIN", 126, 131], ["capsid proteins", "PROTEIN", 223, 238], ["four proteins", "TEST", 22, 35], ["VP1", "TEST", 37, 40], ["VP2", "TEST", 42, 45], ["VP3", "TEST", 47, 50], ["VP4", "TEST", 55, 58], ["Asia I", "TEST", 100, 106], ["SAT", "TEST", 108, 111], ["SAT", "TEST", 115, 118], ["SAT", "TEST", 126, 129], ["the capsid proteins", "TEST", 219, 238], ["seven", "OBSERVATION_MODIFIER", 74, 79], ["serotypes", "OBSERVATION", 80, 89]]], ["Although genome sequences of FMDV have been published and some studies have been performed on them in recent years [27] [28] [29] [30] , little codon usage analysis is available.", [["FMDV", "ORGANISM", 29, 33], ["FMDV", "SPECIES", 29, 33], ["FMDV", "SPECIES", 29, 33], ["FMDV", "PROBLEM", 29, 33], ["some studies", "TEST", 58, 70], ["little codon usage analysis", "TEST", 137, 164]]], ["Such information might give some clues to the features of virus biology and some evolutionary information of this virus, and also it is of interest to understand the factors that shape codon usage in this species.", [["this virus", "PROBLEM", 109, 119]]], ["In the present study, the codon usage bias was analyzed in these seven serotypes of FMDV genomes.", [["FMDV", "ORGANISM", 84, 88], ["FMDV genomes", "DNA", 84, 96], ["FMDV", "SPECIES", 84, 88], ["FMDV", "SPECIES", 84, 88], ["the present study", "TEST", 3, 20], ["the codon usage bias", "TREATMENT", 22, 42], ["FMDV genomes", "OBSERVATION", 84, 96]]], ["The key evolutionary determinants of codon usage bias in these viruses were also investigated.FMDV genome sequencesA total of 40 FMDV genomes were used in this study (Table 1) , including 23 Type O genomes, four type A, six type C, two type Asia I , one Type SAT1, three Type SAT2, and one Type SAT3.", [["FMDV", "ORGANISM", 129, 133], ["SAT1", "GENE_OR_GENE_PRODUCT", 259, 263], ["SAT2", "GENE_OR_GENE_PRODUCT", 276, 280], ["SAT3", "GENE_OR_GENE_PRODUCT", 295, 299], ["FMDV genome", "DNA", 94, 105], ["40 FMDV genomes", "DNA", 126, 141], ["Type O genomes", "DNA", 191, 205], ["Type SAT1", "DNA", 254, 263], ["Type SAT2", "DNA", 271, 280], ["Type SAT3", "DNA", 290, 299], ["FMDV", "SPECIES", 94, 98], ["FMDV", "SPECIES", 129, 133], ["FMDV", "SPECIES", 94, 98], ["FMDV", "SPECIES", 129, 133], ["Asia I", "SPECIES", 241, 247], ["codon usage bias in these viruses", "PROBLEM", 37, 70], ["40 FMDV genomes", "TREATMENT", 126, 141], ["this study", "TEST", 155, 165], ["viruses", "OBSERVATION", 63, 70]]], ["The complete sequences these FMDV genomes were obtained from EMBI (http://www. ebi.ac.uk/cgi/) and NCBI (http://www.ncbi.nlm.nih.gov/).", [["FMDV", "ORGANISM", 29, 33], ["FMDV genomes", "DNA", 29, 41], ["ebi.ac.uk", "DNA", 79, 88], ["FMDV", "SPECIES", 29, 33], ["FMDV", "SPECIES", 29, 33]]], ["Serial number (SN), length of each genome, EMBI or GenBank accession numbers are listed in Table 1 .", [["EMBI", "DNA", 43, 47]]], ["FMDV genomes SN 6, 9, 13 and 19 have been reported to be from cattle.", [["cattle", "ORGANISM", 62, 68], ["FMDV genomes SN 6, 9, 13 and 19", "DNA", 0, 31], ["FMDV", "SPECIES", 0, 4], ["cattle", "SPECIES", 62, 68], ["FMDV", "SPECIES", 0, 4], ["cattle", "SPECIES", 62, 68]]], ["FMDV genomes SN 14, 23 were from pigs and FMDV genomes SN 15,16 and 17 have been reported to pig-adapted isolates carrying a deletion in 3A (codons93-102).", [["FMDV", "ORGANISM", 0, 4], ["SN 14", "ORGANISM", 13, 18], ["pigs", "ORGANISM", 33, 37], ["SN 15,16", "ORGANISM", 55, 63], ["FMDV genomes", "DNA", 0, 12], ["FMDV", "SPECIES", 0, 4], ["pigs", "SPECIES", 33, 37], ["FMDV", "SPECIES", 42, 46], ["FMDV", "SPECIES", 0, 4], ["pigs", "SPECIES", 33, 37], ["FMDV", "SPECIES", 42, 46], ["a deletion in 3A", "PROBLEM", 123, 139], ["codons93", "TEST", 141, 149]]], ["Alterations or deletion in this region are associated with the reduced ability of the virus to cause FMD in cattle.", [["FMD", "DISEASE", 101, 104], ["cattle", "SPECIES", 108, 114], ["FMD", "SPECIES", 101, 104], ["cattle", "SPECIES", 108, 114], ["deletion in this region", "PROBLEM", 15, 38], ["the virus", "PROBLEM", 82, 91], ["deletion", "OBSERVATION_MODIFIER", 15, 23]]], ["A program based on Perl has been developed to extract the annotated ORF sequences from each genome.Synonymous codon usage measuresIn order to examine synonymous codon usage without the confounding influence of amino acid composition of different ORF samples, relative synonymous codon usage values (RSCU) of different codons in each ORF sample was calculated as described previously [31] .", [["amino acid", "CHEMICAL", 210, 220], ["amino acid", "CHEMICAL", 210, 220], ["amino acid", "AMINO_ACID", 210, 220], ["ORF sequences", "DNA", 68, 81], ["the annotated ORF sequences", "TEST", 54, 81], ["Synonymous codon usage measures", "TREATMENT", 99, 130], ["synonymous codon usage", "TREATMENT", 150, 172], ["amino acid composition", "TREATMENT", 210, 232], ["different ORF samples", "PROBLEM", 236, 257], ["relative synonymous codon usage values", "PROBLEM", 259, 297], ["different codons", "TREATMENT", 308, 324], ["each ORF sample", "TEST", 328, 343], ["codon usage", "OBSERVATION", 110, 121], ["synonymous codon", "OBSERVATION", 268, 284]]], ["Additionally, the 'Effective Number of Codons' (ENC) was used to quantify the codon usage bias of a ORF [32] , which is the best overall estimator of absolute synonymous codon usage bias (Comeron and Aguade, 1998) [51] .", [["ORF", "DNA", 100, 103], ["Codons' (ENC)", "TREATMENT", 39, 52], ["synonymous codon", "OBSERVATION", 159, 175]]], ["The reported value of ENC is always between 20 (when only one codon is used for each amino acid) and 61 (when all codons are used equally) [32] .", [["amino acid", "CHEMICAL", 85, 95], ["amino acid", "CHEMICAL", 85, 95], ["amino acid", "AMINO_ACID", 85, 95], ["ENC", "DNA", 22, 25], ["ENC", "TEST", 22, 25], ["each amino acid", "TEST", 80, 95], ["all codons", "TREATMENT", 110, 120]]], ["GC 3S , the frequency of the nucleotide G + C at the synonymous third codon position (excluding Met, Trp and the termination codons), was also used to calculate the extent of base composition bias.", [["nucleotide", "CHEMICAL", 29, 39], ["nucleotide", "CHEMICAL", 29, 39], ["Met", "CHEMICAL", 96, 99], ["Trp", "CHEMICAL", 101, 104], ["GC 3S", "GENE_OR_GENE_PRODUCT", 0, 5], ["G + C", "GENE_OR_GENE_PRODUCT", 40, 45], ["Met", "GENE_OR_GENE_PRODUCT", 96, 99], ["Trp", "AMINO_ACID", 101, 104], ["synonymous third codon position", "DNA", 53, 84], ["GC 3S", "TEST", 0, 5], ["the nucleotide G", "TEST", 25, 41], ["Trp", "TEST", 101, 104], ["base", "OBSERVATION_MODIFIER", 175, 179], ["composition bias", "OBSERVATION", 180, 196]]], ["Similarly, GC 1S and GC 2S are the frequencies of the nucleotide G + C at the synonymous first and second position, respectively.", [["nucleotide", "CHEMICAL", 54, 64], ["nucleotide", "CHEMICAL", 54, 64], ["GC 1S", "GENE_OR_GENE_PRODUCT", 11, 16], ["GC 2S", "GENE_OR_GENE_PRODUCT", 21, 26], ["G + C", "GENE_OR_GENE_PRODUCT", 65, 70], ["nucleotide G + C", "DNA", 54, 70], ["synonymous first and second position", "DNA", 78, 114], ["GC 1S", "TEST", 11, 16], ["GC 2S", "TEST", 21, 26], ["the nucleotide G", "TEST", 50, 66], ["second", "OBSERVATION_MODIFIER", 99, 105], ["position", "OBSERVATION_MODIFIER", 106, 114]]], ["In oder to examine the relationship between codon usage variation and compositional constraints, the GC 1S , GC 2S and GC 3S of each selected ORF have been calculated.Correspondence analysisCorrespondence analysis (COA) was used to investigate the major trend in codon usage variation among ORFs.", [["GC 1S , GC 2S and GC 3S", "DNA", 101, 124], ["ORF", "DNA", 142, 145], ["ORFs", "DNA", 291, 295], ["codon usage variation", "TREATMENT", 44, 65], ["the GC 1S", "TEST", 97, 106], ["GC 2S", "TEST", 109, 114], ["GC 3S", "TEST", 119, 124], ["Correspondence analysisCorrespondence analysis", "TEST", 167, 213]]], ["In order to minimize the effect of amino acid composition on The axis of a correspondence analysis identifies the source of the variation among a set of multivariate data points.", [["amino acid", "CHEMICAL", 35, 45], ["amino acid", "CHEMICAL", 35, 45], ["amino acid", "AMINO_ACID", 35, 45], ["amino acid composition", "TREATMENT", 35, 57], ["a correspondence analysis", "TEST", 73, 98]]], ["This method has been successfully used to investigate the variation of RSCU values among ORFs [33] [34] [35] [36] [37] [38] .Statistical analysisCorrelation analysis was carried out using the Spearman's rank correlation analysis method.", [["[33] [34] [35] [36] [37]", "CHEMICAL", 94, 118], ["RSCU", "SIMPLE_CHEMICAL", 71, 75], ["[33] [34] [35] [36] [37] [38]", "SIMPLE_CHEMICAL", 94, 123], ["RSCU", "DNA", 71, 75], ["ORFs", "DNA", 89, 93], ["This method", "TREATMENT", 0, 11], ["Statistical analysis", "TEST", 125, 145], ["Correlation analysis", "TEST", 145, 165]]], ["Cluster analysis was done by Hierarchical cluster method and the distances between selected sequences were calculated by the Euclidean distance method.Analysis toolsThe RSCU, GC3s, ENC, G + C, GRAVY, Length value, and COA were calculated using the program CodonW version 1.4 (http://codonw.sourceforge.net).", [["G + C", "GENE_OR_GENE_PRODUCT", 186, 191], ["RSCU", "DNA", 169, 173], ["GC3s", "DNA", 175, 179], ["ENC", "DNA", 181, 184], ["Cluster analysis", "TEST", 0, 16], ["Analysis tools", "TEST", 151, 165], ["The RSCU", "TEST", 165, 173], ["GC3s", "TEST", 175, 179], ["ENC", "TEST", 181, 184], ["G", "TEST", 186, 187], ["Length value", "TEST", 200, 212], ["COA", "TEST", 218, 221], ["COA", "ANATOMY", 218, 221]]], ["The correlation analysis and Cluster analysis were carried out by using the multianalysis software SPSS version 13.0 (http://spss. com).Synonymous codon usage in FMDIn order to better understand the synonymous codon usage variation among FMDV isolates, the average codon usage was analyzed for these 40 FMDV genomes.", [["FMDV genomes", "DNA", 303, 315], ["FMDV", "SPECIES", 238, 242], ["FMDV", "SPECIES", 303, 307], ["FMDV", "SPECIES", 238, 242], ["FMDV", "SPECIES", 303, 307], ["The correlation analysis", "TEST", 0, 24], ["Cluster analysis", "TEST", 29, 45], ["SPSS version", "TEST", 99, 111], ["Synonymous codon usage", "TREATMENT", 136, 158], ["the synonymous codon usage", "TREATMENT", 195, 221], ["FMDV isolates", "TREATMENT", 238, 251], ["the average codon usage", "TREATMENT", 253, 276]]], ["As shown in Table 2 (see http://222.210.17.171/ yak/FMDV/ Table 2 . doc for details)., the codons ending in G or C are favored and the global pattern of codon usage is very similar among all FMDV genome examined, which indicates that there have not been significant compositional changes since these species diverged from their last common ancestor.Compositional properties of coding sequencesIn order to investigate if these 40 FMD viruses' coding sequences examined display similar compositional features, mean ENC and GC 3S , were calculated and summarized in Table 3 .", [["G or C", "GENE_OR_GENE_PRODUCT", 108, 114], ["yak/FMDV", "PROTEIN", 48, 56], ["FMDV genome", "DNA", 191, 202], ["coding sequences", "DNA", 377, 393], ["ENC", "DNA", 513, 516], ["FMDV", "SPECIES", 191, 195], ["FMDV", "SPECIES", 191, 195], ["the codons", "PROBLEM", 87, 97], ["codon usage", "PROBLEM", 153, 164], ["significant compositional changes", "PROBLEM", 254, 287], ["these species", "PROBLEM", 294, 307], ["coding sequences", "TEST", 377, 393], ["coding sequences", "TEST", 442, 458], ["mean ENC", "TEST", 508, 516], ["GC 3S", "TEST", 521, 526]]], ["The values of ENC among these FMDV genomes examined are very similar, which vary from 50.02 to 52.79 with a mean value of 51.58 and S.D. of 0.67.", [["FMDV", "ORGANISM", 30, 34], ["ENC", "DNA", 14, 17], ["FMDV genomes", "DNA", 30, 42], ["FMDV", "SPECIES", 30, 34], ["FMDV", "SPECIES", 30, 34], ["The values", "TEST", 0, 10], ["these FMDV genomes", "TEST", 24, 42], ["S.D.", "TEST", 132, 136]]], ["All the ENC values of these strains are more than 50.Compositional properties of coding sequencesThe data suggest the homogeneity of synonymous codon usage among FMDV genomes examined.", [["ENC", "DNA", 8, 11], ["coding sequences", "DNA", 81, 97], ["FMDV genomes", "DNA", 162, 174], ["FMDV", "SPECIES", 162, 166], ["FMDV", "SPECIES", 162, 166], ["All the ENC values", "TEST", 0, 18], ["these strains", "TEST", 22, 35], ["coding sequences", "TEST", 81, 97], ["The data", "TEST", 97, 105], ["synonymous codon usage", "TREATMENT", 133, 155], ["synonymous codon", "OBSERVATION", 133, 149]]], ["The concept is further supported by the GC 3S values for each FMDV strain, which range from 61.00 to 68.00% with a mean of 63.80% and S.D. of 0.01.", [["FMDV", "SPECIES", 62, 66], ["FMDV", "SPECIES", 62, 66], ["the GC 3S values", "TEST", 36, 52], ["each FMDV strain", "PROBLEM", 57, 73], ["S.D.", "TEST", 134, 138]]], ["Therefore, taken together with published data of codon usage bias among some RNA viruses [5, 13, [39] [40] [41] , we could conclude that codon usage bias in FMDV genomes is less biased, and there is no significant variation of synonymous codon usage among FMDV seven serotypes.Correspondence analysis on codon usageIn order to investigate the variation of RSCU values among ORFs, correspondence analysis (COA) was implemented on these 40 FMDV genomes examined as a single-datasetbased on the RSCU value of each strain' ORFs.", [["FMDV", "ORGANISM", 157, 161], ["FMDV genomes", "DNA", 157, 169], ["RSCU", "DNA", 356, 360], ["ORFs", "DNA", 374, 378], ["FMDV genomes", "DNA", 438, 450], ["ORFs", "DNA", 519, 523], ["FMDV", "SPECIES", 157, 161], ["FMDV", "SPECIES", 256, 260], ["FMDV", "SPECIES", 438, 442], ["FMDV", "SPECIES", 157, 161], ["FMDV", "SPECIES", 256, 260], ["FMDV", "SPECIES", 438, 442], ["codon usage bias", "PROBLEM", 49, 65], ["some RNA viruses", "PROBLEM", 72, 88], ["codon usage bias in FMDV genomes", "PROBLEM", 137, 169], ["synonymous codon usage", "TREATMENT", 227, 249], ["Correspondence analysis", "TEST", 277, 300], ["codon usageIn", "TREATMENT", 304, 317], ["RSCU values", "TEST", 356, 367], ["correspondence analysis", "TEST", 380, 403], ["no", "UNCERTAINTY", 199, 201], ["significant", "OBSERVATION_MODIFIER", 202, 213], ["synonymous codon", "OBSERVATION", 227, 243]]], ["As mentioned, the axis of a correspondence analysis identifies the source of the variation among a set of multivariate data points.", [["a correspondence analysis", "TEST", 26, 51]]], ["The four largest trends in codon usage among these ORFs were observed: the first axis accounts for 31.20% of all variation among genomes, whereas the next three axes accounts for 16.50%, 12.40%, and 8.10%, respectively.Effect of mutational bias on codon usageIn order to investigate if the evolution of codon usage bias is controlled by mutation pressure or by natural selection, firstly, G + C content at the first and second codon positions (G + C 12 ) was compared with that at synonymous third codon positions (G + C 3S ) (Fig. 1) .", [["G + C", "GENE_OR_GENE_PRODUCT", 389, 394], ["ORFs", "DNA", 51, 55], ["first and second codon positions", "DNA", 410, 442], ["synonymous third codon positions", "DNA", 481, 513], ["codon usage", "TREATMENT", 27, 38], ["these ORFs", "TEST", 45, 55], ["mutational bias", "PROBLEM", 229, 244], ["codon usage", "TREATMENT", 248, 259], ["codon usage bias", "PROBLEM", 303, 319], ["mutation pressure", "TEST", 337, 354], ["G + C content", "PROBLEM", 389, 402], ["G + C", "TEST", 444, 449], ["G", "TEST", 515, 516], ["four", "OBSERVATION_MODIFIER", 4, 8], ["largest", "OBSERVATION_MODIFIER", 9, 16]]], ["A highly significant correlation was observed (r = 0.432, P \u00a00.05), indicating that patterns of base composition are most likely the result of mutation pressure, and not natural selection, since the effects are present at all codon positions.", [["base composition", "PROBLEM", 96, 112], ["mutation pressure", "PROBLEM", 143, 160], ["base", "ANATOMY_MODIFIER", 96, 100], ["most likely", "UNCERTAINTY", 117, 128], ["mutation pressure", "OBSERVATION", 143, 160]]], ["Second, for each strain, actual codon bias was plotted against both G + C 3S and the expected ENC value if codon usage bias is solely due to biased base composition (i.e., G + C content).Effect of mutational bias on codon usageResult showed that the actual codon usage indices are close to the values expected from their G + C composition, although all are slightly lower (Fig. 2) .", [["G + C 3S", "GENE_OR_GENE_PRODUCT", 68, 76], ["G + C", "SIMPLE_CHEMICAL", 172, 177], ["G + C", "SIMPLE_CHEMICAL", 321, 326], ["ENC", "DNA", 94, 97], ["each strain", "PROBLEM", 12, 23], ["actual codon bias", "PROBLEM", 25, 42], ["codon usage bias", "PROBLEM", 107, 123], ["biased base composition", "PROBLEM", 141, 164], ["mutational bias", "PROBLEM", 197, 212], ["codon usage", "TREATMENT", 216, 227], ["the actual codon usage indices", "PROBLEM", 246, 276], ["their G + C composition", "PROBLEM", 315, 338], ["slightly", "OBSERVATION_MODIFIER", 357, 365], ["lower", "OBSERVATION", 366, 371]]], ["Thirdly, we plotted the first and second axis values in COA and GC 3S values of each strains (Fig. 3A,B) .", [["COA", "TEST", 56, 59], ["COA", "ANATOMY", 56, 59]]], ["The patterns of codon usage in different strains also appear to be closely related to the GC content on the third codon position.", [["third codon position", "DNA", 108, 128], ["codon usage", "TREATMENT", 16, 27], ["different strains", "PROBLEM", 31, 48], ["codon usage", "OBSERVATION", 16, 27], ["GC content", "OBSERVATION", 90, 100]]], ["Linear regression analysis has been implemented to each virus genome to find some correlation between synonymous codon usage and nucleotide compositions of the ORFs.", [["nucleotide", "CHEMICAL", 129, 139], ["nucleotide", "CHEMICAL", 129, 139], ["virus genome", "DNA", 56, 68], ["ORFs", "DNA", 160, 164], ["Linear regression analysis", "PROBLEM", 0, 26], ["synonymous codon usage", "TREATMENT", 102, 124], ["nucleotide compositions", "TREATMENT", 129, 152], ["synonymous codon", "OBSERVATION", 102, 118]]], ["We also found that axis 1 coordinates are correlated with GC 3S and GC (r = 0.843, P \u00a00.01; r = 0.813, P \u00a00.01), while there are significant correlations between axis 2 value and GC 3S (r = 0.355, P \u00a00.05).", [["GC 3S", "GENE_OR_GENE_PRODUCT", 179, 184], ["GC 3S", "TEST", 58, 63], ["GC", "TEST", 68, 70], ["P", "TEST", 83, 84], ["r", "TEST", 92, 93], ["P", "TEST", 103, 104], ["axis", "TEST", 162, 166], ["GC", "TEST", 179, 181], ["P", "TEST", 197, 198]]], ["Taken together, these analyses indicate that most of the codon usage bias among these FMDV genomes is directly related to the nucleotide composition.", [["nucleotide", "CHEMICAL", 126, 136], ["nucleotide", "CHEMICAL", 126, 136], ["FMDV", "ORGANISM", 86, 90], ["FMDV genomes", "DNA", 86, 98], ["FMDV", "SPECIES", 86, 90], ["FMDV", "SPECIES", 86, 90], ["these analyses", "TEST", 16, 30], ["the codon usage bias", "TREATMENT", 53, 73], ["these FMDV genomes", "PROBLEM", 80, 98], ["FMDV genomes", "OBSERVATION", 86, 98]]], ["Furthermore mutational bias is the major factor responsible for the variation of synonymous codon usage among ORFs in these virus genomes.Effect of other factors on codon usageGenerally, mutational bias and natural selection, such as, ORF length and the hydrophobicity of each protein are thought to be the factors accounting for the codon usage variation among ORFs in different organisms.", [["ORFs", "DNA", 110, 114], ["virus genomes", "DNA", 124, 137], ["ORF length", "DNA", 235, 245], ["ORFs", "DNA", 362, 366], ["mutational bias", "PROBLEM", 12, 27], ["synonymous codon usage", "PROBLEM", 81, 103], ["ORFs in these virus genomes", "PROBLEM", 110, 137], ["other factors", "PROBLEM", 148, 161], ["codon usage", "TREATMENT", 165, 176], ["mutational bias and natural selection", "PROBLEM", 187, 224], ["ORF length", "TEST", 235, 245], ["the hydrophobicity of each protein", "PROBLEM", 250, 284], ["the codon usage variation", "PROBLEM", 330, 355], ["ORFs in different organisms", "PROBLEM", 362, 389], ["synonymous codon", "OBSERVATION", 81, 97], ["virus genomes", "OBSERVATION", 124, 137], ["thought to be", "UNCERTAINTY", 289, 302]]], ["However, whether there is any selection pressure that also contributes to the codon usage variation among these virus ORFs and which selection pressure determines the codon usage variation remained to be understood.", [["virus ORFs", "DNA", 112, 122], ["any selection pressure", "PROBLEM", 26, 48], ["the codon usage variation", "PROBLEM", 74, 99], ["these virus ORFs", "TREATMENT", 106, 122], ["selection pressure", "TEST", 133, 151]]], ["Therefore, we performed a linear regression analysis on axis 1, axis 2 and axis 3 between the hydrophobicity of each protein and ORF length.", [["a linear regression analysis", "TEST", 24, 52], ["axis", "TEST", 56, 60], ["axis", "TEST", 64, 68], ["length", "OBSERVATION_MODIFIER", 133, 139]]], ["It was found that axis 2 coordinates are also significantly correlated with the hydrophobicity of each protein (r = 0.659, P \u00a00.01), while axis 1 and axis 3 coordinates are also significantly correlated with the ORF length (r = -0.564, P \u00a00.01; r = 0.610, P \u00a00.01) respectively, indicating that the hydrophobicity of each protein and ORF length are also critical in affecting these viruses' codon usage, although they were less important than that of the mutational bias.ClusterBased on the RSCU variation of these 40 FMDV strains examined, a cluster tree was generated by using a hierarchical cluster method.", [["axis 1", "GENE_OR_GENE_PRODUCT", 139, 145], ["axis 3", "GENE_OR_GENE_PRODUCT", 150, 156], ["FMDV", "SPECIES", 518, 522], ["FMDV", "SPECIES", 518, 522], ["each protein", "TEST", 98, 110], ["P", "TEST", 123, 124], ["the ORF length", "TEST", 208, 222], ["P", "TEST", 236, 237], ["P", "TEST", 256, 257], ["the hydrophobicity of each protein and ORF length", "PROBLEM", 295, 344], ["these 40 FMDV strains", "PROBLEM", 509, 530], ["a hierarchical cluster method", "TREATMENT", 579, 608]]], ["As shown in Fig. 4 , these 40 FMDV strains examined were divided into three main lineages (I, II and III).", [["FMDV", "ORGANISM", 30, 34], ["FMDV", "SPECIES", 30, 34], ["FMDV", "SPECIES", 30, 34], ["these 40 FMDV strains", "TEST", 21, 42]]], ["Lineage I mainly contained strains of A, O, C and Asia 1, and branched to give eight sublineages (I1-I8).", [["O, C", "CELL", 41, 45], ["Asia 1", "CELL", 50, 56], ["strains", "OBSERVATION_MODIFIER", 27, 34]]], ["Five C [27] [28] [29] [30] 39] strains were clustered into sublineage I1 and another C [26] was clustered into sublineage I5 separately.", [["sublineage I1", "DNA", 59, 72], ["sublineage I5", "DNA", 111, 124], ["strains", "PROBLEM", 31, 38]]], ["Two O [1, 6] strains were clustered into sublineage I3.", [["strains", "PROBLEM", 13, 20], ["sublineage I3", "OBSERVATION", 41, 54]]], ["Sublineage I4 was composed of the two O strains [2] , while 14 A strains [3-5, 8-13, 17-20, 22] and one Asia 1 strain [31] were clustered into sublineage I6.", [["A", "GENE_OR_GENE_PRODUCT", 63, 64], ["Asia 1", "SPECIES", 104, 110], ["Sublineage I4", "TREATMENT", 0, 13]]], ["Lineage II comprised five strains [33] [34] [35] [36] 37 ] from SAT1, SAT2 and SAT3.ClusterLineage III included five strains [7, [14] [15] [16] 21] from O.DiscussionCodon usage bias in FMDV was investigated in the present study.", [["SAT1", "GENE_OR_GENE_PRODUCT", 64, 68], ["SAT2", "GENE_OR_GENE_PRODUCT", 70, 74], ["SAT3", "GENE_OR_GENE_PRODUCT", 79, 83], ["[14] [15] [16] 21", "SIMPLE_CHEMICAL", 129, 146], ["O.DiscussionCodon", "SIMPLE_CHEMICAL", 153, 170], ["FMDV", "ORGANISM", 185, 189], ["SAT3", "PROTEIN", 79, 83], ["FMDV", "SPECIES", 185, 189], ["FMDV", "SPECIES", 185, 189], ["Lineage II comprised five strains", "PROBLEM", 0, 33], ["SAT1", "TEST", 64, 68], ["SAT2", "TEST", 70, 74], ["SAT3", "TEST", 79, 83], ["five strains", "TEST", 112, 124], ["the present study", "TEST", 210, 227]]], ["Up to now, it is unclear how FMDV serotypes might affect codon choice in FMD viruses and we used RSCU [42] , ENC [32] , COA [43, 44] and GC 3S , to measure the synonymous codon usage bias in order to minimize the effects of serotypes on codon bias, which have been successfully used to analyze the variation of codon usage among different viruses species [11, 13, 14, 22, 45, 46] .", [["FMDV", "ORGANISM", 29, 33], ["FMDV", "SPECIES", 29, 33], ["FMDV", "SPECIES", 29, 33], ["FMD viruses", "SPECIES", 73, 84], ["FMDV serotypes", "PROBLEM", 29, 43], ["COA", "TEST", 120, 123], ["GC 3S", "TEST", 137, 142], ["codon bias", "TREATMENT", 237, 247], ["codon usage", "TREATMENT", 311, 322], ["different viruses species", "PROBLEM", 329, 354]]], ["The analysis revealed that codon usage bias is low in most cases.", [["The analysis", "TEST", 0, 12], ["codon usage bias", "PROBLEM", 27, 43], ["low", "OBSERVATION_MODIFIER", 47, 50]]], ["In the case of human RNA viruses, the average ENC value also probably lies close to 45 since the distribution of values for [13] individual virus ranges uniformly from just under 38.5 to 58.3 [13] .", [["human", "ORGANISM", 15, 20], ["ENC", "DNA", 46, 49], ["human", "SPECIES", 15, 20], ["human", "SPECIES", 15, 20], ["human RNA viruses", "PROBLEM", 15, 32], ["the average ENC value", "TEST", 34, 55], ["individual virus ranges", "TEST", 129, 152], ["RNA viruses", "OBSERVATION", 21, 32]]], ["One possible explanation about why FMDV had had a lower codon usage bias than other RNA viruses [13, 14, 22, 47] is that a low bias is advantageous to viruses that need to replicate efficiently in vertebrate cells, with potentially distinct codon preferences.", [["cells", "ANATOMY", 208, 213], ["FMDV", "ORGANISM", 35, 39], ["cells", "CELL", 208, 213], ["vertebrate cells", "CELL_TYPE", 197, 213], ["FMDV", "SPECIES", 35, 39], ["FMDV", "SPECIES", 35, 39], ["FMDV", "PROBLEM", 35, 39], ["a lower codon usage bias", "PROBLEM", 48, 72], ["other RNA viruses", "PROBLEM", 78, 95], ["a low bias", "PROBLEM", 121, 131], ["viruses", "PROBLEM", 151, 158], ["distinct codon", "OBSERVATION", 232, 246]]], ["A general mutational bias, which affects the whole genome would, certainly account for the majority of the codon usage variation.", [["A general mutational bias", "PROBLEM", 0, 25], ["mutational bias", "OBSERVATION", 10, 25]]], ["The genome base compositions affected the codon usage in Entamoeba histolytica genome [48] .", [["Entamoeba histolytica", "ORGANISM", 57, 78], ["Entamoeba histolytica", "SPECIES", 57, 78], ["Entamoeba histolytica", "SPECIES", 57, 78], ["The genome base compositions", "TREATMENT", 0, 28], ["base", "OBSERVATION_MODIFIER", 11, 15], ["compositions", "OBSERVATION_MODIFIER", 16, 28]]], ["Although the Chlamydomonas reinhardtii genome [49] had high GC contents, there was a little evidence that the genome composition shaped the codon usages in this genome.", [["Chlamydomonas reinhardtii", "ORGANISM", 13, 38], ["Chlamydomonas reinhardtii genome", "DNA", 13, 45], ["Chlamydomonas reinhardtii", "SPECIES", 13, 38], ["Chlamydomonas reinhardtii", "SPECIES", 13, 38], ["the Chlamydomonas reinhardtii genome", "PROBLEM", 9, 45], ["high GC contents", "PROBLEM", 55, 71], ["Chlamydomonas", "OBSERVATION", 13, 26], ["reinhardtii genome", "OBSERVATION", 27, 45], ["codon usages", "OBSERVATION", 140, 152]]], ["C. elegans showed a weak, but statistically significantly negative correlation between 'G + C' content and gene expression levels [50] .", [["C. elegans", "ORGANISM", 0, 10], ["G + C", "GENE_OR_GENE_PRODUCT", 88, 93], ["C. elegans", "SPECIES", 0, 10], ["C. elegans", "SPECIES", 0, 10], ["C. elegans", "TEST", 0, 10], ["a weak", "PROBLEM", 18, 24], ["gene expression levels", "TEST", 107, 129]]], ["In human RNA viruses, H5N1 virus and SARS Coronavirus, mutation pressure rather than natural (translational) selection is the most important determinant of the codon bias.", [["SARS", "DISEASE", 37, 41], ["human", "ORGANISM", 3, 8], ["H5N1 virus", "ORGANISM", 22, 32], ["SARS Coronavirus", "ORGANISM", 37, 53], ["human", "SPECIES", 3, 8], ["H5N1 virus", "SPECIES", 22, 32], ["human", "SPECIES", 3, 8], ["H5N1 virus", "SPECIES", 22, 32], ["human RNA viruses", "PROBLEM", 3, 20], ["H5N1 virus", "PROBLEM", 22, 32], ["SARS Coronavirus", "PROBLEM", 37, 53], ["mutation pressure", "TEST", 55, 72], ["natural (translational) selection", "TREATMENT", 85, 118], ["RNA viruses", "OBSERVATION", 9, 20], ["H5N1 virus", "OBSERVATION", 22, 32]]], ["In this study, the general association between codon usage bias and base composition suggests that mutational pressure, rather than natural (translational) selection is supported by the highly significant correlation between GC 12 and GC 3S (r = 0.432, P \u00a00.05), and the result of ENC-plot (Fig. 2) .", [["this study", "TEST", 3, 13], ["mutational pressure", "PROBLEM", 99, 118], ["GC", "TEST", 225, 227], ["GC 3S", "TEST", 235, 240], ["P", "TEST", 253, 254], ["ENC", "TEST", 281, 284], ["mutational pressure", "OBSERVATION", 99, 118]]], ["The fact that GC content varies in a similar way at all codon positions is usually assumed to be the result of mutational bias.", [["GC content", "PROBLEM", 14, 24], ["mutational bias", "PROBLEM", 111, 126], ["GC content", "OBSERVATION", 14, 24]]], ["A general mutational bias, which affects the whole genome would certainly account for the majority of the codon usage variation.", [["A general mutational bias", "PROBLEM", 0, 25], ["mutational bias", "OBSERVATION", 10, 25]]], ["A similar pattern of codon usage has been reported amongst some RNA viruses [13] .", [["codon usage", "PROBLEM", 21, 32], ["codon usage", "OBSERVATION", 21, 32]]], ["Since mutation rates in RNA viruses are much higher than those in DNA viruses [40] , it is understandable that mutation pressure is the determinant source of codon usage bias in the 40 FMDV strains included in this study.", [["DNA", "CELLULAR_COMPONENT", 66, 69], ["FMDV", "SPECIES", 185, 189], ["FMDV", "SPECIES", 185, 189], ["mutation rates in RNA viruses", "PROBLEM", 6, 35], ["DNA viruses", "PROBLEM", 66, 77], ["mutation pressure", "TEST", 111, 128], ["codon usage bias", "PROBLEM", 158, 174], ["this study", "TEST", 210, 220], ["RNA viruses", "OBSERVATION", 24, 35]]], ["Therefore, mutational bias is the major factor responsible for the variation of synonymous codon usage among ORFs in these virus genomes.DiscussionIn Drosophila [51] genome, longer genes had lower codon usage bias.", [["ORFs", "DNA", 109, 113], ["virus genomes", "DNA", 123, 136], ["Drosophila [51] genome", "DNA", 150, 172], ["Drosophila", "SPECIES", 150, 160], ["mutational bias", "PROBLEM", 11, 26], ["synonymous codon usage", "PROBLEM", 80, 102], ["ORFs in these virus genomes", "PROBLEM", 109, 136], ["synonymous codon", "OBSERVATION", 80, 96], ["virus genomes", "OBSERVATION", 123, 136]]], ["But, the longer genes had higher expression level and higher codon usage bias in S.penumoniaes genome [52] .", [["S.penumoniaes genome", "DNA", 81, 101], ["higher expression level", "PROBLEM", 26, 49]]], ["In some virus, such as nucleopolyhedroviruses [11] , H5N1 virus [14] , SARS Coronavirus [22] , adenoviruses [47] , ORF length has no effect on the variations of synonymous codon usage.", [["SARS Coronavirus", "DISEASE", 71, 87], ["H5N1 virus [14]", "ORGANISM", 53, 68], ["SARS Coronavirus", "ORGANISM", 71, 87], ["adenoviruses", "ORGANISM", 95, 107], ["ORF length", "DNA", 115, 125], ["H5N1 virus", "SPECIES", 53, 63], ["H5N1 virus", "SPECIES", 53, 63], ["some virus", "PROBLEM", 3, 13], ["nucleopolyhedroviruses", "TEST", 23, 45], ["H5N1 virus", "PROBLEM", 53, 63], ["SARS Coronavirus", "TEST", 71, 87], ["adenoviruses", "TEST", 95, 107], ["ORF length", "TEST", 115, 125], ["synonymous codon usage", "TREATMENT", 161, 183], ["virus", "OBSERVATION", 8, 13], ["no", "UNCERTAINTY", 130, 132], ["synonymous codon", "OBSERVATION", 161, 177]]], ["Those indicated that different genomes had different ORF lengths which accommodated their particular genome's best requirements, and there were not universal rules about ORF length and codon usage in all genomes.", [["ORF lengths", "DNA", 53, 64], ["ORF length", "DNA", 170, 180], ["different ORF lengths", "PROBLEM", 43, 64], ["ORF length", "PROBLEM", 170, 180]]], ["In this study, the ORF length had played a critical role in affecting FMDV codon usage.", [["FMDV", "ORGANISM", 70, 74], ["ORF length", "DNA", 19, 29], ["FMDV", "SPECIES", 70, 74], ["FMDV", "SPECIES", 70, 74], ["this study", "TEST", 3, 13], ["FMDV codon", "OBSERVATION", 70, 80]]], ["The mechanisms that lead this is not clear, which is needed a more comprehensive analysis.DiscussionIt was reported that codon choices were influenced the hydropathy level of each protein in Chlamydia trachomatis, and Thermotoga maritime [53, 54] .", [["Chlamydia trachomatis", "DISEASE", 191, 212], ["Chlamydia trachomatis", "ORGANISM", 191, 212], ["Chlamydia trachomatis", "SPECIES", 191, 212], ["Chlamydia trachomatis", "SPECIES", 191, 212], ["a more comprehensive analysis", "TEST", 60, 89], ["codon choices", "PROBLEM", 121, 134], ["the hydropathy level", "PROBLEM", 151, 171], ["Chlamydia trachomatis", "PROBLEM", 191, 212], ["Chlamydia trachomatis", "OBSERVATION", 191, 212]]], ["In this study, codon usage is significantly positively correlated with the hydrophobicity of each FMDV.", [["FMDV", "SPECIES", 98, 102], ["FMDV", "SPECIES", 98, 102], ["this study", "TEST", 3, 13]]], ["The link with hydropathy and codon usage may be caused by the fact that the expressed sequences are hydrophilic just because they accomplish their function in the aqueous media of the cell.DiscussionUp to date, phylogenetic analyses have been performed largely on FMDV sequences from the 1D coding regions.", [["cell", "ANATOMY", 184, 188], ["cell", "CELL", 184, 188], ["FMDV sequences", "DNA", 264, 278], ["1D coding regions", "DNA", 288, 305], ["FMDV", "SPECIES", 264, 268], ["FMDV", "SPECIES", 264, 268], ["hydropathy", "PROBLEM", 14, 24], ["codon usage", "TREATMENT", 29, 40], ["phylogenetic analyses", "TEST", 211, 232], ["FMDV sequences", "TEST", 264, 278], ["hydropathy", "OBSERVATION", 14, 24], ["codon usage", "OBSERVATION", 29, 40], ["cell", "ANATOMY", 184, 188]]], ["These analyses have permitted the discrimination among serotypically related FMDV strains [55] .", [["FMDV", "ORGANISM", 77, 81], ["FMDV", "SPECIES", 77, 81], ["FMDV", "SPECIES", 77, 81], ["These analyses", "TEST", 0, 14], ["FMDV strains", "PROBLEM", 77, 89]]], ["Another analysis of the complete FMDV genomes indicated phylogenetic incongruities between different genomic regions which were suggestive of interserotypic recombination [56] .", [["FMDV genomes", "DNA", 33, 45], ["genomic regions", "DNA", 101, 116], ["FMDV", "SPECIES", 33, 37], ["FMDV", "SPECIES", 33, 37], ["Another analysis", "TEST", 0, 16], ["the complete FMDV genomes", "PROBLEM", 20, 45], ["phylogenetic incongruities between different genomic regions", "PROBLEM", 56, 116], ["interserotypic recombination", "PROBLEM", 142, 170], ["FMDV", "OBSERVATION", 33, 37], ["phylogenetic incongruities", "OBSERVATION", 56, 82], ["suggestive of", "UNCERTAINTY", 128, 141], ["interserotypic recombination", "OBSERVATION", 142, 170]]], ["In this study, phylogenetic analyses based on the RSCU values of the 40 FMDV strains examined were carried out using a hierarchical cluster method.", [["FMDV", "SPECIES", 72, 76], ["FMDV", "SPECIES", 72, 76], ["this study", "TEST", 3, 13], ["phylogenetic analyses", "TEST", 15, 36], ["the RSCU values", "TEST", 46, 61], ["the 40 FMDV strains", "TEST", 65, 84], ["a hierarchical cluster method", "TREATMENT", 117, 146]]], ["The result indicated complex phylogenetic relationships also exist between different FMDV isolates as determined by Carrillo et al.Discussion2005 [56] .", [["FMDV", "ORGANISM", 85, 89], ["FMDV", "SPECIES", 85, 89], ["FMDV", "SPECIES", 85, 89], ["complex phylogenetic relationships", "PROBLEM", 21, 55], ["different FMDV isolates", "TREATMENT", 75, 98], ["complex", "OBSERVATION_MODIFIER", 21, 28], ["phylogenetic", "OBSERVATION", 29, 41]]], ["For instance, Five O strains (HKN/2002, Tau-Yuan TW97 (Taiwan, 1997), Chu-Pei (Taiwan) (pig strain), Yunlin/Taiwan/97, and lz were clustered into Lineage III; One C strain (Argentina/85) was clustered into sublineageI5 and one Asia 1 strain (YNBS/China/58) was clustered into sublineageI6.", [["Tau-Yuan TW97", "ORGANISM", 40, 53], ["Chu-Pei (Taiwan) (pig strain", "ORGANISM", 70, 98], ["Yunlin/Taiwan/97", "ORGANISM", 101, 117], ["lz", "GENE_OR_GENE_PRODUCT", 123, 125], ["One C strain", "ORGANISM", 159, 171], ["pig", "SPECIES", 88, 91], ["pig", "SPECIES", 88, 91], ["Yunlin/Taiwan/97", "SPECIES", 101, 117], ["Asia 1 strain (YNBS/China/58", "SPECIES", 227, 255], ["Yunlin/Taiwan", "TREATMENT", 101, 114], ["One C strain", "PROBLEM", 159, 171], ["lz", "ANATOMY", 123, 125]]], ["Although they all belong to EURO-SA topotype [55] , five C in sublineage I1 are subserotype C1 and one C in sublineage I5 is sub-serotype C3.", [["EURO", "GENE_OR_GENE_PRODUCT", 28, 32], ["subserotype C1", "GENE_OR_GENE_PRODUCT", 80, 94], ["EURO", "PROTEIN", 28, 32], ["sub", "OBSERVATION_MODIFIER", 125, 128], ["serotype C3", "OBSERVATION", 129, 140]]], ["The three A strains in Sublineage I2 was EURO-SA topotype and A strains sublineageI8 is Asia topotype, O stains in sublineageI3 is EURO-SA topotype, while 14 O strains in sublineage I6 belong to ME-SA topotype, PanAsia stains, were clustered into.", [["Sublineage I2", "CELL", 23, 36], ["EURO", "GENE_OR_GENE_PRODUCT", 41, 45], ["O stains", "SIMPLE_CHEMICAL", 103, 111], ["sublineageI3", "ORGANISM", 115, 127], ["EURO", "GENE_OR_GENE_PRODUCT", 131, 135], ["ME-SA", "GENE_OR_GENE_PRODUCT", 195, 200], ["EURO", "TEST", 41, 45], ["A strains sublineageI8", "PROBLEM", 62, 84], ["PanAsia stains", "TEST", 211, 225]]], ["O strains in Lineage III are Cathay topotype.", [["Lineage III", "GENE_OR_GENE_PRODUCT", 13, 24], ["Lineage III", "OBSERVATION_MODIFIER", 13, 24]]], ["All five SAT strains were clustered into Lineage II.", [["Lineage II", "PROTEIN", 41, 51], ["All five SAT strains", "PROBLEM", 0, 20]]], ["Taken together, just as stated by other researchers [30, [56] [57] [58] , these results suggest that FMDV sequences may undergo intertypic recombination, which conceivably undergo complex recombination events and the result of phylogenetic analyses based on the RSCU values fail to display serotype-specific phylogenetic relationships.", [["FMDV", "ORGANISM", 101, 105], ["RSCU", "GENE_OR_GENE_PRODUCT", 262, 266], ["FMDV sequences", "DNA", 101, 115], ["FMDV", "SPECIES", 101, 105], ["FMDV", "SPECIES", 101, 105], ["FMDV sequences", "TEST", 101, 115], ["intertypic recombination", "TREATMENT", 128, 152], ["complex recombination events", "PROBLEM", 180, 208], ["phylogenetic analyses", "TEST", 227, 248], ["the RSCU values", "TEST", 258, 273]]], ["These observations raise interesting questions about FMDV genome evolution in nature and the relative contribution of recombination to the generation of FMDV genetic and population diversity.DiscussionAs we know FMD is highly contagious, affects all cloven-hoofed animals, and is caused by FMDV that exists as antigenically diverse serotypes and intra-typical variants (subtypes); Some published results has shown that the overall extent of codon usage bias in RNA viruses is low and there is a little variation in bias between genes or genomes [13, 14, 21, 22] .", [["FMD", "DISEASE", 212, 215], ["FMDV", "ORGANISM", 53, 57], ["FMDV", "ORGANISM", 290, 294], ["FMDV genome", "DNA", 53, 64], ["FMDV", "SPECIES", 53, 57], ["FMDV", "SPECIES", 153, 157], ["FMDV", "SPECIES", 290, 294], ["FMDV", "SPECIES", 53, 57], ["FMDV", "SPECIES", 153, 157], ["FMDV", "SPECIES", 290, 294], ["FMDV", "PROBLEM", 53, 57], ["FMDV genetic", "TREATMENT", 153, 165], ["FMDV", "PROBLEM", 290, 294], ["antigenically diverse serotypes and intra-typical variants", "PROBLEM", 310, 368], ["codon usage bias in RNA viruses", "PROBLEM", 441, 472], ["codon usage", "OBSERVATION", 441, 452], ["RNA viruses", "OBSERVATION", 461, 472], ["low", "OBSERVATION_MODIFIER", 476, 479], ["little", "OBSERVATION_MODIFIER", 495, 501], ["variation", "OBSERVATION_MODIFIER", 502, 511]]], ["Our analysis revealed that although there are a few, variations in codon usage bias among different FMD viruses, codon usage bias in FMDV is low.", [["FMD viruses", "ORGANISM", 100, 111], ["FMDV", "ORGANISM", 133, 137], ["FMDV", "SPECIES", 133, 137], ["FMD viruses", "SPECIES", 100, 111], ["FMDV", "SPECIES", 133, 137], ["Our analysis", "TEST", 0, 12], ["a few, variations in codon usage bias", "PROBLEM", 46, 83], ["different FMD viruses", "PROBLEM", 90, 111], ["codon usage", "TREATMENT", 113, 124], ["few", "OBSERVATION_MODIFIER", 48, 51], ["FMD", "OBSERVATION_MODIFIER", 100, 103], ["viruses", "OBSERVATION", 104, 111], ["low", "OBSERVATION_MODIFIER", 141, 144]]], ["Due to lack of data and politic factors, in this article, it is impossible to obtain information on the virus isolation background, vaccination etc, but clearly, a more comprehensive analysis is needed to reveal more information about codon usage bias variation within and among FMD viruses and what other factors are responsible, including the influence of factors, such as cell tropism, principal host species, method of transmission, and viral genetic structure.", [["cell", "ANATOMY", 375, 379], ["FMD viruses", "ORGANISM", 279, 290], ["cell", "CELL", 375, 379], ["politic factors", "PROTEIN", 24, 39], ["FMD viruses", "SPECIES", 279, 290], ["politic factors", "PROBLEM", 24, 39], ["the virus isolation background", "TEST", 100, 130], ["a more comprehensive analysis", "TEST", 162, 191], ["codon usage bias variation", "PROBLEM", 235, 261], ["FMD viruses", "PROBLEM", 279, 290], ["cell tropism", "PROBLEM", 375, 387], ["viral genetic structure", "OBSERVATION", 441, 464]]], ["Such information would then allow us to more precisely judge the relative importance of mutation pressure versus natural selection in determining base composition and codon usage in these pathogens.DiscussionThe recent European epizootic of FMD has made us aware of the great economic losses to be endured because no effective preventive and control measures are available for FMD [59] .", [["FMD", "DISEASE", 241, 244], ["FMD", "DISEASE", 377, 380], ["FMD", "SPECIES", 241, 244], ["FMD", "SPECIES", 377, 380], ["mutation pressure", "TREATMENT", 88, 105], ["natural selection", "TREATMENT", 113, 130], ["determining base composition", "TREATMENT", 134, 162], ["codon usage", "TREATMENT", 167, 178], ["these pathogens", "PROBLEM", 182, 197]]], ["Up to our knowledge, our work is the first report of the codon usage analysis on FMDV, which has provided a basic understanding of the mechanisms for codon usage bias and the processes governing the evolution of FMDV", [["FMDV", "ORGANISM", 81, 85], ["FMDV", "SPECIES", 81, 85], ["FMDV", "SPECIES", 212, 216], ["FMDV", "SPECIES", 81, 85], ["FMDV", "SPECIES", 212, 216], ["codon usage bias", "TREATMENT", 150, 166], ["FMDV", "PROBLEM", 212, 216]]]], "PMC7290727": [], "PMC7477604": [["IntroductionThe coronavirus disease-2019 (COVID-19) pandemic has caused untold suffering among all aspects of human lives.", [["coronavirus disease", "DISEASE", 16, 35], ["COVID-19", "CHEMICAL", 42, 50], ["coronavirus", "ORGANISM", 16, 27], ["COVID-19", "ORGANISM", 42, 50], ["human", "ORGANISM", 110, 115], ["human", "SPECIES", 110, 115], ["coronavirus disease-2019 (COVID-19", "SPECIES", 16, 50], ["human", "SPECIES", 110, 115], ["The coronavirus disease", "PROBLEM", 12, 35], ["pandemic", "PROBLEM", 52, 60], ["coronavirus disease", "OBSERVATION", 16, 35]]], ["Without any specific treatment or a vaccine in sight, and the sheer magnitude of cases, worldwide healthcare systems have been hugely impacted (Mamun & Griffiths, 2020a).", [["a vaccine", "TREATMENT", 34, 43]]], ["The restricted social interaction brought about by the protracted lockdowns can have a negative impact both emotionally and psychologically (Dsouza et al., 2020).", [["restricted", "OBSERVATION_MODIFIER", 4, 14], ["social interaction", "OBSERVATION", 15, 33]]], ["Financial recession, economic fallout, joblessness, and closure of businesses are all associated with protracted lockdowns, and have the potential to cause mental instability.", [["joblessness", "DISEASE", 39, 50], ["Financial recession", "PROBLEM", 0, 19], ["economic fallout", "PROBLEM", 21, 37], ["joblessness", "PROBLEM", 39, 50], ["closure of businesses", "TREATMENT", 56, 77], ["mental instability", "PROBLEM", 156, 174], ["recession", "OBSERVATION", 10, 19], ["economic", "OBSERVATION_MODIFIER", 21, 29], ["fallout", "OBSERVATION", 30, 37], ["businesses", "OBSERVATION", 67, 77], ["instability", "OBSERVATION", 163, 174]]], ["A recent study conducted in Bangladesh amongst unemployed individuals observed higher than normal prevalence rates of depression (82%), anxiety (61.5%) and stress (64.8%), such high prevalence rates have not been reported elsewhere in other cohorts (Mamun et al., 2020a).", [["depression", "DISEASE", 118, 128], ["anxiety", "DISEASE", 136, 143], ["individuals", "ORGANISM", 58, 69], ["A recent study", "TEST", 0, 14], ["depression", "PROBLEM", 118, 128], ["anxiety", "PROBLEM", 136, 143], ["stress", "TEST", 156, 162], ["such high prevalence rates", "PROBLEM", 172, 198]]], ["Therefore, it is clearly evident that the financial crisis associated with the COVID-19-related lockdowns can negatively impact the mental health of the masses (Oyesanya et al., 2015;Rafi et al., 2020) and in some extreme cases have the potential to even push the vulnerable population towards suicide (Bhuiyan et al., 2020; Dsouza et al., 2020;Mamun & Ullah, 2020).IntroductionDuring the COVID-19 lockdown, India appears to have had a sudden surge in the reported cases of suicides.", [["COVID-19", "DNA", 79, 87], ["the financial crisis", "PROBLEM", 38, 58], ["the COVID", "TEST", 75, 84], ["the masses", "PROBLEM", 149, 159], ["masses", "OBSERVATION", 153, 159]]], ["The first reported case of suicide related to COVID-19 was in India wherein the victim committed suicide because of the fear of contracting the infection (Goyal et al., 2020).", [["COVID-19", "CHEMICAL", 46, 54], ["infection", "DISEASE", 144, 153], ["the infection", "PROBLEM", 140, 153], ["infection", "OBSERVATION", 144, 153]]], ["The study reported the most common suicide causalities to be (i) fear of infection (n=21) (ii) financial crisis (n=15), (iii) testing positive for COVID-19 (n=7), while the causes for the remaining 26 cases included (iv) being lonely due to home quarantine, (v) being socially boycotted and pressure to be quarantined because others thought the person had COVID-19 (vi) experiencing COVID-19 work-related stress, (vii) being unable to return home after lockdown was imposed, and (viii) being unable to buy alcohol (among those with alcohol use disorder) (Dsouza et al., 2020).IntroductionOne of the possible limitations of this study was its inability to report the professions of the individuals committing suicide, which might also have had a potential impact on the study\u2019s findings.", [["infection", "DISEASE", 73, 82], ["alcohol", "CHEMICAL", 506, 513], ["alcohol use disorder", "DISEASE", 532, 552], ["alcohol", "CHEMICAL", 506, 513], ["alcohol", "CHEMICAL", 532, 539], ["alcohol", "SIMPLE_CHEMICAL", 506, 513], ["person", "SPECIES", 345, 351], ["The study", "TEST", 0, 9], ["infection (n=21) (ii) financial crisis", "PROBLEM", 73, 111], ["COVID", "TEST", 147, 152], ["pressure", "TREATMENT", 291, 299], ["COVID", "TEST", 356, 361], ["COVID", "TEST", 383, 388], ["this study", "TEST", 623, 633], ["the study", "TEST", 765, 774], ["infection", "OBSERVATION", 73, 82]]], ["For instance, individuals with lower income are at a greater risk of suicide, owing to the lockdown associated financial distress as compared to those who are financially stable and have higher incomes (Oyesanya et al., 2015;Mamun & Ullah, 2020).", [["financial distress", "PROBLEM", 111, 129]]], ["Therefore, the present study assessed suicide victims based on a specific high-profile occupation (celebrities working in the entertainment industry).", [["the present study", "TEST", 11, 28]]], ["The present study also examined the probable causality of suicides both before and during the COVID-19 pandemic period.MethodsIn the absence of any updated and functional suicide surveillance system, this study collated relevant information from press reports.", [["The present study", "TEST", 0, 17], ["this study", "TEST", 200, 210]]], ["In context of COVID-19-related suicides, this method has become widely used (e.g., Bhuiyan et al., 2020; Dsouza et al., 2020; Griffiths & Mamun, 2020;Mamun et al., 2020b;2020c).", [["COVID", "TEST", 14, 19]]], ["The search terms included, \u2018Indian cinema celebrities\u2019, \u2018celebrity suicides\u2019, \u2018COVID-19 pandemic\u2019, \u2018depression\u2019, \u2018financial strife\u2019, and \u2018lockdown related restriction\u2019.ResultsOver the past 17 years, several celebrities of Indian cinema have committed suicide.", [["pandemic\u2019", "DISEASE", 88, 97], ["depression", "DISEASE", 100, 110], ["strife\u2019", "DISEASE", 124, 131], ["depression", "PROBLEM", 100, 110]]], ["Between 2002and 2019, 16 such cases of celebrity suicide have been reported in the media (ten males and six females) details of which are presented in the Table 1.", [["celebrity suicide", "DISEASE", 39, 56]]], ["Furthermore, the most common cause of reported suicide during the different time periods was depression (n=17) although, family problems (n=3), bipolar disorder (n=1), and personal reasons (n=1) along with one case wherein the cause of suicide was unreported.", [["depression", "DISEASE", 93, 103], ["bipolar disorder", "DISEASE", 144, 160], ["depression", "PROBLEM", 93, 103], ["bipolar disorder", "PROBLEM", 144, 160], ["most common", "OBSERVATION_MODIFIER", 17, 28]]], ["Mumbai was the city with the highest number of alleged suicides (n=10), followed by Chennai (n=4), Hyderabad (n=3), New Delhi (n=2), Kerala (n=2), Indore (n=1) and the village of Mandhya in Karanataka (n=1).DiscussionTo the best of the authors\u2019 knowledge, the present study is the first to assess the nature of suicide and its associated causality among Indian celebrities.", [["New Delhi (n=2)", "PROBLEM", 116, 131], ["Kerala (n", "TREATMENT", 133, 142], ["the present study", "TEST", 256, 273], ["suicide", "PROBLEM", 311, 318]]], ["The incidence of reported suicides appeared to increase during the COVID-19 pandemic.", [["the COVID", "TEST", 63, 72], ["pandemic", "PROBLEM", 76, 84], ["suicides", "OBSERVATION", 26, 34], ["increase", "OBSERVATION_MODIFIER", 47, 55]]], ["There have been many published reports discussing suicidality during the ongoing COVID-19 pandemic (e.g., Bhuiyan et al., 2020; Dsouza et al., 2020; Goyal et al., 2020; Griffiths & Mamun, 2020; Mamun & Griffiths, 2020a; Mamun & Ullah, 2020; Mamun et al., 2020b; 2020c).", [["suicidality", "DISEASE", 50, 61], ["suicidality", "PROBLEM", 50, 61]]], ["A key difference between the Indian celebrity suicides during the ongoing COVID-19 pandemic and the non-COVID-19 pandemic-related suicides is the time period over which they occurred.", [["pandemic", "DISEASE", 113, 121], ["the ongoing COVID", "TEST", 62, 79], ["pandemic", "PROBLEM", 83, 91], ["difference", "OBSERVATION_MODIFIER", 6, 16]]], ["More specifically, while the 16 celebrity suicides prior to the COVID-19 pandemic were spread over 17 years (2002-2019), the seven celebrity suicides during the COVID-19 pandemic occurred within a three-month period.", [["the COVID", "TEST", 60, 69], ["the COVID", "TEST", 157, 166]]], ["Depression was reported to be the most common cause of celebrity suicides both before and during the COVID-19 pandemic, but the increased incidence of celebrity suicides during the ongoing pandemic suggests a possible association between COVID-19-related restrictions and the exacerbation of preexisting mental health conditions such as depression that increases the risk of suicidality among Indian celebrities.", [["Depression", "DISEASE", 0, 10], ["depression", "DISEASE", 337, 347], ["suicidality", "DISEASE", 375, 386], ["Depression", "PROBLEM", 0, 10], ["the COVID", "TEST", 97, 106], ["COVID", "TEST", 238, 243], ["preexisting mental health conditions", "PROBLEM", 292, 328], ["depression", "PROBLEM", 337, 347], ["suicidality", "PROBLEM", 375, 386], ["increased", "OBSERVATION_MODIFIER", 128, 137]]], ["Strict spatial distancing measures along with social isolation tend to increase anxiety, which can have far-reaching consequences amongst the vulnerable (e.g., elderly, those with preexisting medical conditions such as respiratory problems) and those with preexisting mental conditions (e.g., depression, anxiety, etc.).", [["respiratory", "ANATOMY", 219, 230], ["anxiety", "DISEASE", 80, 87], ["respiratory problems", "DISEASE", 219, 239], ["depression", "DISEASE", 293, 303], ["anxiety", "DISEASE", 305, 312], ["Strict spatial distancing measures", "TREATMENT", 0, 34], ["social isolation", "TREATMENT", 46, 62], ["anxiety", "PROBLEM", 80, 87], ["preexisting medical conditions", "PROBLEM", 180, 210], ["respiratory problems", "PROBLEM", 219, 239], ["preexisting mental conditions", "PROBLEM", 256, 285], ["depression", "PROBLEM", 293, 303], ["anxiety", "PROBLEM", 305, 312], ["spatial", "OBSERVATION_MODIFIER", 7, 14], ["distancing", "OBSERVATION", 15, 25]]], ["These factors have the potential to increase the risk of suicidality (Mamun & Griffiths, 2020b; 2020c).", [["suicidality", "DISEASE", 57, 68], ["suicidality", "PROBLEM", 57, 68]]], ["Lockdown-associated loneliness has the capacity to cause depression, which if left untreated, can lead the sufferer towards suicidality, amongst the celebrities as well as non-celebrities.DiscussionMoreover, celebrity suicide risk factors during the COVID-19 pandemic (e.g., depression) appear to be more restricted than those reported for the Indian general population (Dsouza et al., 2020).", [["loneliness", "DISEASE", 20, 30], ["depression", "DISEASE", 57, 67], ["suicidality", "DISEASE", 124, 135], ["depression", "DISEASE", 275, 285], ["the capacity", "PROBLEM", 35, 47], ["depression", "PROBLEM", 57, 67], ["suicidality", "PROBLEM", 124, 135], ["the COVID", "TEST", 246, 255], ["pandemic", "PROBLEM", 259, 267], ["depression", "PROBLEM", 275, 285]]], ["The presence of depression as a probable cause of suicide is fairly different from the suicide causality reported from other south Asian countries.", [["depression", "DISEASE", 16, 26], ["depression", "PROBLEM", 16, 26], ["suicide", "PROBLEM", 50, 57], ["the suicide causality", "PROBLEM", 83, 104], ["depression", "OBSERVATION", 16, 26], ["probable cause", "UNCERTAINTY", 32, 46]]], ["For instance, Mamun and Ullah (2020) reported Pakistani COVID-19 suicidality cases wherein the economic recession was the cause of 12 of the reported 16 cases, while the probable cause of suicide in the remaining four cases was fear of COVID-19 infection.", [["suicidality", "DISEASE", 65, 76], ["COVID-19", "CHEMICAL", 236, 244], ["infection", "DISEASE", 245, 254], ["Pakistani COVID", "TREATMENT", 46, 61], ["the economic recession", "PROBLEM", 91, 113], ["suicide", "PROBLEM", 188, 195], ["COVID-19 infection", "PROBLEM", 236, 254], ["probable cause", "UNCERTAINTY", 170, 184], ["infection", "OBSERVATION", 245, 254]]], ["One potential limitation of this Pakistani study is that it only included the general population not the celebrities.", [["this Pakistani study", "TEST", 28, 48], ["limitation", "OBSERVATION_MODIFIER", 14, 24]]], ["Even though lockdown-associated economic recession might have the potential to cause depression which can further lead to suicide, depression as the suicide causality was not mentioned in any of the 16 cases discussed by Mamun and Ullah (2020).", [["depression", "DISEASE", 85, 95], ["depression", "DISEASE", 131, 141], ["lockdown", "PROBLEM", 12, 20], ["economic recession", "PROBLEM", 32, 50], ["depression", "PROBLEM", 85, 95], ["depression", "PROBLEM", 131, 141], ["the suicide causality", "PROBLEM", 145, 166], ["economic", "OBSERVATION_MODIFIER", 32, 40], ["recession", "OBSERVATION", 41, 50]]], ["While, depression is usually seen as a distal cause, economic recession tends to be a proximal cause (Mamun & Griffiths, 2020d).DiscussionSimilar findings have also been observed in studies conducted across Bangladesh, where financial distress was reported as being the most common suicide causality (Bhuiyan et al., 2020), although some studies have reported other causes of suicide including fear of COVID-19 infection (Mamun & Griffiths, 2020a).", [["depression", "DISEASE", 7, 17], ["infection", "DISEASE", 411, 420], ["depression", "PROBLEM", 7, 17], ["economic recession", "PROBLEM", 53, 71], ["financial distress", "PROBLEM", 225, 243], ["COVID-19 infection", "PROBLEM", 402, 420], ["depression", "OBSERVATION", 7, 17], ["distal", "OBSERVATION_MODIFIER", 39, 45], ["economic recession", "OBSERVATION", 53, 71]]], ["The economic crisis as a result of COVID-19 lockdown has also been reported in suicidal pacts among a mother and son in Bangladesh as well as a couple in India.", [["COVID-19 lockdown", "CHEMICAL", 35, 52], ["COVID-19 lockdown", "DNA", 35, 52], ["The economic crisis", "PROBLEM", 0, 19], ["economic crisis", "OBSERVATION", 4, 19]]], ["Similarly, the fear of COVID-19 infection was also reported as the cause of suicidal pact amongst a newlywed couple in India (Griffiths & Mamun, 2020).DiscussionCelebrity suicides in some instances have pushed their diehard fans and the vulnerable towards suicidality, in what is referred to as copycat suicides (Jeong et al., 2012).", [["COVID-19", "CHEMICAL", 23, 31], ["infection", "DISEASE", 32, 41], ["suicidal pact", "DISEASE", 76, 89], ["suicidality", "DISEASE", 256, 267], ["COVID-19", "ORGANISM", 23, 31], ["COVID-19", "SPECIES", 23, 31], ["COVID-19 infection", "PROBLEM", 23, 41], ["infection", "OBSERVATION", 32, 41]]], ["Therefore, it is imperative for the press media to take it as a moral responsibility not to sensationalize the celebrity suicide cases and be extremely cautious and responsible while reporting celebrity suicides (Mamun & Griffiths, 2020d).", [["the press media", "TREATMENT", 32, 47]]], ["The criteria relevant to the reporting of the celebrity suicide cases advise the journalists to be cautious in reporting without sensationalizing the suicide (World Health Organization, 2017).ConclusionEven though there have been a number of high-profile instances of Indian celebrity suicides over the past two decades owing mostly to depression, the apparent increase in incidence of celebrity suicides during the ongoing pandemic suggests a possible association between COVID-19-related restrictions and the exacerbation of preexisting mental health conditions such as depression that may increase the risk of suicidality among Indian celebrities.", [["depression", "DISEASE", 336, 346], ["depression", "DISEASE", 572, 582], ["suicidality", "DISEASE", 613, 624], ["depression", "PROBLEM", 336, 346], ["COVID", "TEST", 473, 478], ["preexisting mental health conditions", "PROBLEM", 527, 563], ["depression", "PROBLEM", 572, 582], ["suicidality", "PROBLEM", 613, 624], ["high", "OBSERVATION_MODIFIER", 242, 246], ["-profile", "OBSERVATION_MODIFIER", 246, 254], ["increase", "OBSERVATION_MODIFIER", 361, 369]]], ["Counseling should be provided to those who have a history of mental health illness.", [["mental health illness", "PROBLEM", 61, 82]]]], "88c5dfe922deb41435376fbc6ee160b3b7ec3825": [["more than three million people worldwide.", [["people", "ORGANISM", 24, 30], ["people", "SPECIES", 24, 30]]], ["This infection can become serious in 20% of cases, with a mortality rate of 3-7%, much higher than that of influenza (1%) [1, 2] .", [["infection", "DISEASE", 5, 14], ["influenza", "DISEASE", 107, 116], ["This infection", "PROBLEM", 0, 14], ["a mortality rate", "TEST", 56, 72], ["influenza", "PROBLEM", 107, 116], ["infection", "OBSERVATION", 5, 14]]], ["Hematological patients are a vulnerable subpopulation due to altered immunity secondary to underlying disease and treatment.", [["patients", "ORGANISM", 14, 22], ["patients", "SPECIES", 14, 22], ["a vulnerable subpopulation", "PROBLEM", 27, 53], ["altered immunity", "PROBLEM", 61, 77], ["underlying disease", "PROBLEM", 91, 109], ["treatment", "TREATMENT", 114, 123], ["disease", "OBSERVATION", 102, 109]]]], "PMC7422463": [["BackgroundCoronaviruses, including severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), cause severe acute respiratory failure, which is associated with high mortality rates [1].", [["respiratory", "ANATOMY", 172, 183], ["BackgroundCoronaviruses", "DISEASE", 0, 23], ["acute respiratory syndrome coronavirus", "DISEASE", 42, 80], ["SARS-CoV)", "DISEASE", 82, 91], ["Middle East respiratory syndrome coronavirus", "DISEASE", 96, 140], ["acute respiratory failure", "DISEASE", 166, 191], ["severe acute respiratory syndrome coronavirus", "ORGANISM", 35, 80], ["SARS-CoV", "ORGANISM", 82, 90], ["Middle East respiratory syndrome coronavirus", "ORGANISM", 96, 140], ["MERS-CoV", "ORGANISM", 142, 150], ["coronavirus", "SPECIES", 129, 140], ["severe acute respiratory syndrome coronavirus", "SPECIES", 35, 80], ["SARS-CoV", "SPECIES", 82, 90], ["Middle East respiratory syndrome coronavirus", "SPECIES", 96, 140], ["MERS-CoV", "SPECIES", 142, 150], ["BackgroundCoronaviruses", "PROBLEM", 0, 23], ["severe acute respiratory syndrome coronavirus", "PROBLEM", 35, 80], ["Middle East respiratory syndrome coronavirus", "PROBLEM", 96, 140], ["severe acute respiratory failure", "PROBLEM", 159, 191], ["high mortality rates", "PROBLEM", 218, 238], ["severe", "OBSERVATION_MODIFIER", 35, 41], ["acute", "OBSERVATION_MODIFIER", 42, 47], ["respiratory syndrome coronavirus", "OBSERVATION", 48, 80], ["Middle", "ANATOMY_MODIFIER", 96, 102], ["respiratory syndrome", "OBSERVATION", 108, 128], ["severe", "OBSERVATION_MODIFIER", 159, 165], ["acute", "OBSERVATION_MODIFIER", 166, 171], ["respiratory failure", "OBSERVATION", 172, 191]]], ["The novel SARS-CoV-2 strain exhibits phylogenetic similarities to SARS-CoV and causes coronavirus disease 2019 (COVID-19), which has resulted in more than 540,000 deaths worldwide so far.", [["SARS-CoV", "DISEASE", 66, 74], ["coronavirus disease", "DISEASE", 86, 105], ["deaths", "DISEASE", 163, 169], ["SARS-CoV-2", "ORGANISM", 10, 20], ["SARS-CoV", "ORGANISM", 66, 74], ["SARS-CoV", "SPECIES", 10, 18], ["SARS-CoV", "SPECIES", 66, 74], ["The novel SARS", "TEST", 0, 14], ["CoV", "TEST", 15, 18], ["SARS", "PROBLEM", 66, 70], ["coronavirus disease", "PROBLEM", 86, 105], ["COVID", "TEST", 112, 117], ["coronavirus disease", "OBSERVATION", 86, 105]]], ["As the pandemic has progressed, the pathophysiology of this viral infection has become clearer; in particular, it has been shown that SARS-CoV-2 can directly alter cell function by a link to the angiotensin converting enzyme 2 (ACE2) receptor, which is almost ubiquitous in the human body [2].BackgroundNevertheless, the mechanisms behind the high mortality and severe organ dysfunction associated with COVID-19 remain poorly understood.", [["cell", "ANATOMY", 164, 168], ["body", "ANATOMY", 284, 288], ["organ", "ANATOMY", 369, 374], ["viral infection", "DISEASE", 60, 75], ["angiotensin", "CHEMICAL", 195, 206], ["organ dysfunction", "DISEASE", 369, 386], ["COVID-19", "CHEMICAL", 403, 411], ["COVID-19", "CHEMICAL", 403, 411], ["SARS-CoV-2", "GENE_OR_GENE_PRODUCT", 134, 144], ["cell", "CELL", 164, 168], ["angiotensin converting enzyme 2", "GENE_OR_GENE_PRODUCT", 195, 226], ["ACE2", "GENE_OR_GENE_PRODUCT", 228, 232], ["human", "ORGANISM", 278, 283], ["organ", "ORGAN", 369, 374], ["COVID-19", "GENE_OR_GENE_PRODUCT", 403, 411], ["angiotensin converting enzyme 2 (ACE2) receptor", "PROTEIN", 195, 242], ["human", "SPECIES", 278, 283], ["human", "SPECIES", 278, 283], ["this viral infection", "PROBLEM", 55, 75], ["SARS", "PROBLEM", 134, 138], ["the angiotensin converting enzyme", "TEST", 191, 224], ["the high mortality", "PROBLEM", 339, 357], ["severe organ dysfunction", "PROBLEM", 362, 386], ["COVID", "TEST", 403, 408], ["viral", "OBSERVATION_MODIFIER", 60, 65], ["infection", "OBSERVATION", 66, 75], ["high", "OBSERVATION_MODIFIER", 343, 347], ["severe", "OBSERVATION_MODIFIER", 362, 368], ["organ", "ANATOMY", 369, 374], ["dysfunction", "OBSERVATION", 375, 386]]], ["Controversies exist regarding the occurrence of fatal complications, such as pulmonary embolism or diffuse endothelial injury [3, 4], as well as on the roles of direct viral cellular injury or concomitant comorbidities in the fatality of this disease [5].BackgroundIn this setting, autopsy is of great importance to help physicians understand the biological characteristics and the pathogenesis of COVID-19.", [["pulmonary", "ANATOMY", 77, 86], ["endothelial", "ANATOMY", 107, 118], ["cellular", "ANATOMY", 174, 182], ["pulmonary embolism", "DISEASE", 77, 95], ["endothelial injury", "DISEASE", 107, 125], ["COVID-19", "CHEMICAL", 398, 406], ["pulmonary", "ORGAN", 77, 86], ["endothelial", "TISSUE", 107, 118], ["cellular", "CELL", 174, 182], ["fatal complications", "PROBLEM", 48, 67], ["pulmonary embolism", "PROBLEM", 77, 95], ["diffuse endothelial injury", "PROBLEM", 99, 125], ["direct viral cellular injury", "PROBLEM", 161, 189], ["concomitant comorbidities", "PROBLEM", 193, 218], ["this disease", "PROBLEM", 238, 250], ["COVID", "TEST", 398, 403], ["fatal", "OBSERVATION_MODIFIER", 48, 53], ["complications", "OBSERVATION", 54, 67], ["pulmonary", "ANATOMY", 77, 86], ["embolism", "OBSERVATION", 87, 95], ["diffuse", "OBSERVATION_MODIFIER", 99, 106], ["endothelial injury", "OBSERVATION", 107, 125], ["viral cellular injury", "OBSERVATION", 168, 189], ["concomitant", "OBSERVATION_MODIFIER", 193, 204], ["comorbidities", "OBSERVATION", 205, 218]]], ["Most of the previously reported post-mortem findings focused on lung morphology and few data are available on complete post-mortem analyses of other organs [6, 7].", [["lung", "ANATOMY", 64, 68], ["organs", "ANATOMY", 149, 155], ["lung", "ORGAN", 64, 68], ["organs", "ORGAN", 149, 155], ["lung morphology", "TEST", 64, 79], ["lung", "ANATOMY", 64, 68]]], ["The aim of this study was therefore to investigate the presence of specific features of viral injury as well as the distribution of the virus in different organs of patients who died from COVID-19.Study design ::: MethodsIn this post-mortem study, we included the first 17 adult patients (> 18 years) who died in our hospital (either in a COVID-19 unit or an intensive care unit) from March 13, 2020, with confirmed SARS-CoV-2 infection (i.e., positive RT-PCR assay on nasopharyngeal swab and/or broncho-alveolar lavage specimen).", [["organs", "ANATOMY", 155, 161], ["nasopharyngeal swab", "ANATOMY", 469, 488], ["broncho-alveolar lavage specimen", "ANATOMY", 496, 528], ["viral injury", "DISEASE", 88, 100], ["SARS-CoV-2 infection", "DISEASE", 416, 436], ["COVID-19", "CHEMICAL", 188, 196], ["organs", "ORGAN", 155, 161], ["patients", "ORGANISM", 165, 173], ["patients", "ORGANISM", 279, 287], ["nasopharyngeal swab", "MULTI-TISSUE_STRUCTURE", 469, 488], ["alveolar lavage specimen", "MULTI-TISSUE_STRUCTURE", 504, 528], ["patients", "SPECIES", 165, 173], ["patients", "SPECIES", 279, 287], ["SARS-CoV-2", "SPECIES", 416, 426], ["this study", "TEST", 11, 21], ["viral injury", "PROBLEM", 88, 100], ["the virus", "PROBLEM", 132, 141], ["COVID", "TEST", 188, 193], ["SARS", "PROBLEM", 416, 420], ["CoV-2 infection", "PROBLEM", 421, 436], ["PCR assay", "TEST", 456, 465], ["nasopharyngeal swab", "TEST", 469, 488], ["broncho-alveolar lavage specimen", "TEST", 496, 528], ["viral injury", "OBSERVATION", 88, 100], ["virus", "OBSERVATION", 136, 141], ["infection", "OBSERVATION", 427, 436], ["nasopharyngeal", "ANATOMY", 469, 483], ["alveolar", "ANATOMY", 504, 512], ["lavage", "OBSERVATION", 513, 519]]], ["Exclusion criteria were lack of family consent and a delay of more than 5 days after death before post-mortem examination.", [["death", "DISEASE", 85, 90], ["post-mortem examination", "TEST", 98, 121]]], ["The study protocol was approved by the local ethics committee (P2020/218).Data collection ::: MethodsWe collected demographics, comorbidities, relevant clinical data, including duration between symptom onset or hospitalization and death, the results of chest computed tomography scan, and, if available, microbiological tests and medical treatments (e.g., hydroxychloroquine, antivirals or antibiotics, and use of organ support).", [["organ", "ANATOMY", 414, 419], ["death", "DISEASE", 231, 236], ["hydroxychloroquine", "CHEMICAL", 356, 374], ["hydroxychloroquine", "CHEMICAL", 356, 374], ["hydroxychloroquine", "SIMPLE_CHEMICAL", 356, 374], ["organ", "ORGAN", 414, 419], ["The study protocol", "TEST", 0, 18], ["comorbidities", "PROBLEM", 128, 141], ["chest computed tomography scan", "TEST", 253, 283], ["microbiological tests", "TEST", 304, 325], ["medical treatments", "TREATMENT", 330, 348], ["hydroxychloroquine", "TREATMENT", 356, 374], ["antivirals", "TREATMENT", 376, 386], ["antibiotics", "TREATMENT", 390, 401], ["organ support", "TREATMENT", 414, 427], ["chest", "ANATOMY", 253, 258]]], ["Acute respiratory distress syndrome (ARDS) and acute kidney injury (AKI) were defined according to standard definitions [8, 9].Post-mortem procedure ::: MethodsThe Belgian Public Health Institute (Sciensano) guidelines were integrated into our post-mortem procedure [10].", [["respiratory", "ANATOMY", 6, 17], ["kidney", "ANATOMY", 53, 59], ["Acute respiratory distress syndrome", "DISEASE", 0, 35], ["ARDS", "DISEASE", 37, 41], ["acute kidney injury", "DISEASE", 47, 66], ["AKI", "DISEASE", 68, 71], ["kidney", "ORGAN", 53, 59], ["Acute respiratory distress syndrome", "PROBLEM", 0, 35], ["ARDS", "PROBLEM", 37, 41], ["acute kidney injury", "PROBLEM", 47, 66], ["AKI", "PROBLEM", 68, 71], ["Institute (Sciensano) guidelines", "TREATMENT", 186, 218], ["respiratory", "ANATOMY", 6, 17], ["distress", "OBSERVATION", 18, 26], ["ARDS", "OBSERVATION", 37, 41], ["acute", "OBSERVATION_MODIFIER", 47, 52], ["kidney", "ANATOMY", 53, 59], ["injury", "OBSERVATION", 60, 66], ["AKI", "OBSERVATION", 68, 71]]], ["The cadavers were kept in the refrigerator at 4 \u00b0C and autopsies were performed 72 to 96 h after death to ensure the safety of the autopsy team.", [["cadavers", "ANATOMY", 4, 12], ["death", "DISEASE", 97, 102], ["cadavers", "ORGANISM", 4, 12], ["autopsies", "TEST", 55, 64]]], ["Personal protective equipment consisted of two superposed disposable latex gloves, plastic sleeves, FFP3 mask, scrub hat, clear face visor, surgical gown plus plastic apron, and rubber boots.", [["Personal protective equipment", "TREATMENT", 0, 29], ["two superposed disposable latex gloves", "TREATMENT", 43, 81], ["plastic sleeves", "TREATMENT", 83, 98], ["FFP3 mask", "TREATMENT", 100, 109], ["scrub hat", "TREATMENT", 111, 120], ["clear face visor", "TREATMENT", 122, 138], ["surgical gown", "TREATMENT", 140, 153], ["plastic apron", "TREATMENT", 159, 172], ["rubber boots", "TREATMENT", 178, 190], ["latex gloves", "OBSERVATION", 69, 81], ["plastic sleeves", "OBSERVATION", 83, 98], ["rubber boots", "OBSERVATION", 178, 190]]], ["In the post-mortem room, dirty and clean circulations were used in the airlocks to allow decontamination.", [["airlocks", "ANATOMY", 71, 79], ["decontamination", "TREATMENT", 89, 104], ["dirty", "OBSERVATION", 25, 30], ["clean", "OBSERVATION", 35, 40]]], ["All analyses were performed at normal pressure.Post-mortem procedure ::: MethodsUsing standard surgical pathology processing, complete sets of tissue samples were collected for diagnosis and biobanking.", [["tissue samples", "ANATOMY", 143, 157], ["tissue samples", "CANCER", 143, 157], ["All analyses", "TEST", 0, 12], ["tissue samples", "TEST", 143, 157], ["pressure", "OBSERVATION_MODIFIER", 38, 46]]], ["The banked material consists of 6 samples per organ, including the trachea, thyroid, lymph nodes, heart, spleen, bone marrow, kidney, bladder, liver, stomach, colon, and brain.", [["samples", "ANATOMY", 34, 41], ["organ", "ANATOMY", 46, 51], ["trachea", "ANATOMY", 67, 74], ["thyroid", "ANATOMY", 76, 83], ["lymph nodes", "ANATOMY", 85, 96], ["heart", "ANATOMY", 98, 103], ["spleen", "ANATOMY", 105, 111], ["bone marrow", "ANATOMY", 113, 124], ["kidney", "ANATOMY", 126, 132], ["bladder", "ANATOMY", 134, 141], ["liver", "ANATOMY", 143, 148], ["stomach", "ANATOMY", 150, 157], ["colon", "ANATOMY", 159, 164], ["brain", "ANATOMY", 170, 175], ["organ", "ORGAN", 46, 51], ["trachea", "MULTI-TISSUE_STRUCTURE", 67, 74], ["thyroid", "ORGAN", 76, 83], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 85, 96], ["heart", "ORGAN", 98, 103], ["spleen", "ORGAN", 105, 111], ["bone marrow", "MULTI-TISSUE_STRUCTURE", 113, 124], ["kidney", "ORGAN", 126, 132], ["bladder", "ORGAN", 134, 141], ["liver", "ORGAN", 143, 148], ["stomach", "ORGAN", 150, 157], ["colon", "ORGAN", 159, 164], ["brain", "ORGAN", 170, 175], ["the trachea, thyroid, lymph nodes, heart, spleen, bone marrow, kidney, bladder, liver, stomach, colon, and brain", "PROBLEM", 63, 175], ["organ", "ANATOMY", 46, 51], ["trachea", "ANATOMY", 67, 74], ["thyroid", "ANATOMY", 76, 83], ["lymph nodes", "OBSERVATION", 85, 96], ["heart", "ANATOMY", 98, 103], ["spleen", "ANATOMY", 105, 111], ["bone marrow", "ANATOMY", 113, 124], ["kidney", "ANATOMY", 126, 132], ["bladder", "ANATOMY", 134, 141], ["liver", "ANATOMY", 143, 148], ["stomach", "ANATOMY", 150, 157], ["colon", "ANATOMY", 159, 164], ["brain", "ANATOMY", 170, 175]]], ["For the lungs, we collected six samples per lobe (i.e., a total of 30 samples), except for two patients who had undergone lobectomy for cancer and from whom only 18 samples were taken.", [["lungs", "ANATOMY", 8, 13], ["samples", "ANATOMY", 32, 39], ["lobe", "ANATOMY", 44, 48], ["samples", "ANATOMY", 70, 77], ["cancer", "ANATOMY", 136, 142], ["samples", "ANATOMY", 165, 172], ["cancer", "DISEASE", 136, 142], ["lungs", "ORGAN", 8, 13], ["lobe", "ORGAN", 44, 48], ["samples", "CANCER", 70, 77], ["patients", "ORGANISM", 95, 103], ["cancer", "CANCER", 136, 142], ["patients", "SPECIES", 95, 103], ["lobectomy", "TREATMENT", 122, 131], ["cancer", "PROBLEM", 136, 142], ["lungs", "ANATOMY", 8, 13], ["lobe", "ANATOMY", 44, 48], ["lobectomy", "OBSERVATION", 122, 131], ["cancer", "OBSERVATION", 136, 142]]], ["For safety reasons, complete brain removal was not allowed, but, with the help of a neurosurgeon, in 11 cases, we used a new, safe procedure with drills and protective devices to avoid air dispersion, to obtain between 12 and 51 samples from different brain regions, as detailed in the Additional file 1 (Additional Material).", [["brain", "ANATOMY", 29, 34], ["brain", "ANATOMY", 252, 257], ["brain", "ORGAN", 29, 34], ["brain", "ORGAN", 252, 257], ["complete brain removal", "TREATMENT", 20, 42], ["a new, safe procedure", "TREATMENT", 119, 140], ["drills and protective devices", "TREATMENT", 146, 175], ["air dispersion", "PROBLEM", 185, 199], ["air dispersion", "OBSERVATION", 185, 199], ["brain", "ANATOMY", 252, 257], ["regions", "ANATOMY_MODIFIER", 258, 265]]], ["Formalin-fixed paraffin-embedded (FFPE) tissues underwent standard processing to provide hematoxylin and eosin (H&E)-stained sections.", [["FFPE) tissues", "ANATOMY", 34, 47], ["sections", "ANATOMY", 125, 133], ["Formalin", "CHEMICAL", 0, 8], ["Formalin", "CHEMICAL", 0, 8], ["paraffin", "CHEMICAL", 15, 23], ["hematoxylin", "CHEMICAL", 89, 100], ["eosin", "CHEMICAL", 105, 110], ["FFPE", "TISSUE", 34, 38], ["tissues", "TISSUE", 40, 47], ["hematoxylin", "SIMPLE_CHEMICAL", 89, 100], ["eosin", "SIMPLE_CHEMICAL", 105, 110], ["H&E", "SIMPLE_CHEMICAL", 112, 115], ["Formalin", "TEST", 0, 8], ["fixed paraffin-embedded (FFPE) tissues", "TREATMENT", 9, 47], ["standard processing", "TREATMENT", 58, 77], ["hematoxylin", "TREATMENT", 89, 100], ["eosin", "TREATMENT", 105, 110]]], ["Special stains and immunohistochemistry (IHC) were used for lung (Masson\u2019s trichrome, periodic acid-Schiff [PAS], Gomori-Grocott, anti-CMV IHC, anti-HSV IHC, anti-Pneumocystis J IHC) and kidney (PAS, Masson\u2019s trichrome, Jones methenamine silver) samples.Morphological analysis ::: MethodsMorphological analysis was performed on H&E stained glass slides using the SecundOs digital platform (TribVn Health Care, Chatillon, France) for digital diagnosis, after the acquisition of whole slide digital scans (\u00d7 40 magnification) using a Nanozoomer 2.0 HT slide scanner (Hamamatsu, Hamamatsu City, Japan).SARS-CoV-2 detection by immunohistochemistry ::: MethodsSince no antibody against SARS-CoV-2 has been validated for IHC on FFPE tissues, we selected an anti-SARS-nucleocapsid protein antibody.", [["lung", "ANATOMY", 60, 64], ["kidney", "ANATOMY", 187, 193], ["FFPE tissues", "ANATOMY", 722, 734], ["Jones methenamine silver", "CHEMICAL", 220, 244], ["SARS", "DISEASE", 599, 603], ["silver", "CHEMICAL", 238, 244], ["lung", "ORGAN", 60, 64], ["periodic acid-Schiff", "SIMPLE_CHEMICAL", 86, 106], ["kidney", "ORGAN", 187, 193], ["PAS", "SIMPLE_CHEMICAL", 195, 198], ["Jones methenamine silver", "SIMPLE_CHEMICAL", 220, 244], ["SARS-CoV-2", "ORGANISM", 681, 691], ["FFPE tissues", "TISSUE", 722, 734], ["anti-SARS-nucleocapsid protein antibody", "PROTEIN", 751, 790], ["HSV", "SPECIES", 149, 152], ["SARS-CoV", "SPECIES", 681, 689], ["Special stains", "TEST", 0, 14], ["immunohistochemistry", "TEST", 19, 39], ["lung (Masson\u2019s trichrome", "TEST", 60, 84], ["periodic acid-Schiff", "TEST", 86, 106], ["PAS", "TEST", 108, 111], ["Gomori-Grocott", "TREATMENT", 114, 128], ["anti-CMV IHC", "TEST", 130, 142], ["anti-HSV IHC", "TEST", 144, 156], ["Morphological analysis", "TEST", 254, 276], ["MethodsMorphological analysis", "TEST", 281, 310], ["whole slide digital scans", "TEST", 477, 502], ["a Nanozoomer 2.0 HT slide scanner", "TREATMENT", 530, 563], ["MethodsSince", "TEST", 648, 660], ["antibody", "TEST", 664, 672], ["SARS", "PROBLEM", 681, 685], ["CoV", "TEST", 686, 689], ["IHC on FFPE tissues", "PROBLEM", 715, 734], ["an anti-SARS-nucleocapsid protein antibody", "TEST", 748, 790], ["lung", "ANATOMY", 60, 64], ["kidney", "ANATOMY", 187, 193]]], ["Standard IHC was applied as previously described to 4-\u03bcm-thick post-mortem lung sections (one sample for each lung lobe per patient) to display SARS-nucleocapsid protein (Invitrogen, PA1-41098, dilution 1:50) on Dako Omnis (Agilent Technologies, Santa Clara, CA, USA) using the Envision Flex detection system according to the manufacturer\u2019s protocol [11].", [["lung sections", "ANATOMY", 75, 88], ["sample", "ANATOMY", 94, 100], ["lung lobe", "ANATOMY", 110, 119], ["PA1-41098", "CHEMICAL", 183, 192], ["lung sections", "MULTI-TISSUE_STRUCTURE", 75, 88], ["lung lobe", "MULTI-TISSUE_STRUCTURE", 110, 119], ["patient", "ORGANISM", 124, 131], ["SARS-nucleocapsid protein", "PROTEIN", 144, 169], ["patient", "SPECIES", 124, 131], ["Standard IHC", "TREATMENT", 0, 12], ["thick post-mortem lung sections", "TREATMENT", 57, 88], ["SARS", "TEST", 144, 148], ["nucleocapsid protein", "TEST", 149, 169], ["Invitrogen", "TEST", 171, 181], ["PA1", "TEST", 183, 186], ["dilution", "TEST", 194, 202], ["lung", "ANATOMY", 75, 79], ["lung", "ANATOMY", 110, 114], ["lobe", "ANATOMY_MODIFIER", 115, 119]]], ["The sections were counterstained with hematoxylin.", [["sections", "ANATOMY", 4, 12], ["hematoxylin", "CHEMICAL", 38, 49], ["sections", "MULTI-TISSUE_STRUCTURE", 4, 12], ["hematoxylin", "SIMPLE_CHEMICAL", 38, 49], ["hematoxylin", "TREATMENT", 38, 49]]], ["Negative tissue controls were obtained from patients who had an autopsy before the COVID-19 pandemic.", [["tissue", "ANATOMY", 9, 15], ["patients", "ORGANISM", 44, 52], ["patients", "SPECIES", 44, 52], ["an autopsy", "TEST", 61, 71], ["the COVID", "TEST", 79, 88], ["pandemic", "PROBLEM", 92, 100], ["tissue", "OBSERVATION", 9, 15]]], ["Semi-quantitative IHC evaluation was performed by two senior pathologists (ND, MR) as follows: negative (\u2212); between one and five positive cells per whole slide (scattered cells, +); more than five cells per whole slide but no foci (isolated cells, ++); and with foci (more than 10 cells in one \u00d7 20 field, +++).SARS-CoV-2 detection by rRT-PCR ::: MethodsTotal nucleic acid was extracted from FFPE tissues using the Maxwell RSC DNA FFPE Kit (reference: AS1450.", [["cells", "ANATOMY", 139, 144], ["cells", "ANATOMY", 172, 177], ["cells", "ANATOMY", 198, 203], ["foci", "ANATOMY", 227, 231], ["cells", "ANATOMY", 242, 247], ["foci", "ANATOMY", 263, 267], ["cells", "ANATOMY", 282, 287], ["FFPE tissues", "ANATOMY", 393, 405], ["SARS", "DISEASE", 312, 316], ["nucleic acid", "CHEMICAL", 361, 373], ["cells", "CELL", 139, 144], ["cells", "CELL", 172, 177], ["cells", "CELL", 198, 203], ["cells", "CELL", 242, 247], ["cells", "CELL", 282, 287], ["FFPE tissues", "TISSUE", 393, 405], ["MR", "PROTEIN", 79, 81], ["positive cells", "CELL_TYPE", 130, 144], ["scattered cells", "CELL_TYPE", 162, 177], ["isolated cells", "CELL_TYPE", 233, 247], ["Semi-quantitative IHC evaluation", "TEST", 0, 32], ["MR", "TEST", 79, 81], ["whole slide (scattered cells", "TEST", 149, 177], ["whole slide", "TEST", 208, 219], ["foci (isolated cells", "PROBLEM", 227, 247], ["foci", "PROBLEM", 263, 267], ["MethodsTotal nucleic acid", "TREATMENT", 348, 373], ["no", "UNCERTAINTY", 224, 226], ["foci", "OBSERVATION", 227, 231], ["foci", "OBSERVATION", 263, 267]]], ["Promega Corporation, Madison, WI, USA) and the Promega Maxwell extractor, following the protocol described by the manufacturer.", [["the Promega Maxwell extractor", "TREATMENT", 43, 72], ["the protocol", "TREATMENT", 84, 96]]], ["One-step RT-PCR assays specific for the amplification of SARS-CoV-2 E envelope protein gene were adapted from a published protocol [12].", [["SARS-CoV-2 E", "GENE_OR_GENE_PRODUCT", 57, 69], ["SARS-CoV-2 E envelope protein gene", "DNA", 57, 91], ["SARS-CoV", "SPECIES", 57, 65], ["One-step RT-PCR assays", "TEST", 0, 22], ["SARS", "PROBLEM", 57, 61], ["CoV", "TEST", 62, 65], ["2 E envelope protein gene", "TREATMENT", 66, 91], ["a published protocol", "TREATMENT", 110, 130]]], ["Briefly, 4 \u03bcL of RNA (100 ng) was amplified in 20 \u03bcL reaction mixture containing 5 \u03bcL of TaqMan Fast Virus 1-step master mix (Life Technologies), 0.4 \u03bcM of each forward (ACAGGTACGTTAATAGTTAATAGCGT) and reverse (ATATTGCAGCAGTACGCACACA) primers and 0.2 \u03bcM of probe (FAM-ACACTAGCCATCCTTACTGCGCTTCG-BBQ).", [["reverse (ATATTGCAGCAGTACGCACACA) primers", "DNA", 202, 242], ["RNA", "TREATMENT", 17, 20], ["20 \u03bcL reaction mixture", "TREATMENT", 47, 69], ["TaqMan Fast Virus", "TREATMENT", 89, 106], ["reverse (ATATTGCAGCAGTACGCACACA) primers", "TREATMENT", 202, 242], ["probe (FAM-ACACTAGCCATCCTTACTGCGCTTCG-BBQ)", "TREATMENT", 257, 299]]], ["A clinical sample highly positive for SARS-CoV-2 was diluted 1:1000 and used as a positive control in each analysis.", [["sample", "ANATOMY", 11, 17], ["SARS", "DISEASE", 38, 42], ["SARS-CoV", "SPECIES", 38, 46], ["A clinical sample", "TEST", 0, 17], ["SARS", "PROBLEM", 38, 42], ["CoV", "TEST", 43, 46], ["each analysis", "TEST", 102, 115]]], ["A clinical sample obtained from a patient who was autopsied before the COVID-19 pandemic was used as a negative control.", [["sample", "ANATOMY", 11, 17], ["patient", "ORGANISM", 34, 41], ["patient", "SPECIES", 34, 41], ["A clinical sample", "TEST", 0, 17], ["the COVID", "TEST", 67, 76]]], ["The quality of the RNA from the samples showing negative results was assessed by amplification of the human MET RNA according to a validated ISO:15189 accredited method used as a routine diagnostic method in our laboratory.Statistical analysis ::: MethodsData are reported as counts (percentage) or medians [interquartile ranges (IQRs)].", [["samples", "ANATOMY", 32, 39], ["ISO", "CHEMICAL", 141, 144], ["samples", "CANCER", 32, 39], ["human", "ORGANISM", 102, 107], ["MET", "GENE_OR_GENE_PRODUCT", 108, 111], ["human MET RNA", "RNA", 102, 115], ["human", "SPECIES", 102, 107], ["human", "SPECIES", 102, 107], ["the samples", "TEST", 28, 39]]], ["All data were analyzed using GraphPad Prism Version 8.4.2 (GraphPad Software, San Diego, CA, USA).Study cohort ::: ResultsThe main characteristics of the study cohort (12 males out of 17; median age 72 [62\u201377] years) are given in Table 1.", [["All data", "TEST", 0, 8], ["GraphPad Prism Version", "TEST", 29, 51], ["the study", "TEST", 150, 159], ["main", "OBSERVATION_MODIFIER", 126, 130]]], ["The time period between the onset of symptoms and death ranged from 2 to 40 days (median, 14 days) and between admission and death from 0 to 33 days (median, 10 days).", [["death", "DISEASE", 50, 55], ["death", "DISEASE", 125, 130], ["symptoms", "PROBLEM", 37, 45], ["death", "PROBLEM", 50, 55]]], ["All except two patients had at least one comorbidity, including hypertension (n = 10), diabetes (n = 9), cerebrovascular disease (n = 4), coronary artery disease (n = 4), and solid cancer (n = 4).", [["cerebrovascular", "ANATOMY", 105, 120], ["coronary artery", "ANATOMY", 138, 153], ["solid cancer", "ANATOMY", 175, 187], ["hypertension", "DISEASE", 64, 76], ["diabetes", "DISEASE", 87, 95], ["cerebrovascular disease", "DISEASE", 105, 128], ["coronary artery disease", "DISEASE", 138, 161], ["solid cancer", "DISEASE", 175, 187], ["patients", "ORGANISM", 15, 23], ["coronary artery", "MULTI-TISSUE_STRUCTURE", 138, 153], ["solid cancer", "CANCER", 175, 187], ["patients", "SPECIES", 15, 23], ["hypertension", "PROBLEM", 64, 76], ["diabetes (n", "PROBLEM", 87, 98], ["cerebrovascular disease (n", "PROBLEM", 105, 131], ["coronary artery disease", "PROBLEM", 138, 161], ["solid cancer", "PROBLEM", 175, 187], ["comorbidity", "OBSERVATION", 41, 52], ["hypertension", "OBSERVATION", 64, 76], ["cerebrovascular", "ANATOMY", 105, 120], ["disease", "OBSERVATION", 121, 128], ["coronary artery", "ANATOMY", 138, 153], ["disease", "OBSERVATION", 154, 161], ["solid", "ANATOMY", 175, 180], ["cancer", "OBSERVATION", 181, 187]]], ["None of the patients had tested positive on admission for the respiratory syncytial virus or influenza A and B viruses.", [["respiratory syncytial virus", "DISEASE", 62, 89], ["influenza A and B viruses", "DISEASE", 93, 118], ["patients", "ORGANISM", 12, 20], ["respiratory syncytial virus", "ORGANISM", 62, 89], ["influenza A", "ORGANISM", 93, 104], ["B viruses", "ORGANISM", 109, 118], ["patients", "SPECIES", 12, 20], ["respiratory syncytial virus", "SPECIES", 62, 89], ["the respiratory syncytial virus", "PROBLEM", 58, 89], ["influenza A and B viruses", "PROBLEM", 93, 118], ["respiratory", "ANATOMY", 62, 73], ["syncytial virus", "OBSERVATION", 74, 89]]], ["Eleven of the patients were treated with mechanical ventilation.", [["patients", "ORGANISM", 14, 22], ["patients", "SPECIES", 14, 22], ["mechanical ventilation", "TREATMENT", 41, 63], ["mechanical ventilation", "OBSERVATION", 41, 63]]], ["Eleven patients died in the ICU and 6 on the medical ward; the main causes of death were respiratory failure (n = 9) and multiple organ failure (n = 7).", [["respiratory", "ANATOMY", 89, 100], ["organ", "ANATOMY", 130, 135], ["death", "DISEASE", 78, 83], ["respiratory failure", "DISEASE", 89, 108], ["organ failure", "DISEASE", 130, 143], ["patients", "ORGANISM", 7, 15], ["organ", "ORGAN", 130, 135], ["patients", "SPECIES", 7, 15], ["death", "PROBLEM", 78, 83], ["respiratory failure", "PROBLEM", 89, 108], ["multiple organ failure", "PROBLEM", 121, 143], ["respiratory failure", "OBSERVATION", 89, 108], ["multiple", "OBSERVATION_MODIFIER", 121, 129], ["organ", "ANATOMY", 130, 135], ["failure", "OBSERVATION", 136, 143]]], ["Laboratory data are reported in Additional file 2 (Table S1).", [["Laboratory data", "TEST", 0, 15]]]], "fadc6206ab3aa16956d146bd426a32e9b6d0f9d8": [["IntroductionViruses of many families cause disease in small companion animals and there is much academic and industrial interest in vovirus, calicivirus and coronavirus.", [["vovirus, calicivirus and coronavirus", "DISEASE", 132, 168], ["vovirus, calicivirus", "ORGANISM", 132, 152], ["coronavirus", "ORGANISM", 157, 168], ["coronavirus", "SPECIES", 157, 168], ["disease", "PROBLEM", 43, 50], ["industrial interest in vovirus", "PROBLEM", 109, 139], ["calicivirus", "PROBLEM", 141, 152], ["coronavirus", "PROBLEM", 157, 168], ["small", "OBSERVATION_MODIFIER", 54, 59]]], ["Hence there is, in our view, the need for an appraisal of the current status of the new viral mutants and associated diseases and current and prospective vaccines.", [["the new viral mutants and associated diseases", "PROBLEM", 80, 125], ["current and prospective vaccines", "TREATMENT", 130, 162]]], ["Important areas considered in viral family are epidemiology of infections particularly mode of virus transmission, associated diseases and key determinants in disease pathogenesis.", [["infections", "DISEASE", 63, 73], ["infections", "PROBLEM", 63, 73], ["virus transmission", "PROBLEM", 95, 113], ["associated diseases", "PROBLEM", 115, 134], ["disease pathogenesis", "PROBLEM", 159, 179], ["infections", "OBSERVATION", 63, 73]]], ["Current immunoprophylaxis in relation to prospects of improved and safer vaccines and some difficulties in achieving these objectives for particular viral diseases are reviewed as well.", [["viral diseases", "DISEASE", 149, 163], ["Current immunoprophylaxis", "TREATMENT", 0, 25], ["safer vaccines", "TREATMENT", 67, 81], ["some difficulties", "PROBLEM", 86, 103], ["particular viral diseases", "PROBLEM", 138, 163]]], ["Newly emerging and potential diseases are discussed in the last section.", [["potential diseases", "PROBLEM", 19, 37], ["potential", "OBSERVATION_MODIFIER", 19, 28], ["diseases", "OBSERVATION", 29, 37]]], ["The companion animals presently considered are cats, dogs and rabbits.", [["cats", "ORGANISM", 47, 51], ["dogs", "ORGANISM", 53, 57], ["rabbits", "ORGANISM", 62, 69], ["cats", "SPECIES", 47, 51], ["dogs", "SPECIES", 53, 57], ["rabbits", "SPECIES", 62, 69], ["rabbits", "SPECIES", 62, 69]]], ["Unusual pets such as ferrets, mice, hamsters and snakes in view of the enormity of the task were considered out of scope.", [["ferrets", "ORGANISM", 21, 28], ["mice", "ORGANISM", 30, 34], ["hamsters", "ORGANISM", 36, 44], ["ferrets", "SPECIES", 21, 28], ["mice", "SPECIES", 30, 34], ["hamsters", "SPECIES", 36, 44], ["mice", "SPECIES", 30, 34], ["hamsters", "SPECIES", 36, 44]]], ["Horses [1] [2] [3] and pigeons [4] have already been covered recently.HerpesviridaeHerpesviruses are enveloped, icosahedral viruses with a linear double stranded DNA.", [["HerpesviridaeHerpesviruses", "ORGANISM", 70, 96], ["DNA", "CELLULAR_COMPONENT", 162, 165], ["linear double stranded DNA", "DNA", 139, 165], ["HerpesviridaeHerpesviruses", "PROBLEM", 70, 96], ["icosahedral viruses", "PROBLEM", 112, 131], ["a linear double stranded DNA", "TREATMENT", 137, 165], ["icosahedral viruses", "OBSERVATION", 112, 131], ["linear", "OBSERVATION_MODIFIER", 139, 145], ["double", "OBSERVATION_MODIFIER", 146, 152], ["stranded DNA", "OBSERVATION", 153, 165]]], ["Taxonomically, members have been placed in three subfamilies, alpha, beta and gammaherpesvirinae based on their biology [5] .", [["alpha, beta", "GENE_OR_GENE_PRODUCT", 62, 73], ["gammaherpesvirinae", "GENE_OR_GENE_PRODUCT", 78, 96], ["alpha, beta", "PROTEIN", 62, 73]]], ["An important characteristic of investigated mammalian and avian herpesviruses is their ability to establish latency and remain latent in their primary host for life and recrudesce from latency in response to certain stimuli and be shed.", [["avian herpesviruses", "ORGANISM", 58, 77], ["latency", "PROBLEM", 185, 192]]], ["In latent state, multiple copies of viral DNA are demonstrateable as episomes without active synthesis of viral proteins and precursors.", [["DNA", "CELLULAR_COMPONENT", 42, 45], ["viral DNA", "DNA", 36, 45], ["viral proteins", "PROTEIN", 106, 120], ["viral DNA", "PROBLEM", 36, 45], ["active synthesis of viral proteins", "PROBLEM", 86, 120], ["multiple", "OBSERVATION_MODIFIER", 17, 25], ["viral DNA", "OBSERVATION", 36, 45], ["without", "UNCERTAINTY", 78, 85], ["active", "OBSERVATION_MODIFIER", 86, 92], ["viral proteins", "OBSERVATION", 106, 120]]], ["Alphaherpesviruses tend to frequently but not exclusively, become latent in neural cells of cranial or sacral ganglia, the beta and the gammaviruses in lymphoid cells.", [["neural cells", "ANATOMY", 76, 88], ["cranial", "ANATOMY", 92, 99], ["sacral ganglia", "ANATOMY", 103, 117], ["gammaviruses", "ANATOMY", 136, 148], ["lymphoid cells", "ANATOMY", 152, 166], ["neural cells", "CELL", 76, 88], ["cranial", "ORGAN", 92, 99], ["sacral ganglia", "MULTI-TISSUE_STRUCTURE", 103, 117], ["beta", "GENE_OR_GENE_PRODUCT", 123, 127], ["gammaviruses", "GENE_OR_GENE_PRODUCT", 136, 148], ["lymphoid cells", "CELL", 152, 166], ["neural cells", "CELL_TYPE", 76, 88], ["lymphoid cells", "CELL_TYPE", 152, 166], ["Alphaherpesviruses", "PROBLEM", 0, 18], ["latent", "OBSERVATION", 66, 72], ["neural cells", "OBSERVATION", 76, 88], ["cranial", "ANATOMY_MODIFIER", 92, 99], ["sacral ganglia", "ANATOMY", 103, 117], ["lymphoid cells", "OBSERVATION", 152, 166]]], ["Distinct herpesviruses cause disease in cats and dogs while rabbits may not be the natural host to significant herpesvirus disease.", [["herpesvirus disease", "DISEASE", 111, 130], ["herpesviruses", "ORGANISM", 9, 22], ["cats", "ORGANISM", 40, 44], ["dogs", "ORGANISM", 49, 53], ["rabbits", "ORGANISM", 60, 67], ["herpesvirus", "ORGANISM", 111, 122], ["cats", "SPECIES", 40, 44], ["dogs", "SPECIES", 49, 53], ["rabbits", "SPECIES", 60, 67], ["rabbits", "SPECIES", 60, 67], ["disease in cats and dogs", "PROBLEM", 29, 53], ["significant herpesvirus disease", "PROBLEM", 99, 130], ["herpesviruses", "OBSERVATION", 9, 22], ["significant", "OBSERVATION_MODIFIER", 99, 110], ["herpesvirus", "OBSERVATION", 111, 122]]], ["However, rabbits have been used as models to study disease pathogenesis of some alphaherpesviruses [6] and also gammaherpesvirus [7, 8] .HerpesviridaeCanine alphaherpesvirus-1 (CHV-1) was first identified in USA in 1965 as the cause of a highly fatal, generalised hemorrhagic disease in pups less than 4 weeks of age (fading puppy disease) and has subsequently been detected in most countries where diagnosis was undertaken.", [["hemorrhagic disease", "DISEASE", 264, 283], ["puppy disease", "DISEASE", 325, 338], ["rabbits", "ORGANISM", 9, 16], ["gammaherpesvirus", "ORGANISM", 112, 128], ["HerpesviridaeCanine alphaherpesvirus-1", "ORGANISM", 137, 175], ["CHV-1", "ORGANISM", 177, 182], ["rabbits", "SPECIES", 9, 16], ["HerpesviridaeCanine alphaherpesvirus-1", "SPECIES", 137, 175], ["CHV-1", "SPECIES", 177, 182], ["rabbits", "SPECIES", 9, 16], ["HerpesviridaeCanine alphaherpesvirus-1 (CHV-1", "SPECIES", 137, 182], ["some alphaherpesviruses", "PROBLEM", 75, 98], ["HerpesviridaeCanine alphaherpesvirus", "TREATMENT", 137, 173], ["generalised hemorrhagic disease in pups", "PROBLEM", 252, 291], ["fading puppy disease", "PROBLEM", 318, 338], ["some", "OBSERVATION_MODIFIER", 75, 79], ["alphaherpesviruses", "OBSERVATION", 80, 98], ["gammaherpesvirus", "ANATOMY", 112, 128], ["highly", "OBSERVATION_MODIFIER", 238, 244], ["fatal", "OBSERVATION_MODIFIER", 245, 250], ["generalised", "OBSERVATION_MODIFIER", 252, 263], ["hemorrhagic", "OBSERVATION_MODIFIER", 264, 275], ["disease", "OBSERVATION", 276, 283]]], ["However, CHV-1 prevalence in the dog population as a whole is low [9] , although it may be highly prevalent in kennels.", [["CHV-1", "GENE_OR_GENE_PRODUCT", 9, 14], ["dog", "ORGANISM", 33, 36], ["kennels", "CANCER", 111, 118], ["dog", "SPECIES", 33, 36], ["CHV-1", "SPECIES", 9, 14], ["CHV", "TEST", 9, 12], ["may be", "UNCERTAINTY", 84, 90]]], ["CHV-1 spreads by aerosol and initiates infection in the oropharyngeal mucosa and the local lymph nodes and results in reticuloendothelial cell viraemia.", [["oropharyngeal mucosa", "ANATOMY", 56, 76], ["lymph nodes", "ANATOMY", 91, 102], ["reticuloendothelial cell", "ANATOMY", 118, 142], ["CHV-1", "CHEMICAL", 0, 5], ["infection", "DISEASE", 39, 48], ["viraemia", "DISEASE", 143, 151], ["CHV-1", "GENE_OR_GENE_PRODUCT", 0, 5], ["oropharyngeal mucosa", "MULTI-TISSUE_STRUCTURE", 56, 76], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 91, 102], ["reticuloendothelial cell", "CELL", 118, 142], ["CHV-1", "SPECIES", 0, 5], ["infection in the oropharyngeal mucosa", "PROBLEM", 39, 76], ["the local lymph nodes", "PROBLEM", 81, 102], ["reticuloendothelial cell viraemia", "PROBLEM", 118, 151], ["infection", "OBSERVATION", 39, 48], ["oropharyngeal mucosa", "ANATOMY", 56, 76], ["local", "OBSERVATION_MODIFIER", 85, 90], ["lymph nodes", "OBSERVATION", 91, 102], ["reticuloendothelial cell viraemia", "OBSERVATION", 118, 151]]], ["In puppies less than 3 weeks of age, viraemia disseminates the virus systemically and after replication in organs, causes widespread petechiation in the liver, kidneys, lungs and lymph nodes.", [["organs", "ANATOMY", 107, 113], ["liver", "ANATOMY", 153, 158], ["kidneys", "ANATOMY", 160, 167], ["lungs", "ANATOMY", 169, 174], ["lymph nodes", "ANATOMY", 179, 190], ["viraemia", "DISEASE", 37, 45], ["organs", "ORGAN", 107, 113], ["liver", "ORGAN", 153, 158], ["kidneys", "ORGAN", 160, 167], ["lungs", "ORGAN", 169, 174], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 179, 190], ["viraemia disseminates the virus systemically", "PROBLEM", 37, 81], ["replication in organs", "PROBLEM", 92, 113], ["widespread petechiation in the liver, kidneys, lungs and lymph nodes", "PROBLEM", 122, 190], ["viraemia", "OBSERVATION", 37, 45], ["organs", "ANATOMY", 107, 113], ["widespread", "OBSERVATION_MODIFIER", 122, 132], ["petechiation", "OBSERVATION", 133, 145], ["liver", "ANATOMY", 153, 158], ["kidneys", "ANATOMY", 160, 167], ["lungs", "ANATOMY", 169, 174], ["lymph nodes", "OBSERVATION", 179, 190]]], ["Severely affected puppies may die.", [["puppies", "ORGANISM", 18, 25], ["Severely affected puppies", "PROBLEM", 0, 25], ["puppies", "OBSERVATION", 18, 25]]], ["In adult dogs, CHV-1 infection is less severe and may cause cough and dyspnoea in individuals with generalised infection of the bronchial tree and may be part of the kennel cough syndrome and/or reproductive failure.HerpesviridaeThe cat alphaherpesvirus-1 (FHV-1) is also transmitted by aerosol followed by viral replication in nasal and conjunctival epithelium and subsequent dissemination of progeny virus throughout the bronchial tree.", [["bronchial tree", "ANATOMY", 128, 142], ["nasal", "ANATOMY", 328, 333], ["conjunctival epithelium", "ANATOMY", 338, 361], ["bronchial tree", "ANATOMY", 423, 437], ["infection", "DISEASE", 21, 30], ["cough", "DISEASE", 60, 65], ["dyspnoea", "DISEASE", 70, 78], ["infection of the bronchial tree", "DISEASE", 111, 142], ["cough syndrome", "DISEASE", 173, 187], ["reproductive failure", "DISEASE", 195, 215], ["dogs", "ORGANISM", 9, 13], ["CHV-1", "ORGANISM", 15, 20], ["bronchial tree", "MULTI-TISSUE_STRUCTURE", 128, 142], ["cat alphaherpesvirus-1", "ORGANISM", 233, 255], ["FHV-1", "ORGANISM", 257, 262], ["nasal", "TISSUE", 328, 333], ["conjunctival epithelium", "TISSUE", 338, 361], ["bronchial tree", "MULTI-TISSUE_STRUCTURE", 423, 437], ["dogs", "SPECIES", 9, 13], ["cat alphaherpesvirus-1", "SPECIES", 233, 255], ["CHV-1", "SPECIES", 15, 20], ["cat alphaherpesvirus-1 (FHV-1", "SPECIES", 233, 262], ["CHV-1 infection", "PROBLEM", 15, 30], ["cough", "PROBLEM", 60, 65], ["dyspnoea", "PROBLEM", 70, 78], ["generalised infection of the bronchial tree", "PROBLEM", 99, 142], ["the kennel cough syndrome", "PROBLEM", 162, 187], ["reproductive failure", "PROBLEM", 195, 215], ["Herpesviridae", "TREATMENT", 216, 229], ["The cat alphaherpesvirus", "TEST", 229, 253], ["aerosol", "TREATMENT", 287, 294], ["viral replication in nasal and conjunctival epithelium", "PROBLEM", 307, 361], ["progeny virus", "PROBLEM", 394, 407], ["adult", "OBSERVATION_MODIFIER", 3, 8], ["dogs", "OBSERVATION", 9, 13], ["infection", "OBSERVATION", 21, 30], ["less severe", "OBSERVATION_MODIFIER", 34, 45], ["may cause", "UNCERTAINTY", 50, 59], ["cough", "OBSERVATION", 60, 65], ["dyspnoea", "OBSERVATION", 70, 78], ["generalised", "OBSERVATION_MODIFIER", 99, 110], ["infection", "OBSERVATION", 111, 120], ["bronchial", "ANATOMY", 128, 137], ["tree", "ANATOMY_MODIFIER", 138, 142], ["may be part of", "UNCERTAINTY", 147, 161], ["kennel cough syndrome", "OBSERVATION", 166, 187], ["reproductive", "OBSERVATION_MODIFIER", 195, 207], ["failure", "OBSERVATION", 208, 215], ["viral replication", "OBSERVATION", 307, 324], ["nasal", "ANATOMY", 328, 333], ["conjunctival epithelium", "ANATOMY", 338, 361], ["progeny virus", "OBSERVATION", 394, 407], ["bronchial", "ANATOMY", 423, 432], ["tree", "ANATOMY_MODIFIER", 433, 437]]], ["Typical clinical signs of FHV-1 infection are rhinitis, bronchitis, conjunctivitis, nasal discharge, dyspnoea, fever, coughing and inappetance.", [["nasal", "ANATOMY", 84, 89], ["infection", "DISEASE", 32, 41], ["rhinitis", "DISEASE", 46, 54], ["bronchitis", "DISEASE", 56, 66], ["conjunctivitis", "DISEASE", 68, 82], ["nasal discharge", "DISEASE", 84, 99], ["dyspnoea", "DISEASE", 101, 109], ["fever", "DISEASE", 111, 116], ["coughing", "DISEASE", 118, 126], ["inappetance", "DISEASE", 131, 142], ["FHV-1", "GENE_OR_GENE_PRODUCT", 26, 31], ["nasal", "ORGANISM_SUBDIVISION", 84, 89], ["FHV-1", "SPECIES", 26, 31], ["FHV", "PROBLEM", 26, 29], ["1 infection", "PROBLEM", 30, 41], ["rhinitis", "PROBLEM", 46, 54], ["bronchitis", "PROBLEM", 56, 66], ["conjunctivitis", "PROBLEM", 68, 82], ["nasal discharge", "PROBLEM", 84, 99], ["dyspnoea", "PROBLEM", 101, 109], ["fever", "PROBLEM", 111, 116], ["coughing", "PROBLEM", 118, 126], ["inappetance", "PROBLEM", 131, 142], ["FHV", "OBSERVATION", 26, 29], ["infection", "OBSERVATION", 32, 41], ["rhinitis", "OBSERVATION", 46, 54], ["bronchitis", "OBSERVATION", 56, 66], ["conjunctivitis", "OBSERVATION", 68, 82], ["nasal", "ANATOMY", 84, 89], ["discharge", "OBSERVATION", 90, 99], ["dyspnoea", "OBSERVATION", 101, 109], ["fever", "OBSERVATION", 111, 116]]], ["The FHV-1 disease has some clinical similarities to FCV respiratory disease and is commonly referred to as feline viral rhinotracheitis (FVR).", [["respiratory", "ANATOMY", 56, 67], ["FCV respiratory disease", "DISEASE", 52, 75], ["feline viral rhinotracheitis", "DISEASE", 107, 135], ["FVR", "DISEASE", 137, 140], ["FHV-1", "GENE_OR_GENE_PRODUCT", 4, 9], ["FCV", "ORGANISM", 52, 55], ["feline viral rhinotracheitis", "ORGANISM", 107, 135], ["FVR", "CANCER", 137, 140], ["feline viral rhinotracheitis", "SPECIES", 107, 135], ["FHV-1", "SPECIES", 4, 9], ["FCV", "SPECIES", 52, 55], ["feline viral rhinotracheitis", "SPECIES", 107, 135], ["The FHV-1 disease", "PROBLEM", 0, 17], ["FCV respiratory disease", "PROBLEM", 52, 75], ["feline viral rhinotracheitis", "PROBLEM", 107, 135], ["disease", "OBSERVATION", 10, 17], ["FCV", "OBSERVATION_MODIFIER", 52, 55], ["respiratory disease", "OBSERVATION", 56, 75], ["rhinotracheitis", "OBSERVATION", 120, 135]]], ["Secondary bacterial bronchopneumonia, commonly in kittens but rarely in older cats, may result in death.", [["bronchopneumonia", "DISEASE", 20, 36], ["death", "DISEASE", 98, 103], ["kittens", "ORGANISM", 50, 57], ["cats", "ORGANISM", 78, 82], ["cats", "SPECIES", 78, 82], ["Secondary bacterial bronchopneumonia", "PROBLEM", 0, 36], ["death", "PROBLEM", 98, 103], ["bacterial", "OBSERVATION_MODIFIER", 10, 19], ["bronchopneumonia", "OBSERVATION", 20, 36]]], ["Experimentally, both FHV-1 and CHV-1 were found to cause vaginitis.", [["vaginitis", "DISEASE", 57, 66], ["FHV-1", "GENE_OR_GENE_PRODUCT", 21, 26], ["CHV-1", "ORGANISM", 31, 36], ["CHV-1", "DNA", 31, 36], ["FHV-1", "SPECIES", 21, 26], ["CHV-1", "SPECIES", 31, 36], ["FHV", "TEST", 21, 24], ["CHV", "TEST", 31, 34], ["vaginitis", "PROBLEM", 57, 66], ["vaginitis", "OBSERVATION", 57, 66]]], ["The incubation period for the common disease signs for both viruses is 1-2 days.AdenoviridaeAdenoviruses were first named in 1956 to cluster a new group of cytopathic viruses recovered from explanted human adenoid and tonsillar tissue.", [["adenoid", "ANATOMY", 206, 213], ["tonsillar tissue", "ANATOMY", 218, 234], ["cytopathic viruses", "DISEASE", 156, 174], ["human", "ORGANISM", 200, 205], ["adenoid", "CANCER", 206, 213], ["tonsillar tissue", "TISSUE", 218, 234], ["human", "SPECIES", 200, 205], ["human", "SPECIES", 200, 205], ["the common disease signs", "PROBLEM", 26, 50], ["both viruses", "PROBLEM", 55, 67], ["AdenoviridaeAdenoviruses", "TREATMENT", 80, 104], ["cytopathic viruses", "PROBLEM", 156, 174], ["explanted human adenoid and tonsillar tissue", "PROBLEM", 190, 234], ["viruses", "OBSERVATION", 60, 67], ["cytopathic viruses", "OBSERVATION", 156, 174], ["adenoid", "ANATOMY", 206, 213], ["tonsillar tissue", "ANATOMY", 218, 234]]], ["The family has two genera, the mastaadenoviruses from mammals and aviadenoviruses from birds.", [["mastaadenoviruses", "GENE_OR_GENE_PRODUCT", 31, 48], ["aviadenoviruses", "GENE_OR_GENE_PRODUCT", 66, 81]]], ["Genera are further classified into subgenus, species and strains.", [["strains", "PROBLEM", 57, 64]]], ["Adenoviruses cause disease in dogs and pigeons.", [["Adenoviruses", "DISEASE", 0, 12], ["dogs", "ORGANISM", 30, 34], ["dogs", "SPECIES", 30, 34], ["disease in dogs", "PROBLEM", 19, 34], ["dogs", "OBSERVATION", 30, 34]]], ["Two antigenically related adenoviruses species can cause significant disease in domestic dogs and other canids.", [["adenoviruses", "ORGANISM", 26, 38], ["dogs", "ORGANISM", 89, 93], ["dogs", "SPECIES", 89, 93], ["Two antigenically related adenoviruses species", "PROBLEM", 0, 46], ["significant disease in domestic dogs and other canids", "PROBLEM", 57, 110], ["adenoviruses", "OBSERVATION", 26, 38], ["significant", "OBSERVATION_MODIFIER", 57, 68], ["disease", "OBSERVATION", 69, 76], ["domestic dogs", "OBSERVATION", 80, 93]]], ["The two viruses involved are commonly known as canine adenovirus-1 (CAV-1) and 2 (CAV-2) and also as infectious canine hepatitis virus and infectious canine laryngotracheitis virus respectively.", [["infectious canine hepatitis virus", "DISEASE", 101, 134], ["infectious canine laryngotracheitis virus", "DISEASE", 139, 180], ["canine adenovirus-1", "ORGANISM", 47, 66], ["CAV-1", "ORGANISM", 68, 73], ["CAV-2", "ORGANISM", 82, 87], ["infectious", "ORGANISM", 101, 111], ["canine hepatitis virus", "ORGANISM", 112, 134], ["canine laryngotracheitis virus", "ORGANISM", 150, 180], ["canine adenovirus-1", "SPECIES", 47, 66], ["CAV-1", "SPECIES", 68, 73], ["canine hepatitis virus", "SPECIES", 112, 134], ["canine laryngotracheitis virus", "SPECIES", 150, 180], ["canine adenovirus-1", "SPECIES", 47, 66], ["CAV-1", "SPECIES", 68, 73], ["canine hepatitis virus", "SPECIES", 112, 134], ["canine laryngotracheitis virus", "SPECIES", 150, 180], ["The two viruses", "PROBLEM", 0, 15], ["canine adenovirus", "TEST", 47, 64], ["CAV", "TEST", 68, 71], ["CAV", "TEST", 82, 85], ["infectious canine hepatitis virus", "PROBLEM", 101, 134], ["infectious canine laryngotracheitis virus", "PROBLEM", 139, 180], ["two", "OBSERVATION_MODIFIER", 4, 7], ["viruses", "OBSERVATION", 8, 15], ["infectious", "OBSERVATION_MODIFIER", 101, 111], ["hepatitis virus", "OBSERVATION", 119, 134], ["infectious", "OBSERVATION_MODIFIER", 139, 149]]], ["The close antigenic cross-reactivity is seen at the level of significant reciprocal but unequal cross-neutralisation.", [["unequal cross-neutralisation", "PROBLEM", 88, 116], ["antigenic", "OBSERVATION_MODIFIER", 10, 19], ["cross-reactivity", "OBSERVATION", 20, 36], ["significant", "OBSERVATION_MODIFIER", 61, 72], ["reciprocal", "OBSERVATION_MODIFIER", 73, 83], ["unequal", "OBSERVATION_MODIFIER", 88, 95], ["cross-neutralisation", "OBSERVATION", 96, 116]]], ["The viruses are however unequivocally distinguished by DNA fingerprinting of endonuclease digests of viral DNA.", [["DNA", "CELLULAR_COMPONENT", 55, 58], ["DNA", "CELLULAR_COMPONENT", 107, 110], ["viral DNA", "DNA", 101, 110], ["viral DNA", "PROBLEM", 101, 110], ["viruses", "OBSERVATION", 4, 11], ["viral DNA", "OBSERVATION", 101, 110]]], ["CAV-1 occurs worldwide and infects and replicates in oropharynx after the ingestion of infectious material from respiratory secretions, urine or faeces.", [["oropharynx", "ANATOMY", 53, 63], ["respiratory secretions", "ANATOMY", 112, 134], ["urine", "ANATOMY", 136, 141], ["faeces", "ANATOMY", 145, 151], ["CAV-1", "CHEMICAL", 0, 5], ["CAV-1", "GENE_OR_GENE_PRODUCT", 0, 5], ["oropharynx", "ORGAN", 53, 63], ["secretions", "ORGANISM_SUBSTANCE", 124, 134], ["urine", "ORGANISM_SUBSTANCE", 136, 141], ["faeces", "ORGANISM_SUBSTANCE", 145, 151], ["CAV-1", "SPECIES", 0, 5], ["infectious material", "PROBLEM", 87, 106], ["respiratory secretions", "PROBLEM", 112, 134], ["infects", "OBSERVATION", 27, 34], ["oropharynx", "ANATOMY", 53, 63], ["infectious", "OBSERVATION", 87, 97], ["respiratory", "ANATOMY", 112, 123], ["secretions", "OBSERVATION", 124, 134]]], ["The primary replication in tonsils, Peyers patches and epithelia of oropharynx and bowel results in lymphoid cell viraemia which initiates secondary infection of parenchyma of liver, kidney and lining of blood vessel and sinusoids in these organs and other sites.", [["tonsils", "ANATOMY", 27, 34], ["Peyers patches", "ANATOMY", 36, 50], ["epithelia", "ANATOMY", 55, 64], ["oropharynx", "ANATOMY", 68, 78], ["bowel", "ANATOMY", 83, 88], ["lymphoid cell", "ANATOMY", 100, 113], ["parenchyma", "ANATOMY", 162, 172], ["liver", "ANATOMY", 176, 181], ["kidney", "ANATOMY", 183, 189], ["blood vessel", "ANATOMY", 204, 216], ["sinusoids", "ANATOMY", 221, 230], ["organs", "ANATOMY", 240, 246], ["sites", "ANATOMY", 257, 262], ["viraemia", "DISEASE", 114, 122], ["infection", "DISEASE", 149, 158], ["tonsils", "ORGAN", 27, 34], ["Peyers patches", "TISSUE", 36, 50], ["epithelia", "TISSUE", 55, 64], ["oropharynx", "ORGAN", 68, 78], ["bowel", "ORGAN", 83, 88], ["lymphoid cell", "CELL", 100, 113], ["parenchyma", "TISSUE", 162, 172], ["liver", "ORGAN", 176, 181], ["kidney", "ORGAN", 183, 189], ["blood vessel", "MULTI-TISSUE_STRUCTURE", 204, 216], ["sinusoids", "MULTI-TISSUE_STRUCTURE", 221, 230], ["organs", "ORGAN", 240, 246], ["The primary replication in tonsils", "PROBLEM", 0, 34], ["Peyers patches", "TREATMENT", 36, 50], ["epithelia of oropharynx and bowel", "PROBLEM", 55, 88], ["lymphoid cell viraemia", "PROBLEM", 100, 122], ["secondary infection of parenchyma of liver", "PROBLEM", 139, 181], ["sinusoids in these organs and other sites", "PROBLEM", 221, 262], ["primary", "OBSERVATION_MODIFIER", 4, 11], ["replication", "OBSERVATION", 12, 23], ["tonsils", "ANATOMY", 27, 34], ["epithelia", "ANATOMY_MODIFIER", 55, 64], ["oropharynx", "ANATOMY", 68, 78], ["bowel", "ANATOMY", 83, 88], ["lymphoid cell viraemia", "OBSERVATION", 100, 122], ["secondary", "OBSERVATION_MODIFIER", 139, 148], ["infection", "OBSERVATION", 149, 158], ["parenchyma", "ANATOMY_MODIFIER", 162, 172], ["liver", "ANATOMY", 176, 181], ["kidney", "ANATOMY", 183, 189], ["lining", "ANATOMY_MODIFIER", 194, 200], ["blood vessel", "ANATOMY", 204, 216], ["organs", "ANATOMY", 240, 246]]], ["Infected cells die and lyse leading to mainly pinpoint bleeds and haemorrhages and some times a large bleed if a major vessel is involved.", [["cells", "ANATOMY", 9, 14], ["vessel", "ANATOMY", 119, 125], ["bleeds", "DISEASE", 55, 61], ["haemorrhages", "DISEASE", 66, 78], ["cells", "CELL", 9, 14], ["vessel", "MULTI-TISSUE_STRUCTURE", 119, 125], ["Infected cells die", "PROBLEM", 0, 18], ["lyse", "PROBLEM", 23, 27], ["mainly pinpoint bleeds", "PROBLEM", 39, 61], ["haemorrhages", "PROBLEM", 66, 78], ["a large bleed", "PROBLEM", 94, 107], ["cells die", "OBSERVATION", 9, 18], ["mainly", "OBSERVATION_MODIFIER", 39, 45], ["pinpoint", "OBSERVATION_MODIFIER", 46, 54], ["bleeds", "OBSERVATION", 55, 61], ["haemorrhages", "OBSERVATION", 66, 78], ["large", "OBSERVATION_MODIFIER", 96, 101], ["bleed", "OBSERVATION", 102, 107], ["vessel", "ANATOMY", 119, 125]]], ["CAV-1 causes fatal hepatitis in newly weaned puppies and susceptible young dogs.", [["CAV-1", "CHEMICAL", 0, 5], ["hepatitis", "DISEASE", 19, 28], ["CAV-1", "GENE_OR_GENE_PRODUCT", 0, 5], ["puppies", "ORGANISM_SUBDIVISION", 45, 52], ["dogs", "ORGANISM", 75, 79], ["dogs", "SPECIES", 75, 79], ["CAV-1", "SPECIES", 0, 5], ["CAV", "TEST", 0, 3], ["fatal hepatitis", "PROBLEM", 13, 28], ["susceptible young dogs", "PROBLEM", 57, 79], ["fatal", "OBSERVATION_MODIFIER", 13, 18], ["hepatitis", "OBSERVATION", 19, 28], ["weaned puppies", "OBSERVATION", 38, 52], ["susceptible", "OBSERVATION_MODIFIER", 57, 68], ["young dogs", "OBSERVATION", 69, 79]]], ["Other lesions due to CAV-1 infection comprise subcutaneous oedema, ascites and oedema of the gall bladder wall, immune complex keratitis and nephritis.", [["lesions", "ANATOMY", 6, 13], ["subcutaneous", "ANATOMY", 46, 58], ["ascites", "ANATOMY", 67, 74], ["gall bladder wall", "ANATOMY", 93, 110], ["infection", "DISEASE", 27, 36], ["subcutaneous oedema", "DISEASE", 46, 65], ["ascites", "DISEASE", 67, 74], ["oedema", "DISEASE", 79, 85], ["gall bladder", "DISEASE", 93, 105], ["keratitis", "DISEASE", 127, 136], ["nephritis", "DISEASE", 141, 150], ["lesions", "PATHOLOGICAL_FORMATION", 6, 13], ["CAV-1", "GENE_OR_GENE_PRODUCT", 21, 26], ["subcutaneous oedema", "PATHOLOGICAL_FORMATION", 46, 65], ["gall bladder wall", "MULTI-TISSUE_STRUCTURE", 93, 110], ["CAV-1", "SPECIES", 21, 26], ["Other lesions", "PROBLEM", 0, 13], ["CAV-1 infection", "PROBLEM", 21, 36], ["subcutaneous oedema", "PROBLEM", 46, 65], ["ascites", "PROBLEM", 67, 74], ["oedema of the gall bladder wall", "PROBLEM", 79, 110], ["immune complex keratitis", "PROBLEM", 112, 136], ["nephritis", "PROBLEM", 141, 150], ["lesions", "OBSERVATION", 6, 13], ["CAV", "ANATOMY", 21, 24], ["infection", "OBSERVATION", 27, 36], ["subcutaneous", "ANATOMY", 46, 58], ["oedema", "OBSERVATION", 59, 65], ["ascites", "OBSERVATION", 67, 74], ["oedema", "OBSERVATION", 79, 85], ["gall bladder", "ANATOMY", 93, 105], ["wall", "ANATOMY_MODIFIER", 106, 110], ["immune", "OBSERVATION_MODIFIER", 112, 118], ["complex", "OBSERVATION_MODIFIER", 119, 126], ["keratitis", "OBSERVATION", 127, 136], ["nephritis", "OBSERVATION", 141, 150]]], ["Older dogs may be susceptible but signs are milder with enlargement of tonsils, sub-maxillary lymph nodes and sometimes immune complex keratitis.", [["tonsils", "ANATOMY", 71, 78], ["maxillary lymph nodes", "ANATOMY", 84, 105], ["keratitis", "DISEASE", 135, 144], ["dogs", "ORGANISM", 6, 10], ["tonsils", "ORGAN", 71, 78], ["maxillary lymph nodes", "MULTI-TISSUE_STRUCTURE", 84, 105], ["dogs", "SPECIES", 6, 10], ["enlargement of tonsils", "PROBLEM", 56, 78], ["sub-maxillary lymph nodes", "PROBLEM", 80, 105], ["immune complex keratitis", "PROBLEM", 120, 144], ["milder", "OBSERVATION_MODIFIER", 44, 50], ["enlargement", "OBSERVATION", 56, 67], ["tonsils", "ANATOMY", 71, 78], ["sub", "OBSERVATION_MODIFIER", 80, 83], ["maxillary", "ANATOMY", 84, 93], ["lymph nodes", "OBSERVATION", 94, 105], ["immune", "OBSERVATION_MODIFIER", 120, 126], ["complex", "OBSERVATION_MODIFIER", 127, 134], ["keratitis", "OBSERVATION", 135, 144]]], ["Isolates of CAV-1 vary in virulence for the domestic dog, some cause sub-clinical diseases while others acute disease with severe abdominal pain followed by death.", [["abdominal", "ANATOMY", 130, 139], ["acute disease", "DISEASE", 104, 117], ["abdominal pain", "DISEASE", 130, 144], ["death", "DISEASE", 157, 162], ["CAV-1", "ORGANISM", 12, 17], ["dog", "ORGANISM", 53, 56], ["abdominal", "ORGANISM_SUBDIVISION", 130, 139], ["CAV-1", "SPECIES", 12, 17], ["dog", "SPECIES", 53, 56], ["CAV-1", "SPECIES", 12, 17], ["domestic dog", "SPECIES", 44, 56], ["CAV", "TEST", 12, 15], ["clinical diseases", "PROBLEM", 73, 90], ["acute disease", "PROBLEM", 104, 117], ["severe abdominal pain", "PROBLEM", 123, 144], ["death", "PROBLEM", 157, 162], ["CAV", "ANATOMY", 12, 15], ["acute", "OBSERVATION_MODIFIER", 104, 109], ["disease", "OBSERVATION", 110, 117], ["severe", "OBSERVATION_MODIFIER", 123, 129], ["abdominal", "ANATOMY", 130, 139], ["pain", "OBSERVATION", 140, 144]]], ["Wild and farmed dogs are highly susceptible to some strains of CAV-1 encephalitis.", [["encephalitis", "DISEASE", 69, 81], ["dogs", "ORGANISM", 16, 20], ["CAV-1 encephalitis", "ORGANISM", 63, 81], ["dogs", "SPECIES", 16, 20], ["CAV-1", "SPECIES", 63, 68], ["CAV-1", "SPECIES", 63, 68], ["CAV-1 encephalitis", "PROBLEM", 63, 81], ["CAV", "ANATOMY", 63, 66], ["encephalitis", "OBSERVATION", 69, 81]]], ["CAV-1 can often cause immune complex vasculitis, commonly known as blue eye.AdenoviridaeCAV-2 transmission among dogs is mainly by inhalation and virus is widely prevalent.", [["eye", "ANATOMY", 72, 75], ["CAV-1", "CHEMICAL", 0, 5], ["vasculitis", "DISEASE", 37, 47], ["CAV-1", "GENE_OR_GENE_PRODUCT", 0, 5], ["eye", "ORGAN", 72, 75], ["AdenoviridaeCAV-2", "GENE_OR_GENE_PRODUCT", 76, 93], ["dogs", "ORGANISM", 113, 117], ["dogs", "SPECIES", 113, 117], ["CAV", "TEST", 0, 3], ["immune complex vasculitis", "PROBLEM", 22, 47], ["AdenoviridaeCAV-2 transmission among dogs", "TREATMENT", 76, 117], ["virus", "PROBLEM", 146, 151], ["vasculitis", "OBSERVATION", 37, 47], ["eye", "ANATOMY", 72, 75]]], ["CAV-2 is a major cause of kennel cough syndrome.", [["cough syndrome", "DISEASE", 33, 47], ["CAV-2", "GENE_OR_GENE_PRODUCT", 0, 5], ["kennel cough syndrome", "PROBLEM", 26, 47], ["kennel cough syndrome", "OBSERVATION", 26, 47]]], ["CAV-2 causes extensive lesions in the upper and the lower respiratory tract resulting in interstitial pneumonia often with necrotising bronchitis and bronchiolitis, focal necrosis of the turbinate and tonsillar epithelium.", [["lesions", "ANATOMY", 23, 30], ["upper", "ANATOMY", 38, 43], ["lower respiratory tract", "ANATOMY", 52, 75], ["interstitial", "ANATOMY", 89, 101], ["turbinate", "ANATOMY", 187, 196], ["tonsillar epithelium", "ANATOMY", 201, 221], ["CAV-2", "CHEMICAL", 0, 5], ["interstitial pneumonia", "DISEASE", 89, 111], ["bronchitis", "DISEASE", 135, 145], ["bronchiolitis", "DISEASE", 150, 163], ["necrosis", "DISEASE", 171, 179], ["CAV-2", "GENE_OR_GENE_PRODUCT", 0, 5], ["lesions", "PATHOLOGICAL_FORMATION", 23, 30], ["upper", "ORGANISM_SUBDIVISION", 38, 43], ["lower", "ORGANISM_SUBDIVISION", 52, 57], ["respiratory tract", "ORGANISM_SUBDIVISION", 58, 75], ["turbinate", "ORGAN", 187, 196], ["tonsillar epithelium", "TISSUE", 201, 221], ["CAV", "TEST", 0, 3], ["extensive lesions in the upper and the lower respiratory tract", "PROBLEM", 13, 75], ["interstitial pneumonia", "PROBLEM", 89, 111], ["necrotising bronchitis", "PROBLEM", 123, 145], ["bronchiolitis", "PROBLEM", 150, 163], ["focal necrosis of the turbinate and tonsillar epithelium", "PROBLEM", 165, 221], ["extensive", "OBSERVATION_MODIFIER", 13, 22], ["lesions", "OBSERVATION", 23, 30], ["upper", "ANATOMY_MODIFIER", 38, 43], ["lower", "ANATOMY_MODIFIER", 52, 57], ["respiratory tract", "ANATOMY", 58, 75], ["interstitial", "ANATOMY_MODIFIER", 89, 101], ["pneumonia", "OBSERVATION", 102, 111], ["necrotising", "OBSERVATION_MODIFIER", 123, 134], ["bronchitis", "OBSERVATION", 135, 145], ["bronchiolitis", "OBSERVATION", 150, 163], ["focal", "OBSERVATION_MODIFIER", 165, 170], ["necrosis", "OBSERVATION", 171, 179], ["turbinate", "ANATOMY", 187, 196], ["tonsillar", "ANATOMY", 201, 210], ["epithelium", "ANATOMY_MODIFIER", 211, 221]]], ["The disease is more severe when associated with concurrent bacterial infection.", [["bacterial infection", "DISEASE", 59, 78], ["The disease", "PROBLEM", 0, 11], ["concurrent bacterial infection", "PROBLEM", 48, 78], ["disease", "OBSERVATION", 4, 11], ["more severe", "OBSERVATION_MODIFIER", 15, 26], ["bacterial", "OBSERVATION_MODIFIER", 59, 68], ["infection", "OBSERVATION", 69, 78]]], ["Often the bronchial nodes are congested and haemorrhagic but gross liver and gall bladder lesions are usually absent.", [["bronchial nodes", "ANATOMY", 10, 25], ["liver", "ANATOMY", 67, 72], ["gall bladder lesions", "ANATOMY", 77, 97], ["haemorrhagic", "DISEASE", 44, 56], ["liver and gall bladder lesions", "DISEASE", 67, 97], ["bronchial nodes", "MULTI-TISSUE_STRUCTURE", 10, 25], ["liver", "ORGAN", 67, 72], ["gall bladder lesions", "CANCER", 77, 97], ["congested", "PROBLEM", 30, 39], ["haemorrhagic", "PROBLEM", 44, 56], ["gross liver and gall bladder lesions", "PROBLEM", 61, 97], ["bronchial", "ANATOMY", 10, 19], ["nodes", "OBSERVATION", 20, 25], ["congested", "OBSERVATION", 30, 39], ["haemorrhagic", "OBSERVATION_MODIFIER", 44, 56], ["gross", "OBSERVATION_MODIFIER", 61, 66], ["liver", "ANATOMY", 67, 72], ["gall bladder", "ANATOMY", 77, 89], ["lesions", "OBSERVATION", 90, 97]]], ["CAV-2 infection in dogs has not been associated with hepatitis.", [["CAV-2", "CHEMICAL", 0, 5], ["infection", "DISEASE", 6, 15], ["hepatitis", "DISEASE", 53, 62], ["CAV-2", "GENE_OR_GENE_PRODUCT", 0, 5], ["dogs", "ORGANISM", 19, 23], ["dogs", "SPECIES", 19, 23], ["CAV", "PROBLEM", 0, 3], ["2 infection in dogs", "PROBLEM", 4, 23], ["hepatitis", "PROBLEM", 53, 62], ["infection", "OBSERVATION", 6, 15], ["not been associated with", "UNCERTAINTY", 28, 52], ["hepatitis", "OBSERVATION", 53, 62]]], ["Other signs of CAV-2 infection may be fever, mild depression and nasal and/or ocular discharge; corneal opacity is sometimes seen.PoxviridaeMembers are large, enveloped, highly resistant viruses with a double-stranded linear DNA genome which replicates in cytoplasm of infected cells.", [["nasal", "ANATOMY", 65, 70], ["ocular", "ANATOMY", 78, 84], ["corneal", "ANATOMY", 96, 103], ["cytoplasm", "ANATOMY", 256, 265], ["cells", "ANATOMY", 278, 283], ["CAV-2 infection", "DISEASE", 15, 30], ["fever", "DISEASE", 38, 43], ["depression", "DISEASE", 50, 60], ["corneal opacity", "DISEASE", 96, 111], ["nasal", "ORGANISM_SUBDIVISION", 65, 70], ["corneal", "TISSUE", 96, 103], ["PoxviridaeMembers", "GENE_OR_GENE_PRODUCT", 130, 147], ["DNA", "CELLULAR_COMPONENT", 225, 228], ["cytoplasm", "ORGANISM_SUBSTANCE", 256, 265], ["cells", "CELL", 278, 283], ["double-stranded linear DNA genome", "DNA", 202, 235], ["infected cells", "CELL_TYPE", 269, 283], ["CAV-2 infection", "PROBLEM", 15, 30], ["fever", "PROBLEM", 38, 43], ["mild depression and nasal and/or ocular discharge", "PROBLEM", 45, 94], ["corneal opacity", "PROBLEM", 96, 111], ["PoxviridaeMembers", "TREATMENT", 130, 147], ["highly resistant viruses", "PROBLEM", 170, 194], ["a double-stranded linear DNA genome", "TREATMENT", 200, 235], ["infected cells", "PROBLEM", 269, 283], ["CAV", "OBSERVATION", 15, 18], ["infection", "OBSERVATION", 21, 30], ["mild", "OBSERVATION_MODIFIER", 45, 49], ["depression", "OBSERVATION", 50, 60], ["nasal", "ANATOMY", 65, 70], ["ocular", "ANATOMY", 78, 84], ["corneal", "ANATOMY", 96, 103], ["opacity", "OBSERVATION", 104, 111], ["large", "OBSERVATION_MODIFIER", 152, 157], ["enveloped", "OBSERVATION_MODIFIER", 159, 168], ["highly", "OBSERVATION_MODIFIER", 170, 176], ["resistant", "OBSERVATION_MODIFIER", 177, 186], ["viruses", "OBSERVATION", 187, 194], ["stranded linear", "OBSERVATION_MODIFIER", 209, 224], ["DNA genome", "OBSERVATION", 225, 235], ["cytoplasm", "OBSERVATION_MODIFIER", 256, 265], ["infected cells", "OBSERVATION", 269, 283]]], ["The subfamily Chordopoxvirinae has members affecting vertebrates classified into six genera [10] .", [["Chordopoxvirinae", "CHEMICAL", 14, 30], ["Chordopoxvirinae", "GENE_OR_GENE_PRODUCT", 14, 30]]], ["The vertebrate poxviruses usually produce proliferative focal lesions and are occasionally fatal when they generalise.", [["focal lesions", "ANATOMY", 56, 69], ["poxviruses", "ORGANISM", 15, 25], ["focal lesions", "PATHOLOGICAL_FORMATION", 56, 69], ["proliferative focal lesions", "PROBLEM", 42, 69], ["vertebrate", "OBSERVATION_MODIFIER", 4, 14], ["poxviruses", "OBSERVATION", 15, 25], ["proliferative", "OBSERVATION_MODIFIER", 42, 55], ["focal", "OBSERVATION_MODIFIER", 56, 61], ["lesions", "OBSERVATION", 62, 69], ["occasionally", "OBSERVATION_MODIFIER", 78, 90], ["fatal", "OBSERVATION_MODIFIER", 91, 96]]], ["Members are very stable and virus shed in scabs survives for months or years in dust particularly in dry conditions.", [["scabs", "ANATOMY", 42, 47], ["scabs", "CANCER", 42, 47], ["stable", "OBSERVATION_MODIFIER", 17, 23]]], ["Companion animal species affected by poxviruses are rabbits, pigeons and mild disease due to cowpoxvirus has been reported in cats.", [["cowpoxvirus", "CHEMICAL", 93, 104], ["poxviruses", "ORGANISM", 37, 47], ["rabbits", "ORGANISM", 52, 59], ["cats", "ORGANISM", 126, 130], ["rabbits", "SPECIES", 52, 59], ["cats", "SPECIES", 126, 130], ["rabbits", "SPECIES", 52, 59], ["mild disease", "PROBLEM", 73, 85], ["cowpoxvirus", "PROBLEM", 93, 104], ["mild", "OBSERVATION_MODIFIER", 73, 77], ["disease", "OBSERVATION", 78, 85]]], ["Myxomavirus (MV) in genus leporipoxvirus causes myxomatosis, a systemic and usually a fatal disease in European rabbits (Oryctolagus cuniculus) but a benign disease in its natural host, Sylvilagus rabbits in the Americas [11, 12] .", [["myxomatosis", "DISEASE", 48, 59], ["Myxomavirus", "GENE_OR_GENE_PRODUCT", 0, 11], ["genus leporipoxvirus", "ORGANISM", 20, 40], ["rabbits", "ORGANISM", 112, 119], ["Oryctolagus cuniculus", "ORGANISM", 121, 142], ["Sylvilagus rabbits", "ORGANISM", 186, 204], ["rabbits", "SPECIES", 112, 119], ["Oryctolagus cuniculus", "SPECIES", 121, 142], ["Sylvilagus rabbits", "SPECIES", 186, 204], ["MV", "SPECIES", 13, 15], ["European rabbits", "SPECIES", 103, 119], ["Oryctolagus cuniculus", "SPECIES", 121, 142], ["Myxomavirus (MV) in genus leporipoxvirus", "PROBLEM", 0, 40], ["myxomatosis", "PROBLEM", 48, 59], ["a systemic", "PROBLEM", 61, 71], ["a fatal disease", "PROBLEM", 84, 99], ["a benign disease", "PROBLEM", 148, 164], ["fatal", "OBSERVATION_MODIFIER", 86, 91], ["disease", "OBSERVATION", 92, 99], ["benign", "OBSERVATION_MODIFIER", 150, 156], ["disease", "OBSERVATION", 157, 164]]], ["MV spreads mechanically by blood-feeding arthropod vectors such as mosquitoes and fleas and to a lesser degree by direct contact or aerosol [9] .", [["blood", "ANATOMY", 27, 32], ["blood", "ORGANISM_SUBSTANCE", 27, 32], ["MV", "SPECIES", 0, 2], ["blood", "TEST", 27, 32], ["feeding arthropod vectors", "TREATMENT", 33, 58]]], ["Virus remains infectious for several months in vectors.", [["Virus", "ORGANISM", 0, 5], ["Virus", "PROBLEM", 0, 5], ["infectious", "PROBLEM", 14, 24], ["infectious", "OBSERVATION", 14, 24]]], ["In rabbit MV replicates subcutaneously locally followed by viraemia and generalised dissemination to connective tissue cells initiating a proliferative response and exudative erythematous dermatitis around the face, eyes and skin surfaces generally.", [["subcutaneously", "ANATOMY", 24, 38], ["connective tissue cells", "ANATOMY", 101, 124], ["face", "ANATOMY", 210, 214], ["eyes", "ANATOMY", 216, 220], ["skin", "ANATOMY", 225, 229], ["viraemia", "DISEASE", 59, 67], ["dermatitis", "DISEASE", 188, 198], ["rabbit", "ORGANISM", 3, 9], ["connective tissue cells", "CELL", 101, 124], ["eyes", "ORGAN", 216, 220], ["skin", "ORGAN", 225, 229], ["connective tissue cells", "CELL_TYPE", 101, 124], ["rabbit", "SPECIES", 3, 9], ["rabbit", "SPECIES", 3, 9], ["MV", "SPECIES", 10, 12], ["rabbit MV", "TREATMENT", 3, 12], ["viraemia", "PROBLEM", 59, 67], ["generalised dissemination to connective tissue cells", "PROBLEM", 72, 124], ["a proliferative response", "PROBLEM", 136, 160], ["exudative erythematous dermatitis", "PROBLEM", 165, 198], ["rabbit MV", "OBSERVATION", 3, 12], ["connective tissue cells", "OBSERVATION", 101, 124], ["proliferative response", "OBSERVATION", 138, 160], ["exudative", "OBSERVATION_MODIFIER", 165, 174], ["erythematous", "OBSERVATION_MODIFIER", 175, 187], ["dermatitis", "OBSERVATION", 188, 198], ["face", "ANATOMY", 210, 214], ["eyes", "ANATOMY", 216, 220], ["skin", "ANATOMY", 225, 229], ["surfaces", "ANATOMY_MODIFIER", 230, 238]]], ["The lesions become ulcerated and covered with weeping crusts [11, 12] .", [["lesions", "ANATOMY", 4, 11], ["ulcerated", "DISEASE", 19, 28], ["lesions", "PATHOLOGICAL_FORMATION", 4, 11], ["The lesions", "PROBLEM", 0, 11], ["ulcerated", "PROBLEM", 19, 28], ["weeping crusts", "PROBLEM", 46, 60], ["lesions", "OBSERVATION", 4, 11], ["ulcerated", "OBSERVATION", 19, 28], ["weeping", "OBSERVATION_MODIFIER", 46, 53], ["crusts", "OBSERVATION_MODIFIER", 54, 60]]], ["Field epizootics have resulted in mortality rates approaching 100%.PoxviridaeCats occasionally become infected with a poxvirus which is indistinguishable from cow poxvirus in genus orthopoxvirus.", [["epizootics", "DISEASE", 6, 16], ["PoxviridaeCats", "SIMPLE_CHEMICAL", 67, 81], ["cow poxvirus", "ORGANISM", 159, 171], ["cow", "SPECIES", 159, 162], ["cow poxvirus", "SPECIES", 159, 171], ["mortality rates", "TEST", 34, 49], ["PoxviridaeCats", "TREATMENT", 67, 81], ["a poxvirus", "PROBLEM", 116, 126], ["cow poxvirus in genus orthopoxvirus", "PROBLEM", 159, 194], ["infected", "OBSERVATION", 102, 110], ["poxvirus", "OBSERVATION", 118, 126], ["genus orthopoxvirus", "OBSERVATION", 175, 194]]], ["Infection in cats is acquired from rodent bites and develops as small red macular eruptions which develop into papules or ulcers which scab over several days on the legs and/or head which in some infected cats become more widespread and may spread to lungs.ParvoviridaeMembers are the smallest, along with circoviruses, of DNA viruses and include important pathogens of cats and dogs.", [["macular", "ANATOMY", 74, 81], ["papules", "ANATOMY", 111, 118], ["ulcers", "ANATOMY", 122, 128], ["scab", "ANATOMY", 135, 139], ["legs", "ANATOMY", 165, 169], ["head", "ANATOMY", 177, 181], ["lungs", "ANATOMY", 251, 256], ["Infection", "DISEASE", 0, 9], ["rodent bites", "DISEASE", 35, 47], ["papules", "DISEASE", 111, 118], ["ulcers", "DISEASE", 122, 128], ["cats", "ORGANISM", 13, 17], ["papules", "PATHOLOGICAL_FORMATION", 111, 118], ["ulcers", "PATHOLOGICAL_FORMATION", 122, 128], ["legs", "ORGANISM_SUBDIVISION", 165, 169], ["head", "ORGANISM_SUBDIVISION", 177, 181], ["cats", "ORGANISM", 205, 209], ["lungs", "ORGAN", 251, 256], ["ParvoviridaeMembers", "GENE_OR_GENE_PRODUCT", 257, 276], ["DNA", "CELLULAR_COMPONENT", 323, 326], ["cats", "ORGANISM", 370, 374], ["dogs", "ORGANISM", 379, 383], ["cats", "SPECIES", 13, 17], ["rodent", "SPECIES", 35, 41], ["cats", "SPECIES", 205, 209], ["cats", "SPECIES", 370, 374], ["dogs", "SPECIES", 379, 383], ["Infection in cats", "PROBLEM", 0, 17], ["rodent bites", "PROBLEM", 35, 47], ["small red macular eruptions", "PROBLEM", 64, 91], ["papules", "PROBLEM", 111, 118], ["ulcers", "PROBLEM", 122, 128], ["scab", "PROBLEM", 135, 139], ["head", "PROBLEM", 177, 181], ["some infected cats", "PROBLEM", 191, 209], ["ParvoviridaeMembers", "TREATMENT", 257, 276], ["circoviruses", "TREATMENT", 306, 318], ["DNA viruses", "PROBLEM", 323, 334], ["small", "OBSERVATION_MODIFIER", 64, 69], ["red", "OBSERVATION_MODIFIER", 70, 73], ["macular eruptions", "OBSERVATION", 74, 91], ["papules", "OBSERVATION_MODIFIER", 111, 118], ["ulcers", "OBSERVATION", 122, 128], ["scab", "OBSERVATION", 135, 139], ["legs", "ANATOMY", 165, 169], ["head", "ANATOMY", 177, 181], ["infected", "OBSERVATION", 196, 204], ["lungs", "ANATOMY", 251, 256], ["smallest", "OBSERVATION_MODIFIER", 285, 293]]], ["Parvoviruses and circoviruses have a predilection for replication in rapidly dividing cells of bone marrow, enteric epithelium and the foetus.", [["cells", "ANATOMY", 86, 91], ["bone marrow", "ANATOMY", 95, 106], ["enteric epithelium", "ANATOMY", 108, 126], ["foetus", "ANATOMY", 135, 141], ["circoviruses", "CANCER", 17, 29], ["cells", "CELL", 86, 91], ["bone marrow", "MULTI-TISSUE_STRUCTURE", 95, 106], ["enteric epithelium", "TISSUE", 108, 126], ["foetus", "ORGAN", 135, 141], ["rapidly dividing cells", "CELL_TYPE", 69, 91], ["Parvoviruses", "PROBLEM", 0, 12], ["circoviruses", "TREATMENT", 17, 29], ["replication", "PROBLEM", 54, 65], ["bone marrow", "PROBLEM", 95, 106], ["bone marrow", "ANATOMY", 95, 106], ["enteric epithelium", "OBSERVATION", 108, 126]]], ["A parvovirus with predilection for rabbit small intestine and lymphoid tissues and liver has been known for sometime but the virus does not appear to be a significant rabbit pathogen and only causes mild catarrhal enteritis [13] .", [["small intestine", "ANATOMY", 42, 57], ["lymphoid tissues", "ANATOMY", 62, 78], ["liver", "ANATOMY", 83, 88], ["enteritis", "DISEASE", 214, 223], ["parvovirus", "ORGANISM", 2, 12], ["rabbit", "ORGANISM", 35, 41], ["small intestine", "TISSUE", 42, 57], ["lymphoid tissues", "TISSUE", 62, 78], ["liver", "ORGAN", 83, 88], ["rabbit", "ORGANISM", 167, 173], ["rabbit", "SPECIES", 35, 41], ["rabbit", "SPECIES", 167, 173], ["rabbit", "SPECIES", 35, 41], ["rabbit", "SPECIES", 167, 173], ["A parvovirus", "PROBLEM", 0, 12], ["rabbit small intestine and lymphoid tissues", "PROBLEM", 35, 78], ["the virus", "PROBLEM", 121, 130], ["a significant rabbit pathogen", "PROBLEM", 153, 182], ["mild catarrhal enteritis", "PROBLEM", 199, 223], ["parvovirus", "OBSERVATION", 2, 12], ["intestine", "ANATOMY", 48, 57], ["lymphoid tissues", "OBSERVATION", 62, 78], ["liver", "ANATOMY", 83, 88], ["significant", "OBSERVATION_MODIFIER", 155, 166], ["rabbit", "OBSERVATION_MODIFIER", 167, 173], ["pathogen", "OBSERVATION", 174, 182], ["mild", "OBSERVATION_MODIFIER", 199, 203], ["catarrhal enteritis", "OBSERVATION", 204, 223]]], ["Members have an icosahedral capsid with an over all diameter of 18-25 nm and contain linear, single-stranded DNA.ParvoviridaeThe known carnivore parvoviruses named feline panleukopenia virus (FPLV), canine parvovirus (CPV-types 1, 2, 2a, 2b and 2c), mink enteritis virus (MEV-types 1, 2 and 3) and those isolated from wild felids and canids such as raccoons, foxes (red and blue species), leopards and cheetahs are genetically related and interspecies transmissions among carnivores occur readily [14, 15] .", [["Parvoviridae", "CHEMICAL", 113, 125], ["feline panleukopenia", "DISEASE", 164, 184], ["canine parvovirus", "DISEASE", 199, 216], ["mink enteritis", "DISEASE", 250, 264], ["DNA", "CELLULAR_COMPONENT", 109, 112], ["carnivore parvoviruses", "ORGANISM", 135, 157], ["feline panleukopenia virus", "ORGANISM", 164, 190], ["FPLV", "ORGANISM", 192, 196], ["canine parvovirus", "ORGANISM", 199, 216], ["CPV-types 1", "ORGANISM", 218, 229], ["b", "GENE_OR_GENE_PRODUCT", 239, 240], ["2c", "GENE_OR_GENE_PRODUCT", 245, 247], ["mink enteritis virus", "ORGANISM", 250, 270], ["blue species", "ORGANISM", 374, 386], ["linear, single-stranded DNA", "DNA", 85, 112], ["feline panleukopenia virus", "SPECIES", 164, 190], ["canine parvovirus", "SPECIES", 199, 216], ["mink enteritis virus", "SPECIES", 250, 270], ["feline panleukopenia virus", "SPECIES", 164, 190], ["FPLV", "SPECIES", 192, 196], ["canine parvovirus (CPV-types 1", "SPECIES", 199, 229], ["mink enteritis virus", "SPECIES", 250, 270], ["an icosahedral capsid", "PROBLEM", 13, 34], ["linear, single-stranded DNA", "PROBLEM", 85, 112], ["Parvoviridae", "TREATMENT", 113, 125], ["The known carnivore parvoviruses", "PROBLEM", 125, 157], ["canine parvovirus", "PROBLEM", 199, 216], ["CPV", "TEST", 218, 221], ["2a", "TEST", 234, 236], ["mink enteritis virus", "PROBLEM", 250, 270], ["MEV-types", "TEST", 272, 281], ["foxes (red and blue species", "PROBLEM", 359, 386], ["icosahedral", "OBSERVATION_MODIFIER", 16, 27], ["capsid", "OBSERVATION", 28, 34], ["linear", "OBSERVATION_MODIFIER", 85, 91], ["stranded DNA", "OBSERVATION_MODIFIER", 100, 112], ["carnivore parvoviruses", "OBSERVATION", 135, 157], ["enteritis virus", "OBSERVATION", 255, 270]]], ["CPV-2 was first recognised in 1978 as the cause of new disease in dogs which rapidly spread worldwide [16] [17] [18] [19] .", [["CPV-2", "ORGANISM", 0, 5], ["dogs", "ORGANISM", 66, 70], ["dogs", "SPECIES", 66, 70], ["CPV-2", "SPECIES", 0, 5], ["CPV", "TEST", 0, 3], ["new disease in dogs", "PROBLEM", 51, 70], ["new", "OBSERVATION_MODIFIER", 51, 54], ["disease", "OBSERVATION", 55, 62]]], ["Evidence suggests that the CPV arose from the long recognised FPLV or related virus infecting another carnivore such as mink, raccoon, artic fox or other.", [["CPV", "ORGANISM", 27, 30], ["FPLV", "GENE_OR_GENE_PRODUCT", 62, 66], ["mink", "ORGANISM", 120, 124], ["raccoon", "ORGANISM", 126, 133], ["artic fox", "ORGANISM", 135, 144], ["mink", "SPECIES", 120, 124], ["CPV", "SPECIES", 27, 30], ["mink", "SPECIES", 120, 124], ["the CPV", "PROBLEM", 23, 30], ["the long recognised FPLV", "PROBLEM", 42, 66], ["related virus", "PROBLEM", 70, 83]]], ["The new virus differed from FPLV like viruses in less than 1% in genomic sequence [20] [21] [22] [23] .", [["FPLV like viruses", "ORGANISM", 28, 45], ["The new virus", "PROBLEM", 0, 13], ["FPLV like viruses", "PROBLEM", 28, 45], ["genomic sequence", "TEST", 65, 81], ["new", "OBSERVATION_MODIFIER", 4, 7], ["virus", "OBSERVATION", 8, 13], ["viruses", "OBSERVATION", 38, 45]]], ["However, the life of firstly identified CPV variant in nature was brief [24] .", [["CPV", "ORGANISM", 40, 43], ["CPV", "SPECIES", 40, 43], ["CPV variant", "OBSERVATION", 40, 51]]], ["By 1981 CPV-2 was replaced by CPV-2a which in turn was replaced between 1984 and 1990 by CPV-2b.", [["CPV-2a", "CHEMICAL", 30, 36], ["CPV-2b", "CHEMICAL", 89, 95], ["CPV-2a", "ORGANISM", 30, 36], ["CPV-2b", "ORGANISM", 89, 95], ["CPV-2a", "SPECIES", 30, 36], ["CPV-2b", "SPECIES", 89, 95], ["CPV", "TEST", 8, 11]]], ["In each case the replacement was global.", [["the replacement", "TREATMENT", 13, 28], ["replacement", "OBSERVATION", 17, 28]]], ["Interestingly, CPV-2 and its 2a and 2b variants differed by less than 0.2% in their genome sequence and involved substitution of 3-4 amino acids in virus capsid protein VP2 [20] [21] [22] [23] 25] .", [["amino acids", "CHEMICAL", 133, 144], ["amino acids", "CHEMICAL", 133, 144], ["CPV-2", "GENE_OR_GENE_PRODUCT", 15, 20], ["2a", "GENE_OR_GENE_PRODUCT", 29, 31], ["2b", "GENE_OR_GENE_PRODUCT", 36, 38], ["amino acids", "AMINO_ACID", 133, 144], ["virus capsid protein", "PROTEIN", 148, 168], ["CPV-2", "SPECIES", 15, 20], ["CPV", "TEST", 15, 18], ["its 2a and 2b variants", "TREATMENT", 25, 47], ["substitution", "TEST", 113, 125], ["amino acids", "TEST", 133, 144], ["capsid protein VP2", "TEST", 154, 172]]], ["This change was ongoing with the identification of CPV-2c in late 1990s [26] .", [["CPV-2c", "GENE_OR_GENE_PRODUCT", 51, 57], ["CPV", "SPECIES", 51, 54], ["CPV", "TEST", 51, 54]]], ["The latter variant has also spread widely [27] .", [["spread", "OBSERVATION_MODIFIER", 28, 34], ["widely", "OBSERVATION_MODIFIER", 35, 41]]], ["CPV-2c has one amino acid substitution in VP2 [26] .", [["CPV-2c", "CHEMICAL", 0, 6], ["amino acid", "CHEMICAL", 15, 25], ["amino acid", "CHEMICAL", 15, 25], ["CPV-2c", "GENE_OR_GENE_PRODUCT", 0, 6], ["amino acid", "AMINO_ACID", 15, 25], ["CPV", "SPECIES", 0, 3], ["CPV", "TEST", 0, 3], ["one amino acid substitution in VP2", "TREATMENT", 11, 45]]], ["Whilst this change in VP2 is minor it was nonetheless significant in conferring a broader host range phenotype to the variants.", [["VP2", "GENE_OR_GENE_PRODUCT", 22, 25], ["VP2", "DNA", 22, 25], ["this change in VP2", "PROBLEM", 7, 25], ["significant", "OBSERVATION_MODIFIER", 54, 65], ["host range", "OBSERVATION", 90, 100]]], ["Thus experimentally cats were refractory to infection by CPV-2 but readily susceptible to infection by CPV-2a and 2b viruses [23] .", [["infection", "DISEASE", 44, 53], ["infection", "DISEASE", 90, 99], ["cats", "ORGANISM", 20, 24], ["CPV-2", "ORGANISM", 57, 62], ["CPV-2a", "ORGANISM", 103, 109], ["2b viruses", "ORGANISM", 114, 124], ["CPV-2", "SPECIES", 57, 62], ["CPV-2a", "SPECIES", 103, 109], ["experimentally cats", "PROBLEM", 5, 24], ["infection", "PROBLEM", 44, 53], ["CPV", "TEST", 57, 60], ["infection", "PROBLEM", 90, 99], ["CPV", "TEST", 103, 106], ["2b viruses", "PROBLEM", 114, 124], ["infection", "OBSERVATION", 44, 53], ["infection", "OBSERVATION", 90, 99]]], ["These viruses occur worldwide and are evolving rapidly [28, 15, 29] .", [["These viruses", "PROBLEM", 0, 13], ["viruses", "OBSERVATION", 6, 13], ["rapidly", "OBSERVATION_MODIFIER", 47, 54]]], ["However, their evolutionary history is complex and possibly not fully unravelled and it has been suggested that their current classification and naming of new isolates needs revision [15] .ParvoviridaeA key factor in the epidemiology and evolution of carnivore parvoviruses has been the virus tropism for the gut and the survival of virus shed in faeces for long periods (several months to 2 years).", [["gut", "ANATOMY", 309, 312], ["faeces", "ANATOMY", 347, 353], ["ParvoviridaeA", "CHEMICAL", 189, 202], ["carnivore parvoviruses", "DISEASE", 251, 273], ["carnivore parvoviruses", "ORGANISM", 251, 273], ["gut", "ORGANISM_SUBDIVISION", 309, 312], ["faeces", "ORGANISM_SUBDIVISION", 347, 353], ["ParvoviridaeA key factor", "PROTEIN", 189, 213], ["new isolates needs revision", "TREATMENT", 155, 182], ["carnivore parvoviruses", "PROBLEM", 251, 273], ["the virus tropism", "PROBLEM", 283, 300], ["virus", "PROBLEM", 333, 338], ["carnivore parvoviruses", "OBSERVATION", 251, 273]]], ["Faecal-oral route is the main mode of virus transmission of these important carnivore viruses.", [["oral", "ANATOMY", 7, 11], ["Faecal", "ORGANISM_SUBSTANCE", 0, 6], ["oral", "ORGANISM_SUBDIVISION", 7, 11], ["carnivore viruses", "ORGANISM", 76, 93], ["Faecal-oral route", "TREATMENT", 0, 17], ["virus transmission", "TREATMENT", 38, 56], ["carnivore viruses", "OBSERVATION", 76, 93]]], ["However, in vivo tissue tropism of FPLV and CPV vary with respect to ability to replicate in enteric epithelium and produce faecal virus in quantity.", [["tissue", "ANATOMY", 17, 23], ["enteric epithelium", "ANATOMY", 93, 111], ["tissue", "TISSUE", 17, 23], ["FPLV", "GENE_OR_GENE_PRODUCT", 35, 39], ["CPV", "ORGANISM", 44, 47], ["enteric epithelium", "TISSUE", 93, 111], ["faecal virus", "ORGANISM", 124, 136], ["FPLV", "SPECIES", 35, 39], ["CPV", "SPECIES", 44, 47], ["FPLV", "TEST", 35, 39], ["CPV", "PROBLEM", 44, 47], ["faecal virus in quantity", "PROBLEM", 124, 148], ["enteric epithelium", "ANATOMY", 93, 111], ["faecal virus", "OBSERVATION", 124, 136]]], ["In cats FPLV replicates in lymph nodes, thymus, spleen and intestine and large quantities are shed in faeces while in dogs FPLV replication occurs in the thymus and bone marrow but not in the gut and mesenteric lymph node [30] .", [["lymph nodes", "ANATOMY", 27, 38], ["thymus", "ANATOMY", 40, 46], ["spleen", "ANATOMY", 48, 54], ["intestine", "ANATOMY", 59, 68], ["faeces", "ANATOMY", 102, 108], ["thymus", "ANATOMY", 154, 160], ["bone marrow", "ANATOMY", 165, 176], ["gut", "ANATOMY", 192, 195], ["mesenteric lymph node", "ANATOMY", 200, 221], ["cats", "ORGANISM", 3, 7], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 27, 38], ["thymus", "ORGAN", 40, 46], ["spleen", "ORGAN", 48, 54], ["intestine", "ORGAN", 59, 68], ["faeces", "ORGANISM_SUBDIVISION", 102, 108], ["dogs", "ORGANISM", 118, 122], ["FPLV", "GENE_OR_GENE_PRODUCT", 123, 127], ["thymus", "ORGAN", 154, 160], ["bone marrow", "MULTI-TISSUE_STRUCTURE", 165, 176], ["gut", "ORGAN", 192, 195], ["mesenteric lymph node", "MULTI-TISSUE_STRUCTURE", 200, 221], ["cats", "SPECIES", 3, 7], ["dogs", "SPECIES", 118, 122], ["FPLV", "SPECIES", 123, 127], ["large quantities", "PROBLEM", 73, 89], ["lymph nodes", "OBSERVATION", 27, 38], ["thymus", "ANATOMY", 40, 46], ["spleen", "ANATOMY", 48, 54], ["intestine", "ANATOMY", 59, 68], ["large", "OBSERVATION_MODIFIER", 73, 78], ["quantities", "OBSERVATION_MODIFIER", 79, 89], ["thymus", "ANATOMY", 154, 160], ["bone marrow", "ANATOMY", 165, 176], ["gut", "ANATOMY", 192, 195], ["mesenteric", "ANATOMY", 200, 210], ["lymph node", "OBSERVATION", 211, 221]]], ["CPV and FPLV also initiate infection in the mucosa and lymphoid tissue of the buccal cavity and result in leukocyte-associated viraemia followed by progeny virus spread to internal organs.", [["mucosa", "ANATOMY", 44, 50], ["lymphoid tissue", "ANATOMY", 55, 70], ["buccal cavity", "ANATOMY", 78, 91], ["leukocyte", "ANATOMY", 106, 115], ["organs", "ANATOMY", 181, 187], ["infection", "DISEASE", 27, 36], ["viraemia", "DISEASE", 127, 135], ["CPV", "ORGANISM", 0, 3], ["FPLV", "GENE_OR_GENE_PRODUCT", 8, 12], ["mucosa", "MULTI-TISSUE_STRUCTURE", 44, 50], ["lymphoid tissue", "TISSUE", 55, 70], ["buccal cavity", "ORGAN", 78, 91], ["leukocyte", "CELL", 106, 115], ["organs", "ORGAN", 181, 187], ["CPV", "SPECIES", 0, 3], ["FPLV", "SPECIES", 8, 12], ["CPV", "PROBLEM", 0, 3], ["FPLV", "TREATMENT", 8, 12], ["infection in the mucosa and lymphoid tissue of the buccal cavity", "PROBLEM", 27, 91], ["leukocyte", "TEST", 106, 115], ["viraemia", "PROBLEM", 127, 135], ["progeny virus spread", "PROBLEM", 148, 168], ["infection", "OBSERVATION", 27, 36], ["mucosa", "ANATOMY", 44, 50], ["lymphoid tissue", "OBSERVATION", 55, 70], ["buccal cavity", "ANATOMY", 78, 91], ["leukocyte", "OBSERVATION", 106, 115], ["viraemia", "OBSERVATION", 127, 135], ["internal", "ANATOMY_MODIFIER", 172, 180], ["organs", "ANATOMY", 181, 187]]], ["In puppies ingested virus replicates in crypts of small intestine resulting in leukocyte viraemia, viral dissemination and secondary infection of the liver and of cardiac myocytes although the latter is rarely seen today due to effective vaccination.", [["crypts", "ANATOMY", 40, 46], ["small intestine", "ANATOMY", 50, 65], ["leukocyte", "ANATOMY", 79, 88], ["liver", "ANATOMY", 150, 155], ["cardiac myocytes", "ANATOMY", 163, 179], ["viraemia", "DISEASE", 89, 97], ["infection of the liver", "DISEASE", 133, 155], ["puppies", "ORGANISM", 3, 10], ["crypts", "MULTI-TISSUE_STRUCTURE", 40, 46], ["small intestine", "ORGAN", 50, 65], ["leukocyte", "CELL", 79, 88], ["liver", "ORGAN", 150, 155], ["cardiac myocytes", "CELL", 163, 179], ["small intestine", "PROBLEM", 50, 65], ["leukocyte viraemia", "PROBLEM", 79, 97], ["viral dissemination", "PROBLEM", 99, 118], ["secondary infection of the liver", "PROBLEM", 123, 155], ["cardiac myocytes", "PROBLEM", 163, 179], ["virus", "OBSERVATION", 20, 25], ["small intestine", "ANATOMY", 50, 65], ["leukocyte viraemia", "OBSERVATION", 79, 97], ["viral dissemination", "OBSERVATION", 99, 118], ["secondary", "OBSERVATION_MODIFIER", 123, 132], ["infection", "OBSERVATION", 133, 142], ["liver", "ANATOMY", 150, 155], ["cardiac myocytes", "ANATOMY", 163, 179]]], ["Infection of these vital organs may cause eventual heart failure associated with pulmonary oedema, hepatomegaly and ascites.", [["organs", "ANATOMY", 25, 31], ["heart", "ANATOMY", 51, 56], ["pulmonary", "ANATOMY", 81, 90], ["ascites", "ANATOMY", 116, 123], ["heart failure", "DISEASE", 51, 64], ["pulmonary oedema", "DISEASE", 81, 97], ["hepatomegaly", "DISEASE", 99, 111], ["ascites", "DISEASE", 116, 123], ["organs", "ORGAN", 25, 31], ["heart", "ORGAN", 51, 56], ["pulmonary", "ORGAN", 81, 90], ["Infection of these vital organs", "PROBLEM", 0, 31], ["eventual heart failure", "PROBLEM", 42, 64], ["pulmonary oedema", "PROBLEM", 81, 97], ["hepatomegaly", "PROBLEM", 99, 111], ["ascites", "PROBLEM", 116, 123], ["heart", "ANATOMY", 51, 56], ["failure", "OBSERVATION", 57, 64], ["pulmonary", "ANATOMY", 81, 90], ["oedema", "OBSERVATION", 91, 97], ["hepatomegaly", "OBSERVATION", 99, 111], ["ascites", "OBSERVATION", 116, 123]]], ["Mortality is high.", [["high", "OBSERVATION_MODIFIER", 13, 17]]], ["In older dogs ingested virus replicates in intestinal crypts which more commonly results in vomiting, diarrhoea and leucopoenia with high morbidity but low mortality.ParvoviridaePathogenesis of FPLV infection in cats is similar to CPV disease in dogs.", [["intestinal crypts", "ANATOMY", 43, 60], ["vomiting", "DISEASE", 92, 100], ["diarrhoea", "DISEASE", 102, 111], ["leucopoenia", "DISEASE", 116, 127], ["FPLV infection", "DISEASE", 194, 208], ["CPV disease", "DISEASE", 231, 242], ["dogs", "ORGANISM", 9, 13], ["intestinal crypts", "MULTI-TISSUE_STRUCTURE", 43, 60], ["FPLV", "GENE_OR_GENE_PRODUCT", 194, 198], ["cats", "ORGANISM", 212, 216], ["CPV", "ORGANISM", 231, 234], ["dogs", "ORGANISM", 246, 250], ["dogs", "SPECIES", 9, 13], ["cats", "SPECIES", 212, 216], ["dogs", "SPECIES", 246, 250], ["FPLV", "SPECIES", 194, 198], ["CPV", "SPECIES", 231, 234], ["intestinal crypts", "PROBLEM", 43, 60], ["vomiting", "PROBLEM", 92, 100], ["diarrhoea", "PROBLEM", 102, 111], ["leucopoenia", "PROBLEM", 116, 127], ["high morbidity", "PROBLEM", 133, 147], ["low mortality", "PROBLEM", 152, 165], ["FPLV infection in cats", "PROBLEM", 194, 216], ["CPV disease in dogs", "PROBLEM", 231, 250], ["virus", "OBSERVATION", 23, 28], ["intestinal crypts", "ANATOMY", 43, 60], ["high", "OBSERVATION_MODIFIER", 133, 137], ["morbidity", "OBSERVATION", 138, 147], ["infection", "OBSERVATION", 199, 208], ["CPV disease", "OBSERVATION", 231, 242]]], ["Viraemia following the respiratory and the enteric phases of viral replication leads to secondary infection of bone marrow, spleen and lymph nodes.", [["respiratory", "ANATOMY", 23, 34], ["bone marrow", "ANATOMY", 111, 122], ["spleen", "ANATOMY", 124, 130], ["lymph nodes", "ANATOMY", 135, 146], ["Viraemia", "DISEASE", 0, 8], ["infection", "DISEASE", 98, 107], ["bone marrow", "MULTI-TISSUE_STRUCTURE", 111, 122], ["spleen", "ORGAN", 124, 130], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 135, 146], ["Viraemia", "PROBLEM", 0, 8], ["viral replication", "TREATMENT", 61, 78], ["secondary infection of bone marrow, spleen and lymph nodes", "PROBLEM", 88, 146], ["enteric phases", "OBSERVATION_MODIFIER", 43, 57], ["viral replication", "OBSERVATION", 61, 78], ["secondary", "OBSERVATION_MODIFIER", 88, 97], ["infection", "OBSERVATION", 98, 107], ["bone marrow", "ANATOMY", 111, 122], ["spleen", "ANATOMY", 124, 130], ["lymph nodes", "OBSERVATION", 135, 146]]], ["This results in transient leukocytosis followed by a marked leucopoenia and anaemia.", [["leukocytosis", "DISEASE", 26, 38], ["leucopoenia", "DISEASE", 60, 71], ["anaemia", "DISEASE", 76, 83], ["transient leukocytosis", "PROBLEM", 16, 38], ["a marked leucopoenia", "PROBLEM", 51, 71], ["anaemia", "PROBLEM", 76, 83], ["transient", "OBSERVATION_MODIFIER", 16, 25], ["leukocytosis", "OBSERVATION", 26, 38], ["marked", "OBSERVATION_MODIFIER", 53, 59], ["leucopoenia", "OBSERVATION", 60, 71], ["anaemia", "OBSERVATION", 76, 83]]], ["Virus is shed by most routes 2-6 days after infection.CaliciviridaeMembers are non-enveloped icosahedral very small (27-40 nm) viruses with a linear, positive sense single stranded RNA genome and replicate in cell cytoplasm.", [["cell cytoplasm", "ANATOMY", 209, 223], ["infection", "DISEASE", 44, 53], ["Virus", "ORGANISM", 0, 5], ["CaliciviridaeMembers", "GENE_OR_GENE_PRODUCT", 54, 74], ["cell cytoplasm", "ORGANISM_SUBSTANCE", 209, 223], ["linear, positive sense single stranded RNA genome", "RNA", 142, 191], ["Virus", "PROBLEM", 0, 5], ["infection", "PROBLEM", 44, 53], ["CaliciviridaeMembers", "TEST", 54, 74], ["viruses", "PROBLEM", 127, 134], ["a linear, positive sense single stranded RNA genome", "PROBLEM", 140, 191], ["infection", "OBSERVATION", 44, 53], ["non-enveloped", "OBSERVATION_MODIFIER", 79, 92], ["icosahedral", "OBSERVATION_MODIFIER", 93, 104], ["very", "OBSERVATION_MODIFIER", 105, 109], ["small", "OBSERVATION_MODIFIER", 110, 115], ["linear", "OBSERVATION_MODIFIER", 142, 148], ["stranded RNA genome", "OBSERVATION", 172, 191], ["cell cytoplasm", "OBSERVATION", 209, 223]]], ["Three viral species in family Caliciviridae cause significant diseases in cats, rabbits and brown hares.", [["Caliciviridae", "CHEMICAL", 30, 43], ["cats", "ORGANISM", 74, 78], ["rabbits", "ORGANISM", 80, 87], ["cats", "SPECIES", 74, 78], ["rabbits", "SPECIES", 80, 87], ["rabbits", "SPECIES", 80, 87], ["brown hares", "SPECIES", 92, 103], ["significant diseases in cats", "PROBLEM", 50, 78], ["viral species", "OBSERVATION", 6, 19], ["significant", "OBSERVATION_MODIFIER", 50, 61], ["diseases", "OBSERVATION", 62, 70]]], ["Feline calicivirus (FCV) belongs to the distinct phylogenetic clade in genus vesivirus.", [["Feline calicivirus", "DISEASE", 0, 18], ["Feline calicivirus", "ORGANISM", 0, 18], ["FCV", "ORGANISM", 20, 23], ["Feline calicivirus", "SPECIES", 0, 18], ["Feline calicivirus", "SPECIES", 0, 18], ["FCV", "SPECIES", 20, 23], ["Feline calicivirus (FCV", "PROBLEM", 0, 23], ["calicivirus", "OBSERVATION", 7, 18], ["distinct", "OBSERVATION_MODIFIER", 40, 48], ["phylogenetic clade", "OBSERVATION", 49, 67], ["genus vesivirus", "OBSERVATION", 71, 86]]], ["Rabbit haemorrhagic disease virus (RHDV) and European brown hare syndrome virus (EBHSV) belong to the distinct phylogenetic clade in genus lagovirus.", [["Rabbit haemorrhagic disease", "DISEASE", 0, 27], ["hare syndrome", "DISEASE", 60, 73], ["Rabbit haemorrhagic disease virus", "ORGANISM", 0, 33], ["RHDV", "ORGANISM", 35, 39], ["European", "ORGANISM", 45, 53], ["brown hare syndrome virus", "ORGANISM", 54, 79], ["Rabbit haemorrhagic disease virus", "SPECIES", 0, 33], ["RHDV", "SPECIES", 35, 39], ["brown hare syndrome virus", "SPECIES", 54, 79], ["Rabbit haemorrhagic disease virus", "SPECIES", 0, 33], ["RHDV", "SPECIES", 35, 39], ["European brown hare syndrome virus", "SPECIES", 45, 79], ["EBHSV", "SPECIES", 81, 86], ["Rabbit haemorrhagic disease virus", "PROBLEM", 0, 33], ["RHDV", "PROBLEM", 35, 39], ["European brown hare syndrome virus (EBHSV)", "PROBLEM", 45, 87], ["distinct", "OBSERVATION_MODIFIER", 102, 110], ["phylogenetic clade", "OBSERVATION", 111, 129], ["genus lagovirus", "OBSERVATION", 133, 148]]], ["RHDV and EBHSV share antigenic epitopes which elicit cross-protective antibodies.", [["RHDV", "ORGANISM", 0, 4], ["EBHSV", "GENE_OR_GENE_PRODUCT", 9, 14], ["EBHSV", "PROTEIN", 9, 14], ["antigenic epitopes", "PROTEIN", 21, 39], ["cross-protective antibodies", "PROTEIN", 53, 80], ["RHDV", "SPECIES", 0, 4], ["RHDV", "SPECIES", 0, 4], ["EBHSV", "SPECIES", 9, 14], ["RHDV", "PROBLEM", 0, 4], ["antigenic epitopes", "PROBLEM", 21, 39]]], ["Caliciviruses are not considered significant pathogens of domestic dogs nor are they isolated frequently.", [["dogs", "ORGANISM", 67, 71], ["dogs", "SPECIES", 67, 71], ["Caliciviruses", "PROBLEM", 0, 13], ["not considered", "UNCERTAINTY", 18, 32], ["significant", "OBSERVATION_MODIFIER", 33, 44], ["pathogens", "OBSERVATION", 45, 54]]], ["However both FCV related and unrelated caliciviruses have been isolated from faeces of puppies and dogs with diarrhoea [31] [32] [33] .", [["faeces", "ANATOMY", 77, 83], ["diarrhoea", "DISEASE", 109, 118], ["FCV", "ORGANISM", 13, 16], ["caliciviruses", "CANCER", 39, 52], ["faeces", "ORGANISM_SUBDIVISION", 77, 83], ["puppies", "ORGANISM_SUBDIVISION", 87, 94], ["dogs", "ORGANISM", 99, 103], ["puppies", "SPECIES", 87, 94], ["dogs", "SPECIES", 99, 103], ["FCV", "SPECIES", 13, 16], ["both FCV", "PROBLEM", 8, 16], ["unrelated caliciviruses", "PROBLEM", 29, 52], ["diarrhoea", "PROBLEM", 109, 118], ["FCV", "OBSERVATION", 13, 16], ["caliciviruses", "OBSERVATION", 39, 52]]], ["Canine caliciviruses (CCoV) at present remain unclassified [34] .", [["Canine caliciviruses", "DISEASE", 0, 20], ["Canine caliciviruses", "ORGANISM", 0, 20], ["CCoV", "CANCER", 22, 26], ["Canine", "SPECIES", 0, 6], ["Canine caliciviruses", "SPECIES", 0, 20], ["CCoV", "SPECIES", 22, 26], ["Canine caliciviruses", "PROBLEM", 0, 20], ["caliciviruses", "OBSERVATION", 7, 20]]], ["However, it is possible that one or more of these dog isolates of caliciviruses have the potential to adapt, spread and establish in dog populations to cause clinically important disease.", [["dog", "ORGANISM", 50, 53], ["caliciviruses", "CANCER", 66, 79], ["dog", "ORGANISM", 133, 136], ["dog", "SPECIES", 133, 136], ["caliciviruses", "PROBLEM", 66, 79], ["clinically important disease", "PROBLEM", 158, 186], ["caliciviruses", "OBSERVATION", 66, 79]]], ["Caliciviruses do mutate readily in nature as is indicated by the emergence of a highly virulent haemorrhagic variant of FCV [35] [36] [37] which has spread rapidly [38, 39] .", [["FCV", "ORGANISM", 120, 123], ["FCV", "SPECIES", 120, 123], ["Caliciviruses", "PROBLEM", 0, 13], ["a highly virulent haemorrhagic variant of FCV", "PROBLEM", 78, 123]]], ["The newly emergent FCV variants have been named virulent systemic FCV (VS-FCV) to distinguish them from the common FCV strains.", [["FCV", "ORGANISM", 19, 22], ["FCV", "ORGANISM", 66, 69], ["VS-FCV", "ORGANISM", 71, 77], ["FCV", "ORGANISM", 115, 118], ["FCV", "SPECIES", 19, 22], ["FCV", "SPECIES", 66, 69], ["FCV", "SPECIES", 74, 77], ["FCV", "SPECIES", 115, 118], ["The newly emergent FCV variants", "PROBLEM", 0, 31], ["common FCV", "ANATOMY", 108, 118]]], ["FCV has a worldwide distribution while VS-FCV is, at present, limited to USA and the UK [36] but very likely to become more prevalent.", [["FCV", "DISEASE", 0, 3], ["FCV", "ORGANISM", 0, 3], ["FCV", "ORGANISM", 42, 45], ["FCV", "SPECIES", 0, 3], ["FCV", "SPECIES", 42, 45], ["VS", "TEST", 39, 41], ["worldwide", "OBSERVATION_MODIFIER", 10, 19], ["distribution", "OBSERVATION_MODIFIER", 20, 32]]], ["VS-FCV strains appear to have arisen independently of one another and have not spread from a single case [37] .", [["VS-FCV", "ORGANISM", 0, 6], ["FCV", "SPECIES", 3, 6], ["VS", "TEST", 0, 2], ["FCV strains", "PROBLEM", 3, 14]]], ["Both virus types are excreted in urine, saliva, ocular and respiratory secretions and are transmitted via aerosol, orally and on fomites.", [["urine", "ANATOMY", 33, 38], ["saliva", "ANATOMY", 40, 46], ["ocular", "ANATOMY", 48, 54], ["respiratory secretions", "ANATOMY", 59, 81], ["urine", "ORGANISM_SUBSTANCE", 33, 38], ["saliva", "ORGANISM_SUBSTANCE", 40, 46], ["ocular", "ORGANISM_SUBDIVISION", 48, 54], ["ocular and respiratory secretions", "PROBLEM", 48, 81], ["virus", "OBSERVATION", 5, 10], ["excreted", "OBSERVATION_MODIFIER", 21, 29], ["ocular", "ANATOMY", 48, 54], ["respiratory", "ANATOMY", 59, 70], ["secretions", "OBSERVATION", 71, 81]]], ["Usually, virus shedding is for up to 2 weeks but some recovered cats shed the virus intermittently [40] .", [["cats", "ORGANISM", 64, 68], ["virus shedding", "PROBLEM", 9, 23], ["virus", "OBSERVATION", 9, 14]]], ["Primary infection by both virus types is often in the upper respiratory tract and/or oral mucosa with an incubation period of 2-3 days resulting in epithelial cell necrosis with vesicle or ulceration of the external nares and oral mucosa.", [["upper respiratory tract", "ANATOMY", 54, 77], ["oral mucosa", "ANATOMY", 85, 96], ["epithelial cell", "ANATOMY", 148, 163], ["vesicle", "ANATOMY", 178, 185], ["external nares", "ANATOMY", 207, 221], ["oral mucosa", "ANATOMY", 226, 237], ["infection", "DISEASE", 8, 17], ["necrosis", "DISEASE", 164, 172], ["upper respiratory", "ORGANISM_SUBDIVISION", 54, 71], ["tract", "ORGANISM_SUBDIVISION", 72, 77], ["oral mucosa", "MULTI-TISSUE_STRUCTURE", 85, 96], ["epithelial cell", "CELL", 148, 163], ["vesicle", "CELLULAR_COMPONENT", 178, 185], ["nares", "ORGANISM_SUBDIVISION", 216, 221], ["oral mucosa", "MULTI-TISSUE_STRUCTURE", 226, 237], ["Primary infection", "PROBLEM", 0, 17], ["both virus types", "PROBLEM", 21, 37], ["the upper respiratory tract", "PROBLEM", 50, 77], ["oral mucosa", "PROBLEM", 85, 96], ["epithelial cell necrosis", "PROBLEM", 148, 172], ["vesicle", "PROBLEM", 178, 185], ["ulceration of the external nares and oral mucosa", "PROBLEM", 189, 237], ["infection", "OBSERVATION", 8, 17], ["both virus types", "OBSERVATION", 21, 37], ["upper", "ANATOMY_MODIFIER", 54, 59], ["respiratory tract", "ANATOMY", 60, 77], ["oral mucosa", "ANATOMY", 85, 96], ["epithelial cell necrosis", "OBSERVATION", 148, 172], ["vesicle", "OBSERVATION_MODIFIER", 178, 185], ["ulceration", "OBSERVATION", 189, 199], ["external nares", "ANATOMY", 207, 221], ["oral mucosa", "ANATOMY", 226, 237]]], ["Virulent FCV strains may also cause interstitial pneumonia.", [["interstitial", "ANATOMY", 36, 48], ["interstitial pneumonia", "DISEASE", 36, 58], ["FCV", "ORGANISM", 9, 12], ["FCV", "SPECIES", 9, 12], ["Virulent FCV strains", "PROBLEM", 0, 20], ["interstitial pneumonia", "PROBLEM", 36, 58], ["FCV strains", "OBSERVATION", 9, 20], ["may also cause", "UNCERTAINTY", 21, 35], ["interstitial", "ANATOMY_MODIFIER", 36, 48], ["pneumonia", "OBSERVATION", 49, 58]]], ["Infected cats may also manifest fever, anorexia, conjunctivitis, lethargy and stiffness, nasal and ocular discharge, sneezing and rales.", [["nasal", "ANATOMY", 89, 94], ["ocular", "ANATOMY", 99, 105], ["fever", "DISEASE", 32, 37], ["anorexia", "DISEASE", 39, 47], ["conjunctivitis", "DISEASE", 49, 63], ["lethargy", "DISEASE", 65, 73], ["stiffness", "DISEASE", 78, 87], ["sneezing", "DISEASE", 117, 125], ["cats", "ORGANISM", 9, 13], ["nasal", "ORGANISM_SUBDIVISION", 89, 94], ["cats", "SPECIES", 9, 13], ["Infected cats", "PROBLEM", 0, 13], ["fever", "PROBLEM", 32, 37], ["anorexia", "PROBLEM", 39, 47], ["conjunctivitis", "PROBLEM", 49, 63], ["lethargy", "PROBLEM", 65, 73], ["stiffness", "PROBLEM", 78, 87], ["nasal and ocular discharge", "PROBLEM", 89, 115], ["sneezing", "PROBLEM", 117, 125], ["rales", "PROBLEM", 130, 135], ["anorexia", "OBSERVATION", 39, 47], ["conjunctivitis", "OBSERVATION", 49, 63], ["lethargy", "OBSERVATION", 65, 73], ["stiffness", "OBSERVATION_MODIFIER", 78, 87], ["nasal", "ANATOMY", 89, 94], ["ocular", "ANATOMY", 99, 105], ["discharge", "OBSERVATION", 106, 115], ["sneezing", "OBSERVATION", 117, 125], ["rales", "OBSERVATION", 130, 135]]], ["Some FCV but most VS-FCV strains are fatal [35, 36] .CaliciviridaeRHDV and EBHSV infections are highly contagious and acute fatal diseases caused by distinct but antigenically related caliciviruses.", [["CaliciviridaeRHDV", "CHEMICAL", 53, 70], ["EBHSV infections", "DISEASE", 75, 91], ["FCV", "ORGANISM", 5, 8], ["VS-FCV", "ORGANISM", 18, 24], ["EBHSV infections", "ORGANISM", 75, 91], ["caliciviruses", "CANCER", 184, 197], ["FCV", "SPECIES", 5, 8], ["FCV", "SPECIES", 21, 24], ["CaliciviridaeRHDV", "SPECIES", 53, 70], ["EBHSV", "SPECIES", 75, 80], ["Some FCV", "PROBLEM", 0, 8], ["most VS", "TEST", 13, 20], ["FCV strains", "TEST", 21, 32], ["CaliciviridaeRHDV", "TREATMENT", 53, 70], ["EBHSV infections", "PROBLEM", 75, 91], ["acute fatal diseases", "PROBLEM", 118, 138], ["antigenically related caliciviruses", "PROBLEM", 162, 197], ["FCV", "OBSERVATION", 5, 8], ["infections", "OBSERVATION", 81, 91], ["contagious", "OBSERVATION_MODIFIER", 103, 113], ["acute", "OBSERVATION_MODIFIER", 118, 123], ["fatal", "OBSERVATION_MODIFIER", 124, 129], ["diseases", "OBSERVATION", 130, 138], ["caliciviruses", "OBSERVATION", 184, 197]]], ["RHD was first reported in the People's Republic of China in imported Angora rabbits imported from German Democratic Republic [41] while EBHS was described in brown hares (Lepus europeus) and mountain hares (Lepus timidus) in 1981 in Sweden [42] .", [["RHD", "DISEASE", 0, 3], ["EBHS", "CHEMICAL", 136, 140], ["rabbits", "ORGANISM", 76, 83], ["brown hares", "ORGANISM", 158, 169], ["Lepus europeus", "ORGANISM", 171, 185], ["Lepus timidus", "ORGANISM", 207, 220], ["rabbits", "SPECIES", 76, 83], ["Lepus europeus", "SPECIES", 171, 185], ["Lepus timidus", "SPECIES", 207, 220], ["brown hares", "SPECIES", 158, 169], ["Lepus europeus", "SPECIES", 171, 185], ["mountain hares", "SPECIES", 191, 205], ["Lepus timidus", "SPECIES", 207, 220], ["RHD", "PROBLEM", 0, 3], ["EBHS", "TEST", 136, 140]]], ["However, epidemiological investigations indicated presence of these viruses in Europe much before the above published reports.", [["epidemiological investigations", "TEST", 9, 39], ["these viruses", "PROBLEM", 62, 75], ["viruses", "OBSERVATION", 68, 75]]], ["One line of data supporting this conclusion was the detection of RHDV antibodies in rabbit sera collected in early 1970s [43] .", [["sera", "ANATOMY", 91, 95], ["RHDV", "ORGANISM", 65, 69], ["rabbit", "ORGANISM", 84, 90], ["sera", "ORGANISM_SUBSTANCE", 91, 95], ["RHDV antibodies", "PROTEIN", 65, 80], ["rabbit", "SPECIES", 84, 90], ["RHDV", "SPECIES", 65, 69], ["rabbit", "SPECIES", 84, 90], ["RHDV antibodies", "TEST", 65, 80], ["rabbit sera", "TEST", 84, 95], ["RHDV", "OBSERVATION", 65, 69]]], ["RHDV is endemic in most parts of Europe, Asia and parts of Africa, Australia and New Zealand.", [["RHDV", "DISEASE", 0, 4], ["RHDV", "ORGANISM", 0, 4], ["RHDV", "SPECIES", 0, 4], ["RHDV", "PROBLEM", 0, 4], ["endemic", "PROBLEM", 8, 15], ["endemic", "OBSERVATION_MODIFIER", 8, 15], ["most parts", "OBSERVATION_MODIFIER", 19, 29], ["Africa", "OBSERVATION_MODIFIER", 59, 65], ["New", "OBSERVATION_MODIFIER", 81, 84], ["Zealand", "OBSERVATION_MODIFIER", 85, 92]]], ["RHDV was imported into Australia in 1991 for biological control of wild rabbits but the virus escaped from Wardang island quarantine facility in 1995 and became established across Southern Australia [44] .", [["RHDV", "ORGANISM", 0, 4], ["rabbits", "ORGANISM", 72, 79], ["rabbits", "SPECIES", 72, 79], ["RHDV", "SPECIES", 0, 4], ["rabbits", "SPECIES", 72, 79], ["wild rabbits", "PROBLEM", 67, 79], ["the virus", "PROBLEM", 84, 93]]], ["Insect vectors were suspected as to have spread the virus from Wardang Island [45] .", [["Insect vectors", "TREATMENT", 0, 14]]], ["EBHSV is widespread wherever hares (L. europeus and sub species) are endemic as is the case in Europe [46] .", [["EBHSV", "CHEMICAL", 0, 5], ["L. europeus", "ORGANISM", 36, 47], ["L. europeus", "SPECIES", 36, 47], ["EBHSV", "SPECIES", 0, 5], ["L. europeus", "SPECIES", 36, 47], ["widespread", "OBSERVATION_MODIFIER", 9, 19]]], ["Rabbit species vary in their susceptibility to RHDV infection.", [["RHDV infection", "DISEASE", 47, 61], ["Rabbit", "ORGANISM", 0, 6], ["RHDV", "ORGANISM", 47, 51], ["Rabbit", "SPECIES", 0, 6], ["RHDV", "SPECIES", 47, 51], ["RHDV", "SPECIES", 47, 51], ["Rabbit species", "PROBLEM", 0, 14], ["RHDV infection", "PROBLEM", 47, 61], ["RHDV", "OBSERVATION_MODIFIER", 47, 51], ["infection", "OBSERVATION", 52, 61]]], ["American cottontail rabbits (Sylvilagus floridanus) appear to be refractory to infection by RHDV [47, 48] .", [["infection", "DISEASE", 79, 88], ["RHDV", "DISEASE", 92, 96], ["cottontail rabbits", "ORGANISM", 9, 27], ["Sylvilagus floridanus", "ORGANISM", 29, 50], ["RHDV", "ORGANISM", 92, 96], ["rabbits", "SPECIES", 20, 27], ["Sylvilagus floridanus", "SPECIES", 29, 50], ["American cottontail rabbits", "SPECIES", 0, 27], ["Sylvilagus floridanus", "SPECIES", 29, 50], ["RHDV", "SPECIES", 92, 96], ["American cottontail rabbits (Sylvilagus floridanus", "TREATMENT", 0, 50], ["infection", "PROBLEM", 79, 88], ["refractory", "OBSERVATION_MODIFIER", 65, 75], ["infection", "OBSERVATION", 79, 88]]], ["RHDV transmission is by direct contact and via fomites [45] .", [["RHDV", "DISEASE", 0, 4], ["RHDV", "ORGANISM", 0, 4], ["RHDV", "SPECIES", 0, 4]]], ["Thus primary infection is at an oral and/or conjunctival mucosa.", [["oral", "ANATOMY", 32, 36], ["conjunctival mucosa", "ANATOMY", 44, 63], ["primary infection", "DISEASE", 5, 22], ["oral", "ORGANISM_SUBDIVISION", 32, 36], ["conjunctival mucosa", "MULTI-TISSUE_STRUCTURE", 44, 63], ["primary infection", "PROBLEM", 5, 22], ["conjunctival mucosa", "PROBLEM", 44, 63], ["primary", "OBSERVATION_MODIFIER", 5, 12], ["infection", "OBSERVATION", 13, 22], ["conjunctival mucosa", "ANATOMY", 44, 63]]], ["EBHSV is likely to be similarly transmitted among hares.", [["EBHSV", "GENE_OR_GENE_PRODUCT", 0, 5], ["EBHSV", "SPECIES", 0, 5], ["likely to be", "UNCERTAINTY", 9, 21]]], ["Flies of the genus Phormia in Europe transmit RHDV via the conjunctiva while in Australia bush flies (Musa vestustissima) and blow flies (Caliphora dubia) were identified as potential vectors [49, 50, 45] .", [["conjunctiva", "ANATOMY", 59, 70], ["RHDV", "ORGANISM", 46, 50], ["conjunctiva", "ORGAN", 59, 70], ["Australia", "ORGANISM", 80, 89], ["bush flies", "ORGANISM", 90, 100], ["Musa vestustissima", "ORGANISM", 102, 120], ["blow flies", "ORGANISM", 126, 136], ["Caliphora dubia", "ORGANISM", 138, 153], ["RHDV", "SPECIES", 46, 50], ["Musa vestustissima", "SPECIES", 102, 120], ["flies", "SPECIES", 131, 136], ["Caliphora dubia", "SPECIES", 138, 153], ["RHDV", "SPECIES", 46, 50], ["Australia bush flies", "SPECIES", 80, 100], ["Musa vestustissima", "SPECIES", 102, 120], ["Caliphora dubia", "SPECIES", 138, 153], ["blow flies (Caliphora dubia", "PROBLEM", 126, 153], ["genus Phormia", "OBSERVATION", 13, 26], ["conjunctiva", "ANATOMY", 59, 70]]], ["Rabbit fleas (Siplopsyllus cuniculi and Xenopsylla cunicularis) and mosquitoes (Culex annulirostris) were shown to transmit RHDV to rabbits under laboratory conditions [51, 45] .", [["Rabbit fleas", "ORGANISM", 0, 12], ["Siplopsyllus cuniculi", "ORGANISM", 14, 35], ["Xenopsylla cunicularis", "ORGANISM", 40, 62], ["mosquitoes", "ORGANISM", 68, 78], ["Culex annulirostris", "ORGANISM", 80, 99], ["RHDV", "ORGANISM", 124, 128], ["rabbits", "ORGANISM", 132, 139], ["Rabbit", "SPECIES", 0, 6], ["Siplopsyllus cuniculi", "SPECIES", 14, 35], ["Xenopsylla cunicularis", "SPECIES", 40, 62], ["Culex annulirostris", "SPECIES", 80, 99], ["rabbits", "SPECIES", 132, 139], ["Rabbit fleas", "SPECIES", 0, 12], ["Siplopsyllus cuniculi", "SPECIES", 14, 35], ["Xenopsylla cunicularis", "SPECIES", 40, 62], ["Culex annulirostris", "SPECIES", 80, 99], ["RHDV", "SPECIES", 124, 128], ["rabbits", "SPECIES", 132, 139], ["Rabbit fleas", "TEST", 0, 12], ["Siplopsyllus cuniculi and Xenopsylla cunicularis", "TREATMENT", 14, 62]]], ["Molecular epidemiological studies, thus far, have shown a low (less than 10% nucleotide) genomic variation among RHDV isolates collected over a period of several years from different geographical areas [52, 53] .", [["nucleotide", "CHEMICAL", 77, 87], ["nucleotide", "CHEMICAL", 77, 87], ["RHDV", "ORGANISM", 113, 117], ["RHDV", "SPECIES", 113, 117], ["Molecular epidemiological studies", "TEST", 0, 33], ["a low (less than 10% nucleotide) genomic variation among RHDV isolates", "PROBLEM", 56, 126], ["low", "OBSERVATION_MODIFIER", 58, 61]]], ["However, natural mutational changes in the field have been recorded [54] .", [["natural mutational changes in the field", "PROBLEM", 9, 48]]], ["A question that remains unresolved is that of how virus persists in nature from year to year.", [["how virus", "PROBLEM", 46, 55], ["unresolved", "OBSERVATION", 24, 34], ["virus", "OBSERVATION", 50, 55]]], ["Typically in the field RHDV infected rabbits die within 24-48 h with few outward signs excepting bloody mucous discharge from the nose.CaliciviridaeFollowing the primary replication in oronasal and/or ocular mucosa RHDV infects macrophages and other mononuclear cells (circulatory and alveolar macrophages) and these infected cells disseminate the virus to the internal organs particularly the liver and kidneys where virus undergoes secondary replication [55] .", [["mucous", "ANATOMY", 104, 110], ["nose", "ANATOMY", 130, 134], ["oronasal", "ANATOMY", 185, 193], ["ocular mucosa", "ANATOMY", 201, 214], ["macrophages", "ANATOMY", 228, 239], ["mononuclear cells", "ANATOMY", 250, 267], ["circulatory", "ANATOMY", 269, 280], ["alveolar macrophages", "ANATOMY", 285, 305], ["cells", "ANATOMY", 326, 331], ["organs", "ANATOMY", 370, 376], ["liver", "ANATOMY", 394, 399], ["kidneys", "ANATOMY", 404, 411], ["RHDV infected", "DISEASE", 23, 36], ["CaliciviridaeFollowing", "CHEMICAL", 135, 157], ["RHDV", "ORGANISM", 23, 27], ["rabbits", "ORGANISM", 37, 44], ["mucous", "ORGANISM_SUBDIVISION", 104, 110], ["nose", "ORGAN", 130, 134], ["oronasal", "ORGAN", 185, 193], ["ocular mucosa", "MULTI-TISSUE_STRUCTURE", 201, 214], ["RHDV", "ORGANISM", 215, 219], ["macrophages", "CELL", 228, 239], ["mononuclear cells", "CELL", 250, 267], ["circulatory", "CELL", 269, 280], ["alveolar macrophages", "CELL", 285, 305], ["cells", "CELL", 326, 331], ["organs", "ORGAN", 370, 376], ["liver", "ORGAN", 394, 399], ["kidneys", "ORGAN", 404, 411], ["macrophages", "CELL_TYPE", 228, 239], ["mononuclear cells", "CELL_TYPE", 250, 267], ["circulatory and alveolar macrophages", "CELL_TYPE", 269, 305], ["infected cells", "CELL_TYPE", 317, 331], ["rabbits", "SPECIES", 37, 44], ["RHDV", "SPECIES", 23, 27], ["rabbits", "SPECIES", 37, 44], ["RHDV", "SPECIES", 215, 219], ["few outward signs", "PROBLEM", 69, 86], ["bloody mucous discharge from the nose", "PROBLEM", 97, 134], ["CaliciviridaeFollowing", "TREATMENT", 135, 157], ["ocular mucosa RHDV infects macrophages", "PROBLEM", 201, 239], ["other mononuclear cells (circulatory and alveolar macrophages", "PROBLEM", 244, 305], ["these infected cells", "PROBLEM", 311, 331], ["the virus", "PROBLEM", 344, 353], ["virus", "PROBLEM", 418, 423], ["RHDV", "OBSERVATION_MODIFIER", 23, 27], ["infected", "OBSERVATION", 28, 36], ["nose", "ANATOMY", 130, 134], ["primary replication", "OBSERVATION", 162, 181], ["oronasal", "ANATOMY", 185, 193], ["ocular mucosa", "ANATOMY", 201, 214], ["mononuclear cells", "OBSERVATION", 250, 267], ["alveolar macrophages", "OBSERVATION", 285, 305], ["infected cells", "OBSERVATION", 317, 331], ["virus", "OBSERVATION", 348, 353], ["internal", "ANATOMY_MODIFIER", 361, 369], ["liver", "ANATOMY", 394, 399], ["kidneys", "ANATOMY", 404, 411], ["secondary replication", "OBSERVATION", 434, 455]]], ["Cells of the mononuclear phagocyte lineage are also likely to be involved in transmission of EBHSV to the internal organs of infected hares.", [["Cells", "ANATOMY", 0, 5], ["mononuclear phagocyte lineage", "ANATOMY", 13, 42], ["internal organs", "ANATOMY", 106, 121], ["Cells", "CELL", 0, 5], ["mononuclear phagocyte lineage", "CELL", 13, 42], ["EBHSV", "GENE_OR_GENE_PRODUCT", 93, 98], ["organs", "ORGAN", 115, 121], ["mononuclear phagocyte lineage", "CELL_TYPE", 13, 42], ["EBHSV", "SPECIES", 93, 98], ["mononuclear phagocyte lineage", "OBSERVATION", 13, 42], ["likely to be", "UNCERTAINTY", 52, 64], ["internal organs", "ANATOMY", 106, 121], ["infected", "OBSERVATION", 125, 133]]], ["In both RHD and EBHS, a consistent finding is severe necrotising hepatitis, characteristic lesion being coagulation liver necrosis in RHD and lytic necrosis in EBHS [56] .", [["lesion", "ANATOMY", 91, 97], ["liver", "ANATOMY", 116, 121], ["RHD", "DISEASE", 8, 11], ["EBHS", "DISEASE", 16, 20], ["necrotising hepatitis", "DISEASE", 53, 74], ["coagulation liver necrosis", "DISEASE", 104, 130], ["RHD", "DISEASE", 134, 137], ["necrosis", "DISEASE", 148, 156], ["EBHS", "DISEASE", 160, 164], ["EBHS", "CANCER", 16, 20], ["lesion", "CANCER", 91, 97], ["liver", "ORGAN", 116, 121], ["severe necrotising hepatitis", "PROBLEM", 46, 74], ["characteristic lesion", "PROBLEM", 76, 97], ["coagulation liver necrosis", "PROBLEM", 104, 130], ["RHD", "PROBLEM", 134, 137], ["lytic necrosis", "PROBLEM", 142, 156], ["consistent finding", "UNCERTAINTY", 24, 42], ["severe", "OBSERVATION_MODIFIER", 46, 52], ["necrotising", "OBSERVATION_MODIFIER", 53, 64], ["hepatitis", "OBSERVATION", 65, 74], ["characteristic", "OBSERVATION_MODIFIER", 76, 90], ["lesion", "OBSERVATION", 91, 97], ["coagulation", "OBSERVATION_MODIFIER", 104, 115], ["liver", "ANATOMY", 116, 121], ["necrosis", "OBSERVATION", 122, 130], ["lytic", "OBSERVATION_MODIFIER", 142, 147], ["necrosis", "OBSERVATION", 148, 156]]], ["However, the two diseases also have characteristic pathological differences.", [["the two diseases", "PROBLEM", 9, 25], ["characteristic pathological differences", "PROBLEM", 36, 75], ["two", "OBSERVATION_MODIFIER", 13, 16], ["diseases", "OBSERVATION", 17, 25], ["characteristic", "OBSERVATION_MODIFIER", 36, 50], ["pathological", "OBSERVATION", 51, 63]]], ["In RHD, disseminated intravascular coagulation (DIC) and thrombi in kidneys and lungs are common lesions while DIC has not been observed in hares with EBHS and haemorrhages are also infrequent [56] .", [["intravascular", "ANATOMY", 21, 34], ["thrombi", "ANATOMY", 57, 64], ["kidneys", "ANATOMY", 68, 75], ["lungs", "ANATOMY", 80, 85], ["lesions", "ANATOMY", 97, 104], ["RHD", "DISEASE", 3, 6], ["disseminated intravascular coagulation", "DISEASE", 8, 46], ["DIC", "DISEASE", 48, 51], ["thrombi", "DISEASE", 57, 64], ["DIC", "DISEASE", 111, 114], ["EBHS", "DISEASE", 151, 155], ["haemorrhages", "DISEASE", 160, 172], ["intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 21, 34], ["kidneys", "ORGAN", 68, 75], ["lungs", "ORGAN", 80, 85], ["lesions", "PATHOLOGICAL_FORMATION", 97, 104], ["RHD", "PROBLEM", 3, 6], ["disseminated intravascular coagulation", "PROBLEM", 8, 46], ["DIC)", "PROBLEM", 48, 52], ["thrombi in kidneys and lungs", "PROBLEM", 57, 85], ["common lesions", "PROBLEM", 90, 104], ["DIC", "PROBLEM", 111, 114], ["EBHS", "TEST", 151, 155], ["haemorrhages", "PROBLEM", 160, 172], ["RHD", "OBSERVATION", 3, 6], ["disseminated", "OBSERVATION_MODIFIER", 8, 20], ["intravascular coagulation", "OBSERVATION", 21, 46], ["thrombi", "OBSERVATION", 57, 64], ["kidneys", "ANATOMY", 68, 75], ["lungs", "ANATOMY", 80, 85], ["common", "OBSERVATION_MODIFIER", 90, 96], ["lesions", "OBSERVATION", 97, 104], ["haemorrhages", "OBSERVATION", 160, 172]]], ["Depletion of splenic lymphocytes is observed in both diseases.", [["splenic lymphocytes", "ANATOMY", 13, 32], ["splenic lymphocytes", "CELL", 13, 32], ["splenic lymphocytes", "CELL_TYPE", 13, 32], ["splenic lymphocytes", "PROBLEM", 13, 32], ["splenic", "ANATOMY", 13, 20], ["lymphocytes", "OBSERVATION", 21, 32], ["both", "OBSERVATION_MODIFIER", 48, 52], ["diseases", "OBSERVATION", 53, 61]]], ["Apoptosis of hepatocytes, macrophages and endothelial cells along with DIC and progressive jaundice are common features in RHD of rabbits [57] .", [["hepatocytes", "ANATOMY", 13, 24], ["macrophages", "ANATOMY", 26, 37], ["endothelial cells", "ANATOMY", 42, 59], ["DIC", "DISEASE", 71, 74], ["jaundice", "DISEASE", 91, 99], ["RHD", "DISEASE", 123, 126], ["hepatocytes", "CELL", 13, 24], ["macrophages", "CELL", 26, 37], ["endothelial cells", "CELL", 42, 59], ["rabbits", "ORGANISM", 130, 137], ["hepatocytes", "CELL_TYPE", 13, 24], ["macrophages", "CELL_TYPE", 26, 37], ["endothelial cells", "CELL_TYPE", 42, 59], ["rabbits", "SPECIES", 130, 137], ["Apoptosis of hepatocytes", "PROBLEM", 0, 24], ["macrophages", "PROBLEM", 26, 37], ["endothelial cells", "PROBLEM", 42, 59], ["DIC", "PROBLEM", 71, 74], ["progressive jaundice", "PROBLEM", 79, 99], ["hepatocytes", "ANATOMY", 13, 24], ["macrophages", "OBSERVATION", 26, 37], ["endothelial cells", "OBSERVATION", 42, 59], ["progressive", "OBSERVATION_MODIFIER", 79, 90], ["jaundice", "OBSERVATION", 91, 99]]], ["An interesting hypothesis put forward to explain the differences in types of lesions between RHD and EBHS was suggested as due to the genetic difference between the two affected lagomorphs species.", [["lesions", "ANATOMY", 77, 84], ["RHD", "DISEASE", 93, 96], ["EBHS", "DISEASE", 101, 105], ["lesions", "PATHOLOGICAL_FORMATION", 77, 84], ["EBHS", "CANCER", 101, 105], ["An interesting hypothesis", "PROBLEM", 0, 25], ["lesions between RHD", "PROBLEM", 77, 96], ["EBHS", "TEST", 101, 105], ["the genetic difference", "PROBLEM", 130, 152], ["the two affected lagomorphs species", "PROBLEM", 161, 196], ["lesions", "OBSERVATION", 77, 84]]], ["Evidence supporting this hypothesis has been the observation of liver lesions in RHDV infected hares that were indistinguishable from those seen following EBHSV disease of hares [56] .", [["liver lesions", "ANATOMY", 64, 77], ["liver lesions", "DISEASE", 64, 77], ["RHDV infected", "DISEASE", 81, 94], ["liver lesions", "PATHOLOGICAL_FORMATION", 64, 77], ["RHDV", "ORGANISM", 81, 85], ["RHDV", "SPECIES", 81, 85], ["EBHSV", "SPECIES", 155, 160], ["liver lesions", "PROBLEM", 64, 77], ["RHDV infected hares", "PROBLEM", 81, 100], ["EBHSV disease of hares", "PROBLEM", 155, 177], ["liver", "ANATOMY", 64, 69], ["lesions", "OBSERVATION", 70, 77], ["RHDV", "OBSERVATION_MODIFIER", 81, 85], ["infected", "OBSERVATION", 86, 94]]], ["Thus the type of lesions is apparently not determined by the virus species.", [["lesions", "ANATOMY", 17, 24], ["lesions", "PATHOLOGICAL_FORMATION", 17, 24], ["lesions", "PROBLEM", 17, 24], ["the virus species", "PROBLEM", 57, 74], ["lesions", "OBSERVATION", 17, 24], ["apparently not determined", "UNCERTAINTY", 28, 53], ["virus", "OBSERVATION", 61, 66]]], ["As in FCV infection of cats, protection against RHDV disease is conferred by virus neutralising antibody to the major viral capsid protein namely VP60 in RHDV.CoronaviridaeCoronaviruses (CoVs) (family Coronaviridae, order Nidovirales) are a group of enveloped positive-strand large RNA viruses of mammals and birds and are found worldwide.", [["FCV infection", "DISEASE", 6, 19], ["RHDV disease", "DISEASE", 48, 60], ["CoronaviridaeCoronaviruses", "CHEMICAL", 159, 185], ["FCV", "ORGANISM", 6, 9], ["cats", "ORGANISM", 23, 27], ["RHDV", "ORGANISM", 48, 52], ["VP60", "GENE_OR_GENE_PRODUCT", 146, 150], ["RHDV", "ORGANISM", 154, 158], ["CoronaviridaeCoronaviruses", "GENE_OR_GENE_PRODUCT", 159, 185], ["CoVs", "GENE_OR_GENE_PRODUCT", 187, 191], ["Nidovirales", "GENE_OR_GENE_PRODUCT", 222, 233], ["virus neutralising antibody", "PROTEIN", 77, 104], ["major viral capsid protein", "PROTEIN", 112, 138], ["VP60", "PROTEIN", 146, 150], ["cats", "SPECIES", 23, 27], ["RHDV", "SPECIES", 48, 52], ["RHDV", "SPECIES", 154, 158], ["FCV", "SPECIES", 6, 9], ["RHDV", "SPECIES", 48, 52], ["RHDV", "SPECIES", 154, 158], ["FCV infection of cats", "PROBLEM", 6, 27], ["protection", "TREATMENT", 29, 39], ["RHDV disease", "PROBLEM", 48, 60], ["virus neutralising antibody", "TREATMENT", 77, 104], ["strand large RNA viruses of mammals", "PROBLEM", 269, 304], ["infection", "OBSERVATION", 10, 19], ["strand large", "OBSERVATION_MODIFIER", 269, 281], ["RNA viruses", "OBSERVATION", 282, 293]]], ["The coronavirus genus has been classified into three clusters or groups based on antigenic cross reactivity and other criteria.", [["coronavirus", "ORGANISM", 4, 15], ["The coronavirus genus", "PROBLEM", 0, 21], ["coronavirus genus", "OBSERVATION", 4, 21]]], ["Group 1 has dog (CCoV), cat (FCoV), human (HCoV-229E), pig epidemic diarrhoea (PEDV), pig respiratory (PRCoV), pig transmissible gastroenteritis (TGEV) CoVs.", [["HCoV-229E", "CHEMICAL", 43, 52], ["pig epidemic diarrhoea", "DISEASE", 55, 77], ["transmissible gastroenteritis", "DISEASE", 115, 144], ["TGEV", "DISEASE", 146, 150], ["dog", "ORGANISM", 12, 15], ["CCoV", "ORGANISM", 17, 21], ["cat", "ORGANISM", 24, 27], ["human", "ORGANISM", 36, 41], ["HCoV-229E", "ORGANISM", 43, 52], ["pig", "ORGANISM", 55, 58], ["pig", "ORGANISM", 86, 89], ["pig", "ORGANISM", 111, 114], ["TGEV", "ORGANISM", 146, 150], ["dog", "SPECIES", 12, 15], ["cat", "SPECIES", 24, 27], ["human", "SPECIES", 36, 41], ["pig", "SPECIES", 55, 58], ["pig", "SPECIES", 86, 89], ["pig", "SPECIES", 111, 114], ["TGEV", "SPECIES", 146, 150], ["CCoV", "SPECIES", 17, 21], ["cat", "SPECIES", 24, 27], ["FCoV", "SPECIES", 29, 33], ["human", "SPECIES", 36, 41], ["HCoV-229E", "SPECIES", 43, 52], ["pig", "SPECIES", 55, 58], ["PEDV", "SPECIES", 79, 83], ["pig", "SPECIES", 86, 89], ["PRCoV", "SPECIES", 103, 108], ["pig", "SPECIES", 111, 114], ["TGEV", "SPECIES", 146, 150], ["pig epidemic diarrhoea", "PROBLEM", 55, 77], ["pig respiratory (PRCoV)", "TREATMENT", 86, 109], ["pig transmissible gastroenteritis", "PROBLEM", 111, 144], ["gastroenteritis", "OBSERVATION", 129, 144]]], ["Group 2 species are bovine (BCoV), human (HCoV-OC43), mouse (MHV), pig haemagglutinating encephalomyelitis (HEV), SARS (SARS-CoV), canine respiratory coronavirus (CRCoV) and other CoVs.", [["haemagglutinating encephalomyelitis", "DISEASE", 71, 106], ["SARS (SARS-CoV)", "DISEASE", 114, 129], ["canine respiratory coronavirus", "DISEASE", 131, 161], ["bovine", "ORGANISM", 20, 26], ["BCoV", "ORGANISM", 28, 32], ["human", "ORGANISM", 35, 40], ["HCoV-OC43", "ORGANISM", 42, 51], ["mouse", "ORGANISM", 54, 59], ["(MHV)", "ORGANISM", 60, 65], ["pig haemagglutinating encephalomyelitis", "ORGANISM", 67, 106], ["HEV", "ORGANISM", 108, 111], ["SARS (SARS-CoV", "ORGANISM", 114, 128], ["canine respiratory coronavirus", "ORGANISM", 131, 161], ["CRCoV", "ORGANISM", 163, 168], ["CoVs", "CANCER", 180, 184], ["bovine", "SPECIES", 20, 26], ["human", "SPECIES", 35, 40], ["mouse", "SPECIES", 54, 59], ["pig haemagglutinating encephalomyelitis", "SPECIES", 67, 106], ["canine respiratory coronavirus", "SPECIES", 131, 161], ["BCoV", "SPECIES", 28, 32], ["human", "SPECIES", 35, 40], ["HCoV", "SPECIES", 42, 46], ["mouse", "SPECIES", 54, 59], ["MHV", "SPECIES", 61, 64], ["pig haemagglutinating encephalomyelitis", "SPECIES", 67, 106], ["HEV", "SPECIES", 108, 111], ["SARS-CoV", "SPECIES", 120, 128], ["canine respiratory coronavirus", "SPECIES", 131, 161], ["CRCoV", "SPECIES", 163, 168], ["human (HCoV", "TREATMENT", 35, 46], ["mouse (MHV", "TREATMENT", 54, 64], ["pig haemagglutinating encephalomyelitis", "PROBLEM", 67, 106], ["SARS (SARS-CoV)", "PROBLEM", 114, 129], ["canine respiratory coronavirus", "PROBLEM", 131, 161], ["other CoVs", "PROBLEM", 174, 184], ["haemagglutinating encephalomyelitis", "OBSERVATION", 71, 106], ["respiratory coronavirus", "ANATOMY", 138, 161]]], ["Group 3 consists exclusively of avian CoVs.", [["CoVs", "ANATOMY", 38, 42], ["avian", "ORGANISM", 32, 37], ["CoVs", "CANCER", 38, 42], ["avian CoVs", "OBSERVATION", 32, 42]]], ["Most members usually cause mild enteric and/or respiratory disease and hence are generally considered of minor clinical importance.", [["respiratory", "ANATOMY", 47, 58], ["enteric and/or respiratory disease", "DISEASE", 32, 66], ["mild enteric and/or respiratory disease", "PROBLEM", 27, 66], ["mild", "OBSERVATION_MODIFIER", 27, 31], ["enteric", "OBSERVATION", 32, 39], ["respiratory", "ANATOMY", 47, 58], ["disease", "OBSERVATION", 59, 66]]], ["The large genome is prone to high frequency mutations [58] [59] [60] .", [["large", "OBSERVATION_MODIFIER", 4, 9], ["genome", "OBSERVATION", 10, 16]]], ["CoVs have the potential to jump the species barrier and cause severe disease as was the case for severe acute respiratory syndrome (SARS) in Southern China [61] .", [["acute respiratory syndrome", "DISEASE", 104, 130], ["SARS", "DISEASE", 132, 136], ["CoVs", "GENE_OR_GENE_PRODUCT", 0, 4], ["CoVs", "PROTEIN", 0, 4], ["CoVs", "PROBLEM", 0, 4], ["the species barrier", "TREATMENT", 32, 51], ["severe disease", "PROBLEM", 62, 76], ["severe acute respiratory syndrome", "PROBLEM", 97, 130], ["severe", "OBSERVATION_MODIFIER", 62, 68], ["disease", "OBSERVATION", 69, 76], ["severe", "OBSERVATION_MODIFIER", 97, 103], ["acute", "OBSERVATION_MODIFIER", 104, 109], ["respiratory syndrome", "OBSERVATION", 110, 130]]], ["Studies by different groups demonstrated that SARS-CoV succeeded in spillover from a wildlife reservoir (probably bats) to human population via an intermediate host(s) and that rapid viral evolution played a key role in the adaptation of SARS-CoVs in at least two nonreservoir species within a short period [62] .", [["SARS", "DISEASE", 46, 50], ["SARS", "DISEASE", 238, 242], ["SARS-CoV", "ORGANISM", 46, 54], ["human", "ORGANISM", 123, 128], ["SARS-CoVs", "GENE_OR_GENE_PRODUCT", 238, 247], ["human", "SPECIES", 123, 128], ["SARS-CoV", "SPECIES", 46, 54], ["human", "SPECIES", 123, 128], ["SARS-CoVs", "SPECIES", 238, 247], ["SARS", "PROBLEM", 46, 50], ["CoV", "PROBLEM", 51, 54], ["a wildlife reservoir", "TREATMENT", 83, 103], ["rapid viral evolution", "PROBLEM", 177, 198], ["SARS", "PROBLEM", 238, 242], ["CoVs", "PROBLEM", 243, 247], ["SARS", "OBSERVATION", 46, 50]]], ["It has been shown that cats and ferrets can be infected with this virus as well [63] .", [["cats", "ORGANISM", 23, 27], ["ferrets", "ORGANISM", 32, 39], ["cats", "SPECIES", 23, 27], ["ferrets", "SPECIES", 32, 39], ["ferrets", "SPECIES", 32, 39], ["this virus", "PROBLEM", 61, 71]]], ["Virus transmission is by inhalation and/or ingestion of virus in faeces, saliva and aerosol.", [["faeces", "ANATOMY", 65, 71], ["Virus", "ORGANISM", 0, 5], ["faeces", "ORGANISM_SUBSTANCE", 65, 71], ["saliva", "ORGANISM_SUBSTANCE", 73, 79], ["Virus transmission", "TEST", 0, 18], ["virus", "PROBLEM", 56, 61], ["aerosol", "TREATMENT", 84, 91]]], ["This results in limited virus replication in upper respiratory tract (URT) and/or intestinal mucosa and associated lymphoid tissues and progeny virus does not normally or only limitedly generalises to internal organs with some exceptions.", [["upper respiratory tract", "ANATOMY", 45, 68], ["URT", "ANATOMY", 70, 73], ["intestinal mucosa", "ANATOMY", 82, 99], ["lymphoid tissues", "ANATOMY", 115, 131], ["organs", "ANATOMY", 210, 216], ["upper respiratory", "ORGANISM_SUBDIVISION", 45, 62], ["tract", "ORGANISM_SUBDIVISION", 63, 68], ["URT", "CANCER", 70, 73], ["intestinal mucosa", "MULTI-TISSUE_STRUCTURE", 82, 99], ["lymphoid tissues", "TISSUE", 115, 131], ["organs", "ORGAN", 210, 216], ["limited virus replication in upper respiratory tract", "PROBLEM", 16, 68], ["intestinal mucosa", "PROBLEM", 82, 99], ["associated lymphoid tissues", "PROBLEM", 104, 131], ["progeny virus", "PROBLEM", 136, 149], ["upper", "ANATOMY_MODIFIER", 45, 50], ["respiratory tract", "ANATOMY", 51, 68], ["intestinal mucosa", "ANATOMY", 82, 99], ["lymphoid tissues", "OBSERVATION", 115, 131], ["progeny virus", "OBSERVATION", 136, 149], ["internal", "ANATOMY_MODIFIER", 201, 209], ["organs", "ANATOMY", 210, 216]]], ["However combined secondary bacterial infection often exacerbates the clinical disease.", [["bacterial infection", "DISEASE", 27, 46], ["combined secondary bacterial infection", "PROBLEM", 8, 46], ["the clinical disease", "PROBLEM", 65, 85], ["secondary", "OBSERVATION_MODIFIER", 17, 26], ["bacterial", "OBSERVATION_MODIFIER", 27, 36], ["infection", "OBSERVATION", 37, 46]]], ["Dogs are susceptible to two CoVs, the enteric (CCoV) [64] and the newly recognised respiratory CoV (CRCoV) [65, 66] ; the latter virus has been placed in antigenic group 2 along with BCoV and others.", [["Dogs", "ORGANISM", 0, 4], ["CoVs", "GENE_OR_GENE_PRODUCT", 28, 32], ["respiratory CoV", "ORGANISM", 83, 98], ["BCoV", "CANCER", 183, 187], ["Dogs", "SPECIES", 0, 4], ["CCoV", "SPECIES", 47, 51], ["CRCoV", "SPECIES", 100, 105], ["BCoV", "SPECIES", 183, 187], ["two CoVs", "PROBLEM", 24, 32], ["the latter virus", "PROBLEM", 118, 134], ["two CoVs", "OBSERVATION", 24, 32], ["enteric", "ANATOMY", 38, 45], ["respiratory CoV", "OBSERVATION", 83, 98]]], ["The group 1 CCoVs have been placed into two serotypes (I and II).", [["The group 1 CCoVs", "TREATMENT", 0, 17]]], ["CCoVs primarily cause mild enteric disease in puppies manifest as fever, depression, anorexia and diarrhoea.", [["enteric disease", "DISEASE", 27, 42], ["fever", "DISEASE", 66, 71], ["depression", "DISEASE", 73, 83], ["anorexia", "DISEASE", 85, 93], ["diarrhoea", "DISEASE", 98, 107], ["CCoVs", "GENE_OR_GENE_PRODUCT", 0, 5], ["puppies", "ORGANISM", 46, 53], ["mild enteric disease in puppies", "PROBLEM", 22, 53], ["fever", "PROBLEM", 66, 71], ["depression", "PROBLEM", 73, 83], ["anorexia", "PROBLEM", 85, 93], ["diarrhoea", "PROBLEM", 98, 107], ["mild", "OBSERVATION_MODIFIER", 22, 26], ["enteric", "OBSERVATION_MODIFIER", 27, 34], ["disease", "OBSERVATION", 35, 42], ["puppies", "OBSERVATION", 46, 53], ["fever", "OBSERVATION", 66, 71], ["anorexia", "OBSERVATION", 85, 93], ["diarrhoea", "OBSERVATION", 98, 107]]], ["Severe disease due to CCoV is infrequent [60] .", [["CCoV", "DISEASE", 22, 26], ["Severe disease", "PROBLEM", 0, 14], ["CCoV", "TEST", 22, 26], ["disease", "OBSERVATION", 7, 14]]], ["However, a pantropic virulent variant of serotype II CCoV with much broader viscerotropic phenotype was recognised recently [67] .", [["serotype II CCoV", "ORGANISM", 41, 57], ["serotype II CCoV", "PROTEIN", 41, 57], ["serotype II CCoV", "SPECIES", 41, 57], ["a pantropic virulent variant", "PROBLEM", 9, 37], ["serotype II CCoV", "TREATMENT", 41, 57], ["much broader viscerotropic phenotype", "PROBLEM", 63, 99], ["virulent", "OBSERVATION_MODIFIER", 21, 29], ["serotype II", "OBSERVATION_MODIFIER", 41, 52]]], ["This variant (designated CB/05), in addition to the usual enteric replication, also spreads to and replicates in internal organs (lungs, spleen, liver, kidney and brain) and was the cause of deaths of some dogs [67] [68] [69] .CoronaviridaeFCoVs occur as two serotypes with different serological and biological characteristics, particularly in sequence homology of the viral surface S glycoprotein [59] .", [["organs", "ANATOMY", 122, 128], ["lungs", "ANATOMY", 130, 135], ["spleen", "ANATOMY", 137, 143], ["liver", "ANATOMY", 145, 150], ["kidney", "ANATOMY", 152, 158], ["brain", "ANATOMY", 163, 168], ["surface", "ANATOMY", 375, 382], ["deaths", "DISEASE", 191, 197], ["organs", "ORGAN", 122, 128], ["lungs", "ORGAN", 130, 135], ["spleen", "ORGAN", 137, 143], ["liver", "ORGAN", 145, 150], ["kidney", "ORGAN", 152, 158], ["brain", "ORGAN", 163, 168], ["CoronaviridaeFCoVs", "SIMPLE_CHEMICAL", 227, 245], ["CB/05", "CELL_LINE", 25, 30], ["viral surface S glycoprotein", "PROTEIN", 369, 397], ["dogs", "SPECIES", 206, 210], ["the usual enteric replication", "TREATMENT", 48, 77], ["some dogs", "PROBLEM", 201, 210], ["CoronaviridaeFCoVs", "TREATMENT", 227, 245], ["replication", "OBSERVATION", 66, 77], ["internal", "ANATOMY_MODIFIER", 113, 121], ["organs", "ANATOMY", 122, 128], ["lungs", "ANATOMY", 130, 135], ["spleen", "ANATOMY", 137, 143], ["liver", "ANATOMY", 145, 150], ["kidney", "ANATOMY", 152, 158], ["brain", "ANATOMY", 163, 168]]], ["Like CCoVs, most FCoVs cause mild enteric disease but could give rise to highly pathogenic variants in individual infections causing peritonitis (FIP).", [["enteric disease", "DISEASE", 34, 49], ["infections", "DISEASE", 114, 124], ["peritonitis", "DISEASE", 133, 144], ["FIP", "DISEASE", 146, 149], ["CCoVs", "GENE_OR_GENE_PRODUCT", 5, 10], ["FCoVs", "GENE_OR_GENE_PRODUCT", 17, 22], ["CCoVs", "PROTEIN", 5, 10], ["mild enteric disease", "PROBLEM", 29, 49], ["highly pathogenic variants", "PROBLEM", 73, 99], ["individual infections", "PROBLEM", 103, 124], ["peritonitis", "PROBLEM", 133, 144], ["most FCoVs", "OBSERVATION_MODIFIER", 12, 22], ["mild", "OBSERVATION_MODIFIER", 29, 33], ["enteric disease", "OBSERVATION", 34, 49], ["infections", "OBSERVATION", 114, 124], ["peritonitis", "OBSERVATION", 133, 144], ["FIP", "OBSERVATION_MODIFIER", 146, 149]]], ["Both serotypes of FCoV mutate to virulent FIPV variants.", [["FCoV", "GENE_OR_GENE_PRODUCT", 18, 22], ["FIPV", "GENE_OR_GENE_PRODUCT", 42, 46], ["virulent FIPV variants", "DNA", 33, 55], ["FCoV", "SPECIES", 18, 22], ["FCoV mutate", "OBSERVATION", 18, 29], ["virulent", "OBSERVATION_MODIFIER", 33, 41], ["FIPV variants", "OBSERVATION", 42, 55]]], ["Their relative prevalence in nature varies but type I FIPV/FCoV strains are generally dominant in the field [70] .", [["FIPV", "GENE_OR_GENE_PRODUCT", 54, 58], ["FCoV", "GENE_OR_GENE_PRODUCT", 59, 63], ["type I FIPV/FCoV strains", "PROBLEM", 47, 71], ["FCoV strains", "OBSERVATION", 59, 71], ["dominant", "OBSERVATION_MODIFIER", 86, 94]]], ["FIPV variants of FCoV have been the cause of fatal peritonitis in some cases [71, 72] .", [["peritonitis", "DISEASE", 51, 62], ["FIPV", "GENE_OR_GENE_PRODUCT", 0, 4], ["FCoV", "GENE_OR_GENE_PRODUCT", 17, 21], ["FIPV", "SPECIES", 0, 4], ["FCoV", "PROBLEM", 17, 21], ["fatal peritonitis", "PROBLEM", 45, 62], ["FCoV", "OBSERVATION", 17, 21], ["fatal", "OBSERVATION_MODIFIER", 45, 50], ["peritonitis", "OBSERVATION", 51, 62]]], ["FCoVs are transmitted via the faecal-oral route and primarily replicate in enterocytes [73] from where the progeny virus disseminates to internal organs via monocyte-associated viraemia.", [["oral", "ANATOMY", 37, 41], ["enterocytes", "ANATOMY", 75, 86], ["organs", "ANATOMY", 146, 152], ["monocyte", "ANATOMY", 157, 165], ["FCoVs", "CHEMICAL", 0, 5], ["viraemia", "DISEASE", 177, 185], ["FCoVs", "GENE_OR_GENE_PRODUCT", 0, 5], ["faecal", "ORGANISM_SUBDIVISION", 30, 36], ["oral", "ORGANISM_SUBDIVISION", 37, 41], ["enterocytes", "CELL", 75, 86], ["progeny virus", "ORGANISM", 107, 120], ["organs", "ORGAN", 146, 152], ["monocyte", "CELL", 157, 165], ["the progeny virus", "PROBLEM", 103, 120], ["viraemia", "PROBLEM", 177, 185], ["enterocytes", "ANATOMY", 75, 86], ["internal organs", "ANATOMY", 137, 152], ["monocyte", "OBSERVATION", 157, 165], ["viraemia", "OBSERVATION", 177, 185]]], ["Although FCoV is highly prevalent, FIP morbidity is relatively low, rarely exceeding 5% [73] .", [["FIP", "DISEASE", 35, 38], ["FCoV", "GENE_OR_GENE_PRODUCT", 9, 13], ["FCoV", "SPECIES", 9, 13], ["FCoV", "PROBLEM", 9, 13], ["FIP morbidity", "PROBLEM", 35, 48], ["FCoV", "OBSERVATION", 9, 13], ["highly prevalent", "OBSERVATION_MODIFIER", 17, 33], ["FIP", "OBSERVATION_MODIFIER", 35, 38], ["morbidity", "OBSERVATION", 39, 48], ["low", "OBSERVATION_MODIFIER", 63, 66]]], ["Feline infectious peritonitis (FIP) is a progressive debilitating disease.", [["Feline infectious peritonitis", "DISEASE", 0, 29], ["FIP", "DISEASE", 31, 34], ["Feline", "ORGANISM", 0, 6], ["Feline infectious peritonitis", "PROBLEM", 0, 29], ["a progressive debilitating disease", "PROBLEM", 39, 73], ["infectious", "OBSERVATION_MODIFIER", 7, 17], ["peritonitis", "OBSERVATION", 18, 29], ["FIP", "OBSERVATION_MODIFIER", 31, 34], ["progressive", "OBSERVATION_MODIFIER", 41, 52], ["debilitating", "OBSERVATION_MODIFIER", 53, 65], ["disease", "OBSERVATION", 66, 73]]], ["A pathognomic feature of FIP is widespread occurrence of pyogranulomatous lesions in majority of organs (lungs, liver, spleen, omentum and brain) and other tissues [74, 75] .", [["pyogranulomatous lesions", "ANATOMY", 57, 81], ["organs", "ANATOMY", 97, 103], ["lungs", "ANATOMY", 105, 110], ["liver", "ANATOMY", 112, 117], ["spleen", "ANATOMY", 119, 125], ["omentum", "ANATOMY", 127, 134], ["brain", "ANATOMY", 139, 144], ["tissues", "ANATOMY", 156, 163], ["FIP", "DISEASE", 25, 28], ["pyogranulomatous lesions", "PATHOLOGICAL_FORMATION", 57, 81], ["organs", "ORGAN", 97, 103], ["lungs", "ORGAN", 105, 110], ["liver", "ORGAN", 112, 117], ["spleen", "ORGAN", 119, 125], ["omentum", "MULTI-TISSUE_STRUCTURE", 127, 134], ["brain", "ORGAN", 139, 144], ["tissues", "TISSUE", 156, 163], ["FIP", "PROBLEM", 25, 28], ["pyogranulomatous lesions in majority of organs (lungs, liver, spleen, omentum and brain) and other tissues", "PROBLEM", 57, 163], ["FIP", "OBSERVATION", 25, 28], ["widespread", "OBSERVATION_MODIFIER", 32, 42], ["pyogranulomatous", "OBSERVATION_MODIFIER", 57, 73], ["lesions", "OBSERVATION", 74, 81], ["majority", "ANATOMY_MODIFIER", 85, 93], ["organs", "ANATOMY", 97, 103], ["lungs", "ANATOMY", 105, 110], ["liver", "ANATOMY", 112, 117], ["spleen", "ANATOMY", 119, 125], ["omentum", "ANATOMY", 127, 134], ["brain", "ANATOMY", 139, 144]]], ["Other features of FIP involve a marked T-cell depletion, particularly in end-stage FIP [76] and hypergammaglobulinemia [77] ; B-cell leucopoenia is also a feature in FIP disease [78] .", [["T-cell", "ANATOMY", 39, 45], ["B-cell", "ANATOMY", 126, 132], ["FIP", "DISEASE", 18, 21], ["FIP", "DISEASE", 83, 86], ["hypergammaglobulinemia", "DISEASE", 96, 118], ["B-cell leucopoenia", "DISEASE", 126, 144], ["FIP disease", "DISEASE", 166, 177], ["T-cell", "CELL", 39, 45], ["FIP", "PROBLEM", 18, 21], ["a marked T-cell depletion", "PROBLEM", 30, 55], ["hypergammaglobulinemia", "PROBLEM", 96, 118], ["B-cell leucopoenia", "PROBLEM", 126, 144], ["FIP disease", "PROBLEM", 166, 177], ["FIP", "OBSERVATION", 18, 21], ["marked", "OBSERVATION_MODIFIER", 32, 38], ["cell depletion", "OBSERVATION", 41, 55], ["stage FIP", "OBSERVATION_MODIFIER", 77, 86], ["hypergammaglobulinemia", "OBSERVATION", 96, 118], ["B-cell leucopoenia", "OBSERVATION", 126, 144], ["FIP disease", "OBSERVATION", 166, 177]]], ["The T-cell depletion is apparently not the result of virus infection since T-cells appear not to support virus replication [76] .", [["T-cell", "ANATOMY", 4, 10], ["T-cells", "ANATOMY", 75, 82], ["infection", "DISEASE", 59, 68], ["T-cell", "CELL", 4, 10], ["T-cells", "CELL", 75, 82], ["T-cells", "CELL_TYPE", 75, 82], ["The T-cell depletion", "PROBLEM", 0, 20], ["virus infection", "PROBLEM", 53, 68], ["cell depletion", "OBSERVATION", 6, 20], ["apparently not the result of", "UNCERTAINTY", 24, 52], ["virus", "OBSERVATION", 53, 58]]], ["Other important determinants in FIP pathogenesis appear to be (i) dissemination of mutant progeny FIPV by activated macrophages and monocytes and their availability [79] and (ii) types of viral S protein neutralising antibodies at suboptimal concentration which opsonise the virus and enhance its infectivity for target cells via Fc receptor mediated attachment [80] [81] [82] .", [["macrophages", "ANATOMY", 116, 127], ["monocytes", "ANATOMY", 132, 141], ["cells", "ANATOMY", 320, 325], ["FIP", "DISEASE", 32, 35], ["FIP", "ORGANISM", 32, 35], ["FIPV", "GENE_OR_GENE_PRODUCT", 98, 102], ["macrophages", "CELL", 116, 127], ["monocytes", "CELL", 132, 141], ["cells", "CELL", 320, 325], ["Fc receptor", "GENE_OR_GENE_PRODUCT", 330, 341], ["activated macrophages", "CELL_TYPE", 106, 127], ["monocytes", "CELL_TYPE", 132, 141], ["viral S protein", "PROTEIN", 188, 203], ["neutralising antibodies", "PROTEIN", 204, 227], ["target cells", "CELL_TYPE", 313, 325], ["Fc receptor", "PROTEIN", 330, 341], ["mutant progeny FIPV", "PROBLEM", 83, 102], ["viral S protein neutralising antibodies", "PROBLEM", 188, 227], ["suboptimal concentration", "PROBLEM", 231, 255], ["the virus", "PROBLEM", 271, 280], ["progeny FIPV", "OBSERVATION", 90, 102]]], ["There is also complement activation with resultant platelet aggregation, intravascular coagulation necrotising lesions and exudation of fluid into the abdomen and thoracic cavity in the so-called wet form of FIP.", [["platelet", "ANATOMY", 51, 59], ["intravascular", "ANATOMY", 73, 86], ["lesions", "ANATOMY", 111, 118], ["fluid", "ANATOMY", 136, 141], ["abdomen", "ANATOMY", 151, 158], ["thoracic cavity", "ANATOMY", 163, 178], ["platelet aggregation", "DISEASE", 51, 71], ["intravascular coagulation", "DISEASE", 73, 98], ["FIP", "DISEASE", 208, 211], ["platelet", "CELL", 51, 59], ["intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 73, 86], ["lesions", "PATHOLOGICAL_FORMATION", 111, 118], ["abdomen", "ORGAN", 151, 158], ["thoracic cavity", "ORGANISM_SUBDIVISION", 163, 178], ["complement activation", "PROBLEM", 14, 35], ["resultant platelet aggregation", "PROBLEM", 41, 71], ["intravascular coagulation necrotising lesions", "PROBLEM", 73, 118], ["exudation of fluid into the abdomen and thoracic cavity", "PROBLEM", 123, 178], ["FIP", "PROBLEM", 208, 211], ["platelet aggregation", "OBSERVATION", 51, 71], ["intravascular", "OBSERVATION_MODIFIER", 73, 86], ["coagulation", "OBSERVATION_MODIFIER", 87, 98], ["necrotising", "OBSERVATION_MODIFIER", 99, 110], ["lesions", "OBSERVATION", 111, 118], ["exudation", "OBSERVATION_MODIFIER", 123, 132], ["fluid", "OBSERVATION", 136, 141], ["abdomen", "ANATOMY", 151, 158], ["thoracic cavity", "ANATOMY", 163, 178], ["wet", "OBSERVATION", 196, 199], ["FIP", "OBSERVATION", 208, 211]]], ["Wet FIP is most common in kittens under one year of age and the incidence declines by 5 years of age when the dry form of FIP is more common [82] .", [["FIP", "DISEASE", 4, 7], ["FIP", "DISEASE", 122, 125], ["kittens", "ORGANISM", 26, 33], ["FIP", "OBSERVATION", 4, 7], ["most common", "OBSERVATION_MODIFIER", 11, 22], ["FIP", "OBSERVATION", 122, 125]]], ["Whilst there is no protective immunity in wet FIP, the dry form is a result of partial immunological protection [82] [83] .", [["FIP", "DISEASE", 46, 49], ["no", "UNCERTAINTY", 16, 18], ["protective", "OBSERVATION_MODIFIER", 19, 29], ["immunity", "OBSERVATION", 30, 38]]], ["Some of these pathogenetic features of FIP notably the Tcell lymphopenia, multiphasic disease course and viral persistence have been seen in SARS.", [["FIP", "DISEASE", 39, 42], ["lymphopenia", "DISEASE", 61, 72], ["SARS", "DISEASE", 141, 145], ["FIP", "ORGANISM", 39, 42], ["FIP", "PROBLEM", 39, 42], ["the Tcell lymphopenia", "PROBLEM", 51, 72], ["multiphasic disease course", "PROBLEM", 74, 100], ["viral persistence", "PROBLEM", 105, 122], ["SARS", "PROBLEM", 141, 145], ["FIP", "OBSERVATION", 39, 42], ["Tcell lymphopenia", "OBSERVATION", 55, 72], ["multiphasic", "OBSERVATION_MODIFIER", 74, 85], ["disease", "OBSERVATION", 86, 93], ["viral persistence", "OBSERVATION", 105, 122]]], ["Both these diseases are an enigma possibly stemming from virus-induced immune dysregulation.ParamyxoviridaeMembers in the family are enveloped viruses with single stranded negative-sense RNA genome.Currently the family Paramyxoviridae has two subfamilies named Paramyxovirinae and Pneumovirinae.The former has five genera: respirovirus, morbillivirus, rubulavirus, henipavirus and avulavirus.", [["ParamyxoviridaeMembers", "CHEMICAL", 92, 114], ["ParamyxoviridaeMembers", "GENE_OR_GENE_PRODUCT", 92, 114], ["Paramyxovirinae", "GENE_OR_GENE_PRODUCT", 261, 276], ["Pneumovirinae", "GENE_OR_GENE_PRODUCT", 281, 294], ["respirovirus", "GENE_OR_GENE_PRODUCT", 323, 335], ["morbillivirus", "GENE_OR_GENE_PRODUCT", 337, 350], ["single stranded negative-sense RNA genome", "DNA", 156, 197], ["Pneumovirinae", "PROTEIN", 281, 294], ["an enigma", "PROBLEM", 24, 33], ["virus", "PROBLEM", 57, 62], ["immune dysregulation", "PROBLEM", 71, 91], ["ParamyxoviridaeMembers", "TREATMENT", 92, 114], ["Pneumovirinae", "TREATMENT", 281, 294], ["respirovirus", "TEST", 323, 335], ["morbillivirus", "PROBLEM", 337, 350], ["henipavirus", "PROBLEM", 365, 376], ["avulavirus", "PROBLEM", 381, 391], ["diseases", "OBSERVATION", 11, 19], ["immune dysregulation", "OBSERVATION", 71, 91], ["RNA genome", "OBSERVATION", 187, 197], ["morbillivirus", "OBSERVATION", 337, 350], ["henipavirus", "ANATOMY", 365, 376]]], ["The latter has two genera: pneumovirus and metapneumovirus.", [["pneumovirus", "GENE_OR_GENE_PRODUCT", 27, 38], ["metapneumovirus", "ORGANISM", 43, 58], ["pneumovirus", "PROBLEM", 27, 38], ["metapneumovirus", "PROBLEM", 43, 58], ["genera", "OBSERVATION_MODIFIER", 19, 25], ["metapneumovirus", "OBSERVATION", 43, 58]]], ["The members survive moderately well in the environment; all replicate in the upper respiratory tract epithelium and have a broad host range affecting farm and companion animals, birds and man.", [["upper respiratory tract epithelium", "ANATOMY", 77, 111], ["upper respiratory", "ORGANISM_SUBDIVISION", 77, 94], ["tract epithelium", "TISSUE", 95, 111], ["birds", "ORGANISM", 178, 183], ["man", "ORGANISM", 188, 191], ["man", "SPECIES", 188, 191], ["upper", "ANATOMY_MODIFIER", 77, 82], ["respiratory tract", "ANATOMY", 83, 100]]], ["Some members also have cell tropism for reticuloendothelial, enteric and neural cells causing significant pathology and disease of the bowel and/or CNS.", [["cell", "ANATOMY", 23, 27], ["reticuloendothelial", "ANATOMY", 40, 59], ["enteric", "ANATOMY", 61, 68], ["neural cells", "ANATOMY", 73, 85], ["bowel", "ANATOMY", 135, 140], ["CNS", "ANATOMY", 148, 151], ["disease of the bowel and/or CNS", "DISEASE", 120, 151], ["cell", "CELL", 23, 27], ["reticuloendothelial", "CELL", 40, 59], ["enteric", "CELL", 61, 68], ["neural cells", "CELL", 73, 85], ["bowel", "ORGAN", 135, 140], ["CNS", "ANATOMICAL_SYSTEM", 148, 151], ["reticuloendothelial, enteric and neural cells", "CELL_TYPE", 40, 85], ["cell tropism", "PROBLEM", 23, 35], ["reticuloendothelial, enteric and neural cells", "PROBLEM", 40, 85], ["significant pathology", "PROBLEM", 94, 115], ["disease of the bowel", "PROBLEM", 120, 140], ["cell tropism", "OBSERVATION", 23, 35], ["enteric", "ANATOMY", 61, 68], ["neural cells", "ANATOMY", 73, 85], ["significant", "OBSERVATION_MODIFIER", 94, 105], ["pathology", "OBSERVATION", 106, 115], ["bowel", "ANATOMY", 135, 140], ["CNS", "ANATOMY", 148, 151]]], ["In dogs two members are significant pathogens.", [["dogs", "ORGANISM", 3, 7], ["dogs", "SPECIES", 3, 7], ["significant pathogens", "PROBLEM", 24, 45], ["significant", "OBSERVATION_MODIFIER", 24, 35], ["pathogens", "OBSERVATION", 36, 45]]], ["The viruses concerned are canine distemper virus (CDV) in genus morbillivirus and parainfluenzavirus-2 (PIV-2) in genus respirovirus.", [["canine distemper", "DISEASE", 26, 42], ["canine distemper virus", "ORGANISM", 26, 48], ["CDV", "ORGANISM", 50, 53], ["genus morbillivirus", "ORGANISM", 58, 77], ["parainfluenzavirus-2", "ORGANISM", 82, 102], ["PIV-2", "ORGANISM", 104, 109], ["canine distemper virus", "SPECIES", 26, 48], ["canine distemper virus", "SPECIES", 26, 48], ["CDV", "SPECIES", 50, 53], ["The viruses", "PROBLEM", 0, 11], ["canine distemper virus", "PROBLEM", 26, 48], ["genus morbillivirus", "TEST", 58, 77], ["parainfluenzavirus", "TEST", 82, 100], ["PIV", "TEST", 104, 107], ["viruses", "OBSERVATION", 4, 11], ["distemper virus", "OBSERVATION", 33, 48], ["genus morbillivirus", "ANATOMY", 58, 77], ["genus respirovirus", "ANATOMY", 114, 132]]], ["Both viruses are transmitted by aerosol which initiates primary infection in respiratory tract and/or tonsilar epithelium and dissemination throughout the bronchial tree.", [["respiratory tract", "ANATOMY", 77, 94], ["tonsilar epithelium", "ANATOMY", 102, 121], ["bronchial tree", "ANATOMY", 155, 169], ["primary infection", "DISEASE", 56, 73], ["respiratory tract", "PATHOLOGICAL_FORMATION", 77, 94], ["tonsilar epithelium", "TISSUE", 102, 121], ["bronchial tree", "MULTI-TISSUE_STRUCTURE", 155, 169], ["aerosol", "TREATMENT", 32, 39], ["primary infection in respiratory tract", "PROBLEM", 56, 94], ["tonsilar epithelium", "PROBLEM", 102, 121], ["dissemination throughout the bronchial tree", "PROBLEM", 126, 169], ["viruses", "OBSERVATION", 5, 12], ["primary", "OBSERVATION_MODIFIER", 56, 63], ["infection", "OBSERVATION", 64, 73], ["respiratory tract", "ANATOMY", 77, 94], ["tonsilar", "ANATOMY_MODIFIER", 102, 110], ["epithelium", "ANATOMY_MODIFIER", 111, 121], ["dissemination", "OBSERVATION", 126, 139], ["bronchial", "ANATOMY", 155, 164], ["tree", "ANATOMY_MODIFIER", 165, 169]]], ["Two-5 days later respiratory disease may follow with signs of primary fever, dyspnoea, nasal discharge, inappetance.", [["respiratory", "ANATOMY", 17, 28], ["nasal", "ANATOMY", 87, 92], ["respiratory disease", "DISEASE", 17, 36], ["primary fever", "DISEASE", 62, 75], ["dyspnoea", "DISEASE", 77, 85], ["nasal", "ORGANISM_SUBDIVISION", 87, 92], ["respiratory disease", "PROBLEM", 17, 36], ["primary fever", "PROBLEM", 62, 75], ["dyspnoea", "PROBLEM", 77, 85], ["nasal discharge", "PROBLEM", 87, 102], ["inappetance", "TREATMENT", 104, 115], ["respiratory", "ANATOMY", 17, 28], ["disease", "OBSERVATION", 29, 36], ["nasal", "ANATOMY", 87, 92]]], ["Progeny virus from primary CDV replication also initiates infection of macrophages and then of lymphocytes both of which disseminate the progeny virus to the epithelium and lymphoid tissue of small intestine giving rise to vomiting and diarrhoea and then anorexia.", [["macrophages", "ANATOMY", 71, 82], ["lymphocytes", "ANATOMY", 95, 106], ["epithelium", "ANATOMY", 158, 168], ["lymphoid tissue", "ANATOMY", 173, 188], ["small intestine", "ANATOMY", 192, 207], ["infection", "DISEASE", 58, 67], ["vomiting", "DISEASE", 223, 231], ["diarrhoea", "DISEASE", 236, 245], ["anorexia", "DISEASE", 255, 263], ["Progeny virus", "ORGANISM", 0, 13], ["CDV", "ORGANISM", 27, 30], ["macrophages", "CELL", 71, 82], ["lymphocytes", "CELL", 95, 106], ["epithelium", "TISSUE", 158, 168], ["lymphoid tissue", "TISSUE", 173, 188], ["small intestine", "ORGAN", 192, 207], ["macrophages", "CELL_TYPE", 71, 82], ["lymphocytes", "CELL_TYPE", 95, 106], ["Progeny virus", "SPECIES", 0, 13], ["CDV", "SPECIES", 27, 30], ["Progeny virus", "PROBLEM", 0, 13], ["primary CDV replication", "TREATMENT", 19, 42], ["infection of macrophages", "PROBLEM", 58, 82], ["lymphocytes", "PROBLEM", 95, 106], ["small intestine", "PROBLEM", 192, 207], ["vomiting", "PROBLEM", 223, 231], ["diarrhoea", "PROBLEM", 236, 245], ["anorexia", "PROBLEM", 255, 263], ["CDV replication", "OBSERVATION", 27, 42], ["infection", "OBSERVATION", 58, 67], ["macrophages", "OBSERVATION", 71, 82], ["progeny virus", "OBSERVATION", 137, 150], ["epithelium", "ANATOMY_MODIFIER", 158, 168], ["lymphoid tissue", "OBSERVATION", 173, 188], ["small", "OBSERVATION_MODIFIER", 192, 197], ["intestine", "ANATOMY", 198, 207]]], ["Other organs infected following macrophage-lymphocyte viraemia are neurones and brain macrophages and epithelia of endometrium.", [["organs", "ANATOMY", 6, 12], ["macrophage-lymphocyte", "ANATOMY", 32, 53], ["neurones", "ANATOMY", 67, 75], ["brain macrophages", "ANATOMY", 80, 97], ["epithelia", "ANATOMY", 102, 111], ["endometrium", "ANATOMY", 115, 126], ["viraemia", "DISEASE", 54, 62], ["organs", "ORGAN", 6, 12], ["macrophage", "CELL", 32, 42], ["lymphocyte", "CELL", 43, 53], ["neurones", "CELL", 67, 75], ["brain macrophages", "CELL", 80, 97], ["epithelia", "TISSUE", 102, 111], ["endometrium", "MULTI-TISSUE_STRUCTURE", 115, 126], ["brain macrophages", "CELL_TYPE", 80, 97], ["macrophage", "TEST", 32, 42], ["lymphocyte viraemia", "PROBLEM", 43, 62], ["epithelia of endometrium", "PROBLEM", 102, 126], ["organs", "ANATOMY", 6, 12], ["infected", "OBSERVATION", 13, 21], ["macrophage", "OBSERVATION_MODIFIER", 32, 42], ["lymphocyte viraemia", "OBSERVATION", 43, 62], ["brain", "ANATOMY", 80, 85], ["macrophages", "OBSERVATION", 86, 97], ["epithelia", "ANATOMY_MODIFIER", 102, 111], ["endometrium", "ANATOMY", 115, 126]]], ["Significant infection at these sites may result in CNS disease and/or transplacental invasion of the foetus which may die.", [["sites", "ANATOMY", 31, 36], ["CNS", "ANATOMY", 51, 54], ["foetus", "ANATOMY", 101, 107], ["infection", "DISEASE", 12, 21], ["CNS", "ANATOMICAL_SYSTEM", 51, 54], ["foetus", "ORGAN", 101, 107], ["Significant infection at these sites", "PROBLEM", 0, 36], ["CNS disease", "PROBLEM", 51, 62], ["transplacental invasion of the foetus", "PROBLEM", 70, 107], ["infection", "OBSERVATION", 12, 21], ["CNS", "ANATOMY", 51, 54], ["disease", "OBSERVATION", 55, 62], ["invasion", "OBSERVATION", 85, 93]]], ["The CNS disease signs observed are ataxia, muscle tremors and paralysis and coma.", [["CNS", "ANATOMY", 4, 7], ["muscle", "ANATOMY", 43, 49], ["ataxia", "DISEASE", 35, 41], ["muscle tremors", "DISEASE", 43, 57], ["paralysis", "DISEASE", 62, 71], ["coma", "DISEASE", 76, 80], ["CNS", "ANATOMICAL_SYSTEM", 4, 7], ["muscle", "ORGAN", 43, 49], ["The CNS disease signs", "PROBLEM", 0, 21], ["ataxia", "PROBLEM", 35, 41], ["muscle tremors", "PROBLEM", 43, 57], ["paralysis", "PROBLEM", 62, 71], ["coma", "PROBLEM", 76, 80], ["CNS", "ANATOMY", 4, 7], ["disease", "OBSERVATION", 8, 15], ["muscle", "ANATOMY", 43, 49], ["tremors", "OBSERVATION", 50, 57], ["paralysis", "OBSERVATION", 62, 71]]], ["PIV-2 has been associated with kennel cough.", [["cough", "DISEASE", 38, 43], ["PIV-2", "GENE_OR_GENE_PRODUCT", 0, 5], ["PIV", "TREATMENT", 0, 3], ["kennel cough", "PROBLEM", 31, 43], ["kennel cough", "OBSERVATION", 31, 43]]], ["Severe disease results during combined infection with CDV or Bordetella bronchiseptica.RhabdoviridaeRabies virus (RV) in genus lyssavirus of family Rhabdoviridae has long been the most feared zoonosis.", [["infection", "DISEASE", 39, 48], ["Bordetella bronchiseptica", "DISEASE", 61, 86], ["Rhabdoviridae", "CHEMICAL", 148, 161], ["zoonosis", "DISEASE", 192, 200], ["CDV", "ORGANISM", 54, 57], ["Bordetella bronchiseptica", "ORGANISM", 61, 86], ["RhabdoviridaeRabies virus", "ORGANISM", 87, 112], ["genus lyssavirus", "ORGANISM", 121, 137], ["Rhabdoviridae", "GENE_OR_GENE_PRODUCT", 148, 161], ["Bordetella bronchiseptica", "SPECIES", 61, 86], ["RhabdoviridaeRabies virus", "SPECIES", 87, 112], ["CDV", "SPECIES", 54, 57], ["Bordetella bronchiseptica", "SPECIES", 61, 86], ["RhabdoviridaeRabies virus", "SPECIES", 87, 112], ["RV", "SPECIES", 114, 116], ["Severe disease", "PROBLEM", 0, 14], ["combined infection", "PROBLEM", 30, 48], ["CDV", "PROBLEM", 54, 57], ["Bordetella bronchiseptica", "PROBLEM", 61, 86], ["RhabdoviridaeRabies virus", "TREATMENT", 87, 112], ["Rhabdoviridae", "TREATMENT", 148, 161], ["disease", "OBSERVATION", 7, 14], ["infection", "OBSERVATION", 39, 48], ["Bordetella bronchiseptica", "OBSERVATION", 61, 86]]], ["All mammals are susceptible to RV.", [["RV", "ANATOMY", 31, 33]]], ["Viral particles are bacilliform and/or bullet-shaped, enveloped and contain one molecule of non-infectious, linear, negative-sense, single-stranded RNA.", [["bacilliform", "ANATOMY", 20, 31], ["non-infectious, linear, negative-sense, single-stranded RNA", "RNA", 92, 151], ["Viral particles", "PROBLEM", 0, 15], ["bacilliform", "PROBLEM", 20, 31], ["bullet-shaped", "PROBLEM", 39, 52], ["non-infectious", "PROBLEM", 92, 106], ["single-stranded RNA", "PROBLEM", 132, 151], ["particles", "OBSERVATION", 6, 15], ["bullet", "OBSERVATION_MODIFIER", 39, 45], ["shaped", "OBSERVATION_MODIFIER", 46, 52], ["one", "OBSERVATION_MODIFIER", 76, 79], ["molecule", "OBSERVATION_MODIFIER", 80, 88], ["non-infectious", "OBSERVATION", 92, 106], ["linear", "OBSERVATION_MODIFIER", 108, 114], ["negative", "OBSERVATION", 116, 124], ["stranded RNA", "OBSERVATION_MODIFIER", 139, 151]]], ["Common reservoir hosts are members of canids (fox, dog, wolf and jackal), mustelidae (skunk, polecat and some other species) and chiropetra (bats).", [["canids", "ORGANISM", 38, 44], ["fox", "ORGANISM_SUBDIVISION", 46, 49], ["dog", "ORGANISM_SUBDIVISION", 51, 54], ["wolf", "ORGANISM_SUBDIVISION", 56, 60], ["skunk", "ORGANISM_SUBDIVISION", 86, 91], ["dog", "SPECIES", 51, 54], ["mustelidae", "SPECIES", 74, 84], ["mustelidae (skunk, polecat", "PROBLEM", 74, 100]]], ["RV transmission is usually by bite of infected animals shedding virus produced in salivary gland.", [["salivary gland", "ANATOMY", 82, 96], ["RV", "MULTI-TISSUE_STRUCTURE", 0, 2], ["salivary gland", "ORGAN", 82, 96], ["RV transmission", "TEST", 0, 15], ["infected animals shedding virus", "PROBLEM", 38, 69], ["infected", "OBSERVATION", 38, 46], ["salivary gland", "ANATOMY", 82, 96]]], ["Primary virus replication occurs in muscle fibres at the site of bite from where the progeny virus gains access into the nerve fibres and migrates along the axoplasm centripetally.", [["muscle fibres", "ANATOMY", 36, 49], ["nerve fibres", "ANATOMY", 121, 133], ["axoplasm", "ANATOMY", 157, 165], ["muscle fibres", "TISSUE", 36, 49], ["nerve fibres", "TISSUE", 121, 133], ["axoplasm centripetally", "CELLULAR_COMPONENT", 157, 179], ["Primary virus replication", "TREATMENT", 0, 25], ["muscle fibres", "PROBLEM", 36, 49], ["virus replication", "OBSERVATION", 8, 25], ["muscle fibres", "OBSERVATION", 36, 49], ["nerve fibres", "ANATOMY", 121, 133], ["axoplasm centripetally", "OBSERVATION", 157, 179]]], ["Once in the neurone cell body virus replicates followed by centrifugal migration down the cranial nerves to the salivary gland where the virus replicates and is shed in saliva.", [["neurone cell body", "ANATOMY", 12, 29], ["cranial nerves", "ANATOMY", 90, 104], ["salivary gland", "ANATOMY", 112, 126], ["neurone cell body virus", "ORGANISM", 12, 35], ["cranial nerves", "MULTI-TISSUE_STRUCTURE", 90, 104], ["salivary gland", "ORGAN", 112, 126], ["saliva", "ORGANISM_SUBSTANCE", 169, 175], ["the virus", "PROBLEM", 133, 142], ["centrifugal migration", "OBSERVATION", 59, 80], ["cranial nerves", "ANATOMY", 90, 104], ["salivary gland", "ANATOMY", 112, 126], ["virus", "OBSERVATION", 137, 142]]], ["Rabies is an increasing threat to cats and dogs in endemic areas and the infection is almost always fatal after a paralytic and respiratory distress disease.", [["respiratory", "ANATOMY", 128, 139], ["Rabies", "DISEASE", 0, 6], ["infection", "DISEASE", 73, 82], ["respiratory distress disease", "DISEASE", 128, 156], ["Rabies", "ORGANISM", 0, 6], ["cats", "ORGANISM", 34, 38], ["cats", "SPECIES", 34, 38], ["dogs", "SPECIES", 43, 47], ["dogs in endemic areas", "PROBLEM", 43, 64], ["the infection", "PROBLEM", 69, 82], ["a paralytic", "PROBLEM", 112, 123], ["respiratory distress disease", "PROBLEM", 128, 156], ["increasing", "OBSERVATION_MODIFIER", 13, 23], ["endemic", "OBSERVATION_MODIFIER", 51, 58], ["infection", "OBSERVATION", 73, 82], ["paralytic", "OBSERVATION", 114, 123], ["respiratory distress", "OBSERVATION", 128, 148]]], ["In usual circumstances the only risk of rabies virus transmission is by the bite or scratch of a rabid animal, highly humid environment such as in bat caves the virus may be transmitted via aerosols as well.", [["rabies virus transmission", "DISEASE", 40, 65], ["rabies virus", "ORGANISM", 40, 52], ["rabies virus", "SPECIES", 40, 52], ["rabies virus transmission", "TREATMENT", 40, 65], ["the virus", "PROBLEM", 157, 166]]], ["The control of rabies in different regions of the world poses very different problems, depending on which reservoir hosts are present and the level of infection therein [9] .RetroviridaeThe family name derives from members possessing reverse transcriptase enzyme (RT).", [["rabies", "DISEASE", 15, 21], ["infection", "DISEASE", 151, 160], ["rabies", "ORGANISM", 15, 21], ["reverse transcriptase enzyme", "GENE_OR_GENE_PRODUCT", 234, 262], ["reverse transcriptase enzyme", "PROTEIN", 234, 262], ["RT", "PROTEIN", 264, 266], ["rabies", "SPECIES", 15, 21], ["very different problems", "PROBLEM", 62, 85], ["infection therein", "PROBLEM", 151, 168], ["different", "OBSERVATION_MODIFIER", 67, 76], ["problems", "OBSERVATION", 77, 85], ["infection", "OBSERVATION", 151, 160]]], ["The family is sub divided into 3 subfamilies: Oncovirinae, Lentivirinae and Spumavirinae.", [["Oncovirinae", "GENE_OR_GENE_PRODUCT", 46, 57], ["Spumavirinae", "GENE_OR_GENE_PRODUCT", 76, 88], ["Oncovirinae", "TREATMENT", 46, 57], ["Lentivirinae", "TREATMENT", 59, 71], ["Spumavirinae", "TREATMENT", 76, 88]]], ["Virus particles are enveloped covering an icosahedral capsid containing helical nucleocapsid.", [["Virus", "ORGANISM", 0, 5], ["icosahedral capsid", "PROTEIN", 42, 60], ["helical nucleocapsid", "PROTEIN", 72, 92], ["Virus particles", "PROBLEM", 0, 15], ["an icosahedral capsid containing helical nucleocapsid", "PROBLEM", 39, 92], ["icosahedral capsid", "OBSERVATION", 42, 60], ["helical nucleocapsid", "OBSERVATION", 72, 92]]], ["The genome comprises two copies of linear positive-sense, single-stranded RNA (+ssRNA) which is not infectious per se.", [["linear positive-sense, single-stranded RNA", "RNA", 35, 77], ["linear positive-sense", "PROBLEM", 35, 56], ["single-stranded RNA", "PROBLEM", 58, 77], ["ssRNA", "PROBLEM", 80, 85], ["linear", "OBSERVATION_MODIFIER", 35, 41], ["positive", "OBSERVATION", 42, 50], ["not", "UNCERTAINTY", 96, 99], ["infectious", "OBSERVATION_MODIFIER", 100, 110]]], ["The viral genome occurs as an inverted dimer held together at the 5 end by hydrogen bonds possibly through base paring.", [["hydrogen", "CHEMICAL", 75, 83], ["viral genome", "DNA", 4, 16], ["5 end", "DNA", 66, 71], ["The viral genome", "PROBLEM", 0, 16], ["an inverted dimer", "TREATMENT", 27, 44], ["viral genome", "OBSERVATION", 4, 16], ["hydrogen bonds", "OBSERVATION", 75, 89], ["base", "ANATOMY_MODIFIER", 107, 111]]], ["Retrovirus replication is unique among +ssRNA viruses because they first convert +ssRNA to \u2212DNA copy using the virion RT (RNA dependent DNA polymerase) and then a circular double-stranded (DS) DNA copy which is integrated into host cell chromosome by a second viral enzyme, a DNA ligase.", [["cell chromosome", "ANATOMY", 232, 247], ["DNA", "CELLULAR_COMPONENT", 92, 95], ["DNA", "CELLULAR_COMPONENT", 136, 139], ["DNA", "CELLULAR_COMPONENT", 193, 196], ["cell chromosome", "CELLULAR_COMPONENT", 232, 247], ["DNA", "CELLULAR_COMPONENT", 276, 279], ["virion RT", "DNA", 111, 120], ["RNA dependent DNA polymerase", "PROTEIN", 122, 150], ["circular double-stranded (DS) DNA copy", "DNA", 163, 201], ["host cell chromosome", "DNA", 227, 247], ["viral enzyme", "PROTEIN", 260, 272], ["DNA ligase", "PROTEIN", 276, 286], ["Retrovirus replication", "TREATMENT", 0, 22], ["ssRNA viruses", "PROBLEM", 40, 53], ["ssRNA", "PROBLEM", 82, 87], ["the virion RT (RNA dependent DNA polymerase", "TREATMENT", 107, 150], ["a circular double-stranded (DS) DNA copy", "TREATMENT", 161, 201], ["a second viral enzyme", "TEST", 251, 272], ["a DNA ligase", "TEST", 274, 286], ["ssRNA viruses", "OBSERVATION", 40, 53], ["host cell chromosome", "OBSERVATION", 227, 247]]], ["The integrated DS DNA then codes for new +ssRNAs which then serve as new genomes or messenger RNAs.", [["DNA", "CELLULAR_COMPONENT", 18, 21], ["DS DNA", "DNA", 15, 21], ["messenger RNAs", "RNA", 84, 98], ["new +ssRNAs", "PROBLEM", 37, 48], ["messenger RNAs", "OBSERVATION", 84, 98]]], ["The later stage of viral replication is catalysed using cellular enzymes and organelles.RetroviridaeIn companion animals Feline leukaemia virus (FeLV) in subfamily Oncovirinae and feline immunodeficiency virus (FIV) in subfamily Lentivirinae cause significant diseases in cats.", [["cellular", "ANATOMY", 56, 64], ["organelles", "ANATOMY", 77, 87], ["Feline leukaemia virus", "DISEASE", 121, 143], ["feline immunodeficiency virus", "DISEASE", 180, 209], ["cellular", "CELL", 56, 64], ["organelles", "CELLULAR_COMPONENT", 77, 87], ["RetroviridaeIn companion animals", "ORGANISM", 88, 120], ["Feline leukaemia virus", "ORGANISM", 121, 143], ["FeLV", "ORGANISM", 145, 149], ["subfamily Oncovirinae", "ORGANISM", 154, 175], ["feline immunodeficiency virus", "ORGANISM", 180, 209], ["FIV", "ORGANISM", 211, 214], ["subfamily Lentivirinae", "ORGANISM", 219, 241], ["cats", "ORGANISM", 272, 276], ["cellular enzymes", "PROTEIN", 56, 72], ["Feline leukaemia virus", "SPECIES", 121, 143], ["feline immunodeficiency virus", "SPECIES", 180, 209], ["cats", "SPECIES", 272, 276], ["Feline leukaemia virus", "SPECIES", 121, 143], ["FeLV", "SPECIES", 145, 149], ["feline immunodeficiency virus", "SPECIES", 180, 209], ["FIV", "SPECIES", 211, 214], ["viral replication", "PROBLEM", 19, 36], ["cellular enzymes", "TEST", 56, 72], ["Feline leukaemia virus (FeLV)", "PROBLEM", 121, 150], ["Oncovirinae", "TREATMENT", 164, 175], ["feline immunodeficiency virus", "PROBLEM", 180, 209], ["significant diseases in cats", "PROBLEM", 248, 276], ["viral replication", "OBSERVATION", 19, 36], ["leukaemia virus", "OBSERVATION", 128, 143], ["significant", "OBSERVATION_MODIFIER", 248, 259], ["diseases", "OBSERVATION", 260, 268]]], ["However in dogs and rabbits retroviruses are not significant pathogens.", [["dogs", "ORGANISM", 11, 15], ["rabbits retroviruses", "ORGANISM", 20, 40], ["dogs", "SPECIES", 11, 15], ["rabbits", "SPECIES", 20, 27], ["rabbits", "SPECIES", 20, 27], ["significant pathogens", "PROBLEM", 49, 70], ["not", "UNCERTAINTY", 45, 48], ["significant", "OBSERVATION_MODIFIER", 49, 60], ["pathogens", "OBSERVATION", 61, 70]]], ["FeLV is a leading killer of cats causing lymphosarcoma and leukaemia which are the most important and common tumours of cats.", [["killer", "ANATOMY", 18, 24], ["lymphosarcoma", "ANATOMY", 41, 54], ["leukaemia", "ANATOMY", 59, 68], ["tumours", "ANATOMY", 109, 116], ["FeLV", "DISEASE", 0, 4], ["lymphosarcoma", "DISEASE", 41, 54], ["leukaemia", "DISEASE", 59, 68], ["FeLV", "ORGANISM", 0, 4], ["cats", "ORGANISM", 28, 32], ["lymphosarcoma", "CANCER", 41, 54], ["leukaemia", "CANCER", 59, 68], ["tumours", "CANCER", 109, 116], ["cats", "ORGANISM", 120, 124], ["cats", "SPECIES", 28, 32], ["cats", "SPECIES", 120, 124], ["FeLV", "SPECIES", 0, 4], ["FeLV", "PROBLEM", 0, 4], ["lymphosarcoma", "PROBLEM", 41, 54], ["leukaemia", "PROBLEM", 59, 68], ["lymphosarcoma", "OBSERVATION", 41, 54], ["leukaemia", "OBSERVATION", 59, 68]]], ["Cats become infected through close contact with other infected cats and ingestion of or contamination from licking of wounds by infectious saliva during mutual grooming.", [["wounds", "ANATOMY", 118, 124], ["wounds", "DISEASE", 118, 124], ["cats", "ORGANISM", 63, 67], ["wounds", "PATHOLOGICAL_FORMATION", 118, 124], ["saliva", "ORGANISM_SUBSTANCE", 139, 145], ["cats", "SPECIES", 63, 67], ["infected", "PROBLEM", 12, 20], ["other infected cats", "PROBLEM", 48, 67], ["licking of wounds", "PROBLEM", 107, 124], ["infectious saliva", "PROBLEM", 128, 145], ["infected", "OBSERVATION", 12, 20], ["wounds", "OBSERVATION", 118, 124], ["infectious", "OBSERVATION", 128, 138]]], ["Virus replicates in oropharynx and/or leukocytes followed by viraemia due to infected leukocytes (B cells, monocytes and macrophages) which disseminate the virus to bone marrow, thymus, salivary glands and reproductive organs.", [["oropharynx", "ANATOMY", 20, 30], ["leukocytes", "ANATOMY", 38, 48], ["leukocytes", "ANATOMY", 86, 96], ["B cells", "ANATOMY", 98, 105], ["monocytes", "ANATOMY", 107, 116], ["macrophages", "ANATOMY", 121, 132], ["bone marrow", "ANATOMY", 165, 176], ["thymus", "ANATOMY", 178, 184], ["salivary glands", "ANATOMY", 186, 201], ["reproductive organs", "ANATOMY", 206, 225], ["viraemia", "DISEASE", 61, 69], ["Virus", "ORGANISM", 0, 5], ["oropharynx", "ORGAN", 20, 30], ["leukocytes", "CELL", 38, 48], ["leukocytes", "CELL", 86, 96], ["B cells", "CELL", 98, 105], ["monocytes", "CELL", 107, 116], ["macrophages", "CELL", 121, 132], ["bone marrow", "MULTI-TISSUE_STRUCTURE", 165, 176], ["thymus", "ORGAN", 178, 184], ["salivary glands", "ORGAN", 186, 201], ["reproductive organs", "MULTI-TISSUE_STRUCTURE", 206, 225], ["leukocytes", "CELL_TYPE", 38, 48], ["infected leukocytes", "CELL_TYPE", 77, 96], ["B cells", "CELL_TYPE", 98, 105], ["monocytes", "CELL_TYPE", 107, 116], ["macrophages", "CELL_TYPE", 121, 132], ["Virus replicates in oropharynx", "PROBLEM", 0, 30], ["leukocytes", "PROBLEM", 38, 48], ["viraemia", "PROBLEM", 61, 69], ["infected leukocytes", "PROBLEM", 77, 96], ["B cells", "TEST", 98, 105], ["monocytes", "TEST", 107, 116], ["macrophages", "TEST", 121, 132], ["the virus to bone marrow", "TEST", 152, 176], ["oropharynx", "ANATOMY", 20, 30], ["leukocytes", "ANATOMY", 38, 48], ["viraemia", "OBSERVATION", 61, 69], ["infected leukocytes", "OBSERVATION", 77, 96], ["macrophages", "ANATOMY", 121, 132], ["bone marrow", "ANATOMY", 165, 176], ["thymus", "ANATOMY", 178, 184], ["salivary glands", "ANATOMY", 186, 201]]], ["In the majority of cats FeLV causes a self limiting infection.", [["FeLV", "DISEASE", 24, 28], ["infection", "DISEASE", 52, 61], ["cats", "ORGANISM", 19, 23], ["FeLV", "ORGANISM", 24, 28], ["cats", "SPECIES", 19, 23], ["a self limiting infection", "PROBLEM", 36, 61], ["cats FeLV", "OBSERVATION", 19, 28], ["self limiting", "OBSERVATION_MODIFIER", 38, 51], ["infection", "OBSERVATION", 52, 61]]], ["But in some 30% of infected cats a persistent infection remains depending on age.", [["infection", "DISEASE", 46, 55], ["cats", "ORGANISM", 28, 32], ["cats", "SPECIES", 28, 32], ["infected cats", "PROBLEM", 19, 32], ["a persistent infection", "PROBLEM", 33, 55], ["infected", "OBSERVATION", 19, 27], ["persistent", "OBSERVATION_MODIFIER", 35, 45], ["infection", "OBSERVATION", 46, 55]]], ["They remain non-viraemic with neutralising and Feline Oncovirus Membrane Associated (FOCMA) antibodies.", [["Feline", "ORGANISM", 47, 53], ["Feline Oncovirus Membrane Associated (FOCMA) antibodies", "PROTEIN", 47, 102], ["non-viraemic", "PROBLEM", 12, 24], ["neutralising and Feline Oncovirus Membrane Associated (FOCMA) antibodies", "PROBLEM", 30, 102]]], ["They do not shed virus and do not develop leukaemia.", [["leukaemia", "ANATOMY", 42, 51], ["leukaemia", "DISEASE", 42, 51], ["leukaemia", "CANCER", 42, 51], ["leukaemia", "PROBLEM", 42, 51], ["leukaemia", "OBSERVATION", 42, 51]]], ["However, in some cats, a persistent viremia is accompanied with high FOCMA specific antibodies.", [["viremia", "DISEASE", 36, 43], ["cats", "ORGANISM", 17, 21], ["FOCMA specific antibodies", "PROTEIN", 69, 94], ["cats", "SPECIES", 17, 21], ["a persistent viremia", "PROBLEM", 23, 43], ["high FOCMA specific antibodies", "PROBLEM", 64, 94], ["persistent", "OBSERVATION_MODIFIER", 25, 35], ["viremia", "OBSERVATION", 36, 43]]], ["These cats develop neutralising antibodies and become healthy or the FOCMA antibodies decline and the cats develop leukaemia.", [["leukaemia", "ANATOMY", 115, 124], ["leukaemia", "DISEASE", 115, 124], ["cats", "ORGANISM", 6, 10], ["cats", "ORGANISM", 102, 106], ["leukaemia", "CANCER", 115, 124], ["neutralising antibodies", "PROTEIN", 19, 42], ["FOCMA antibodies", "PROTEIN", 69, 85], ["cats", "SPECIES", 6, 10], ["cats", "SPECIES", 102, 106], ["neutralising antibodies", "PROBLEM", 19, 42], ["the FOCMA antibodies decline", "PROBLEM", 65, 93], ["leukaemia", "PROBLEM", 115, 124], ["leukaemia", "OBSERVATION", 115, 124]]], ["Persistently infected cats are the source of disease spread.", [["cats", "ORGANISM", 22, 26], ["cats", "SPECIES", 22, 26], ["Persistently infected cats", "PROBLEM", 0, 26], ["disease spread", "PROBLEM", 45, 59], ["infected", "OBSERVATION_MODIFIER", 13, 21], ["cats", "OBSERVATION", 22, 26], ["disease", "OBSERVATION", 45, 52]]], ["The virus is immune suppressive in those cats upon infection of T and B lymphocytes and myeloid cells.", [["T", "ANATOMY", 64, 65], ["B lymphocytes", "ANATOMY", 70, 83], ["myeloid cells", "ANATOMY", 88, 101], ["infection", "DISEASE", 51, 60], ["cats", "ORGANISM", 41, 45], ["T", "CELL", 64, 65], ["B lymphocytes", "CELL", 70, 83], ["myeloid cells", "CELL", 88, 101], ["T and B lymphocytes", "CELL_TYPE", 64, 83], ["myeloid cells", "CELL_TYPE", 88, 101], ["cats", "SPECIES", 41, 45], ["The virus", "PROBLEM", 0, 9], ["immune suppressive", "PROBLEM", 13, 31], ["infection of T and B lymphocytes", "PROBLEM", 51, 83], ["myeloid cells", "PROBLEM", 88, 101], ["virus", "OBSERVATION", 4, 9], ["immune", "OBSERVATION_MODIFIER", 13, 19], ["suppressive", "OBSERVATION_MODIFIER", 20, 31], ["infection", "OBSERVATION", 51, 60], ["lymphocytes", "ANATOMY", 72, 83], ["myeloid cells", "OBSERVATION", 88, 101]]], ["This is manifest as lymphoid or myeloid leukaemia with increased blood count of lymphoblasts or myeloblasts, respectively, and lymphosarcoma.", [["lymphoid", "ANATOMY", 20, 28], ["myeloid leukaemia", "ANATOMY", 32, 49], ["blood", "ANATOMY", 65, 70], ["lymphoblasts", "ANATOMY", 80, 92], ["myeloblasts", "ANATOMY", 96, 107], ["lymphosarcoma", "ANATOMY", 127, 140], ["lymphoid or myeloid leukaemia", "DISEASE", 20, 49], ["lymphosarcoma", "DISEASE", 127, 140], ["lymphoid", "CELL", 20, 28], ["myeloid leukaemia", "CANCER", 32, 49], ["blood", "ORGANISM_SUBSTANCE", 65, 70], ["lymphoblasts", "CELL", 80, 92], ["myeloblasts", "CELL", 96, 107], ["lymphosarcoma", "CANCER", 127, 140], ["lymphoblasts", "CELL_TYPE", 80, 92], ["myeloblasts", "CELL_TYPE", 96, 107], ["myeloid leukaemia", "PROBLEM", 32, 49], ["increased blood count of lymphoblasts", "PROBLEM", 55, 92], ["myeloblasts", "PROBLEM", 96, 107], ["lymphosarcoma", "PROBLEM", 127, 140], ["lymphoid", "ANATOMY", 20, 28], ["myeloid leukaemia", "OBSERVATION", 32, 49], ["increased", "OBSERVATION_MODIFIER", 55, 64], ["blood count", "OBSERVATION", 65, 76], ["lymphoblasts", "OBSERVATION", 80, 92], ["myeloblasts", "OBSERVATION", 96, 107], ["lymphosarcoma", "OBSERVATION", 127, 140]]], ["On the other hand infection may also lead to severe immunodeficiency without lymphosarcoma development.", [["lymphosarcoma", "ANATOMY", 77, 90], ["infection", "DISEASE", 18, 27], ["immunodeficiency", "DISEASE", 52, 68], ["lymphosarcoma", "DISEASE", 77, 90], ["lymphosarcoma", "CANCER", 77, 90], ["the other hand infection", "PROBLEM", 3, 27], ["severe immunodeficiency", "PROBLEM", 45, 68], ["lymphosarcoma development", "PROBLEM", 77, 102], ["infection", "OBSERVATION", 18, 27], ["severe", "OBSERVATION_MODIFIER", 45, 51], ["immunodeficiency", "OBSERVATION", 52, 68], ["without", "UNCERTAINTY", 69, 76], ["lymphosarcoma", "OBSERVATION", 77, 90]]], ["Although the viral genome has been demonstrated in the tumours, the virus itself can be rarely isolated from such tumours.", [["tumours", "ANATOMY", 55, 62], ["tumours", "ANATOMY", 114, 121], ["tumours", "CANCER", 55, 62], ["tumours", "CANCER", 114, 121], ["viral genome", "DNA", 13, 25], ["the viral genome", "PROBLEM", 9, 25], ["the virus", "PROBLEM", 64, 73], ["viral genome", "OBSERVATION", 13, 25], ["tumours", "OBSERVATION", 55, 62], ["virus", "OBSERVATION", 68, 73], ["tumours", "OBSERVATION", 114, 121]]], ["Generalised B cell tumours of lymph nodes (known as multicentric lymphosarcoma), thymic and alimentary lymphosarcomas have been observed in FeLV infected cats.", [["B cell tumours", "ANATOMY", 12, 26], ["lymph nodes", "ANATOMY", 30, 41], ["multicentric lymphosarcoma", "ANATOMY", 52, 78], ["thymic", "ANATOMY", 81, 87], ["alimentary lymphosarcomas", "ANATOMY", 92, 117], ["lymphosarcoma", "DISEASE", 65, 78], ["thymic and alimentary lymphosarcomas", "DISEASE", 81, 117], ["FeLV infected", "DISEASE", 140, 153], ["B cell tumours", "CANCER", 12, 26], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 30, 41], ["lymphosarcoma", "CANCER", 65, 78], ["thymic", "CANCER", 81, 87], ["alimentary lymphosarcomas", "CANCER", 92, 117], ["FeLV", "ORGANISM", 140, 144], ["cats", "ORGANISM", 154, 158], ["cats", "SPECIES", 154, 158], ["Generalised B cell tumours of lymph nodes", "PROBLEM", 0, 41], ["multicentric lymphosarcoma", "PROBLEM", 52, 78], ["thymic and alimentary lymphosarcomas", "PROBLEM", 81, 117], ["B cell tumours", "OBSERVATION", 12, 26], ["lymph nodes", "OBSERVATION", 30, 41], ["multicentric", "OBSERVATION_MODIFIER", 52, 64], ["lymphosarcoma", "OBSERVATION", 65, 78], ["thymic", "ANATOMY", 81, 87], ["alimentary lymphosarcomas", "OBSERVATION", 92, 117], ["FeLV", "OBSERVATION_MODIFIER", 140, 144], ["infected cats", "OBSERVATION", 145, 158]]], ["In the thymic form there is marked T cell hyperplasia enlarging thymus which eventually fills most of the thoracic cavity causing dyspnoea.", [["thymic", "ANATOMY", 7, 13], ["T cell", "ANATOMY", 35, 41], ["thymus", "ANATOMY", 64, 70], ["thoracic cavity", "ANATOMY", 106, 121], ["dyspnoea", "DISEASE", 130, 138], ["thymic", "ORGAN", 7, 13], ["T cell", "CELL", 35, 41], ["thymus", "ORGAN", 64, 70], ["thoracic cavity", "ORGAN", 106, 121], ["marked T cell hyperplasia enlarging thymus", "PROBLEM", 28, 70], ["dyspnoea", "PROBLEM", 130, 138], ["thymic", "ANATOMY", 7, 13], ["marked", "OBSERVATION_MODIFIER", 28, 34], ["T cell hyperplasia", "OBSERVATION", 35, 53], ["enlarging", "OBSERVATION_MODIFIER", 54, 63], ["thymus", "OBSERVATION", 64, 70], ["thoracic cavity", "ANATOMY", 106, 121], ["dyspnoea", "OBSERVATION", 130, 138]]], ["In the alimentary form B cell tumours develop in the wall of the intestine.", [["alimentary form B cell tumours", "ANATOMY", 7, 37], ["wall", "ANATOMY", 53, 57], ["intestine", "ANATOMY", 65, 74], ["B cell tumours", "CANCER", 23, 37], ["wall", "TISSUE", 53, 57], ["intestine", "ORGAN", 65, 74], ["B cell tumours", "PROBLEM", 23, 37], ["cell tumours", "OBSERVATION", 25, 37], ["wall", "ANATOMY_MODIFIER", 53, 57], ["intestine", "ANATOMY", 65, 74]]], ["These FeLV induced neoplasms may also result in haemolytic or hypoplastic anaemia, immunosuppression and reproductive failure.", [["neoplasms", "ANATOMY", 19, 28], ["FeLV", "DISEASE", 6, 10], ["neoplasms", "DISEASE", 19, 28], ["hypoplastic anaemia", "DISEASE", 62, 81], ["immunosuppression", "DISEASE", 83, 100], ["reproductive failure", "DISEASE", 105, 125], ["FeLV", "ORGANISM", 6, 10], ["neoplasms", "CANCER", 19, 28], ["These FeLV induced neoplasms", "PROBLEM", 0, 28], ["haemolytic", "PROBLEM", 48, 58], ["hypoplastic anaemia", "PROBLEM", 62, 81], ["immunosuppression", "TREATMENT", 83, 100], ["reproductive failure", "PROBLEM", 105, 125], ["FeLV", "OBSERVATION", 6, 10], ["neoplasms", "OBSERVATION", 19, 28], ["may also result in", "UNCERTAINTY", 29, 47], ["haemolytic", "OBSERVATION_MODIFIER", 48, 58], ["hypoplastic", "OBSERVATION_MODIFIER", 62, 73], ["anaemia", "OBSERVATION", 74, 81], ["reproductive failure", "OBSERVATION", 105, 125]]], ["Infection of placenta followed by transplacental infection of foetus may result in foetal death.RetroviridaeFIV is found worldwide in domestic cats and wild felids namely snow leopards, lions, tigers, jaguars and bobcats.", [["placenta", "ANATOMY", 13, 21], ["foetus", "ANATOMY", 62, 68], ["foetal", "ANATOMY", 83, 89], ["transplacental infection", "DISEASE", 34, 58], ["foetal death", "DISEASE", 83, 95], ["RetroviridaeFIV", "CHEMICAL", 96, 111], ["placenta", "ORGAN", 13, 21], ["foetus", "ORGANISM", 62, 68], ["foetal", "ORGANISM_SUBDIVISION", 83, 89], ["RetroviridaeFIV", "GENE_OR_GENE_PRODUCT", 96, 111], ["cats", "ORGANISM", 143, 147], ["cats", "SPECIES", 143, 147], ["RetroviridaeFIV", "SPECIES", 96, 111], ["Infection of placenta", "PROBLEM", 0, 21], ["transplacental infection of foetus", "PROBLEM", 34, 68], ["foetal death", "PROBLEM", 83, 95], ["placenta", "ANATOMY", 13, 21], ["infection", "OBSERVATION", 49, 58], ["worldwide", "OBSERVATION_MODIFIER", 121, 130]]], ["FIV infection in cats has three stages, just like HIV infection in humans.", [["FIV infection", "DISEASE", 0, 13], ["HIV infection", "DISEASE", 50, 63], ["FIV", "ORGANISM", 0, 3], ["cats", "ORGANISM", 17, 21], ["HIV", "ORGANISM", 50, 53], ["humans", "ORGANISM", 67, 73], ["cats", "SPECIES", 17, 21], ["HIV", "SPECIES", 50, 53], ["humans", "SPECIES", 67, 73], ["FIV", "SPECIES", 0, 3], ["HIV", "SPECIES", 50, 53], ["humans", "SPECIES", 67, 73], ["FIV infection in cats", "PROBLEM", 0, 21], ["HIV infection in humans", "PROBLEM", 50, 73], ["infection", "OBSERVATION", 4, 13], ["three stages", "OBSERVATION_MODIFIER", 26, 38], ["HIV", "OBSERVATION_MODIFIER", 50, 53], ["infection", "OBSERVATION", 54, 63]]], ["The initial acute stage is characterised by fever, swollen lymph nodes, oral, respiratory, eye and intestinal symptoms which may be recurrent or chronic in occurrence.", [["lymph nodes", "ANATOMY", 59, 70], ["oral", "ANATOMY", 72, 76], ["respiratory", "ANATOMY", 78, 89], ["eye", "ANATOMY", 91, 94], ["intestinal", "ANATOMY", 99, 109], ["fever", "DISEASE", 44, 49], ["oral, respiratory, eye and intestinal symptoms", "DISEASE", 72, 118], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 59, 70], ["oral", "ORGANISM_SUBDIVISION", 72, 76], ["eye", "ORGAN", 91, 94], ["intestinal", "ORGAN", 99, 109], ["fever", "PROBLEM", 44, 49], ["swollen lymph nodes", "PROBLEM", 51, 70], ["oral, respiratory, eye and intestinal symptoms", "PROBLEM", 72, 118], ["acute", "OBSERVATION_MODIFIER", 12, 17], ["fever", "OBSERVATION", 44, 49], ["swollen", "OBSERVATION_MODIFIER", 51, 58], ["lymph nodes", "OBSERVATION", 59, 70], ["respiratory", "ANATOMY", 78, 89], ["eye", "ANATOMY", 91, 94], ["intestinal", "ANATOMY", 99, 109], ["symptoms", "OBSERVATION", 110, 118], ["may be", "UNCERTAINTY", 125, 131], ["recurrent", "OBSERVATION_MODIFIER", 132, 141], ["chronic", "OBSERVATION_MODIFIER", 145, 152]]], ["Affected cats may have nasal and eye discharge, cloudy cornea and diarrhoea.", [["nasal", "ANATOMY", 23, 28], ["eye", "ANATOMY", 33, 36], ["cornea", "ANATOMY", 55, 61], ["nasal and eye discharge", "DISEASE", 23, 46], ["diarrhoea", "DISEASE", 66, 75], ["cats", "ORGANISM", 9, 13], ["nasal", "ORGANISM_SUBDIVISION", 23, 28], ["eye", "ORGAN", 33, 36], ["cornea", "MULTI-TISSUE_STRUCTURE", 55, 61], ["cats", "SPECIES", 9, 13], ["Affected cats", "PROBLEM", 0, 13], ["nasal and eye discharge", "PROBLEM", 23, 46], ["cloudy cornea", "PROBLEM", 48, 61], ["diarrhoea", "PROBLEM", 66, 75], ["nasal", "ANATOMY", 23, 28], ["eye", "ANATOMY", 33, 36], ["discharge", "OBSERVATION", 37, 46], ["cloudy cornea", "OBSERVATION", 48, 61], ["diarrhoea", "OBSERVATION", 66, 75]]], ["In the second latent stage, often lasting many years the immune system is slowly destroyed leading to immunodeficiency followed by the third AIDS-like stage.", [["immune system", "ANATOMY", 57, 70], ["immunodeficiency", "DISEASE", 102, 118], ["AIDS", "DISEASE", 141, 145], ["immunodeficiency", "PROBLEM", 102, 118], ["the third AIDS", "PROBLEM", 131, 145], ["second", "OBSERVATION_MODIFIER", 7, 13], ["latent", "OBSERVATION_MODIFIER", 14, 20], ["stage", "OBSERVATION_MODIFIER", 21, 26]]], ["Feline immunodeficiency virus is shed mainly in the saliva and the principal mode of transmission is through bites.", [["saliva", "ANATOMY", 52, 58], ["Feline immunodeficiency virus", "DISEASE", 0, 29], ["Feline immunodeficiency virus", "ORGANISM", 0, 29], ["saliva", "ORGANISM_SUBSTANCE", 52, 58], ["Feline immunodeficiency virus", "SPECIES", 0, 29], ["Feline immunodeficiency virus", "SPECIES", 0, 29], ["Feline immunodeficiency virus", "PROBLEM", 0, 29], ["immunodeficiency virus", "OBSERVATION", 7, 29]]], ["In this perspective free-roaming animals are at the greatest risk of infection and hence FIV is uncommon in closed catteries.", [["infection", "DISEASE", 69, 78], ["FIV", "DISEASE", 89, 92], ["animals", "ORGANISM", 33, 40], ["FIV", "ORGANISM", 89, 92], ["FIV", "SPECIES", 89, 92], ["infection", "PROBLEM", 69, 78], ["infection", "OBSERVATION", 69, 78]]], ["Sexual contact does not appear to be a significant mode of transmission although the virus may be shed in semen.", [["semen", "ANATOMY", 106, 111], ["semen", "ORGANISM_SUBSTANCE", 106, 111], ["the virus", "PROBLEM", 81, 90], ["virus", "OBSERVATION", 85, 90]]], ["The virus is transmitted to kittens from acutely infected queens through colostrum and milk [9] .Emergent and potential virus diseasesAn important event in companion animal viral disease ecology has been the jump by contemporary strains of equine influenza H3N8 virus (Orthomyxovirus) to racing dogs first recognised during an outbreak of respiratory disease in racing greyhounds at a kennel in Florida in January 2004 [84] .", [["colostrum", "ANATOMY", 73, 82], ["milk", "ANATOMY", 87, 91], ["respiratory", "ANATOMY", 339, 350], ["viral disease", "DISEASE", 173, 186], ["influenza H3N8 virus", "DISEASE", 247, 267], ["respiratory disease", "DISEASE", 339, 358], ["kittens", "ORGANISM", 28, 35], ["colostrum", "ORGANISM_SUBSTANCE", 73, 82], ["milk", "ORGANISM_SUBSTANCE", 87, 91], ["equine influenza H3N8 virus", "ORGANISM", 240, 267], ["Orthomyxovirus", "CANCER", 269, 283], ["dogs", "ORGANISM", 295, 299], ["colostrum", "SPECIES", 73, 82], ["equine influenza H3N8 virus", "SPECIES", 240, 267], ["dogs", "SPECIES", 295, 299], ["equine influenza H3N8 virus", "SPECIES", 240, 267], ["The virus", "PROBLEM", 0, 9], ["potential virus diseases", "PROBLEM", 110, 134], ["animal viral disease ecology", "PROBLEM", 166, 194], ["equine influenza H3N8 virus", "PROBLEM", 240, 267], ["respiratory disease", "PROBLEM", 339, 358], ["virus", "OBSERVATION", 4, 9], ["acutely", "OBSERVATION_MODIFIER", 41, 48], ["infected", "OBSERVATION", 49, 57], ["potential", "UNCERTAINTY", 110, 119], ["virus diseases", "OBSERVATION", 120, 134], ["viral disease", "OBSERVATION", 173, 186], ["respiratory disease", "OBSERVATION", 339, 358]]], ["In this outbreak 8 greyhounds died of haemorrhagic pneumonia while 14 remaining dogs had a milder illness manifest initially as fever and then coughing for 10-14 days.", [["pneumonia", "DISEASE", 51, 60], ["illness", "DISEASE", 98, 105], ["fever", "DISEASE", 128, 133], ["coughing", "DISEASE", 143, 151], ["dogs", "ORGANISM", 80, 84], ["dogs", "SPECIES", 80, 84], ["haemorrhagic pneumonia", "PROBLEM", 38, 60], ["a milder illness", "PROBLEM", 89, 105], ["fever", "PROBLEM", 128, 133], ["coughing", "PROBLEM", 143, 151], ["haemorrhagic", "OBSERVATION_MODIFIER", 38, 50], ["pneumonia", "OBSERVATION", 51, 60]]], ["A variety of tests including genetic sequence analysis and phylogenetic comparisons led to the conclusion that all three canine flu virus isolates from January 2004 outbreak had evolved from equine influenza H3N8 virus and formed a single phylogenetic cluster.", [["influenza H3N8 virus", "DISEASE", 198, 218], ["canine flu virus", "ORGANISM", 121, 137], ["equine influenza H3N8 virus", "ORGANISM", 191, 218], ["canine flu virus", "SPECIES", 121, 137], ["equine influenza H3N8 virus", "SPECIES", 191, 218], ["canine flu virus", "SPECIES", 121, 137], ["equine influenza H3N8 virus", "SPECIES", 191, 218], ["A variety of tests", "TEST", 0, 18], ["genetic sequence analysis", "TEST", 29, 54], ["phylogenetic comparisons", "TEST", 59, 83], ["all three canine flu virus isolates", "PROBLEM", 111, 146], ["equine influenza H3N8 virus", "PROBLEM", 191, 218]]], ["The prototype strain was then named A/canine/Florida/43/2004 (canine/FL/04).These authors also concluded that the entire (all eight RNA segments) of the horse virus had been transmitted to the dog.", [["canine", "ORGANISM", 38, 44], ["43/2004", "ORGANISM", 53, 60], ["canine", "ORGANISM", 62, 68], ["horse virus", "ORGANISM", 153, 164], ["dog", "ORGANISM", 193, 196], ["horse", "SPECIES", 153, 158], ["dog", "SPECIES", 193, 196], ["A/canine/Florida/43/2004 (canine/FL/04", "SPECIES", 36, 74], ["horse virus", "SPECIES", 153, 164], ["The prototype strain", "PROBLEM", 0, 20], ["the horse virus", "PROBLEM", 149, 164]]], ["This may have been neither the first nor the last episode of the disease.", [["the disease", "PROBLEM", 61, 72], ["disease", "OBSERVATION", 65, 72]]], ["Tests on archival dog sera and lung tissue and dog sera collected in early 2005 from various states of USA indicate occurrence of canine H3N8 influenza virus prior to and after the 2004 outbreak [84] .", [["sera", "ANATOMY", 22, 26], ["lung tissue", "ANATOMY", 31, 42], ["sera", "ANATOMY", 51, 55], ["influenza virus", "DISEASE", 142, 157], ["dog", "ORGANISM", 18, 21], ["sera", "ORGANISM_SUBSTANCE", 22, 26], ["lung tissue", "TISSUE", 31, 42], ["dog", "ORGANISM", 47, 50], ["sera", "ORGANISM_SUBSTANCE", 51, 55], ["canine H3N8 influenza virus", "ORGANISM", 130, 157], ["dog", "SPECIES", 18, 21], ["dog", "SPECIES", 47, 50], ["canine H3N8 influenza virus", "SPECIES", 130, 157], ["dog", "SPECIES", 18, 21], ["dog", "SPECIES", 47, 50], ["canine H3N8 influenza virus", "SPECIES", 130, 157], ["Tests", "TEST", 0, 5], ["archival dog sera", "TEST", 9, 26], ["lung tissue", "TEST", 31, 42], ["dog sera", "TEST", 47, 55], ["canine H3N8 influenza virus", "PROBLEM", 130, 157], ["lung", "ANATOMY", 31, 35]]], ["These authors also provide evidence of the virus's transmissibility to pet dogs and the data suggest virus transmission by virus aerosol.", [["dogs", "SPECIES", 75, 79], ["the virus's transmissibility", "PROBLEM", 39, 67], ["pet dogs", "TEST", 71, 79], ["the data", "TEST", 84, 92], ["virus transmission", "TREATMENT", 101, 119], ["virus aerosol", "TREATMENT", 123, 136]]], ["Occurrence of an isolated case of canine H3N8 flu virus in the UK was identified by serology [85] .", [["canine", "ORGANISM", 34, 40], ["H3N8 flu virus", "ORGANISM", 41, 55], ["UK", "GENE_OR_GENE_PRODUCT", 63, 65], ["canine H3N8 flu virus", "SPECIES", 34, 55], ["canine H3N8 flu virus", "SPECIES", 34, 55], ["canine H3N8 flu virus", "PROBLEM", 34, 55], ["serology", "TEST", 84, 92]]], ["One important factor in interspecies transmission of any virus including influenza viruses is the presence of appropriate viral receptors in the respiratory tract epithelial cells of the novel host.", [["respiratory tract epithelial cells", "ANATOMY", 145, 179], ["influenza viruses", "DISEASE", 73, 90], ["influenza viruses", "ORGANISM", 73, 90], ["respiratory tract epithelial cells", "CELL", 145, 179], ["viral receptors", "PROTEIN", 122, 137], ["respiratory tract epithelial cells", "CELL_TYPE", 145, 179], ["any virus", "PROBLEM", 53, 62], ["influenza viruses", "PROBLEM", 73, 90], ["appropriate viral receptors", "PROBLEM", 110, 137], ["viral receptors", "OBSERVATION", 122, 137], ["respiratory tract", "ANATOMY", 145, 162], ["epithelial cells", "OBSERVATION", 163, 179]]], ["The equine influenza haemagglutinin recognises \u24232,3 sialic acid linkages.", [["\u24232,3 sialic acid", "CHEMICAL", 47, 63], ["\u24232,3 sialic acid", "CHEMICAL", 47, 63], ["equine influenza haemagglutinin", "ORGANISM", 4, 35], ["\u24232,3 sialic acid", "SIMPLE_CHEMICAL", 47, 63], ["equine influenza haemagglutinin", "SPECIES", 4, 35], ["equine influenza haemagglutinin", "SPECIES", 4, 35], ["The equine influenza haemagglutinin recognises", "TEST", 0, 46]]], ["Of concern would be if the new H3N8 dog flu virus became more widespread in dog populations and if it jumped to cats.", [["H3N8", "ORGANISM", 31, 35], ["dog flu virus", "ORGANISM", 36, 49], ["dog", "ORGANISM", 76, 79], ["cats", "ORGANISM", 112, 116], ["dog flu virus", "SPECIES", 36, 49], ["dog", "SPECIES", 76, 79], ["cats", "SPECIES", 112, 116], ["H3N8 dog flu virus", "SPECIES", 31, 49], ["dog", "SPECIES", 76, 79], ["the new H3N8 dog flu virus", "PROBLEM", 23, 49]]], ["The dog is also susceptible to highly pathogenic avian influenza (HPAI) virus of H5N1 subtype [86, 87] and the virus was the cause of fatal dog infection in Thailand [88, 86] .", [["avian influenza", "DISEASE", 49, 64], ["HPAI", "DISEASE", 66, 70], ["H5N1", "DISEASE", 81, 85], ["dog infection", "DISEASE", 140, 153], ["dog", "ORGANISM", 4, 7], ["avian influenza (HPAI) virus", "ORGANISM", 49, 77], ["H5N1 subtype", "ORGANISM", 81, 93], ["dog", "ORGANISM", 140, 143], ["dog", "SPECIES", 4, 7], ["avian influenza (HPAI", "SPECIES", 49, 70], ["dog", "SPECIES", 140, 143], ["HPAI", "SPECIES", 66, 70], ["dog", "SPECIES", 140, 143], ["highly pathogenic avian influenza (HPAI) virus of H5N1 subtype", "PROBLEM", 31, 93], ["the virus", "PROBLEM", 107, 116], ["fatal dog infection", "PROBLEM", 134, 153], ["fatal", "OBSERVATION_MODIFIER", 134, 139], ["dog infection", "OBSERVATION", 140, 153]]], ["Suceptibility of dogs to HPAI H5N1 disease has been reproduced experimentally [87] .Emergent and potential virus diseasesHPAI H5N1 virus has also jumped to domestic cats and wild felids and natural HPAI H5N1 virus infection was the cause of fatal disease in domestic cats and other large felids such as tigers and leopards in Thailand [89, 90, 86] .", [["HPAI H5N1 disease", "DISEASE", 25, 42], ["HPAI H5N1 virus infection", "DISEASE", 198, 223], ["dogs", "ORGANISM", 17, 21], ["HPAI H5N1", "ORGANISM", 25, 34], ["virus diseasesHPAI H5N1 virus", "ORGANISM", 107, 136], ["cats", "ORGANISM", 165, 169], ["wild felids", "ORGANISM", 174, 185], ["natural", "ORGANISM", 190, 197], ["HPAI H5N1 virus", "ORGANISM", 198, 213], ["cats", "ORGANISM", 267, 271], ["dogs", "SPECIES", 17, 21], ["HPAI H5N1", "SPECIES", 25, 34], ["virus diseasesHPAI H5N1 virus", "SPECIES", 107, 136], ["cats", "SPECIES", 165, 169], ["HPAI H5N1 virus", "SPECIES", 198, 213], ["cats", "SPECIES", 267, 271], ["HPAI H5N1", "SPECIES", 25, 34], ["virus diseasesHPAI H5N1 virus", "SPECIES", 107, 136], ["HPAI H5N1 virus", "SPECIES", 198, 213], ["dogs", "PROBLEM", 17, 21], ["HPAI H5N1 disease", "PROBLEM", 25, 42], ["potential virus diseasesHPAI H5N1 virus", "PROBLEM", 97, 136], ["domestic cats", "TREATMENT", 156, 169], ["wild felids", "PROBLEM", 174, 185], ["natural HPAI H5N1 virus infection", "PROBLEM", 190, 223], ["fatal disease in domestic cats", "PROBLEM", 241, 271], ["H5N1", "OBSERVATION", 30, 34], ["potential", "UNCERTAINTY", 97, 106], ["virus diseasesHPAI", "OBSERVATION", 107, 125], ["fatal", "OBSERVATION_MODIFIER", 241, 246], ["disease", "OBSERVATION", 247, 254], ["large", "OBSERVATION_MODIFIER", 282, 287], ["felids", "OBSERVATION", 288, 294]]], ["The susceptibility of domestic cats to HPAI H5N1 virus was also proven experimentally [91] [92] [93] 87] .", [["cats", "ORGANISM", 31, 35], ["HPAI H5N1 virus", "ORGANISM", 39, 54], ["cats", "SPECIES", 31, 35], ["HPAI H5N1 virus", "SPECIES", 39, 54], ["HPAI H5N1 virus", "SPECIES", 39, 54], ["HPAI H5N1 virus", "TEST", 39, 54]]], ["The availability of appropriate receptor(s) in the lower respiratory tract (LTR) of the novel host is an important prerequisite for the novel virus to initiate infection in the new host and cause viral pneumonia.", [["lower respiratory tract", "ANATOMY", 51, 74], ["LTR", "ANATOMY", 76, 79], ["infection", "DISEASE", 160, 169], ["pneumonia", "DISEASE", 202, 211], ["lower respiratory", "ORGANISM_SUBDIVISION", 51, 68], ["tract", "ORGANISM_SUBDIVISION", 69, 74], ["LTR", "CELLULAR_COMPONENT", 76, 79], ["LTR", "DNA", 76, 79], ["the novel virus", "PROBLEM", 132, 147], ["infection", "PROBLEM", 160, 169], ["viral pneumonia", "PROBLEM", 196, 211], ["lower", "ANATOMY_MODIFIER", 51, 56], ["respiratory tract", "ANATOMY", 57, 74], ["infection", "OBSERVATION", 160, 169], ["viral", "OBSERVATION_MODIFIER", 196, 201], ["pneumonia", "OBSERVATION", 202, 211]]], ["Like the dog, cat LTR (and also human's) has terminal \u24232,3-Gal linkages in the LTR [94] which are the preferred ligands for H5N1 virus and apparently also for H3N8 influenza virus.Emergent and potential virus diseasesIn view of the fact that two newly emergent paramyxoviruses in the new genus henipavirus namely Hendravirus and Nipahvirus have jumped species from reservoir petropid fruit bats to man, horses and pigs in Australia and the Far East causing fatalities in all three unnatural hosts [95, 96] it is important to be aware of experimental studies showing susceptibility of domestic cats to these new important pathogens.", [["LTR", "ANATOMY", 18, 21], ["LTR", "ANATOMY", 79, 82], ["influenza", "DISEASE", 164, 173], ["Hendravirus", "CHEMICAL", 313, 324], ["Nipahvirus", "CHEMICAL", 329, 339], ["dog", "ORGANISM", 9, 12], ["cat", "ORGANISM", 14, 17], ["LTR", "CELLULAR_COMPONENT", 18, 21], ["human", "ORGANISM", 32, 37], ["2,3-Gal", "GENE_OR_GENE_PRODUCT", 55, 62], ["LTR", "CELLULAR_COMPONENT", 79, 82], ["H5N1 virus", "ORGANISM", 124, 134], ["H3N8 influenza virus", "ORGANISM", 159, 179], ["man", "ORGANISM", 398, 401], ["horses", "ORGANISM_SUBDIVISION", 403, 409], ["pigs", "ORGANISM", 414, 418], ["cats", "ORGANISM", 593, 597], ["cat LTR", "DNA", 14, 21], ["LTR", "DNA", 79, 82], ["dog", "SPECIES", 9, 12], ["human", "SPECIES", 32, 37], ["H3N8 influenza virus", "SPECIES", 159, 179], ["fruit", "SPECIES", 384, 389], ["man", "SPECIES", 398, 401], ["horses", "SPECIES", 403, 409], ["pigs", "SPECIES", 414, 418], ["human", "SPECIES", 32, 37], ["H5N1 virus", "SPECIES", 124, 134], ["H3N8 influenza virus", "SPECIES", 159, 179], ["pigs", "SPECIES", 414, 418], ["H5N1 virus", "PROBLEM", 124, 134], ["H3N8 influenza virus", "PROBLEM", 159, 179], ["potential virus diseases", "PROBLEM", 193, 217], ["two newly emergent paramyxoviruses", "PROBLEM", 242, 276], ["the new genus henipavirus", "PROBLEM", 280, 305], ["jumped species", "PROBLEM", 345, 359], ["experimental studies", "TEST", 537, 557], ["domestic cats", "TREATMENT", 584, 597], ["potential", "UNCERTAINTY", 193, 202], ["virus diseases", "OBSERVATION", 203, 217], ["paramyxoviruses", "OBSERVATION", 261, 276], ["new", "OBSERVATION_MODIFIER", 284, 287], ["genus henipavirus", "OBSERVATION", 288, 305]]], ["Transmission of both henipaviruses to cats is possible since infected horses and pigs shed virus oronasally [97, 98] .", [["cats", "ORGANISM", 38, 42], ["horses", "ORGANISM", 70, 76], ["pigs", "ORGANISM", 81, 85], ["cats", "SPECIES", 38, 42], ["pigs", "SPECIES", 81, 85], ["horses", "SPECIES", 70, 76], ["pigs shed virus", "SPECIES", 81, 96], ["infected horses", "PROBLEM", 61, 76]]], ["Experimentally cats were susceptible to Hendravirus by subcutaneous, intranasal, oral inoculation and also to in contact transmission resulting in severe interstitial pneumonia, generalised thrombosis and necrosis of small blood vessels and necrotic lesions in lungs, intestine, liver and kidneys; infected cats shed virus in secretions of oropharynx and urine [99] .", [["subcutaneous", "ANATOMY", 55, 67], ["oral", "ANATOMY", 81, 85], ["interstitial", "ANATOMY", 154, 166], ["blood vessels", "ANATOMY", 223, 236], ["necrotic lesions", "ANATOMY", 241, 257], ["lungs", "ANATOMY", 261, 266], ["intestine", "ANATOMY", 268, 277], ["liver", "ANATOMY", 279, 284], ["kidneys", "ANATOMY", 289, 296], ["secretions", "ANATOMY", 326, 336], ["oropharynx", "ANATOMY", 340, 350], ["urine", "ANATOMY", 355, 360], ["Hendravirus", "CHEMICAL", 40, 51], ["interstitial pneumonia", "DISEASE", 154, 176], ["thrombosis", "DISEASE", 190, 200], ["necrosis", "DISEASE", 205, 213], ["necrotic", "DISEASE", 241, 249], ["cats", "ORGANISM", 15, 19], ["oral", "ORGANISM_SUBDIVISION", 81, 85], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 223, 236], ["necrotic lesions", "PATHOLOGICAL_FORMATION", 241, 257], ["lungs", "ORGAN", 261, 266], ["intestine", "ORGAN", 268, 277], ["liver", "ORGAN", 279, 284], ["kidneys", "ORGAN", 289, 296], ["cats", "ORGANISM", 307, 311], ["secretions", "ORGANISM_SUBDIVISION", 326, 336], ["oropharynx", "ORGAN", 340, 350], ["urine", "ORGANISM_SUBSTANCE", 355, 360], ["cats", "SPECIES", 15, 19], ["cats", "SPECIES", 307, 311], ["Hendravirus", "TREATMENT", 40, 51], ["intranasal", "TREATMENT", 69, 79], ["oral inoculation", "TREATMENT", 81, 97], ["severe interstitial pneumonia", "PROBLEM", 147, 176], ["generalised thrombosis", "PROBLEM", 178, 200], ["necrosis", "PROBLEM", 205, 213], ["small blood vessels", "PROBLEM", 217, 236], ["necrotic lesions in lungs, intestine, liver and kidneys", "PROBLEM", 241, 296], ["infected cats shed virus in secretions of oropharynx and urine", "PROBLEM", 298, 360], ["severe", "OBSERVATION_MODIFIER", 147, 153], ["interstitial", "ANATOMY_MODIFIER", 154, 166], ["pneumonia", "OBSERVATION", 167, 176], ["generalised", "OBSERVATION_MODIFIER", 178, 189], ["thrombosis", "OBSERVATION", 190, 200], ["necrosis", "OBSERVATION", 205, 213], ["small", "OBSERVATION_MODIFIER", 217, 222], ["blood vessels", "ANATOMY", 223, 236], ["necrotic", "OBSERVATION_MODIFIER", 241, 249], ["lesions", "OBSERVATION", 250, 257], ["lungs", "ANATOMY", 261, 266], ["intestine", "ANATOMY", 268, 277], ["liver", "ANATOMY", 279, 284], ["kidneys", "ANATOMY", 289, 296], ["infected", "OBSERVATION", 298, 306], ["virus", "OBSERVATION_MODIFIER", 317, 322], ["oropharynx", "ANATOMY", 340, 350]]], ["Oronasal inoculation of cats with a human isolate of Nipahvirus resulted in febrile respiratory and neurological disease in cats which also incurred vasculatis and haemorrhages in lymph nodes, trachea, lung and pulmonary infarcts.Emergent and potential virus diseasesAnother potential cat pathogen is West Nile virus (WNV).", [["respiratory", "ANATOMY", 84, 95], ["neurological", "ANATOMY", 100, 112], ["vasculatis", "ANATOMY", 149, 159], ["lymph nodes", "ANATOMY", 180, 191], ["trachea", "ANATOMY", 193, 200], ["lung", "ANATOMY", 202, 206], ["pulmonary", "ANATOMY", 211, 220], ["Nipahvirus", "CHEMICAL", 53, 63], ["febrile respiratory and neurological disease", "DISEASE", 76, 120], ["vasculatis", "DISEASE", 149, 159], ["haemorrhages", "DISEASE", 164, 176], ["pulmonary infarcts", "DISEASE", 211, 229], ["cats", "ORGANISM", 24, 28], ["human", "ORGANISM", 36, 41], ["cats", "ORGANISM", 124, 128], ["vasculatis", "CANCER", 149, 159], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 180, 191], ["trachea", "MULTI-TISSUE_STRUCTURE", 193, 200], ["lung", "ORGAN", 202, 206], ["pulmonary", "ORGAN", 211, 220], ["cat", "ORGANISM", 285, 288], ["West Nile virus", "ORGANISM", 301, 316], ["WNV", "ORGANISM", 318, 321], ["cats", "SPECIES", 24, 28], ["human", "SPECIES", 36, 41], ["cats", "SPECIES", 124, 128], ["West Nile virus", "SPECIES", 301, 316], ["human", "SPECIES", 36, 41], ["West Nile virus", "SPECIES", 301, 316], ["WNV", "SPECIES", 318, 321], ["Oronasal inoculation of cats", "PROBLEM", 0, 28], ["a human isolate of Nipahvirus", "TREATMENT", 34, 63], ["febrile respiratory and neurological disease in cats", "PROBLEM", 76, 128], ["vasculatis", "PROBLEM", 149, 159], ["haemorrhages in lymph nodes", "PROBLEM", 164, 191], ["trachea, lung and pulmonary infarcts", "PROBLEM", 193, 229], ["potential virus diseases", "PROBLEM", 243, 267], ["Another potential cat pathogen", "PROBLEM", 267, 297], ["febrile", "OBSERVATION_MODIFIER", 76, 83], ["respiratory", "ANATOMY", 84, 95], ["neurological disease", "OBSERVATION", 100, 120], ["haemorrhages", "OBSERVATION", 164, 176], ["lymph nodes", "OBSERVATION", 180, 191], ["trachea", "ANATOMY", 193, 200], ["lung", "ANATOMY", 202, 206], ["pulmonary", "ANATOMY", 211, 220], ["infarcts", "OBSERVATION", 221, 229], ["potential", "UNCERTAINTY", 243, 252], ["virus diseases", "OBSERVATION", 253, 267], ["potential", "UNCERTAINTY", 275, 284], ["cat pathogen", "OBSERVATION", 285, 297]]], ["WNV is mosquito-transmitted flavivirus belonging to the Japanese encephalitis (JE) serocomplex of the family Flaviviridae [100] .", [["WNV", "DISEASE", 0, 3], ["mosquito-transmitted flavivirus", "DISEASE", 7, 38], ["Japanese encephalitis", "DISEASE", 56, 77], ["JE", "DISEASE", 79, 81], ["WNV", "ORGANISM", 0, 3], ["flavivirus", "ORGANISM", 28, 38], ["Japanese encephalitis", "ORGANISM", 56, 77], ["WNV", "SPECIES", 0, 3], ["Japanese encephalitis (JE)", "SPECIES", 56, 82], ["WNV", "PROBLEM", 0, 3], ["mosquito", "PROBLEM", 7, 15], ["transmitted flavivirus", "PROBLEM", 16, 38], ["the Japanese encephalitis", "PROBLEM", 52, 77]]], ["All members of the JE complex are transmitted by mosquitoes.", [["JE", "ORGANISM", 19, 21], ["JE complex", "PROTEIN", 19, 29]]], ["Birdfeeding mosquitoes are the principal vectors of WNV.", [["WNV", "DISEASE", 52, 55], ["WNV", "ORGANISM", 52, 55], ["WNV", "SPECIES", 52, 55], ["WNV", "OBSERVATION", 52, 55]]], ["WNV has been isolated from 43 mosquitoe species mainly of the genus Culex [101] .", [["WNV", "DISEASE", 0, 3], ["WNV", "ORGANISM", 0, 3], ["WNV", "SPECIES", 0, 3], ["WNV", "PROBLEM", 0, 3], ["43 mosquitoe species", "PROBLEM", 27, 47], ["43 mosquitoe", "OBSERVATION_MODIFIER", 27, 39], ["genus Culex", "OBSERVATION", 62, 73]]], ["High long-term viraemia, sufficient to infect vector mosquitoes is required for field transmission of WNV.", [["viraemia", "DISEASE", 15, 23], ["WNV", "DISEASE", 102, 105], ["WNV", "ORGANISM", 102, 105], ["WNV", "SPECIES", 102, 105], ["High long-term viraemia", "PROBLEM", 0, 23], ["WNV", "PROBLEM", 102, 105], ["long-term", "OBSERVATION_MODIFIER", 5, 14], ["viraemia", "OBSERVATION", 15, 23], ["WNV", "OBSERVATION", 102, 105]]], ["The latter occurs in infected birds which are the principal reservoir hosts of WNV whereas mammals are less important.", [["birds", "ORGANISM", 30, 35], ["WNV", "ORGANISM", 79, 82], ["WNV", "SPECIES", 79, 82], ["infected birds", "OBSERVATION", 21, 35], ["principal", "OBSERVATION_MODIFIER", 50, 59], ["reservoir hosts", "OBSERVATION", 60, 75]]], ["Bird-mosquitoe cycle in wetlands is the common mode of WNV transmission but bird-tick cycle in certain dry and warm habitats also occurs [101] .", [["WNV", "ORGANISM", 55, 58], ["WNV", "SPECIES", 55, 58], ["Bird-mosquitoe cycle in wetlands", "TREATMENT", 0, 32], ["bird-tick cycle", "TREATMENT", 76, 91], ["WNV", "OBSERVATION", 55, 58]]], ["Importantly for this paper WNV naturally infects dogs [102] [103] [104] [105] , cats [104] .", [["WNV", "ORGANISM", 27, 30], ["dogs", "ORGANISM", 49, 53], ["cats", "ORGANISM", 80, 84], ["dogs", "SPECIES", 49, 53], ["WNV", "SPECIES", 27, 30], ["cats", "TEST", 80, 84]]], ["Susceptibility of dogs and cats to WNV has also been investigated experimentally [106] .", [["WNV", "DISEASE", 35, 38], ["dogs", "ORGANISM", 18, 22], ["cats", "ORGANISM", 27, 31], ["WNV", "ORGANISM", 35, 38], ["dogs", "SPECIES", 18, 22], ["cats", "SPECIES", 27, 31], ["WNV", "SPECIES", 35, 38]]], ["Strains of WNV vary significantly in virulence for mammalian and avian species [107] [108] [109] .", [["WNV", "ORGANISM", 11, 14], ["WNV", "SPECIES", 11, 14], ["WNV", "PROBLEM", 11, 14], ["WNV", "OBSERVATION", 11, 14]]], ["The insect bite results in viraemia and visceral viral replication which produces secondary viraemia which could lead to CNS infection.", [["visceral", "ANATOMY", 40, 48], ["CNS", "ANATOMY", 121, 124], ["insect bite", "DISEASE", 4, 15], ["viraemia", "DISEASE", 27, 35], ["viraemia", "DISEASE", 92, 100], ["infection", "DISEASE", 125, 134], ["visceral", "ORGANISM_SUBDIVISION", 40, 48], ["CNS", "ANATOMICAL_SYSTEM", 121, 124], ["viraemia", "PROBLEM", 27, 35], ["visceral viral replication", "TREATMENT", 40, 66], ["secondary viraemia", "PROBLEM", 82, 100], ["CNS infection", "PROBLEM", 121, 134], ["viraemia", "OBSERVATION", 27, 35], ["visceral", "ANATOMY", 40, 48], ["viral replication", "OBSERVATION", 49, 66], ["secondary viraemia", "OBSERVATION", 82, 100], ["CNS", "ANATOMY", 121, 124], ["infection", "OBSERVATION", 125, 134]]], ["The visceral viral replication may cause fever, depression anorexia and some mortality while CNS replication may result in encephalitis and neurological signs such as tremors, ataxia and death [110, 108, 111] .", [["visceral", "ANATOMY", 4, 12], ["CNS", "ANATOMY", 93, 96], ["neurological", "ANATOMY", 140, 152], ["fever", "DISEASE", 41, 46], ["depression anorexia", "DISEASE", 48, 67], ["encephalitis", "DISEASE", 123, 135], ["neurological signs", "DISEASE", 140, 158], ["tremors", "DISEASE", 167, 174], ["ataxia", "DISEASE", 176, 182], ["death", "DISEASE", 187, 192], ["The visceral viral replication", "TREATMENT", 0, 30], ["fever", "PROBLEM", 41, 46], ["depression anorexia", "PROBLEM", 48, 67], ["some mortality", "PROBLEM", 72, 86], ["CNS replication", "TREATMENT", 93, 108], ["encephalitis", "PROBLEM", 123, 135], ["neurological signs", "PROBLEM", 140, 158], ["tremors", "PROBLEM", 167, 174], ["ataxia", "PROBLEM", 176, 182], ["death", "PROBLEM", 187, 192], ["visceral", "ANATOMY", 4, 12], ["viral replication", "OBSERVATION", 13, 30], ["may cause", "UNCERTAINTY", 31, 40], ["encephalitis", "OBSERVATION", 123, 135]]], ["Infected dogs and cats may undergo this pattern of disease pathogenesis although it is very rare for cats and dogs to be infected in the wild.ImmunoprophylaxisAs described earlier, vaccines are available for many years against the common well known diseases.", [["dogs", "ORGANISM", 9, 13], ["cats", "ORGANISM", 18, 22], ["cats", "ORGANISM", 101, 105], ["dogs", "ORGANISM", 110, 114], ["dogs", "SPECIES", 9, 13], ["cats", "SPECIES", 18, 22], ["cats", "SPECIES", 101, 105], ["dogs", "SPECIES", 110, 114], ["Infected dogs and cats", "PROBLEM", 0, 22], ["disease pathogenesis", "PROBLEM", 51, 71], ["dogs", "PROBLEM", 110, 114], ["ImmunoprophylaxisAs", "TREATMENT", 142, 161], ["vaccines", "TREATMENT", 181, 189], ["the common well known diseases", "PROBLEM", 227, 257], ["dogs", "OBSERVATION", 9, 13], ["disease", "OBSERVATION", 51, 58], ["infected", "OBSERVATION", 121, 129], ["diseases", "OBSERVATION", 249, 257]]], ["For dog viral (and bacterial) diseases, vaccines offered by the major companies are against CDV, CAV-1 and 2, CPV, CPI-2 and rabies and some companies also for CCoV and one for CHV-1 in various combinations.", [["dog viral (and bacterial) diseases", "DISEASE", 4, 38], ["CCoV", "CHEMICAL", 160, 164], ["dog", "ORGANISM", 4, 7], ["CDV", "ORGANISM", 92, 95], ["CAV-1", "ORGANISM", 97, 102], ["CPV", "ORGANISM", 110, 113], ["CPI-2", "ORGANISM", 115, 120], ["rabies", "ORGANISM", 125, 131], ["CCoV", "CANCER", 160, 164], ["CHV-1", "ORGANISM", 177, 182], ["dog", "SPECIES", 4, 7], ["dog", "SPECIES", 4, 7], ["CDV", "SPECIES", 92, 95], ["CAV-1", "SPECIES", 97, 102], ["CPV", "SPECIES", 110, 113], ["rabies", "SPECIES", 125, 131], ["CCoV", "SPECIES", 160, 164], ["CHV-1", "SPECIES", 177, 182], ["dog viral (and bacterial) diseases", "PROBLEM", 4, 38], ["vaccines", "TREATMENT", 40, 48], ["CDV", "PROBLEM", 92, 95], ["CAV", "TEST", 97, 100], ["CPV", "TEST", 110, 113], ["CPI", "TEST", 115, 118], ["CCoV", "TREATMENT", 160, 164], ["CHV", "TREATMENT", 177, 180]]], ["For the cat vaccines are available against diseases caused by FPLV, FCV, FHV-1, FeLV, FCoV, FIPV, FIV and rabies virus.", [["FIV and rabies virus", "DISEASE", 98, 118], ["cat", "ORGANISM", 8, 11], ["FPLV", "GENE_OR_GENE_PRODUCT", 62, 66], ["FCV", "ORGANISM", 68, 71], ["FHV-1", "ORGANISM", 73, 78], ["FeLV", "ORGANISM", 80, 84], ["FCoV", "GENE_OR_GENE_PRODUCT", 86, 90], ["FIPV", "GENE_OR_GENE_PRODUCT", 92, 96], ["FIV", "ORGANISM", 98, 101], ["rabies virus", "ORGANISM", 106, 118], ["rabies virus", "SPECIES", 106, 118], ["cat", "SPECIES", 8, 11], ["FPLV", "SPECIES", 62, 66], ["FCV", "SPECIES", 68, 71], ["FHV-1", "SPECIES", 73, 78], ["FeLV", "SPECIES", 80, 84], ["FCoV", "SPECIES", 86, 90], ["FIPV", "SPECIES", 92, 96], ["FIV", "SPECIES", 98, 101], ["rabies virus", "SPECIES", 106, 118], ["the cat vaccines", "TREATMENT", 4, 20], ["diseases", "PROBLEM", 43, 51], ["FPLV", "TEST", 62, 66], ["FCV", "TEST", 68, 71], ["FHV", "TEST", 73, 76], ["FeLV", "PROBLEM", 80, 84], ["FCoV", "PROBLEM", 86, 90], ["FIPV", "PROBLEM", 92, 96], ["FIV", "TREATMENT", 98, 101], ["rabies virus", "PROBLEM", 106, 118]]], ["Vaccines from the companies are broadly similar in formulation and presentations (Tables 1 and 2 ) but vary with respect to the number of components.", [["Vaccines", "TREATMENT", 0, 8]]], ["Furthermore, it is important to point out that some vaccine components consist of live antigens whereas others of killed.", [["live antigens", "PROTEIN", 82, 95], ["some vaccine components", "TREATMENT", 47, 70]]], ["The choice between live and killed depends largely on the immunological response which is to be induced and the immunological background of the target animal (presence of maternal derived antibodies, age at which the animal is supposed to be immune, etc.)", [["maternal derived antibodies", "PROTEIN", 171, 198], ["maternal derived antibodies", "PROBLEM", 171, 198]]], ["Viral vaccines are sometimes dissolved in solvents containing bacterial components such as the Leptospira spp. and Bordetella brochispetica antigens.", [["Leptospira spp.", "ORGANISM", 95, 110], ["Bordetella brochispetica antigens", "GENE_OR_GENE_PRODUCT", 115, 148], ["Bordetella brochispetica antigens", "PROTEIN", 115, 148], ["Leptospira spp.", "SPECIES", 95, 110], ["Bordetella brochispetica", "SPECIES", 115, 139], ["Leptospira spp.", "SPECIES", 95, 110], ["Bordetella brochispetica", "SPECIES", 115, 139], ["Viral vaccines", "TREATMENT", 0, 14], ["bacterial components", "TREATMENT", 62, 82], ["the Leptospira spp.", "TREATMENT", 91, 110], ["Bordetella brochispetica antigens", "PROBLEM", 115, 148], ["bacterial components", "OBSERVATION_MODIFIER", 62, 82]]], ["In the UK, for the dog viruses the number of products ranges from 3 (Pfizer) to as many as 8 (Schering-Plough, S-P).", [["UK", "GENE_OR_GENE_PRODUCT", 7, 9], ["dog", "ORGANISM", 19, 22]]], ["Most companies have 5-6 products, mostly as polyvalent (multi-disease) vaccines.", [["polyvalent (multi-disease) vaccines", "TREATMENT", 44, 79]]], ["For the cat, the products range is 2 (S-P, Virbac), 4 (Intervet), to 6 (F-D, Merial).", [["cat", "ORGANISM", 8, 11], ["the cat", "TEST", 4, 11]]], ["The reason for the multiple product range is likely to be the vaccine duration of immunity (DOI) varying from 1 year or Table 1 Canine viral disease vaccines.", [["DOI", "CHEMICAL", 92, 95], ["viral disease", "DISEASE", 135, 148], ["DOI", "CHEMICAL", 92, 95], ["Canine", "ORGANISM", 128, 134], ["Canine viral disease vaccines", "TREATMENT", 128, 157], ["viral disease", "OBSERVATION", 135, 148]]], ["Apply S/C near or soon after mating and again 1-2 weeks before whelping and similarly at or during each pregnancy. less (CPI-2, FeLV) to 3 years (CDV, CAV-2, CPV and rabies virus); for most diseases one vaccine formulation would protect against diseases ranges from 5 to 8 and 2 to 5 for the dog and cat viral and bacterial diseases, respectively.", [["viral and bacterial diseases", "DISEASE", 304, 332], ["CPI-2", "GENE_OR_GENE_PRODUCT", 121, 126], ["FeLV", "ORGANISM", 128, 132], ["CDV", "ORGANISM", 146, 149], ["CAV-2", "ORGANISM", 151, 156], ["CPV", "ORGANISM", 158, 161], ["rabies virus", "ORGANISM", 166, 178], ["dog", "ORGANISM", 292, 295], ["cat", "ORGANISM", 300, 303], ["rabies virus", "SPECIES", 166, 178], ["dog", "SPECIES", 292, 295], ["cat", "SPECIES", 300, 303], ["CDV", "SPECIES", 146, 149], ["CPV", "SPECIES", 158, 161], ["rabies virus", "SPECIES", 166, 178], ["dog", "SPECIES", 292, 295], ["cat", "SPECIES", 300, 303], ["CPI", "TEST", 121, 124], ["CDV", "PROBLEM", 146, 149], ["CAV", "TEST", 151, 154], ["CPV", "PROBLEM", 158, 161], ["rabies virus", "PROBLEM", 166, 178], ["most diseases", "PROBLEM", 185, 198], ["one vaccine formulation", "TREATMENT", 199, 222], ["the dog and cat viral and bacterial diseases", "PROBLEM", 288, 332], ["CAV", "ANATOMY", 151, 154], ["bacterial diseases", "OBSERVATION", 314, 332]]], ["It should be noted that not all companies claim DOI of 3 years for CPV disease.", [["DOI", "CHEMICAL", 48, 51], ["CPV disease", "DISEASE", 67, 78], ["DOI", "CHEMICAL", 48, 51], ["CPV", "ORGANISM", 67, 70], ["CPV", "SPECIES", 67, 70], ["CPV disease", "PROBLEM", 67, 78], ["disease", "OBSERVATION", 71, 78]]], ["Also noteworthy is the fact that most, with an odd exception, of these vaccines were derived by conventional attenuation and/or inactivation processes in tissue culture some 10-20 years ago.", [["tissue culture", "ANATOMY", 154, 168], ["tissue", "TISSUE", 154, 160], ["these vaccines", "TREATMENT", 65, 79], ["inactivation processes", "PROBLEM", 128, 150], ["tissue culture", "TEST", 154, 168]]], ["The tissue culture technologies have been much refined to aid the production, quality (purity and control) and improved yield of active components.", [["tissue culture", "ANATOMY", 4, 18], ["tissue", "TISSUE", 4, 10], ["The tissue culture technologies", "TEST", 0, 31], ["active components", "PROBLEM", 129, 146], ["active", "OBSERVATION_MODIFIER", 129, 135], ["components", "OBSERVATION_MODIFIER", 136, 146]]], ["Another important point to mention is that these various vaccines contain different viral strains and their efficacy was assessed using different challenges (virus strains, inocula, animals) and sample analysis was using different tests.", [["these various vaccines", "TREATMENT", 43, 65], ["different viral strains", "PROBLEM", 74, 97], ["different challenges (virus strains", "TREATMENT", 136, 171], ["sample analysis", "TEST", 195, 210], ["different tests", "TEST", 221, 236], ["viral strains", "OBSERVATION", 84, 97]]], ["This clearly does not allow an objective analysis of their relative efficacy.", [["an objective analysis", "TEST", 28, 49]]], ["Because of the age of these vaccines and the recent emergence of virulent variants of some viruses notably CPV (the 2a, 2b and 2c variants) and FCV (VS-FCV) [22, 23, 112] and the new respiratory coronavirus (see above for references) the need for assessment of efficacy of these now old vaccines against the newly emergent viruses is clearly necessary but would be costly.", [["respiratory coronavirus", "DISEASE", 183, 206], ["CPV", "ORGANISM", 107, 110], ["2a, 2b", "GENE_OR_GENE_PRODUCT", 116, 122], ["2c", "GENE_OR_GENE_PRODUCT", 127, 129], ["FCV (VS-FCV", "ORGANISM", 144, 155], ["respiratory coronavirus", "ORGANISM", 183, 206], ["CPV", "SPECIES", 107, 110], ["FCV", "SPECIES", 144, 147], ["FCV", "SPECIES", 152, 155], ["respiratory coronavirus", "SPECIES", 183, 206], ["these vaccines", "TREATMENT", 22, 36], ["some viruses", "PROBLEM", 86, 98], ["CPV", "TEST", 107, 110], ["FCV", "TEST", 144, 147], ["the new respiratory coronavirus", "PROBLEM", 175, 206], ["assessment", "TEST", 247, 257], ["old vaccines", "TREATMENT", 283, 295], ["the newly emergent viruses", "PROBLEM", 304, 330], ["viruses", "OBSERVATION", 91, 98], ["new", "OBSERVATION_MODIFIER", 179, 182], ["respiratory coronavirus", "OBSERVATION", 183, 206], ["viruses", "OBSERVATION", 323, 330]]], ["An exception, to our knowledge, is the recent controlled study in susceptible dogs for CPV 2 component in Nobivac DHPPi (Table 1) against CPV 2c oral challenge which showed that the vaccine was fully cross protective [113] .", [["oral", "ANATOMY", 145, 149], ["dogs", "ORGANISM", 78, 82], ["CPV", "ORGANISM", 87, 90], ["CPV 2c", "ORGANISM", 138, 144], ["oral", "ORGANISM_SUBDIVISION", 145, 149], ["dogs", "SPECIES", 78, 82], ["CPV", "SPECIES", 87, 90], ["CPV", "SPECIES", 138, 141], ["the recent controlled study", "TEST", 35, 62], ["CPV 2 component", "TREATMENT", 87, 102], ["Nobivac DHPPi", "TREATMENT", 106, 119], ["CPV 2c oral challenge", "TEST", 138, 159], ["the vaccine", "TREATMENT", 178, 189]]], ["Published information on the prevalence and the incidence of disease due to the recently recognised group 2 respiratory coronavirus [65] is limited but this could be another pathogen for which immunoprophylaxis may be needed.", [["respiratory coronavirus", "DISEASE", 108, 131], ["respiratory coronavirus", "ORGANISM", 108, 131], ["disease", "PROBLEM", 61, 68], ["the recently recognised group 2 respiratory coronavirus", "PROBLEM", 76, 131], ["another pathogen", "PROBLEM", 166, 182], ["immunoprophylaxis", "TREATMENT", 193, 210], ["disease", "OBSERVATION", 61, 68]]], ["Domestic and scavenging dogs are a significant source of human rabies worldwide and vaccination of dogs has been highly beneficial in this respect [114] .", [["rabies", "DISEASE", 63, 69], ["dogs", "ORGANISM", 24, 28], ["human", "ORGANISM", 57, 62], ["dogs", "ORGANISM", 99, 103], ["dogs", "SPECIES", 24, 28], ["human", "SPECIES", 57, 62], ["dogs", "SPECIES", 99, 103], ["human", "SPECIES", 57, 62], ["scavenging dogs", "PROBLEM", 13, 28], ["vaccination of dogs", "TREATMENT", 84, 103], ["scavenging dogs", "OBSERVATION", 13, 28], ["significant", "OBSERVATION_MODIFIER", 35, 46]]], ["CDV is a cause of fatal disease in many species of carnivores.", [["CDV", "DISEASE", 0, 3], ["CDV", "ORGANISM", 0, 3], ["carnivores", "ORGANISM_SUBDIVISION", 51, 61], ["CDV", "SPECIES", 0, 3], ["CDV", "PROBLEM", 0, 3], ["fatal disease", "PROBLEM", 18, 31], ["fatal", "OBSERVATION_MODIFIER", 18, 23], ["disease", "OBSERVATION", 24, 31], ["many", "OBSERVATION_MODIFIER", 35, 39], ["species", "OBSERVATION_MODIFIER", 40, 47]]], ["CDV related viruses have been identified in seals (phocid distemper virus), dolphins, whales and porpoises [115, 116] , and vaccination strategies have shown some success [117] .", [["CDV", "ORGANISM", 0, 3], ["seals", "ORGANISM_SUBDIVISION", 44, 49], ["phocid distemper virus", "ORGANISM", 51, 73], ["phocid distemper virus", "SPECIES", 51, 73], ["CDV", "SPECIES", 0, 3], ["phocid distemper virus", "SPECIES", 51, 73], ["CDV related viruses", "PROBLEM", 0, 19], ["vaccination strategies", "TREATMENT", 124, 146], ["viruses", "OBSERVATION", 12, 19]]], ["CDV transmitted by domestic dogs was associated with fatal neurological disease in lions in Serengeti National Park in Tanzania and dog vaccination against CDV in affected areas was beneficial [118] .", [["neurological", "ANATOMY", 59, 71], ["neurological disease", "DISEASE", 59, 79], ["CDV", "DISEASE", 156, 159], ["CDV", "ORGANISM", 0, 3], ["dogs", "ORGANISM", 28, 32], ["dog", "ORGANISM", 132, 135], ["CDV", "ORGANISM", 156, 159], ["dogs", "SPECIES", 28, 32], ["dog", "SPECIES", 132, 135], ["CDV", "SPECIES", 0, 3], ["dog", "SPECIES", 132, 135], ["CDV", "SPECIES", 156, 159], ["CDV", "PROBLEM", 0, 3], ["fatal neurological disease", "PROBLEM", 53, 79], ["dog vaccination", "TREATMENT", 132, 147], ["CDV in affected areas", "PROBLEM", 156, 177], ["domestic dogs", "OBSERVATION", 19, 32]]], ["Although currently available live CDV vaccines are suitable for immunising domestic dogs and farmed mink.", [["CDV", "ORGANISM", 34, 37], ["dogs", "ORGANISM", 84, 88], ["dogs", "SPECIES", 84, 88], ["mink", "SPECIES", 100, 104], ["CDV", "SPECIES", 34, 37], ["farmed mink", "SPECIES", 93, 104], ["live CDV vaccines", "TREATMENT", 29, 46]]], ["A CDV vaccine based on the Onsterstepoort strain is safe and efficacious in Lions by eliciting a protective neutralising antibody response [119] .", [["CDV", "ORGANISM", 2, 5], ["Onsterstepoort strain", "ORGANISM", 27, 48], ["CDV", "SPECIES", 2, 5], ["A CDV vaccine", "TREATMENT", 0, 13], ["the Onsterstepoort strain", "TREATMENT", 23, 48]]], ["The same vaccine has been used effectively in otters and seals (showing vaccine efficacy in the face of Phocine distemper outbreak (Intervet/Schering-Plough, unpublished).", [["distemper", "DISEASE", 112, 121], ["The same vaccine", "TREATMENT", 0, 16], ["vaccine efficacy", "TREATMENT", 72, 88], ["Phocine distemper outbreak", "PROBLEM", 104, 130]]], ["The live vaccine safety concern and the global CDV distribution involving a wide variety of susceptible species, require new safe vaccines for the protection of wild species as well as eradication or reduction of CDV from wildlife [115] .", [["CDV", "ORGANISM", 47, 50], ["CDV", "ORGANISM", 213, 216], ["CDV", "SPECIES", 47, 50], ["CDV", "SPECIES", 213, 216], ["The live vaccine", "TREATMENT", 0, 16], ["the global CDV distribution", "PROBLEM", 36, 63], ["susceptible species", "PROBLEM", 92, 111], ["new safe vaccines", "TREATMENT", 121, 138], ["wild species", "PROBLEM", 161, 173], ["eradication", "TREATMENT", 185, 196], ["CDV", "PROBLEM", 213, 216], ["global", "OBSERVATION_MODIFIER", 40, 46], ["CDV", "OBSERVATION", 47, 50]]], ["A further requirement is strategies for wildlife vaccination as has been used for rabies and anticipated for RHDV and MV diseases of wild rabbits (see below).", [["rabies", "DISEASE", 82, 88], ["RHDV", "DISEASE", 109, 113], ["rabies", "ORGANISM", 82, 88], ["RHDV", "ORGANISM", 109, 113], ["rabbits", "ORGANISM", 138, 145], ["RHDV", "SPECIES", 109, 113], ["rabbits", "SPECIES", 138, 145], ["rabies", "SPECIES", 82, 88], ["RHDV", "SPECIES", 109, 113], ["MV", "SPECIES", 118, 120], ["rabbits", "SPECIES", 138, 145], ["wildlife vaccination", "TREATMENT", 40, 60], ["rabies", "PROBLEM", 82, 88], ["RHDV", "PROBLEM", 109, 113], ["MV diseases", "PROBLEM", 118, 129], ["wild rabbits", "PROBLEM", 133, 145]]], ["Although canine H3N8 flu virus disease is quite new, plans for vaccine against it were afoot soon after the outbreak of the fatal respiratory disease [84] .", [["respiratory", "ANATOMY", 130, 141], ["flu virus disease", "DISEASE", 21, 38], ["respiratory disease", "DISEASE", 130, 149], ["canine H3N8 flu virus", "ORGANISM", 9, 30], ["canine", "SPECIES", 9, 15], ["H3N8 flu virus", "SPECIES", 16, 30], ["canine H3N8 flu virus", "SPECIES", 9, 30], ["canine H3N8 flu virus disease", "PROBLEM", 9, 38], ["vaccine", "TREATMENT", 63, 70], ["the fatal respiratory disease", "PROBLEM", 120, 149], ["fatal", "OBSERVATION_MODIFIER", 124, 129], ["respiratory disease", "OBSERVATION", 130, 149]]], ["These authors were working towards a vaccine for this new dog disease (personal communication by Dr. Cyanda Crawford to Allison Clark [120] .", [["dog", "ORGANISM", 58, 61], ["dog", "SPECIES", 58, 61], ["a vaccine", "TREATMENT", 35, 44], ["this new dog disease", "PROBLEM", 49, 69]]], ["That there is commercial interest in canine H3N8 flu virus vaccine is indicated by a recent controlled efficacy study in dogs with two experimental canarypoxvirus-H3 subtypes (from two strains) live recombinant vaccine [121] .", [["canine", "ORGANISM", 37, 43], ["H3N8 flu virus", "ORGANISM", 44, 58], ["dogs", "ORGANISM", 121, 125], ["canarypoxvirus-H3", "ORGANISM", 148, 165], ["canine H3N8 flu virus", "SPECIES", 37, 58], ["dogs", "SPECIES", 121, 125], ["canine H3N8 flu virus", "SPECIES", 37, 58], ["canine H3N8 flu virus vaccine", "TREATMENT", 37, 66], ["two experimental canarypoxvirus", "PROBLEM", 131, 162], ["H3 subtypes", "PROBLEM", 163, 174]]], ["This study was a joint effort by Merial, Sanofi Pasteur and Cornell University.ImmunoprophylaxisFor the cat there are FCV vaccines from several companies ( Table 2 ) but their efficacy against the newly emergent VS-FCV [35, 112] remains unknown.", [["cat", "ORGANISM", 104, 107], ["FCV", "ORGANISM", 118, 121], ["VS-FCV", "ORGANISM", 212, 218], ["cat", "SPECIES", 104, 107], ["FCV", "SPECIES", 118, 121], ["This study", "TEST", 0, 10], ["Immunoprophylaxis", "TREATMENT", 79, 96], ["FCV vaccines", "TREATMENT", 118, 130], ["joint", "ANATOMY", 17, 22]]], ["The development of vaccines against FIP coronavirus (FIPV) has proved cumbersome and consequently there is only one (Pfizer's, not in Table 2 ) live intranasal temperature sensitive (TS) vaccine licensed in some countries [122, 123] .", [["FIP coronavirus", "DISEASE", 36, 51], ["FIP coronavirus", "ORGANISM", 36, 51], ["FIPV", "ORGANISM", 53, 57], ["FIP coronavirus", "SPECIES", 36, 51], ["FIPV", "SPECIES", 53, 57], ["vaccines", "TREATMENT", 19, 27], ["FIP coronavirus", "PROBLEM", 36, 51], ["intranasal temperature sensitive (TS) vaccine", "TREATMENT", 149, 194]]], ["However efficacy of this TS FIPV vaccine is a matter of debate [124, 125] .", [["FIPV", "CHEMICAL", 28, 32], ["this TS FIPV vaccine", "TREATMENT", 20, 40]]], ["A promising experimental oronasal live FIPV vaccine lacking groupspecific gene cluster 3abc, derived by site directed mutagenesis of a virulent lethal FIPV strain was an innocuous efficacious vaccine [126] .", [["FIPV", "CHEMICAL", 39, 43], ["FIPV", "CHEMICAL", 151, 155], ["3abc", "GENE_OR_GENE_PRODUCT", 87, 91], ["groupspecific gene cluster 3abc", "DNA", 60, 91], ["FIPV", "SPECIES", 39, 43], ["FIPV", "SPECIES", 151, 155], ["A promising experimental oronasal live FIPV vaccine", "TREATMENT", 0, 51], ["a virulent lethal FIPV strain", "PROBLEM", 133, 162], ["an innocuous efficacious vaccine", "TREATMENT", 167, 199]]], ["Clearly there is a way to derive an effective FIPV vaccine.", [["an effective FIPV vaccine", "TREATMENT", 33, 58]]], ["The observation that cats can recover naturally from FeLV infection led to development of vaccines (see Table 2 ).", [["FeLV infection", "DISEASE", 53, 67], ["cats", "ORGANISM", 21, 25], ["FeLV", "ORGANISM", 53, 57], ["cats", "SPECIES", 21, 25], ["FeLV", "SPECIES", 53, 57], ["FeLV infection", "PROBLEM", 53, 67], ["vaccines", "TREATMENT", 90, 98], ["FeLV infection", "OBSERVATION", 53, 67]]], ["Thus there is an ongoing effort to develop improved effective FeLV vaccines.", [["FeLV", "ORGANISM", 62, 66], ["FeLV", "SPECIES", 62, 66], ["FeLV vaccines", "TREATMENT", 62, 75]]], ["The target is for a vaccine that would prevent establishment of both viraemia and latent bone marrow infection.", [["bone marrow", "ANATOMY", 89, 100], ["viraemia", "DISEASE", 69, 77], ["bone marrow infection", "DISEASE", 89, 110], ["bone marrow", "MULTI-TISSUE_STRUCTURE", 89, 100], ["a vaccine", "TREATMENT", 18, 27], ["both viraemia", "PROBLEM", 64, 77], ["latent bone marrow infection", "PROBLEM", 82, 110], ["both", "OBSERVATION_MODIFIER", 64, 68], ["viraemia", "OBSERVATION", 69, 77], ["latent", "OBSERVATION_MODIFIER", 82, 88], ["bone marrow infection", "OBSERVATION", 89, 110]]], ["The approaches investigated have been vaccinia-FeLV [130] , canarypox-FeLV [131] and FHV-1-FeLV [132] live vector As ICHP from 8 weeks.Immunoprophylaxis4.", [["Immunoprophylaxis4", "CHEMICAL", 135, 153], ["vaccinia", "ORGANISM", 38, 46], ["FeLV", "ORGANISM", 47, 51], ["canarypox", "ORGANISM", 60, 69], ["FeLV", "ORGANISM", 70, 74], ["FHV", "ORGANISM", 85, 88], ["FeLV", "ORGANISM", 91, 95], ["vaccinia", "TEST", 38, 46], ["canarypox", "TEST", 60, 69], ["FHV", "TEST", 85, 88], ["FeLV", "PROBLEM", 91, 95], ["Immunoprophylaxis4", "TEST", 135, 153]]], ["PENTOFEL V. K-FPLV + FHV-1 + FCV + Chlamydophila psittaci + FeLV + adjuvant (Ethylene/maleic anhydride + neocryl XK-62 + emulsigen SA).ImmunoprophylaxisAs ICHP from 9 weeks.", [["FHV-1", "CHEMICAL", 21, 26], ["Ethylene", "CHEMICAL", 77, 85], ["maleic anhydride", "CHEMICAL", 86, 102], ["neocryl XK-62", "CHEMICAL", 105, 118], ["ICHP", "CHEMICAL", 155, 159], ["Ethylene", "CHEMICAL", 77, 85], ["maleic anhydride", "CHEMICAL", 86, 102], ["neocryl XK-62", "CHEMICAL", 105, 118], ["FHV-1", "ORGANISM", 21, 26], ["FCV", "ORGANISM", 29, 32], ["Chlamydophila psittaci", "ORGANISM", 35, 57], ["FeLV", "ORGANISM", 60, 64], ["Ethylene", "SIMPLE_CHEMICAL", 77, 85], ["maleic anhydride", "SIMPLE_CHEMICAL", 86, 102], ["neocryl XK-62", "SIMPLE_CHEMICAL", 105, 118], ["emulsigen SA", "SIMPLE_CHEMICAL", 121, 133], ["Chlamydophila psittaci", "SPECIES", 35, 57], ["FCV", "SPECIES", 29, 32], ["Chlamydophila psittaci", "SPECIES", 35, 57], ["K-FPLV", "TEST", 12, 18], ["FHV", "TEST", 21, 24], ["FCV", "PROBLEM", 29, 32], ["Chlamydophila psittaci", "PROBLEM", 35, 57], ["FeLV", "PROBLEM", 60, 64], ["adjuvant (Ethylene/maleic anhydride", "TREATMENT", 67, 102], ["neocryl XK", "TREATMENT", 105, 115], ["Chlamydophila psittaci", "OBSERVATION", 35, 57]]], ["Reconstitute V. LFD with solvent and apply S/C twice 3-4 weeks apart from 9 weeks and boost annually.", [["S/C", "TREATMENT", 43, 46]]], ["Contra-indicated for pregnant queens.SCHERING-PLOUGH Quantum RangeCat CVRP V. LFD FCV + FHV-1 + FPLV and solvent.", [["FPLV", "SIMPLE_CHEMICAL", 96, 100], ["FHV", "TEST", 88, 91], ["FPLV and solvent", "TREATMENT", 96, 112]]], ["Reconstitute V. LFD with solvent or Quantum cat FELV and apply S/C twice 3-4 weeks apart from 9 weeks and boost annually. vaccines.", [["Quantum cat FELV", "TREATMENT", 36, 52], ["S/C", "TREATMENT", 63, 66], ["vaccines", "TREATMENT", 122, 130]]], ["The vaccinia-FeLV vaccine was ineffective while the other two live vector vaccines were not better than existing vaccines.", [["vaccinia", "ORGANISM", 4, 12], ["FeLV", "ORGANISM", 13, 17], ["The vaccinia", "TREATMENT", 0, 12], ["FeLV vaccine", "TREATMENT", 13, 25], ["live vector vaccines", "TREATMENT", 62, 82], ["existing vaccines", "TREATMENT", 104, 121]]], ["However, experimental vaccines that showed excellent protection were the FeLV iscoms [133] and FeLV DNA co-administered with interleukin 12 (IL-12) and IL-18 cytokine genes [134] .SCHERING-PLOUGH Quantum RangeFIV is a cause of significant disease in domestic cats worldwide.", [["FeLV", "ORGANISM", 73, 77], ["FeLV", "ORGANISM", 95, 99], ["DNA", "CELLULAR_COMPONENT", 100, 103], ["interleukin 12", "GENE_OR_GENE_PRODUCT", 125, 139], ["IL-12", "GENE_OR_GENE_PRODUCT", 141, 146], ["IL-18", "GENE_OR_GENE_PRODUCT", 152, 157], ["cats", "ORGANISM", 259, 263], ["FeLV DNA", "DNA", 95, 103], ["interleukin 12 (IL-12) and IL-18 cytokine genes", "DNA", 125, 172], ["cats", "SPECIES", 259, 263], ["FeLV", "SPECIES", 95, 99], ["experimental vaccines", "TREATMENT", 9, 30], ["the FeLV iscoms", "TEST", 69, 84], ["FeLV DNA co-administered", "TREATMENT", 95, 119], ["interleukin", "TEST", 125, 136], ["IL", "TEST", 141, 143], ["IL", "TEST", 152, 154], ["significant disease", "PROBLEM", 227, 246], ["significant", "OBSERVATION_MODIFIER", 227, 238], ["disease", "OBSERVATION", 239, 246], ["domestic cats", "OBSERVATION", 250, 263]]], ["Immunoprophylaxis for FIV disease is limited and only one company (F-D) offers a vaccine, approved in spring 2002.", [["FIV disease", "DISEASE", 22, 33], ["F-D", "CHEMICAL", 67, 70], ["FIV", "ORGANISM", 22, 25], ["F-D", "SIMPLE_CHEMICAL", 67, 70], ["FIV", "SPECIES", 22, 25], ["Immunoprophylaxis", "TREATMENT", 0, 17], ["FIV disease", "PROBLEM", 22, 33], ["a vaccine", "TREATMENT", 79, 88], ["FIV disease", "OBSERVATION", 22, 33]]], ["Currently the use of the vaccine is not recommended by The American Association of Feline Practitioners.", [["Feline", "ORGANISM", 83, 89], ["the vaccine", "TREATMENT", 21, 32]]], ["Like its human counterpart, the [135] with some success.", [["human", "ORGANISM", 9, 14], ["human", "SPECIES", 9, 14], ["human", "SPECIES", 9, 14]]], ["It has been shown that a multi-epitopic vaccine for instance does induce an immune response which is not protective [136] .", [["a multi-epitopic vaccine", "TREATMENT", 23, 47]]], ["An important difficulty has been the strain specificity of vaccines in that experimental vaccines were not protective for heterologous strains [137] .", [["vaccines", "TREATMENT", 59, 67], ["experimental vaccines", "TREATMENT", 76, 97], ["heterologous strains", "PROBLEM", 122, 142]]], ["The newly emergent HPAI H5N1 induced viral disease in dogs and cats is clearly a new challenge for the institutional and industrial virologists to develop yet another vaccine.", [["H5N1", "DISEASE", 24, 28], ["viral disease", "DISEASE", 37, 50], ["HPAI H5N1", "ORGANISM", 19, 28], ["dogs", "ORGANISM", 54, 58], ["cats", "ORGANISM", 63, 67], ["HPAI H5N1", "SPECIES", 19, 28], ["dogs", "SPECIES", 54, 58], ["cats", "SPECIES", 63, 67], ["HPAI H5N1", "SPECIES", 19, 28], ["The newly emergent HPAI H5N1 induced viral disease in dogs", "PROBLEM", 0, 58], ["another vaccine", "TREATMENT", 159, 174], ["HPAI", "OBSERVATION_MODIFIER", 19, 23], ["H5N1", "OBSERVATION", 24, 28], ["viral disease", "OBSERVATION", 37, 50]]], ["In this regard a conventional killed adjuvanted H5N6 flu virus vaccine was protective against lethal HPAI H5N1 experimental challenge in a controlled efficacy study in cats [93] .", [["H5N1", "DISEASE", 106, 110], ["H5N6 flu virus", "ORGANISM", 48, 62], ["cats", "ORGANISM", 168, 172], ["H5N6 flu virus", "SPECIES", 48, 62], ["HPAI H5N1", "SPECIES", 101, 110], ["cats", "SPECIES", 168, 172], ["H5N6 flu virus", "SPECIES", 48, 62], ["HPAI H5N1", "SPECIES", 101, 110], ["a conventional killed adjuvanted H5N6 flu virus vaccine", "TREATMENT", 15, 70], ["lethal HPAI H5N1 experimental challenge", "TREATMENT", 94, 133]]], ["Booster vaccination after the primary course and DOI is an important issue in the recent vaccination debate particularly for the dog and cat vaccines.", [["DOI", "CHEMICAL", 49, 52], ["DOI", "CHEMICAL", 49, 52], ["dog", "ORGANISM", 129, 132], ["cat", "ORGANISM", 137, 140], ["dog", "SPECIES", 129, 132], ["dog", "SPECIES", 129, 132], ["Booster vaccination", "TREATMENT", 0, 19], ["the dog and cat vaccines", "TREATMENT", 125, 149]]], ["However, the time for the booster vaccination is difficult to assess since (i) response of individual animals to routine vaccination is highly variable which is also influenced by the level of MDA at primary vaccination, (ii) the frequency of field exposure is often unknown and (iii) products vary with respect to potency and formulation.", [["MDA", "CHEMICAL", 193, 196], ["MDA", "CHEMICAL", 193, 196], ["MDA", "SIMPLE_CHEMICAL", 193, 196], ["the booster vaccination", "TREATMENT", 22, 45], ["routine vaccination", "TEST", 113, 132], ["potency and formulation", "TREATMENT", 315, 338]]], ["Antibody test may be appropriate for establishing residual immunity for some antigens but not all and the cost is likely to exceed that of booster vaccination [138] .", [["antigens", "PROTEIN", 77, 85], ["Antibody test", "TEST", 0, 13], ["some antigens", "PROBLEM", 72, 85]]], ["However, in general, for the so-called core dog vaccines for CAV-2, CDV, CPV and rabies and cat vaccines for FPLV, FCV, FHV-1 and rabies published data suggest a minimum DOI of 3 years [139] .", [["DOI", "CHEMICAL", 170, 173], ["DOI", "CHEMICAL", 170, 173], ["dog", "ORGANISM", 44, 47], ["CAV-2", "ORGANISM", 61, 66], ["CDV", "ORGANISM", 68, 71], ["CPV", "ORGANISM", 73, 76], ["rabies", "ORGANISM", 81, 87], ["cat", "ORGANISM", 92, 95], ["FCV", "ORGANISM", 115, 118], ["FHV-1", "ORGANISM", 120, 125], ["rabies", "ORGANISM", 130, 136], ["CDV", "SPECIES", 68, 71], ["CPV", "SPECIES", 73, 76], ["rabies", "SPECIES", 81, 87], ["cat", "SPECIES", 92, 95], ["FPLV", "SPECIES", 109, 113], ["FCV", "SPECIES", 115, 118], ["FHV-1", "SPECIES", 120, 125], ["rabies", "SPECIES", 130, 136], ["the so-called core dog vaccines", "TREATMENT", 25, 56], ["CAV", "TEST", 61, 64], ["CDV", "PROBLEM", 68, 71], ["CPV", "TREATMENT", 73, 76], ["rabies", "TREATMENT", 81, 87], ["cat vaccines", "TREATMENT", 92, 104], ["FPLV", "TEST", 109, 113], ["FCV", "TEST", 115, 118], ["FHV", "TEST", 120, 123]]], ["Therefore for these core vaccines a general vaccination guideline should be first vaccination at as early as 6 weeks of age or older (>12 weeks) depending on disease and available vaccine type (live versus killed), then again at 1 year and then every 3 years.", [["these core vaccines", "TREATMENT", 14, 33], ["a general vaccination guideline", "TREATMENT", 34, 65], ["disease", "PROBLEM", 158, 165]]], ["For the non-core vaccines yearly boosters are recommended.", [["the non-core vaccines", "TREATMENT", 4, 25]]], ["Animals with high MDA may require two vaccinations in the primary vaccination regimes.SCHERING-PLOUGH Quantum RangeFor rabbits, diseases covered by vaccine companies are those due to RHDV and MV but the choice of vaccines is rather limited (Table 3) .", [["MDA", "CHEMICAL", 18, 21], ["RHDV", "DISEASE", 183, 187], ["MDA", "CHEMICAL", 18, 21], ["Animals", "ORGANISM", 0, 7], ["MDA", "SIMPLE_CHEMICAL", 18, 21], ["rabbits", "ORGANISM", 119, 126], ["RHDV", "ORGANISM", 183, 187], ["rabbits", "SPECIES", 119, 126], ["RHDV", "SPECIES", 183, 187], ["MV", "SPECIES", 192, 194], ["two vaccinations", "TREATMENT", 34, 50], ["the primary vaccination regimes", "TREATMENT", 54, 85], ["diseases", "PROBLEM", 128, 136], ["RHDV", "PROBLEM", 183, 187], ["MV", "TREATMENT", 192, 194], ["vaccines", "TREATMENT", 213, 221]]], ["For RHDV CEVA and F-D have a similar formulation of rabbit grown liver antigen [140, 141] plus oil adjuvant.", [["liver", "ANATOMY", 65, 70], ["oil", "ANATOMY", 95, 98], ["140, 141]", "CHEMICAL", 80, 89], ["RHDV", "ORGANISM", 4, 8], ["F-D", "SIMPLE_CHEMICAL", 18, 21], ["rabbit", "ORGANISM", 52, 58], ["liver", "ORGAN", 65, 70], ["oil", "ORGANISM_SUBSTANCE", 95, 98], ["rabbit", "SPECIES", 52, 58], ["RHDV", "SPECIES", 4, 8], ["rabbit", "SPECIES", 52, 58], ["a similar formulation", "TREATMENT", 27, 48], ["liver antigen", "TEST", 65, 78], ["oil adjuvant", "TREATMENT", 95, 107], ["liver", "ANATOMY", 65, 70]]], ["Since RHDV has failed to grow in tissue culture, various expression vectors have been developed for the production of RHDV capsid VP60 protein.", [["tissue culture", "ANATOMY", 33, 47], ["RHDV", "ORGANISM", 6, 10], ["tissue culture", "CELL", 33, 47], ["RHDV", "ORGANISM", 118, 122], ["VP60", "GENE_OR_GENE_PRODUCT", 130, 134], ["RHDV capsid VP60 protein", "PROTEIN", 118, 142], ["RHDV", "SPECIES", 6, 10], ["RHDV", "SPECIES", 118, 122], ["RHDV", "PROBLEM", 6, 10], ["tissue culture", "TEST", 33, 47], ["various expression vectors", "TREATMENT", 49, 75], ["RHDV capsid VP60 protein", "TREATMENT", 118, 142], ["RHDV", "OBSERVATION", 6, 10]]], ["These vectors comprise E. Coli [142] , Saccharomyces cerevisae [143] , poxviruses: myxoma [144] , vaccinia [145] , canarypox [146] .", [["myxoma", "DISEASE", 83, 89], ["E. Coli [142]", "ORGANISM", 23, 36], ["Saccharomyces cerevisae [143]", "ORGANISM", 39, 68], ["poxviruses", "ORGANISM", 71, 81], ["vaccinia", "ORGANISM", 98, 106], ["E. Coli", "SPECIES", 23, 30], ["Saccharomyces cerevisae", "SPECIES", 39, 62], ["E. Coli", "SPECIES", 23, 30], ["Saccharomyces cerevisae", "SPECIES", 39, 62], ["E. Coli", "TEST", 23, 30], ["Saccharomyces cerevisae", "TREATMENT", 39, 62], ["myxoma", "PROBLEM", 83, 89], ["vaccinia", "TREATMENT", 98, 106], ["myxoma", "OBSERVATION", 83, 89]]], ["VP60 was also produced in rabbit kidney cell line RK-13 [147] and potato [148] and baculovirus [149] .", [["kidney cell line", "ANATOMY", 33, 49], ["RK-13 [147] and potato [148]", "CHEMICAL", 50, 78], ["VP60", "GENE_OR_GENE_PRODUCT", 0, 4], ["rabbit", "ORGANISM", 26, 32], ["kidney cell line RK-13 [147]", "CELL", 33, 61], ["potato", "ORGANISM", 66, 72], ["baculovirus", "ORGANISM", 83, 94], ["VP60", "PROTEIN", 0, 4], ["rabbit kidney cell line", "CELL_LINE", 26, 49], ["rabbit", "SPECIES", 26, 32], ["potato", "SPECIES", 66, 72], ["rabbit", "SPECIES", 26, 32], ["potato", "SPECIES", 66, 72], ["baculovirus", "SPECIES", 83, 94], ["VP60", "TEST", 0, 4], ["RK", "TEST", 50, 52], ["potato", "TEST", 66, 72], ["baculovirus", "TEST", 83, 94], ["kidney", "ANATOMY", 33, 39], ["cell line", "OBSERVATION", 40, 49]]], ["Many of the vector expressed VP60 antigens incorporated into experimental vaccines were immunogenic and protective for rabbits against fatal RHDV challenge [150] .", [["RHDV", "DISEASE", 141, 145], ["VP60", "GENE_OR_GENE_PRODUCT", 29, 33], ["rabbits", "ORGANISM", 119, 126], ["RHDV", "ORGANISM", 141, 145], ["VP60 antigens", "PROTEIN", 29, 42], ["rabbits", "SPECIES", 119, 126], ["rabbits", "SPECIES", 119, 126], ["RHDV", "SPECIES", 141, 145], ["experimental vaccines", "TREATMENT", 61, 82], ["rabbits", "TREATMENT", 119, 126], ["fatal RHDV challenge", "PROBLEM", 135, 155]]], ["Commercially only one MV disease for domestic rabbits is marketed by Intervet ( Table 3 ).", [["MV disease", "DISEASE", 22, 32], ["rabbits", "ORGANISM", 46, 53], ["rabbits", "SPECIES", 46, 53], ["MV", "SPECIES", 22, 24], ["rabbits", "SPECIES", 46, 53], ["one MV disease", "PROBLEM", 18, 32], ["domestic rabbits", "TREATMENT", 37, 53], ["one MV", "OBSERVATION_MODIFIER", 18, 24], ["disease", "OBSERVATION", 25, 32]]], ["The latter is a live heterotypic vaccine based on less pathogenic leporipox Shope fibroma virus.", [["fibroma", "DISEASE", 82, 89], ["leporipox Shope fibroma virus", "ORGANISM", 66, 95], ["leporipox Shope fibroma virus", "SPECIES", 66, 95], ["a live heterotypic vaccine", "TREATMENT", 14, 40], ["less pathogenic leporipox Shope fibroma virus", "PROBLEM", 50, 95], ["leporipox Shope fibroma", "OBSERVATION", 66, 89]]], ["For both RHDV and MV diseases a key requirement is vaccines which could be used for both domestic and wild rabbits.", [["RHDV and MV diseases", "DISEASE", 9, 29], ["RHDV", "ORGANISM", 9, 13], ["rabbits", "ORGANISM", 107, 114], ["RHDV", "SPECIES", 9, 13], ["rabbits", "SPECIES", 107, 114], ["RHDV", "SPECIES", 9, 13], ["MV", "SPECIES", 18, 20], ["rabbits", "SPECIES", 107, 114], ["both RHDV", "PROBLEM", 4, 13], ["MV diseases", "PROBLEM", 18, 29], ["a key requirement", "PROBLEM", 30, 47], ["vaccines", "TREATMENT", 51, 59], ["RHDV", "OBSERVATION", 9, 13], ["MV diseases", "OBSERVATION", 18, 29]]], ["This entails a strategy for wildlife immunisation which is feasible as has been achieved for sylvatic rabies control in Europe and North America by oral vaccines delivered by baiting [151] [152] [153] .", [["oral", "ANATOMY", 148, 152], ["rabies", "DISEASE", 102, 108], ["oral", "ORGANISM_SUBDIVISION", 148, 152], ["rabies", "SPECIES", 102, 108], ["a strategy", "TREATMENT", 13, 23], ["wildlife immunisation", "TREATMENT", 28, 49], ["sylvatic rabies control", "TREATMENT", 93, 116]]], ["Other methods are delivery by biting insects and/or by direct horizontal animal to animal vaccine spread.", [["Other methods", "TREATMENT", 0, 13], ["delivery", "TREATMENT", 18, 26]]], ["All these three modes of vaccination against RHDV and MV diseases were elegantly demonstrated by controlled experimental challenge studies [150] .", [["RHDV and MV diseases", "DISEASE", 45, 65], ["RHDV", "ORGANISM", 45, 49], ["RHDV", "SPECIES", 45, 49], ["RHDV", "SPECIES", 45, 49], ["MV", "SPECIES", 54, 56], ["vaccination", "TREATMENT", 25, 36], ["RHDV", "PROBLEM", 45, 49], ["MV diseases", "PROBLEM", 54, 65]]], ["However we do wonder if such a vaccine would indeed be commercialised.ConclusionsThe main conclusions we draw from the above account of important viral diseases of cats, dogs and rabbits are: 1.", [["viral diseases", "DISEASE", 146, 160], ["cats", "ORGANISM", 164, 168], ["dogs", "ORGANISM", 170, 174], ["rabbits", "ORGANISM", 179, 186], ["cats", "SPECIES", 164, 168], ["dogs", "SPECIES", 170, 174], ["rabbits", "SPECIES", 179, 186], ["a vaccine", "TREATMENT", 29, 38], ["important viral diseases of cats", "PROBLEM", 136, 168], ["main", "OBSERVATION_MODIFIER", 85, 89], ["viral diseases", "OBSERVATION", 146, 160]]], ["Viruses from several different families naturally infect these companion animals and cause significant disease.", [["Viruses", "PROBLEM", 0, 7], ["significant disease", "PROBLEM", 91, 110], ["significant", "OBSERVATION_MODIFIER", 91, 102], ["disease", "OBSERVATION", 103, 110]]], ["Most of the viruses are transmitted via the oropharyngeal route by virus shed in secretions of saliva, nasal mucus, aerosol and/or faeces.", [["oropharyngeal", "ANATOMY", 44, 57], ["secretions", "ANATOMY", 81, 91], ["saliva", "ANATOMY", 95, 101], ["nasal mucus", "ANATOMY", 103, 114], ["faeces", "ANATOMY", 131, 137], ["oropharyngeal route", "MULTI-TISSUE_STRUCTURE", 44, 63], ["secretions", "ORGANISM_SUBSTANCE", 81, 91], ["saliva", "ORGANISM_SUBSTANCE", 95, 101], ["nasal mucus", "MULTI-TISSUE_STRUCTURE", 103, 114], ["faeces", "ORGANISM_SUBSTANCE", 131, 137], ["the viruses", "PROBLEM", 8, 19], ["viruses", "OBSERVATION", 12, 19], ["oropharyngeal", "ANATOMY", 44, 57], ["virus", "OBSERVATION", 67, 72], ["nasal mucus", "ANATOMY", 103, 114]]], ["Virus in secretions is inhaled and/or ingested and initiates primary replication in mucosa of the respiratory and/or intestinal tracts; rabies virus shed in saliva, is however delivered to myocytes, the site of primary replication, via bite while myxomavirus is trans-mitted by blood feeding arthropod vectors such as mosquitoes, fleas and others in addition to inhalation of virus.", [["secretions", "ANATOMY", 9, 19], ["mucosa", "ANATOMY", 84, 90], ["respiratory", "ANATOMY", 98, 109], ["intestinal tracts", "ANATOMY", 117, 134], ["myocytes", "ANATOMY", 189, 197], ["blood", "ANATOMY", 278, 283], ["Virus", "ORGANISM", 0, 5], ["secretions", "ORGANISM_SUBSTANCE", 9, 19], ["mucosa", "MULTI-TISSUE_STRUCTURE", 84, 90], ["respiratory", "ORGAN", 98, 109], ["intestinal tracts", "MULTI-TISSUE_STRUCTURE", 117, 134], ["rabies virus", "ORGANISM", 136, 148], ["saliva", "ORGANISM_SUBSTANCE", 157, 163], ["myocytes", "CELL", 189, 197], ["blood", "ORGANISM_SUBSTANCE", 278, 283], ["rabies virus", "SPECIES", 136, 148], ["rabies virus", "SPECIES", 136, 148], ["Virus in secretions", "PROBLEM", 0, 19], ["primary replication in mucosa of the respiratory and/or intestinal tracts", "PROBLEM", 61, 134], ["rabies virus shed in saliva", "PROBLEM", 136, 163], ["primary replication", "TREATMENT", 211, 230], ["blood feeding arthropod vectors", "TREATMENT", 278, 309], ["mosquitoes", "PROBLEM", 318, 328], ["fleas", "PROBLEM", 330, 335], ["inhalation of virus", "PROBLEM", 362, 381], ["secretions", "OBSERVATION", 9, 19], ["respiratory", "ANATOMY", 98, 109], ["intestinal tracts", "ANATOMY", 117, 134], ["rabies virus", "OBSERVATION", 136, 148], ["myocytes", "ANATOMY", 189, 197], ["primary replication", "OBSERVATION", 211, 230]]], ["In disease pathogenesis an important determinant for significant disease is if the virus is able to infect leukocytes and then be disseminated to internal organs for secondary replication and cause pathology.", [["leukocytes", "ANATOMY", 107, 117], ["organs", "ANATOMY", 155, 161], ["leukocytes", "CELL", 107, 117], ["organs", "ORGAN", 155, 161], ["leukocytes", "CELL_TYPE", 107, 117], ["significant disease", "PROBLEM", 53, 72], ["the virus", "PROBLEM", 79, 88], ["secondary replication", "PROBLEM", 166, 187], ["pathology", "PROBLEM", 198, 207], ["disease", "OBSERVATION", 3, 10], ["important determinant for", "UNCERTAINTY", 27, 52], ["significant", "OBSERVATION_MODIFIER", 53, 64], ["disease", "OBSERVATION", 65, 72]]], ["However most cat and dog coronaviruses are generally restricted to the primary site of infection and cause acute, self-limiting mild enteric or respiratory and disease.", [["respiratory", "ANATOMY", 144, 155], ["infection", "DISEASE", 87, 96], ["enteric or respiratory and disease", "DISEASE", 133, 167], ["cat", "ORGANISM", 13, 16], ["dog coronaviruses", "ORGANISM", 21, 38], ["cat", "SPECIES", 13, 16], ["dog", "SPECIES", 21, 24], ["dog coronaviruses", "SPECIES", 21, 38], ["most cat and dog coronaviruses", "PROBLEM", 8, 38], ["infection", "PROBLEM", 87, 96], ["self-limiting mild enteric or respiratory and disease", "PROBLEM", 114, 167], ["dog coronaviruses", "OBSERVATION", 21, 38], ["infection", "OBSERVATION", 87, 96], ["acute", "OBSERVATION_MODIFIER", 107, 112], ["mild", "OBSERVATION_MODIFIER", 128, 132], ["enteric", "OBSERVATION_MODIFIER", 133, 140], ["respiratory", "ANATOMY", 144, 155], ["disease", "OBSERVATION", 160, 167]]], ["Vicerotopic virulent strains also occur naturally with variable frequency following mutational changes.", [["Vicerotopic virulent strains", "PROBLEM", 0, 28], ["mutational changes", "PROBLEM", 84, 102], ["virulent strains", "OBSERVATION", 12, 28]]], ["Examples are FCoVs causing infectious peritonitis and the recent cases of genotype 2 CCoV strain CB/05 disease in dogs.", [["peritonitis", "DISEASE", 38, 49], ["FCoVs", "GENE_OR_GENE_PRODUCT", 13, 18], ["dogs", "ORGANISM", 114, 118], ["dogs", "SPECIES", 114, 118], ["FCoVs", "PROBLEM", 13, 18], ["infectious peritonitis", "PROBLEM", 27, 49], ["genotype 2 CCoV strain CB/05 disease in dogs", "PROBLEM", 74, 118], ["infectious", "OBSERVATION_MODIFIER", 27, 37], ["peritonitis", "OBSERVATION", 38, 49]]], ["Like the coronaviruses, most calicivirus infections of cats are limited to the respiratory tract resulting in self-limiting disease but recent emergence of vicerotropic VS-FCV variants cause severe disease in cats and the disease pathogenesis has similarities to the usually fatal disease of rabbits due to RHDV.", [["respiratory tract", "ANATOMY", 79, 96], ["calicivirus infections", "DISEASE", 29, 51], ["RHDV", "DISEASE", 307, 311], ["calicivirus", "ORGANISM", 29, 40], ["cats", "ORGANISM", 55, 59], ["respiratory tract", "ORGANISM_SUBDIVISION", 79, 96], ["vicerotropic VS-FCV", "ORGANISM", 156, 175], ["cats", "ORGANISM", 209, 213], ["rabbits", "ORGANISM", 292, 299], ["RHDV", "ORGANISM", 307, 311], ["cats", "SPECIES", 55, 59], ["cats", "SPECIES", 209, 213], ["rabbits", "SPECIES", 292, 299], ["rabbits", "SPECIES", 292, 299], ["RHDV", "SPECIES", 307, 311], ["the coronaviruses", "PROBLEM", 5, 22], ["most calicivirus infections of cats", "PROBLEM", 24, 59], ["the respiratory tract", "PROBLEM", 75, 96], ["self-limiting disease", "PROBLEM", 110, 131], ["vicerotropic VS", "TEST", 156, 171], ["FCV variants", "PROBLEM", 172, 184], ["severe disease in cats", "PROBLEM", 191, 213], ["the disease pathogenesis", "PROBLEM", 218, 242], ["the usually fatal disease of rabbits", "PROBLEM", 263, 299], ["RHDV", "PROBLEM", 307, 311], ["coronaviruses", "OBSERVATION", 9, 22], ["calicivirus", "OBSERVATION_MODIFIER", 29, 40], ["infections", "OBSERVATION", 41, 51], ["respiratory tract", "ANATOMY", 79, 96], ["self-limiting", "OBSERVATION_MODIFIER", 110, 123], ["disease", "OBSERVATION", 124, 131], ["severe", "OBSERVATION_MODIFIER", 191, 197], ["disease", "OBSERVATION", 198, 205], ["fatal", "OBSERVATION_MODIFIER", 275, 280], ["disease", "OBSERVATION", 281, 288], ["RHDV", "OBSERVATION", 307, 311]]], ["Leukocyte-associated viraemia is also important in parvovirus disease of cats and dogs and related wild felids and canids.", [["Leukocyte", "ANATOMY", 0, 9], ["viraemia", "DISEASE", 21, 29], ["parvovirus disease", "DISEASE", 51, 69], ["Leukocyte", "CELL", 0, 9], ["parvovirus", "ORGANISM", 51, 61], ["cats", "ORGANISM", 73, 77], ["dogs", "ORGANISM", 82, 86], ["cats", "SPECIES", 73, 77], ["dogs", "SPECIES", 82, 86], ["Leukocyte", "TEST", 0, 9], ["viraemia", "PROBLEM", 21, 29], ["parvovirus disease of cats and dogs", "PROBLEM", 51, 86], ["viraemia", "OBSERVATION", 21, 29], ["parvovirus disease", "OBSERVATION", 51, 69]]], ["The tropism for enteric epithelium and virus survival in faces has been important in evolution of the carnivore parvoviruses.", [["enteric epithelium", "ANATOMY", 16, 34], ["enteric epithelium", "TISSUE", 16, 34], ["carnivore parvoviruses", "ORGANISM", 102, 124], ["enteric epithelium", "PROBLEM", 16, 34], ["virus survival", "TREATMENT", 39, 53], ["the carnivore parvoviruses", "PROBLEM", 98, 124], ["enteric epithelium", "ANATOMY", 16, 34], ["virus survival", "OBSERVATION", 39, 53], ["carnivore parvoviruses", "OBSERVATION", 102, 124]]], ["CPV has naturally evolved relatively rapidly and the small evolutionary changes have been in virus capsid VP2 gene and interestingly were associated with the loss and then renovation of the feline host range.", [["CPV", "ORGANISM", 0, 3], ["VP2", "GENE_OR_GENE_PRODUCT", 106, 109], ["feline", "ORGANISM", 190, 196], ["virus capsid VP2 gene", "DNA", 93, 114], ["CPV", "SPECIES", 0, 3], ["CPV", "PROBLEM", 0, 3], ["the small evolutionary changes", "PROBLEM", 49, 79], ["the loss", "PROBLEM", 154, 162], ["small", "OBSERVATION_MODIFIER", 53, 58], ["VP2 gene", "OBSERVATION", 106, 114], ["feline host range", "OBSERVATION", 190, 207]]], ["For the established viruses of the cats and dogs there is a good choice of vaccines developed 10-20 years ago.", [["cats", "ORGANISM", 35, 39], ["dogs", "ORGANISM", 44, 48], ["cats", "SPECIES", 35, 39], ["dogs", "SPECIES", 44, 48], ["vaccines", "TREATMENT", 75, 83], ["viruses", "OBSERVATION", 20, 27]]], ["Hence, they are due for re-assessment for their efficacy for some components notably the newly emergent CPVs and VS-FCV.", [["CPVs", "CANCER", 104, 108], ["FCV", "ORGANISM", 116, 119], ["re-assessment", "TEST", 24, 37], ["some components", "PROBLEM", 61, 76], ["VS", "TEST", 113, 115]]], ["There is however the need for improved vaccines for FIPV, FeLV and FIV.", [["FIPV", "SIMPLE_CHEMICAL", 52, 56], ["FeLV", "ORGANISM", 58, 62], ["FIV", "ORGANISM", 67, 70], ["FIPV", "SPECIES", 52, 56], ["FeLV", "SPECIES", 58, 62], ["FIV", "SPECIES", 67, 70], ["improved vaccines", "TREATMENT", 30, 47], ["FIPV", "PROBLEM", 52, 56]]], ["This is also the case for MV and RHDV vaccines for rabbits.", [["RHDV", "ORGANISM", 33, 37], ["rabbits", "ORGANISM", 51, 58], ["rabbits", "SPECIES", 51, 58], ["MV", "SPECIES", 26, 28], ["RHDV", "SPECIES", 33, 37], ["rabbits", "SPECIES", 51, 58], ["MV", "TREATMENT", 26, 28], ["RHDV vaccines", "TREATMENT", 33, 46]]], ["Also needed is RHDV vaccine for wild rabbits.", [["RHDV", "ORGANISM", 15, 19], ["rabbits", "ORGANISM", 37, 44], ["rabbits", "SPECIES", 37, 44], ["RHDV", "SPECIES", 15, 19], ["rabbits", "SPECIES", 37, 44], ["RHDV vaccine", "TREATMENT", 15, 27], ["RHDV", "OBSERVATION", 15, 19]]], ["The recent emergence of HPAI H5N1 disease in cats and other large felids and that of H3N8 equine influenza virus in dogs are significant developments and may require vaccines should the viruses get established in these novel hosts and spread more widely.", [["HPAI H5N1 disease", "DISEASE", 24, 41], ["influenza virus", "DISEASE", 97, 112], ["HPAI H5N1", "ORGANISM", 24, 33], ["cats", "ORGANISM", 45, 49], ["H3N8 equine influenza virus", "ORGANISM", 85, 112], ["dogs", "ORGANISM", 116, 120], ["HPAI H5N1", "SPECIES", 24, 33], ["cats", "SPECIES", 45, 49], ["equine influenza virus", "SPECIES", 90, 112], ["dogs", "SPECIES", 116, 120], ["HPAI H5N1", "SPECIES", 24, 33], ["H3N8 equine influenza virus", "SPECIES", 85, 112], ["HPAI H5N1 disease in cats", "PROBLEM", 24, 49], ["other large felids", "PROBLEM", 54, 72], ["H3N8 equine influenza virus in dogs", "PROBLEM", 85, 120], ["vaccines", "TREATMENT", 166, 174], ["the viruses", "PROBLEM", 182, 193], ["HPAI", "OBSERVATION_MODIFIER", 24, 28], ["H5N1", "OBSERVATION", 29, 33]]], ["Also we should be aware that cats and dogs have the potential to acquire new viral diseases for example those due henipa paramyxoviruses.", [["viral diseases", "DISEASE", 77, 91], ["cats", "ORGANISM", 29, 33], ["dogs", "ORGANISM", 38, 42], ["henipa paramyxoviruses", "ORGANISM", 114, 136], ["cats", "SPECIES", 29, 33], ["dogs", "SPECIES", 38, 42], ["new viral diseases", "PROBLEM", 73, 91], ["henipa paramyxoviruses", "PROBLEM", 114, 136]]]], "f4add95c5780a47a61a941086e17d45f1179b3b9": [["(46) , sur une 6tude faite en Angleterre chez des enfants ~g6s de quelques semaines ~ 12 ans, 6voquent le rSle des ent6rovirus dans 5 % des cas 6tudi$s.", [["6voquent le rSle des ent6rovirus dans", "TREATMENT", 94, 131]]], ["Ils montrent, au cours de la m~me 6tude, que ces virus sont beaucoup plus fr6quemment isol6s chez les jeunes enfants (1 ~ 10 ans) que chez les enfants de 10 ~ 16 ans.", [["que ces virus", "PROBLEM", 41, 54]]]], "f0ccb1992b82b281dfe4ebfc9db4c7a29cd41148": [["At Cell Metabolism, we believe the study and evaluation of science is strengthened by diverse perspectives.", [["Cell", "ANATOMY", 3, 7], ["Cell", "CELL", 3, 7], ["the study", "TEST", 31, 40], ["evaluation", "TEST", 45, 55], ["Cell Metabolism", "OBSERVATION", 3, 18]]], ["All minorities and backgrounds of diverse races and ethnicities are paramount to creating an inclusive culture necessary to strengthen science for all (Asai, 2020) .", [["diverse races", "PROBLEM", 34, 47], ["an inclusive culture", "TEST", 90, 110], ["diverse", "OBSERVATION_MODIFIER", 34, 41]]]], "6cae469d9d92e2acd68eb5b615914792ca324eab": [["For instance, in mathlib [10], the mathematical library for the Lean theorem prover [7] , the ring tactic normalises expressions in a commutative (semi)ring.", [["a commutative (semi)ring", "TREATMENT", 132, 156]]], ["The ring tactic in Lean can be directly invoked by the user and is called by the decision procedure linarith.", [["ring", "OBSERVATION_MODIFIER", 4, 8], ["tactic", "OBSERVATION_MODIFIER", 9, 15]]], ["The utility of ring is evident from the fact that it is invoked over 300 times in mathlib.IntroductionThe ring tactic in Lean, and the tactic in Coq it is based on, use a Horner normal form representation of polynomials [4] .", [["The ring tactic in Lean", "TREATMENT", 102, 125], ["ring", "OBSERVATION_MODIFIER", 106, 110], ["tactic", "OBSERVATION_MODIFIER", 111, 117]]], ["The Horner form represents a polynomial f (x) with one of two cases: either it is constant (f (x) = c) or it is of the form f (x) = c + x * g(x).", [["Horner", "DISEASE", 4, 10], ["Horner", "OBSERVATION", 4, 10]]], ["The Horner form fundamentally assumes the degree of a term is a constant integer, so it cannot be simply modified to represent variable exponents, or more generally to represent \u2227 applied to compound expressions.", [["Horner", "DISEASE", 4, 10], ["variable exponents", "PROBLEM", 127, 145], ["Horner", "OBSERVATION", 4, 10], ["variable", "OBSERVATION_MODIFIER", 127, 135], ["exponents", "OBSERVATION", 136, 145]]], ["The analogous procedures in other theorem provers have the same restriction.", [["The analogous procedures", "TREATMENT", 0, 24]]], ["Adding rewrite rules such as x n+1 \u2192 x * x n is not a universal solution.", [["a universal solution", "TREATMENT", 52, 72]]], ["This rule would unfold the expression x 100 into a large term composed of repeated multiplications, reducing the performance of the procedure significantly.", [["repeated multiplications", "TREATMENT", 74, 98], ["the procedure", "TREATMENT", 128, 141]]], ["The result is that ring cannot prove that 2 n+1 \u2212 1 = 2 * 2 n \u2212 1 for a free variable n : N.IntroductionThe ring exp tactic uses a new extensible normal form, currently supporting the operators +, * and \u2227 , numerals and variables.", [["ring exp", "OBSERVATION", 108, 116]]], ["Its domain is a strict superset of the domain of previous semiring tactics, without sacrificing too much of the efficiency of ring.", [["previous semiring tactics", "TREATMENT", 49, 74], ["ring", "OBSERVATION_MODIFIER", 126, 130]]], ["This paper describes the design and engineering challenges encountered in implementing ring exp.IntroductionThe version of ring exp discussed in this paper was merged into mathlib in commit 5c09372658.", [["The version of ring exp", "TREATMENT", 108, 131], ["ring exp", "OBSERVATION", 87, 95]]], ["2Design OverviewThe ring exp tactic uses a normalisation scheme similar to the original ring tactic.", [["The ring exp tactic", "TREATMENT", 16, 35], ["a normalisation scheme", "PROBLEM", 41, 63], ["the original ring tactic", "TREATMENT", 75, 99], ["ring", "OBSERVATION_MODIFIER", 20, 24], ["exp", "OBSERVATION_MODIFIER", 25, 28]]], ["The input from the tactic system is an abstract syntax tree representing the expression to normalise.", [["abstract syntax", "OBSERVATION", 39, 54]]], ["An eval function maps inputs to a type ex of normalised expressions.", [["An eval function maps inputs", "TEST", 0, 28]]], ["The normal form should be designed in such a way that values of type ex are equal if and only if the input expressions can be proved equal using the axioms of commutative semirings.", [["commutative semirings", "TREATMENT", 159, 180], ["normal", "OBSERVATION", 4, 10]]], ["From the ex representation, the normalised output expression is constructed by a function simple.", [["output expression", "OBSERVATION", 43, 60], ["simple", "OBSERVATION_MODIFIER", 90, 96]]], ["Both eval and simple additionally return a proof showing that the input and output expressions are equal.Design OverviewThe ring exp tactic does not use reflection but directly constructs proof terms to be type checked by Lean's kernel, as is typical for tactics in mathlib [10].", [["Both eval", "TEST", 0, 9], ["the input and output expressions", "TEST", 62, 94], ["equal", "OBSERVATION_MODIFIER", 99, 104], ["ring", "OBSERVATION_MODIFIER", 124, 128], ["exp", "OBSERVATION", 129, 132]]], ["Reflective tactics avoid the construction and checking of a large proof term by performing most computation during proof checking, running a verified program [2] .", [["the construction", "TREATMENT", 25, 41]]], ["If the proof checker performs efficient reduction, this results in a significant speed-up of the tactic, at the same time as providing more correctness guarantees.", [["efficient reduction", "TREATMENT", 30, 49]]], ["The input expression can consist of these operators applied to other expressions, with two base cases: natural numerals such as 0 and 37, and atoms.", [["these operators", "TREATMENT", 36, 51]]], ["It is treated as an opaque variable in the expression.", [["opaque", "OBSERVATION_MODIFIER", 20, 26], ["variable", "OBSERVATION_MODIFIER", 27, 35]]], ["Two such expressions are considered equal if in every commutative semiring they evaluate to equal values, for any assignment to the atoms.Design OverviewUsing a suitable representation of the normal form is crucial to easily guarantee correctness of the normaliser.", [["normal", "OBSERVATION", 192, 198]]], ["Since there is no clear way to generalise the Horner form, ring exp instead represents its normal form ex as a tree with operators at the nodes and atoms at the leaves.", [["nodes", "ANATOMY", 138, 143], ["leaves", "ANATOMY", 161, 167], ["Horner", "DISEASE", 46, 52], ["leaves", "ORGANISM_SUBDIVISION", 161, 167], ["ring exp", "PROBLEM", 59, 67], ["no", "UNCERTAINTY", 15, 17], ["clear", "OBSERVATION", 18, 23], ["nodes", "ANATOMY", 138, 143]]], ["Certain classes of nonnormalised expressions are prohibited by restricting which sub-node can occur for each node.", [["sub-node", "ANATOMY", 81, 89], ["node", "ANATOMY", 109, 113], ["-node", "MULTI-TISSUE_STRUCTURE", 84, 89], ["node", "MULTI-TISSUE_STRUCTURE", 109, 113], ["nonnormalised expressions", "PROBLEM", 19, 44], ["nonnormalised expressions", "OBSERVATION", 19, 44], ["node", "OBSERVATION", 85, 89], ["node", "OBSERVATION", 109, 113]]], ["Thus, the term sum (prod (exp (var n) (coeff 1)) (coeff 1)) zero (with ex info fields omitted) is written as n 1 * 1 + 0, and the normalised form of 2 n \u2212 1 is written (2 + 0) n 1 * 1 * 1 + (\u22121) + 0.Design OverviewThe types of the arguments to each constructor are determined by the associativity and distributivity properties of the operators involved, summarised in Table 1 .", [["the term sum (prod (exp (var n) (coeff", "TREATMENT", 6, 44]]], ["Since addition does not distribute over either other operator (as seen from the empty entries on the + row), an expression with a sum as outermost operator cannot be rewritten so that another operator is outermost.", [["a sum as outermost operator", "TREATMENT", 128, 155]]], ["By associativity (the diagonal entries of the table) the left argument to + should have * as outermost operator; otherwise we can apply the rewrite rule (a + b) + c \u2192 a + (b + c).", [["the rewrite rule", "TEST", 136, 152], ["left", "ANATOMY_MODIFIER", 57, 61]]], ["Analogously, the left argument to the prod constructor is not an ex prod but an ex exp, and the left argument to exp is an ex base.Design OverviewThe eval function interprets each operator in the input expression as a corresponding operation on ex, building a normal form for the whole expression out of normalised subexpressions.", [["exp", "DNA", 113, 116], ["an ex exp", "TEST", 77, 86], ["The eval function", "TEST", 146, 163], ["normalised subexpressions", "PROBLEM", 304, 329], ["left", "ANATOMY_MODIFIER", 17, 21], ["ex", "OBSERVATION_MODIFIER", 65, 67], ["prod", "OBSERVATION", 68, 72], ["ex", "OBSERVATION_MODIFIER", 80, 82], ["exp", "OBSERVATION", 83, 86], ["left", "ANATOMY_MODIFIER", 96, 100], ["exp", "OBSERVATION", 113, 116], ["ex", "OBSERVATION", 123, 125], ["base", "ANATOMY_MODIFIER", 126, 130]]], ["The operations on ex build the correctness proof of normalisation out of the proofs for subexpressions using a correctness lemma: for example, the lemma is used on the input expression ps + qs when ps normalises to 0.Design OverviewAdding support for a new operator would take relatively little work: after extending the table of associativity and distributivity relations, one can insert the constructor in ex using the table to determine the relevant ex type, and add an operation on ex that interprets the operator.IntricaciesThe ex type enforces that distributivity and associativity rules are always applied, but commutative semirings have more equations.", [["The operations", "TREATMENT", 0, 14], ["expression ps", "TEST", 174, 187], ["ps normalises", "TEST", 198, 211], ["an operation", "TREATMENT", 470, 482], ["distributivity", "PROBLEM", 555, 569]]], ["In a normal form, arguments to commutative operators should be sorted according to some linear order \u227a: if a \u227a b, then a + (b + 0) is normalised and b + (a + 0) is not.", [["normal", "OBSERVATION", 5, 11]]], ["Defining a linear order on ex requires an order on atoms; definitional equality of atoms is tested (with user control over the amount of definitional unfolding) in the tactic monad [3] , so a well-defined order on atoms cannot be easily expressed on the type level.", [["definitional unfolding", "PROBLEM", 137, 159]]], ["Additionally, the recursive structure of expressions means any expression a can also be represented as (a) 1 * 1 + 0; if the left argument to \u2227 is 0 or a * b + 0, the expression is not in normal form.", [["left", "ANATOMY_MODIFIER", 125, 129], ["normal", "OBSERVATION", 188, 194]]], ["A mistake in maintaining these invariants is not fatal: invariants only protect completeness, not soundness, of ring exp.IntricaciesEfficient handling of numerals in expressions, using the coeff constructor, is required for acceptable running time without sacrificing completeness.", [["ring exp", "PROBLEM", 112, 120], ["the coeff constructor", "TREATMENT", 185, 206], ["mistake", "OBSERVATION", 2, 9], ["ring exp", "OBSERVATION", 112, 120], ["Efficient", "OBSERVATION_MODIFIER", 132, 141], ["handling", "OBSERVATION_MODIFIER", 142, 150]]], ["Representing numerals with the coeff constructor requires an extra step to implement addition.", [["an extra step", "TREATMENT", 58, 71]]], ["Both cases are handled by a function add overlap which returns the correct sum if there is overlap, or indicates that there is no such overlap.", [["no such", "UNCERTAINTY", 127, 134]]], ["By choosing the order on expressions such that overlapping terms will appear adjacent in a sum, add overlap can be applied in one linear scan.IntricaciesA subtle complication arises when normalising in the exponent of an expression a \u2227 b: the type of a is an arbitrary commutative semiring, but b must be a natural number.", [["one linear scan", "TEST", 126, 141], ["A subtle complication", "PROBLEM", 153, 174], ["subtle", "OBSERVATION_MODIFIER", 155, 161], ["complication", "OBSERVATION", 162, 174], ["exponent", "OBSERVATION_MODIFIER", 206, 214]]], ["The calculations of the eval function are thus done in an extension of the tactic monad, called the ring exp m monad.", [["the eval function", "TEST", 20, 37]]], ["Conditionally rewriting avoids the need for an almost-ring concept to treat semirings and rings uniformly [4] .", [["semirings", "DISEASE", 76, 85], ["an almost-ring concept", "TREATMENT", 44, 66]]], ["Cancellation of multiplication and division, such as a * b/a = b, is not supported by the tactic, since such lemmas require an a = 0 side condition.", [["an a = 0 side condition", "TREATMENT", 124, 147]]], ["The ring exp m monad contains a state monad transformer to keep track of which atoms are definitionally equal.", [["ring exp", "OBSERVATION", 4, 12]]], ["Within atoms, there may be subexpressions that can be normalised as well.", [["subexpressions", "PROBLEM", 27, 41], ["may be", "UNCERTAINTY", 20, 26], ["subexpressions", "OBSERVATION", 27, 41]]], ["The simp tactic calls a given normaliser on each subexpression, rewriting it when the normaliser succeeds.OptimisationsAn important practical consideration in implementing ring exp is its efficiency, especially running time.", [["ring exp", "OBSERVATION", 172, 180]]], ["Since ring exp is intended to work as a drop-in replacement for ring, its performance characteristics, especially for linear expressions, should be comparable.OptimisationsOptimising the code was a notable part of the implementation of ring exp.", [["a drop-in replacement for ring", "TREATMENT", 38, 68], ["ring exp", "PROBLEM", 236, 244], ["exp", "OBSERVATION", 11, 14], ["ring exp", "OBSERVATION", 236, 244]]], ["Profiling revealed that up to 90% of running time could be spent on inferring implicit arguments and typeclass instances.", [["Profiling", "TEST", 0, 9]]], ["The solution was to pass all arguments explicitly and maintain a cache of typeclass instances, also caching the expressions for the constants 0 and 1.", [["The solution", "TREATMENT", 0, 12]]], ["It was possible to apply this solution without large changes to the codebase, because the required extra fields were hidden behind the ring exp m and ex info types.OptimisationsThe result of these optimisations can be quantified by comparing the running time of ring and ring exp on randomly generated expressions 3 .", [["this solution", "TREATMENT", 25, 38], ["the codebase", "TREATMENT", 64, 76], ["ring exp", "OBSERVATION", 271, 279]]], ["On arbitrary expressions, the benchmark indicates that ring exp is a factor of approximately 3.9 times slower than ring; on linear expressions such as are passed by linarith, ring exp is 1.7 times slower than ring.OptimisationsCompared to a constant factor difference in the average cases, ring exp has an advantage on problems requiring efficient handling of numeric exponents.", [["ring exp", "PROBLEM", 55, 63], ["ring exp", "PROBLEM", 290, 298], ["numeric exponents", "PROBLEM", 360, 377], ["ring exp", "OBSERVATION", 55, 63], ["ring exp", "OBSERVATION", 175, 183]]], ["The ring exp tactic is a factor 20 faster than ring when showing x 50 * x 50 = x 100 in an arbitrary ring.", [["ring", "OBSERVATION_MODIFIER", 4, 8], ["exp", "OBSERVATION_MODIFIER", 9, 12], ["arbitrary ring", "OBSERVATION", 91, 105]]], ["A similar speedup for ring exp was found in practice, for the goal (1 + x 2 + x 4 + x 6 ) * (1 + x) = 1 + x + x 2 + x 3 + x 4 + x 5 + x 6 + x 7 .", [["ring exp", "PROBLEM", 22, 30]]], ["The Horner normal form used by ring is optimal for representing expressions with additions and multiplications, so a constant-factor slowdown compared to ring on simpler goals is traded off for faster and more powerful handling of more complicated goals.DiscussionThe ring tactic for Coq and Lean can efficiently convert expressions in commutative semirings to normal form.", [["Horner", "DISEASE", 4, 10], ["Coq", "SIMPLE_CHEMICAL", 284, 287], ["Coq", "PROTEIN", 284, 287], ["multiplications", "TREATMENT", 95, 110], ["a constant-factor slowdown", "PROBLEM", 115, 141]]], ["A normalizing procedure for polynomials is also included with the Agda standard library [9] , HOL Light [5] and Isabelle/HOL [8] , and decision procedures exist that support exponential functions [1] ; there is no single normalisation procedure supporting compound expressions in exponents.DiscussionCompared with the ring tactic, the ring exp tactic can deal with a strict superset of expressions, and can do so without sacrificing too much speed.", [["A normalizing procedure for polynomials", "TREATMENT", 0, 39], ["the Agda standard library", "TREATMENT", 62, 87], ["single normalisation procedure", "TREATMENT", 214, 244], ["compound expressions in exponents", "PROBLEM", 256, 289], ["no", "UNCERTAINTY", 211, 213], ["compound expressions", "OBSERVATION", 256, 276]]], ["The extensible nature of the ex type should make it simple to add support for more operators to ring exp.", [["exp", "OBSERVATION", 101, 104]]], ["Although more optimisations are needed to fully equal ring in average case efficiency, the ring exp tactic already achieves its goal of being a useful, more general normalisation tactic.", [["the ring exp tactic", "TREATMENT", 87, 106]]]]}